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Abstract
Sox domain genes encode a family of developmentally important transcription factors
conserved throughout the Metazoa. The subgroup B, which includes the mammalian
Sox1, 2 and 3 proteins and their Drosophila counterparts Dichaete and SoxNeuro, are
particularly important for the development of the nervous system where they appear
to play conserved roles in neuronal specification and differentiation. Despite years of
detailed study we still have a relatively poor idea of how Sox proteins function on a
genome wide scale and the aim of my PhD work was to explore this aspect using the fly
group B protein, Dichaete. A number of studies have shown that Dichaete performs a
variety of critical functions during development and a few individual regulatory targets
have been defined, however, at the start of my work no genome-wide data on Dichaete
action were available. While such data emerged from large scale initiatives during
my work, a systematic analysis of Dichaete action was lacking. Here I describe the
first detailed genomic analysis of Dichaete activity, with a particular focus on three
areas: finding the locations of Dichaete binding in the genome, a prediction of potential
Dichaete cofactors and an analysis of Dichaete effects on gene expression.
To address the issue of where Dichaete binds in the genome, I generated whole genome
DamID data for embryos and followed this with a detailed comparative analysis, com-
bining my data with three newly published ChIP-chip datasets. The combined studies
identify thousands of binding regions, mostly in the vicinity of developmentally impor-
tant genes. The binding profiles were found to be consistent with Dichaete acting on
enhancer regions and also suggest a role in facilitating RNA Polymerase II pausing.
The analysis also identified a Dichaete binding motif closely matching that found with
in vitro studies. By combined ChIP and DamID datasets I generated a very high con-
fidence core Dichaete binding dataset, which should be of considerable use in future
studies.
To identify potential Dichaete cofactors, I compiled the available embryonic transcrip-
tion factor binding data from the Berkeley Drosophila Transcription Network and mod-
ENCODE projects, and identified significant overlaps with the core Dichaete binding
data. A number of the proteins highlighted in this analysis have known roles during
neuroblast development, including Hunchback and Kru¨ppel, transcription factors in-
volved in temporal specification of neuroblast division, and Prospero, which plays a key
role in neuroblast differentiation. The analysis suggests that Dichaete has a role during
early neuroblast divisions, where it likely interacts with Hb and Kr to maintain neurob-
last pluripotency. This is a role consistent with previous studies in Drosophila larval
neuroblasts and is analogous to neural functions of Sox2 in mammals. My analysis
suggests that Dichaete acts on the same target genes as Prospero but in an antago-
nistic role, with Dichaete preventing stem cell differentiation and Prospero promoting
it.
To examine the effects of Dichaete on gene expression, a number of microarray tran-
script profiling studies were performed, including a global study with Dichaete null
mutants, and tissue specific studies in the CNS midline and neuroblasts via the use
of dominant negative constructs. Whole transcriptome expression profiling data was
combined with the binding data to establish a set of high confidence potential Dichaete
targets, both for specific tissues and more globally during neurogenesis. Specific high
confidence targets were found, including bancal during nervous system development.
It was also concluded that Dichaete is likely to prevent cell cycle exit by repressing the
apoptosis genes grim, hid and reaper, as well as the differentiation genes prospero and
miranda. An extensive list of potential Dichaete direct targets was generated and can
be used for validation and future research.
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Chapter 1
Introduction
From so simple a beginning endless forms most beautiful and most wonderful have been,
and are being evolved. – Charles Darwin, 1859
150 years on from Darwin’s Origin of Species, the evolution and development of or-
ganism form is a topic that continues to puzzle and fascinate modern biology. While
the diversity of living forms continues to invoke a sense of wonder, another fascinating
conclusion to arise from this field of biology is that, for a wide range of animals, the
early development of form follows the same blueprints. Because of this powerful idea
and its implications for biomedical science, extensive developmental biology research
has focused on uncovering the genetic logic that underpins this general blueprint of
living beings, as well as for the specific components that make a species unique from
others.
This thesis focuses on a particular transcription factor, Dichaete, involved in a num-
ber of important developmental roles, including the establishment of the basic body
plan and the development of the nervous system. Dichaete belongs to the family
of Sox transcription factors, which are known to have developmental roles in a wide
range of metazoan species. Studying Sox function in Drosophila benefits from a solid
groundwork from previous research to draw on to make sense of the role of Dichaete in
development, while at the same time evidence of functional conservation indicates that
results emerging from these studies may well be relevant to a broad range of species
including mammals. The aim of this introduction is to give an overview of the available
literature on Dichaete and to specify the direction in which my project aims to take
this research further.
As Dichaete is a Group B Sox gene, there will be a brief overview of the evolution and
function of Sox genes in general, with a comparison of vertebrates and invertebrates,
followed by a discussion of the evolution, function and conservation of Group B Sox
genes specifically. There will then be an overview of the literature currently available
on Dichaete and the relationship between Dichaete and SoxNeuro, as well as a brief
discussion of its evolutionary and functional conservation. As a prelude to this discus-
sion I briefly review our current understanding of aspects of eukaryotic transcription
factor biology relevant to my studies.
1.1 Transcription factor theory
1.1.1 How transcription factors find their targets
In their elegant work on the E. coli Lac operon, Lin and Riggs (1975) observed that the
lac repressor molecule was often found in locations not specific to its function - they
estimated that 98% or more of the repressor molecules present were bound to sites other
than the lac operator. They also observed that there was a difference in the binding
affinity for the specific and non-specific binding areas. This was later verified using
X-ray crystallography (Lewis et al., 1996; Kalodimos et al., 2004; Von Hippel, 2004),
which made it possible to compare the binding to specific sites and to non-specific DNA.
It was found that specific binding occurs in the major groove of DNA, but that this is
also supported by electrostatic interactions between the negatively charged phosphates
of the DNA backbone and the basic amino acid residues surrounding the transcription
factor binding domain. The affinity of the transcription factor for non-specific binding
sites is lower because of fewer sequence-specific hydrogen bonds, but the affinity to
the DNA backbone still facilitates protein-DNA interactions. In the case of the lac
repressor, it is thought that the repressor molecule slides along DNA and is capable
of fast conformational changes when it encounters its specific binding sites (Winter
et al., 1981). It is also thought that such non-specific protein-DNA interactions are
crucial to the transcriptional regulation system, playing roles in balancing the overall
thermodynamics of the regulatory process, facilitating the sliding mechanism for target-
finding and also perhaps playing a structural role by orienting the transcription factor
properly with respect to the DNA (Von Hippel, 2004). This system is very sensitive to
the total concentration of DNA present, and it has even been suggested that part of
the reason for the presence of large regions of ’junk’ DNA in eukaryotic genomes is to
optimise the thermodynamics of transcriptional regulation (Lin and Riggs, 1975).
While eukaryotes have more complex gene regulation, these conclusions nonetheless
may be applicable: it is probable that all transcription factors have a general affinity
to DNA and are able to bind to virtually any piece of DNA available, but that some of
them have a higher affinity to their preferred sequences. Transcription factor occupancy
is therefore likely to be resolved through a combination of specific affinity preferences,
the availability of open chromatin and competition with other transcription factors for
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the same binding sites, i.e. through balancing the thermodynamic properties of all
components involved. While there is an obvious mechanism for sequence-specificity of
transcription factors that bind to the major groove, minor groove binding transcription
factors appear to be more of a mystery, since they do not have the same physical
access to the DNA bases. However, recent research suggests that base information
is still available through the changing electrostatic properties of the backbone, which
are sequence dependent (Rohs et al., 2009). The shape of the minor groove changes
depending on the underlying sequence, ending up more narrow in certain sections,
which leads to an increase in its negative electrostatic potential in that location. It is
thought that minor groove binding proteins use amino acids with positively charged
side chains to ’read’ the electrostatic potential of the minor groove (Tullius, 2009).
This is a process different from the sequence specificity of the major groove: while it is
determined by DNA sequence, it is possible for a range of DNA sequences to generate
the same physical minor groove shape, making minor groove binding potentially less
specific.
Sequence specificity in general, while acknowledged to be an important part of tran-
scriptional regulation, does not appear to be a sole or sufficient predictor of binding and
functionality. While matching binding motifs are frequently found within the binding
intervals of sequence-specific transcription factors, they are not particularly reliable
predictors of either binding or function. The largest problem is the high presence of
false positives, as the position weight matrices used for these searches often match a
large number of sites in the genome and rely on somewhat arbitrary thresholds (Stormo,
2000). While it may be theoretically possible for a transcription factor of interest to
bind to all the sites found as far as sequence goes, in practice a lot of additional infor-
mation such as DNA accessibility and competition with other factors would need to
be integrated into the analysis in order to make more accurate predictions. Another
problem with this type of analysis is that most DNA affinity values are measured using
a single protein, whereas proteins frequently pair up in vivo and it has been found
that binding to a cofactor can completely alter the sequence specificity of a protein,
likely due to conformational changes (Kondoh and Kamachi, 2010). Thus it is possible
that some incorrect sequences are used for motif searches. It is also not clear that
sequence specificity is the only determinant of function. There is evidence of enhancers
whose function is conserved despite a lack of conservation of both motif sequences and
enhancer element locations, due to redundancy, and new mutations arising to stabilise
the gene expression pattern (Piano et al., 1999; Ludwig et al., 2000). We do, however,
know that binding location appears to be fully specified by the chromosome structure
and sequence, rather than the environment of the cell - an elegant study by Wilson
et al. (2008) looked at transcription factor binding to human chromosome 21 in a mouse
model and found that despite it being located in mouse cells, the expected human pat-
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tern of binding still occurs. However, in combination, what this tells us is that, while
transcriptional regulation mechanisms are specified in the sequence and structure of the
chromosomes, the logic behind it is not as simple as always having specific sequences
in particular locations in order to facilitate a particular gene expression outcome. In-
stead, the system can be quite flexible, contain redundancy, and combinations of quite
different underlying sequences can facilitate the same gene expression outcomes. This
limits the utility of any conclusions based on sequence content alone, and makes the
problem of understanding the role of DNA sequence in transcriptional regulation quite
a complex one.
1.1.2 Different models of transcriptional control
There are a number of models for how transcription factors act on their targets once
they find them. The more traditional models think of promoter and enhancer regions
as logic gates, with different combinations of transcriptional regulators triggering dif-
ferent outcomes. Perhaps the most famous example is the lac operon, with its dual
logic gate mechanism involving an activator and a repressor (Jacob and Monod, 1961;
Zubay et al., 1970). This model has been used widely to explain more general mecha-
nisms of transcriptional regulation (Ptashne, 2005) and various studies have attempted
to study the promoter components underlying the logical framework (Ligr et al., 2006;
Cox et al., 2007). Work has also been done to use the formal logic framework to ex-
press and model the qualitative aspects of mechanisms of transcriptional regulation in
particular genetic systems (Gonzalez et al., 2008). However, a flaw in this approach is
in the underlying model of transcriptional regulation with rigid outcomes and discrete
regulation modules. Regulatory networks are complex systems, where small quantita-
tive differences in binding may confer different regulatory outcomes and stochasticity
may also play a part. Furthermore, there is considerable redundancy between different
transcription factors, and the slightly varying conditions and positional information in
different cells can result in different regulatory outcomes, meaning the logic gate model
fails to capture much of the inherent complexity of the system.
Nonetheless it is a simple and powerful model, that has been used to great effect to
uncover general organisational properties of transcriptional regulation (Babu et al.,
2004; Barabasi and Oltvai, 2004). Most of these studies focus on network topology
(patterns of connections between network nodes), how this relates to function and how
networks are reorganised under different cellular conditions. In particular, hierarchical
structures have been discovered in both prokaryotic and eukaryotic networks (Ma et al.,
2004; Farkas et al., 2006; Yu and Gerstein, 2006) and have been reported to increase
the adaptability of the network and to avoid conflicting constraints. Transcriptional
regulatory networks display a ”scale-free” topology, with a small number of global hubs
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being connected to a very large number of targets, and the majority of transcription
factors being connected to a small number of targets (Babu et al., 2004; Chalancon
and Babu, 2010). It has been suggested that this structure makes the network more
robust to failure, with the majority of the potential points of failure not crucial to
the overall structure of the network. There have also been attempts to use network
data as a starting point for more detailed quantitative modelling (Zaslaver et al., 2006;
Martinez-Antonio et al., 2008). A recent study looking at networks and transcription
factor dynamics in yeast found that different hierarchical levels of the network have
distinct dynamic properties (Jothi et al., 2009). This shows the connection between
network structures and biological properties, as well as that network representations
can be used as a starting point, then integrated with other datasets to better reflect
quantitative properties.
Another emerging view takes a more quantitative approach, claiming most transcrip-
tion factors bind to most genes in the genome and that the varying levels of tran-
scription factor occupancy have differential outcomes for gene expression (Biggin,
2011). In this model, it is thought that low occupancy binding sites are mainly non-
functional, with the higher occupancy sites having an increasing impact on transcrip-
tion (MacArthur et al., 2009; Biggin, 2011). This view is primarily based on in vivo
crosslinking assays, which show that in a range of eukaryotes there are frequently
thousands of binding sites per transcription factor in the genome and that there is
considerable overlap between unrelated transcription factor families (MacArthur et al.,
2009; Gerstein et al., 2010; Myers et al., 2011; Negre et al., 2011). Computational
modelling also shows some support for this view, finding that the presence of a high
number of multiple and sometimes overlapping sites facilitates the integration of com-
plex signals through competition both between and within individual cis-regulatory
modules (Hermsen et al., 2006).
It appears to be the case that many more transcription factor molecules are present in
the nucleus at any one time than are required for direct modulation of transcription.
Most of these are bound to DNA the majority of the time (Biggin, 2011), suggesting
that most genuine sites of binding in the genome are non-functional. However, it is
unclear whether individual molecules and functional binding sites have a key causal role
in transcription, which is closer to the logic gate model, or whether active regulation
relies on large quantities of a particular regulator being localized in a particular region.
Either model is plausible from our current data. Links between quantitative data and
functionality have been identified in several studies, but it is possible that in order
for a given transcription factor to outcompete others and accurately slot into its active
binding site, there need to be many molecules of that transcription factor in the region,
even though most of them do not interact with the functional binding site.
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1.2 Sox family proteins
1.2.1 Classification and function
Sox proteins are a developmentally important family of transcription factors found in all
metazoans examined to date (Schepers et al., 2002; Koopman et al., 2004; Phochanukul
and Russell, 2009; Zhong et al., 2011). Their defining feature is that they all contain
a High Mobility Group (HMG) binding domain and they are classified according to
their similarity to Sry, the human sex determining factor. Specifically, if a protein has
an HMG-1 type domain with strong amino acid sequence similarity (usually > 50%)
to Sry (Sinclair et al., 1990), it is classified as a Sox family protein (McKimmie et al.,
2005). Due to their important roles in various aspects of development, they have been
the subject of extensive study for a number of years (Wright et al., 1993; Kamachi
et al., 1995; Wegner and Stolt, 2005; Masui et al., 2007; Takahashi and Yamanaka,
2006).
Functional studies of specific Sox genes in model organisms have provided insights
that are likely generalisable to the Sox family in general, and are certainly interest-
ing to consider in the context of studying Dichaete. Most Sox proteins appear to
share similar DNA binding properties, and recognise a similar heptameric sequence:
5’-(A/T)(A/T)CAA(A/T)G-3’ (Harley et al., 1994). However, Sox proteins in vivo
appear to be highly specific, targeting a unique repertoire of genes (Wilson and Koop-
man, 2002). Upon DNA binding, they bend DNA at a sharp angle (Werner, Bianchi,
Gronenborn and Clore, 1995). They generally do not act on their own to alter expres-
sion, instead partner up with specific cofactors to perform their regulatory functions,
for example Pax or POU proteins (Wilson and Koopman, 2002; Dailey and Basilico,
2001; Chi and Epstein, 2002). It is possible that partnering allows them to take part
in a large number of diverse developmental processes, since their action can be context
specific and based on the available cofactors present (Kamachi et al., 2000).
The crystal structure of the POU/HMG ternary complex on the FGF4 enhancer has
been resolved by Remenyi et al. (2003) using domains from Oct1 and Sox2 (Figure
1.1). The Sox2 domain was shown to interact with DNA sequence-specifically, with
the interaction being mediated by a large number of base-pair specific hydrogen bonds.
NMR studies with the HMG-domain of mammalian SRY (Murphy et al., 2001; Werner,
Huth, Gronenborn and Marius Clore, 1995) demonstrate the overall conservation in
HMG domain structure and have also been used to define the DNA bending properties
of the domain (Werner, Bianchi, Gronenborn and Clore, 1995).
In general, Sox genes across a range of metazoan species are classified into groups, A-J
(Bowles et al., 2000), primarily based on sequence alignment: group A contains the
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Figure 1.1: (A) Crystal structure of the Oct1/Sox2/FGF4 enhancer ternary complex.
The Sox2 HMG domain is shown in blue, and the Oct1 POU domain is shown in green.
(B) NMR structure of the HMG domain of mammalian Sry bound to DNA. The model
shows 3 helices in an L-shaped conformation and binding to the minor groove of DNA
while bending and unwinding it (Werner, Bianchi, Gronenborn and Clore, 1995). Image
from a review by Harley et al. (2003).
Sry gene used as the reference for defining the family. The first few studies used HMG
domain sequences and found evidence for subdivision of the Sox family into groups
A-H (Wright et al., 1993; Hiraoka et al., 1998; Osaki et al., 1999; Wegner, 1999), with
a later study, including the full-length protein structure and the exon-intron structure
of the genes, assigning groups I and J (Bowles et al., 2000). The classification is
on the whole very robust for each group in higher animals: most groups were found
to have characteristic amino acid signatures not present in other groups. Some of
the Sox genes are more difficult to assign in groups such as Cnidarians (anemones,
corals and jellyfish) and Ctenophorans (comb jellies), likely due to lineage specific
divergence (Larroux et al., 2008). Group A is only found in eutherian mammals,
groups B-F are found in all higher metazoans and groups G-J are restricted to specific
lineages (Phochanukul and Russell, 2009). While the HMG domain is quite conserved
between different families (by definition, Sox proteins have an HMG domain at least
50% identical to that of Sry), the sequences outside the HMG domain are quite variable.
However, some common non-HMG box features can be identified among a number of
them, with vertebrate orthologues in particular being very similar to each other both
within and outwith the HMG domain (Bowles et al., 2000).
There is some variability in gene structure between the different Sox gene groups.
’HMG box introns’ are introns found within the DNA sequence for the HMG domain,
and the presence of this feature varies in different species. Because an intron is unlikely
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to arise in the same position independently in multiple lineages, and intron gains and
losses represent major genetic rearrangements, looking at intron/exon organisation can
be informative to use as a measure of relatedness of homologous genes between different
species (Bowles et al., 2000). No HMG box introns have been found in vertebrates for
Sox groups A, B, C or G, or in sea urchin group B. Interestingly introns do exist
in a number of Drosophila and C. elegans group B and C Sox genes, and there is
conservation of intron position in the genes in question between the two species, while
based on looking at vertebrates and sea urchin, introns appear to be missing entirely
in group B Sox genes in the deuterostome lineage (Bowles et al., 2000). HMG box
introns have been found in groups D, E, F, H and J, and are in each case conserved
within the group, with the intron for groups D and F also being conserved between the
two groups.
1.2.2 Sox genes in vertebrates
In humans and mice, there are a total of 20 Sox genes found in the genome, grouped
into 8 subgroups (Schepers et al., 2002). At least 30 genes in total are recognised in
mammals (Bowles et al., 2000; Schepers et al., 2002; Wegner, 1999). It was found that in
vertebrates, the similarity of HMG domain sequences is reflective of the evolutionary
relatedness of the proteins, estimated by looking at entire protein sequence (Bowles
et al., 2000). Most of the Sox gene families found in vertebrates are represented by a
single gene in invertebrates, suggesting that duplications and divergence have occured
during vertebrate evolution (Koopman et al., 2004). This is consistent with 2 rounds of
whole genome duplication, and not specific to the Sox gene family in particular.
1.2.3 Sox genes in invertebrates
While genetic studies often focus on a small number of model organisms, invertebrates
are in fact a hugely diverse group, which includes the majority of multicellular animal
species on Earth (Adoutte et al., 2000). Varying numbers of Sox genes have been found
in a diverse range of invertebrate species (Figure 1.2). The evolution of the Sox gene
family broadly follows the trends observed with other transcription factors in terms of
family expansion and evolution (Larroux et al., 2008). The basal metazoans such as
sponges contain 3-4 Sox genes, including a group B member (Phochanukul and Russell,
2009). There is a significant lineage specific expansion in the Radiata, with members
of this group, such as the sea anemone, containing up to 14 Sox genes (Putnam et al.,
2007). The Sox genes in protostomes are less numerous, with less than 10 genes found
in all species examined to date. This is also the case for most bilateria in general,
excluding the vertebrate lineage (Phochanukul and Russell, 2009).
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Much of the study of Sox genes in invertebrates has focused on Drosophila melanogaster,
where 8 Sox genes were found: 4 belonging to group B, and one each in groups C-F
(Cremazy et al., 2001). The sequencing of 11 other Drosophila genomes indicates that
this number and grouping of Sox genes is constant among Drosophilids (Clark et al.,
2007). The same complement of Sox genes is also present in the mosquito Anopheles
gambiae, while the honeybee Apis mellifera and parasitic wasp Nasonia vitripennis
have an additional Group E gene (Phochanukul and Russell, 2009).
Figure 1.2: Phochanukul and Russell (2009) present an overview of the phylogeny of
the metazoa, along with an overview of the identified Sox genes in a variety of species
from the linked taxa.
1.2.4 Group B Sox genes
The B subgroup of Sox genes is the group most closely related to Sry, with some
studies proposing that Sry evolved from Sox3 (Collignon et al., 1996). They appear
to have been conserved during evolution, with group B genes being found in all higher
metazoans (Phochanukul and Russell, 2009). To date, a variety of studies have shown
that the group B family participates in early central nervous system differentiation
in a range of species, including Drosophila, Xenopus, chick and mouse (Sasai et al.,
2001), as well as taking part in a number of other developmental processes, such as
maintaining stem cell pluripotency (Masui et al., 2007), eye development (Ishii et al.,
2009), and segmentation in insects (Russell et al., 1996), among others. Group B
proteins are found to be co-expressed in specific parts of the nervous system, but their
degree of cooperation and functional redundancy is still a subject of study (Uwanogho
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et al., 1995; Rex et al., 1997; Overton et al., 2002).
Group B genes are further subdivided into groups B1 and B2. The two groups have
a very similar HMG domain, as well as similarity in the short extension from the C-
terminus of the HMG domain, but the rest of their sequences are distinct from each
other (Uchikawa et al., 1999). The subdivision was suggested based on full protein
sequence alignment, as well functional data. In the case of vertebrate Sox genes, there
is a clear sequence-based and functional division: group B1 includes Sox1, Sox2 and
Sox3 and these encode proteins that activate gene expression (Kamachi et al., 1995;
Nishiguchi et al., 1998), whereas group B2 includes Sox14 and Sox21 and repress gene
expression (Uchikawa et al., 1999). In Drosophila, the classification is less straight-
forward. There are 4 group B Sox genes in total, but for example, based on its effect
on the expression of ac in proneural clusters (Overton et al., 2002), Dichaete appears
to have the ability to act as a repressor or an activator context specifically, and there is
some debate over its classification as a B1 or B2 gene (McKimmie et al., 2005; Zhong
et al., 2011).
The role of group B Sox genes in embryonic stem cells
The vertebrate group B gene Sox2 is essential for the maintenance of pluripotency in
embryonic stem cells (Liu et al., 2008). Famously, it is one of the Yamanaka factors,
Oct3/4, Sox2, Klf4 and c-Myc, the four transcription factors required for reversing
differentiated cells into an induced stem cell state (Takahashi and Yamanaka, 2006). It
is thought that the main role of Sox2 in ES cells is to regulate a number of transcription
factors which in turn control the levels of expression of Oct3/4 (Masui et al., 2007),
thus stabilising the ES cells in a pluripotent state. It is also known that Oct3/4 and
Sox2 act together on a number of enhancer regions (Boyer et al., 2005; Loh et al.,
2006). However, it was found that Oct3/4 alone was sufficient for the activation of the
enhancers in question, suggesting that the main role of Sox2 in maintaining ES cell
pluripotency is to ensure the correct levels of Oct3/4 are present (Masui et al., 2007).
Another reported role of group B1 genes is in the early stages of neural differentiation
from pluripotent stem cells, where the presence of Sox1, Sox2 or Sox3 has an effect
on directing stem cell fate into the neuroectodermal lineage (Avilion et al., 2003; Zhao
et al., 2004; Stevanovic, 2003). Rather than interrupting proliferation, they merely
convey neuroectodermal competence, which is only realised once the cell exits the cell
cycle.
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The role of group B Sox genes in nervous system development
The group B1 genes Sox1, Sox2 and Sox3 are required for stem cell maintenance in the
central nervous system (CNS) and are counteracted by Sox21. A number of Sox genes
from other families are also active in the same region, for example the group E genes
Sox9 and Sox10. Sox9 changes the potential of stem cells from neurogenic to gliogenic,
and Sox10 is essential for terminal oligodendrocyte differentiation. Interestingly, in the
peripheral nervous system, the same Sox genes are present, but have different functions
(Wegner and Stolt, 2005).
Group B1 genes are widely expressed in the cells that are competent to form the neural
primordium and are later restricted to the cells committed to the neural fate (Pevny
and Placzek, 2005; Wegner and Stolt, 2005). Functional studies have been performed
to determine their role during the development of the CNS in mammals. In the case of
Sox1 in mice, null mutants survive until adulthood, although the spontaneous seizure
phenotype of the mice suggests some role in CNS development (Nishiguchi et al., 1998).
However, since the mice are able to survive, this indicates that either Sox1 only has a
minor role, or there is some redundancy of function with the other two Group B Sox
genes present. In contrast, Sox2 null mutant mice die prior to implantation (Collignon
et al., 1996), indicating its importance during early development.
Sox B1 genes are expressed in the presumptive vertebrate neuroectoderm. They do not
interfere with the self-renewal of embryonic stem cells, but instead trigger a neuroec-
todermal fate after the cells have exited the cell cycle (Avilion et al., 2003; Stevanovic,
2003; Zhao et al., 2004; Wegner and Stolt, 2005). It has been reported that group B1
and group B2 genes act antagonistically (Uchikawa et al., 1999), with B1 genes main-
taining pluripotency and B2 genes acting on the same gene targets, but repressing
rather than activating them. Sox21 in particular is widely coexpressed with group B1
genes and acts to counteract their activity and promote neural differentiation (Sand-
berg et al., 2005). Thus it has been suggested that the correct differentiation of neural
cells is controlled by a precise balance between the presence of Sox21 and of the B1
genes.
1.2.5 Group B Sox genes in Drosophila melanogaster
Of the eight Sox genes found in Drosophila (Cremazy et al., 2001), four belong to
Group B: Dichaete, SoxNeuro, Sox21a and Sox21b (McKimmie et al., 2005). There
is some disagreement about the subclassification into groups B1 and B2. SoxNeuro
clearly shows sequence similarity to the B1 group, and Sox21a to the B2 group. How-
ever, with Dichaete and Sox21b, the classification is less straight-forward, because they
have several unique amino acid mutations that differentiate them from the classic B1
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and B2 groups, suggesting that they may have insect specific adaptations. Functionally
Dichaete displays the behaviour of a B1 group Sox gene, so this is the classification
suggested by McKimmie et al. (2005). They suggest that originally there was a single
ancestral group B Sox gene, which duplicated to produce the ancestors of Dichaete and
SoxN. Subsequently Dichaete then duplicated to make Sox21a, then acquired the in-
sect specific amino acid mutations and underwent another duplication to form Sox21b.
Zhong et al. (2011) disagree with this view and instead suggest that there were two an-
cestral group B genes, SoxB1 and SoxB2, and that tandem duplications of the SoxB2
gene occured after the arthropod-nematode divergence to create the remaining two
SoxB genes. The two models of evolution are shown in Figure 1.3. The model from
Zhong et al. (2011) fits better with the available sequence information, but the clas-
sification of Dichaete as a SoxB2 gene seemingly goes contrary to the reported spe-
cific functional conservation between it and the vertebrate Sox2 (Soriano and Russell,
1998).
Figure 1.3: A figure from Zhong et al. (2011) showing the two competing models of
Sox group B evolution. (A) The model proposed by McKimmie et al. (2005), in which
Dichaete and SoxN are created by a duplication from a single ancestral group B Sox
gene, and a tandem duplication created Sox21a before the Deuterostome/Protostome
split. (B) The model proposed by Zhong et al. (2011), which argues for the existence
of one SoxB1 and one SoxB2 gene, generated by an ancestral duplication before the
Deuterostome/Protostome split.
SoxN is located on the second chromosome, while the other 3 genes are all located
within the same 77 kb region of chromosome 3. SoxN and Dichaete have no introns,
12
while Sox21a and Sox21b have 1 and 6 introns, respectively (McKimmie et al., 2005).
The structure of the SoxB genes in this region appears to be highly conserved across a
range of insect species (Figure 1.4). Dichaete has a large 3’ regulatory region, contain-
ing at least 30 kb of downstream regulatory sequence (Sanchez-Soriano and Russell,
2000). SoxN also sits alone, with no flanking genes for 35 kb proximal and 45 kb distal,
a phenomenon unusual for Drosophila, so it is likely that it has a complex regulatory
region similar to that of Dichaete. Sox21a and Sox21b are located 46 kb downstream of
Dichaete, with no other genes between, and it has been suggested that the 3 genes may
share at least some regulatory sequences (McKimmie et al., 2005), perhaps regulating
their expression in the hindgut and the midline.
Figure 1.4: The organisation of Group B Sox genes on chromosome 3 in the fruit
fly species D. melanogaster and D. pseudoobscura, the mosquito A. gambiae and the
honey bee A. melifora. The overall genome organisation in this region is similar in all
four species. Figure taken from McKimmie et al. (2005).
1.2.6 Advantages of using Drosophila as a model
As previously discussed, Sox genes represent an important gene family involved in a
myriad of fundamental developmental processes. Group B Sox genes are particularly
interesting due to their numerous roles as well as their involvement in the maintenance
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of stem cell pluripotency and nervous system development. Functional studies suggest
a remarkable degree of conservation between SoxB genes in Drosophila and vertebrates
(Soriano and Russell, 1998; Blanco et al., 2005), indicating that studies in model or-
ganisms such as Drosophila will have broader relevance. There are general arguments
for the use of Drosophila as a model organism, such as tractability, fast generation time
and a wealth of available genetic tools. It is also particularly convenient for Sox genes
because of the reported functional conservation and the fact that there are fewer Sox
genes than in vertebrates. For example, things like functional redundancy are easier to
resolve with model systems with two rather than three interacting genes. Furthermore,
the small and dense genome makes high throughput genomics cheaper and the subse-
quent analysis more straight-forward. In general, studies of Sox genes in a large range
of organisms will further our understanding of their function, evolution and variability,
but these are clearly good reasons why Drosophila is particularly suitable for in-depth
studies.
1.3 Dichaete overview
Dichaete is known to be involved in segmentation, CNS and brain development, hindgut
morphogenesis and trichome development. The well known Dichaete wing phenotype
(Figure 1.5), caused by ectopic expression in the wing imaginal discs, was the first
dominant allele found in Drosophila, identifed almost 100 years ago, in 1915, by Calvin
Bridges (Bridges and Morgan, 1923).
Figure 1.5: Dichaete dominant phenotype. Picture taken from Griffiths et al. (2002)
The gene responsible for the phenotype was found independently by 2 different groups
in 1996. Russell et al. (1996) used Sry primers to look for related genes in Drosophila
genomic and cDNA libraries, while Nambu and Nambu (1996) cloned it from a P -
element enhancer trap insertion. An 1800 nt transcript with no introns was found,
which encodes a 382 amino acid protein. Within this, a 76 amino acid stretch was found,
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with 88% similarity to the DNA-binding HMG domain of Sox2 from human, mouse
and chicken, suggesting possible evolutionary conservation of function. Outside of the
DNA binding domain, no conservation was found, except for a 30 amino acid C-terminal
stretch bearing resemblance to a potential Sox2 activation domain (Russell et al., 1996).
A Dichaete protein with the C-terminal stretch removed can still rescue the Dichaete
nervous system phenotype, but interestingly this is not the case when acting in the
wing hinge, suggesting that the C-terminal region of Dichaete has a context dependent
role in gene regulation, perhaps mediating specific co-factor interactions (Soriano and
Russell, 1998). Another study suggests that the role of the C-terminal domain may
not be in transcriptional activation: in yeast-based assays of the N-terminal region
(141 amino acids), HMG domain (79 amino acids) and the C-terminal region (164
amino acids), only the N-terminal region was found to have transcriptional activation
capabilities (Ma et al., 1998).
Figure 1.6: Dichaete binding motif found in a bacterial 1-hybrid experiment. The
motif, published by Noyes et al. (2008), was obtained from the JASPAR database
(Bryne et al., 2007).
As with other Sox family proteins, Dichaete binds to DNA in the minor groove, bending
it at an 85◦ angle (Ma et al., 1998). As expected for a transcription factor, it localises
to the nucleus in most tissues, but it has also been detected in the cytoplasm, for
example in the neuroectoderm (Soriano and Russell, 1998) and it appears that the
nuclear localisation signal is located in the HMG domain (Mukherjee et al., 2000).
It is a sequence-specific transcription factor, which was shown to bind to the general
Sox protein consensus binding sites AACAAT and AACAAAG (Ma et al., 1998). The
result of a bacterial 1-hybrid experiment published by Noyes et al. (2008) was obtained
from the JASPAR database (Bryne et al., 2007) with the characterised sequence motif
shown in Figure 1.6.
1.4 Dichaete expression
1.4.1 Tissue-specific expression during embryonic development
Dichaete is highly expressed in a dynamic pattern during early embryogenesis, followed
by expression at low levels during the rest of the life cycle (Russell et al., 1996). No
maternal contribution of transcript or protein is detected even though the gene is
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expressed in the ovary (Mukherjee et al., 2006; Mutsuddi et al., 2010). Expression is
first initiated at late stage 4 of embryogenesis, starting with a broad central domain
that is rapidly followed by the appearance of an anterior domain. The central domain
then splits, and remains continuous dorsally, splitting into 7 stripes on the ventral side
(Figure 1.7). By the end of stage 5, the dorsal domain and 6 out of 7 of the stripes
fade, but the posterior stripe remains. During stage 6, the remaining stripe follows
the pole cells, and eventually fades. At the same time, Dichaete is activated in the
region of the neuroectoderm that will give rise to the CNS. Initially, 14 discrete stripes
are observed, but the expression quickly becomes a continuum (Russell et al., 1996;
Sanchez-Soriano and Russell, 2000).
Figure 1.7: Anti-Dichaete staining shows the presence of Dichaete at different stages
of embryonic development. (A) At late stage 4, a broad central domain of expression
is established, rapidly followed by an anterior domain. (B) During stage 5, the central
domain remains continuous dorsally, but splits into 7 stripes on the ventral side. In (C)
and (D), Dichaete expression is prominent in the ventral nervous system, with waves of
neuroblasts initiating Dichaete expression. Images from Sanchez-Soriano and Russell
(2000).
Later in development, expression is prominent in the nervous system (Figure 1.7).
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Expression is initially detected in the neuroectoderm at late stage 6 to early stage 7.
Next, waves of neuroblasts in the medial and intermediate columns initiate Dichaete
expression. Dichaete is also expressed in the ventral midline - it is detected weakly at
stage 7, and by stage 9, it strongly labels the 2 rows of midline progenitors (Soriano
and Russell, 1998). At stage 12, it is expressed strongly in the anterior and medial
midline glia (MGA and MGM, respectively), and weakly in the posterior midline glia
(MGP). By stage 14, this reverses, with Dichaete being expressed weakly in the MGA
and MGM, and strongly in the MGP (Soriano and Russell, 1998).
By stage 16, the expression is restricted to 2 clusters of cells in each of the thoracic
segments, and a single cell in each of the abdominal segments, as well as the hindgut,
brain, and the chordotonal organs of the peripheral nervous system (Soriano and Rus-
sell, 1998). In larvae, Dichaete is expressed in discrete patterns in eye-antennal and leg
imaginal discs, the CNS, the hindgut and salivary glands (Mukherjee et al., 2000).
1.4.2 Regulatory regions controlling Dichaete expression
As described above, Dichaete has a complex, dynamic expression pattern, which is
widespread, temporally specific and tissue specific throughout embryogenesis (Russell
et al., 1996; Soriano and Russell, 1998; Ma et al., 1998). In order to determine the reg-
ulatory regions involved in controlling Dichaete, Sanchez-Soriano and Russell (2000)
used both reporter constructs and a number of mutant alleles containing chromoso-
mal aberrations with breakpoints close to the Dichaete gene to characterise Dichaete
expression in different tissues. Dichaete expression during embryonic development is
controlled by a number of cis-regulatory elements, distributed up to 3 kb upstream
and 25 kb downstream of the gene. There are a number of regions controlling the
expression of Dichaete in specific tissues, including different regions for expression in
the blastoderm, early and late midline expression, in the hindgut, and also at different
times in the neuroectoderm (Sanchez-Soriano and Russell, 2000). The summary of
Dichaete regulatory regions is shown in Figure 1.8.
1.5 The role of Dichaete in segmentation
The fruit fly, like all arthropods, has a segmented body. In Drosophila, there are a
total of 14 segments along the AP axis of the body and their location is specified very
early during embryonic development. This is a well-studied process, during which the
embryo is progressively divided by a hierarchy of regulatory genes (Akam, 1987; Driever
and Nusslein-Volhard, 1988). Dichaete null mutants exhibit a range of segmentation
phenotypes, including deletions removing half of the segments, weaker partial deletions
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Figure 1.8: A schematic of the regulatory regions controlling Dichaete expression, as
inferred from experiments utilizing mutant alleles containing chromosomal aberrations
(adapted from Sanchez-Soriano and Russell (2000).
and segment fusions with the even numbered metameres (Russell et al., 1996). Nambu
and Nambu (1996) also observed a loss and/or fusion of abdominal denticle belts, and
stripe-specific defects in pair-rule and segment polarity gene expression.
Dichaete affects the expression of primary pair-rule genes eve, ftz, hairy and runt at
the syncytial blastoderm stage and it can act to both activate and repress a particular
stripe domain. In the particular case of eve, expression in stripe 4 was found to be
fully repressed when ectopic expression of Dichaete was induced, which was thought
to be due to direct action of Dichaete (Russell et al., 1996). Expression of eve in
stripes 1, 5 and 6 is also directly regulated by Dichaete, and this is thought to be
achieved by binding to the eve downstream regulatory regions (Ma et al., 1998). Some
genetic interactions were detected with Dichaete and Pdm mutants, so it is thought
that Dichaete may act together with the POU domain proteins Pdm-1 and Pdm-2 to
regulate eve transcription (Ma et al., 1998).
It has been observed a number of times that the Dichaete segmentation phenotype
is highly variable. In their original Dichaete paper, Russell et al. (1996) speculate
that there are three potential reasons for this: maternal contribution of Dichaete aug-
menting zygotic Dichaete function, partial complementation by other Sox genes, or
the variability intrinsic to Dichaete activity, for example, if it has an accessory role
in transcription rather than being absolutely essential. Out of these, the maternal
contribution hypothesis appears unlikely since no maternal transcripts or protein are
detected. The partial complementation by other Sox genes has been reported to occur
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in the nervous system, but is unlikely to be responsible for the variable segmentation
phenotype since no other Sox gene is expressed this early. The third hypothesis is
certainly possible, particularly if Dichaete acts as a stabiliser of gene expression, re-
sulting more transcriptional variability in the null mutant. There is a possible further
hypothesis, based on network theory. Transcriptional networks tend to be ’scale-free’,
with a small number of hub genes being connected to a very large number of target
genes, and from binding data in the blastoderm (MacArthur et al., 2009), it certainly
appears that Dichaete is one of the highly interconnected hubs. From the structure of
the network, one would expect that while the network may still be partially functional
with a major hub missing due to the existence of other hubs, it is likely to be desta-
bilised and more sensitive to stochastic effects, perhaps accounting for the variability
in phenotype.
1.6 The role of Dichaete in embryonic CNS devel-
opment
1.6.1 Regulation of cell fate in the neuroectoderm
Some of the earliest events in the development of the nervous system have been con-
served during evolution in most higher eukaryotes. The first step in neurogenesis is the
formation of a region of the ectoderm that is competent to adopt a neural fate (Arendt
and Nubler-Jung, 1999). In Drosophila, this is brought about by Sog, which directs
neuroectoderm formation by antagonising Dpp, a process similar to the interaction of
Chordin and BMP4 in vertebrates (Piccolo et al., 1996). The expression of proneural
genes encoded by the Achaete-Scute Complex allows a subsection of the ectoderm to
become competent to adopt a neural fate. Subsequently, neuroblasts are selected from
clusters of equivalent cells through the interaction of Notch and Delta. They then de-
laminate and undergo a sequence of asymmetric divisions, resulting in the programmed
growth of neurons and glia (for a detailed review, see Skeath, 1999).
Neuroblasts acquire fates in a position-specific manner. In Drosophila, there are genetic
mechanisms which establish patterns and convey positional information along the AP
and DV axis. Of particular relevance to neural development are the segment polarity
genes, which divide each segment along the AP axis into four rows (Bhat, 1999), and
the genes vnd, ind, msh and Egfr, which divide the neuroectoderm into three columns
along the DV axis - the medial, intermediate and lateral columns (Skeath, 1999).
These two groups of genes combined create a positional grid, providing markers that
help determine neuroblast fate.
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Dichaete is expressed in the medial and intermediate columns of the neuroectoderm,
and phenotypic analysis indicates that its role there is to regulate cell fate and neurob-
last formation. Specifically, Dichaete acts in concert with Vnd and Ind, which it has
been shown to physically interact with, to establish patterning of the neuroectoderm
along the DV axis (Zhao and Skeath, 2002; Zhao, Boekhoff-Falk, Wilson and Skeath,
2007). It is interesting to note that Dichaete appears to have specific functions in each
domain: Dichaete and Ind act together to repress ac in the intermediate column, while
a Dichaete null mutation appears to have no effect on ac expression in the medial col-
umn because of a degree of functional redundancy with SoxN in this region (Overton
et al., 2002; Zhao, Boekhoff-Falk, Wilson and Skeath, 2007). This is a consequence of
interactions with different cofactors, with Dichaete and Ind together having a repres-
sor effect (Zhao, Boekhoff-Falk, Wilson and Skeath, 2007), while Dichaete and Vnd
together facilitate transcriptional activation (Yu et al., 2005).
1.6.2 Midline
During Drosophila development, midline cells have an important organisational role
in helping correctly establish the axon scaffold, as well as being essential for the dif-
ferentiation of neighbouring mesodermal and ectodermal cells (Crews, 1998). Unlike
embryonic neuroblasts, in which the expression domains of Dichaete and SoxNeuro
partially overlap and show some functional redundancy (Overton et al., 2002), the
midline is a distinct structure where only one Sox gene, Dichaete, is expressed at early
stages of development (Soriano and Russell, 1998). This makes it a convenient model
system for studying Dichaete function, in addition to the general interest in describing
genetic interactions in the midline as a model neural tissue.
Defects have been found in the differentiation of midline glia in Dichaete mutants.
Axonal defects were observed at the same time, with the longitudinal tracts becoming
thinner, and most of the commissures fusing. These defects can be rescued by driving
the expression of Dichaete in the ventral midline (Soriano and Russell, 1998), where
Dichaete was also found to genetically interact with the POU domain gene ventral
veins lacking (vvl). Dichaete and vvl double mutants showed significantly stronger
phenotypes than either of the single mutants, indicating they have a strong synergistic
effect on nerve cord development. In addition, ectopically expressing Dichaete and
vvl together in neuroblasts produced a strong phenotype, whereas expression of either
gene on its own produced relatively mild phenotypes, suggesting that Dichaete and
Vvl work together to regulate gene expression.
In particular, Dichaete and Vvl were found to directly regulate slit, the expression of
which is greatly reduced in double mutants (Soriano and Russell, 1998). Subsequent
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work demonstrated a physical interaction between Dichaete and Vvl on a slit enhancer
(Ma et al., 2000). The same study also found that single-minded (sim), a transcription
factor required for midline development, acts in concert with Dichaete and vvl to
regulate gene expression in the midline. Dichaete, Vvl and Sim were all found to bind
to DNA sites present in a slit 1 kb enhancer region, and there is evidence from yeast
that they can form a ternary complex, suggesting that the three transcription factors
act as coregulators in the midline (Ma et al., 2000). The broader conclusion from this
case study is also that functional interactions of Sox, bHLH-PAS and POU protein
families are possible, and may happen in tissues other than the midline and as part of
various developmental processes.
1.6.3 Neuroblasts
Once a neuroblast delaminates, its particular developmental sequence is specified both
through positional information and through the expression of a temporal sequence of
transcriptional regulators. As previously described, the positional information for each
individual neuroblast is specified by distinct sets of factors along both the AP and the
DV axes, which influence its subsequent cell fates during differentiation. Positional in-
formation along the DV axis is determined by the combined action of columnar genes:
the Epidermal growth factor receptor (Egfr) and the transcriptional regulators Vnd,
Ind and Msh, which are expressed in the medial, intermediate and lateral columns of
the neuroectoderm, respectively (Skeath, 1999). The neural stem cell fate along the
AP axis is regulated by segment polarity genes (such as those discovered by Nusslein-
Volhard and Wieschaus (1980)), such as gsb and wg (Skeath, 1999). The combination
of the AP and the DV axis determinants creates a detailed grid of positional informa-
tion, controlling developmental fates of neuroblasts during early development (Figure
1.9).
As well as the positional information, there is also a temporal sequence of transcrip-
tional regulators (Figure 1.10) that determines the sequence of divisions and the result-
ing developmental fates of differentiating cells (Maurange et al., 2008). The temporal
sequence of transcription factors Hb, Kr, Pdm and Cas (Figure 1.10) in neuroblasts of
Drosophila embryos and their role in specifying cell fate was first described by Isshiki
et al. (2001). Subsequent work shed light on the details of timing-dependent switching
of the temporal transcription factors (Grosskortenhaus et al., 2005) and also uncovered
a particular competence window for responding to the temporal transcription factors,
outside of which their effects on cell fate are different to the effects within it (Cleary
and Doe, 2006). The latter is particularly interesting, and offers a model of how a small
number of transcription factors can result in a large number of different cell fates. It
is thought that Dichaete has an important role during the temporal series. Maurange
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Figure 1.9: The layout of the neuroectoderm. (A) A ventral view of a Drosophila
embryo undergoing the second wave of neuroblast divisions, stained for the Snail protein
which marks all neuroblasts. A single hemisegment is labelled with a rectangle. (B)
’NB formation’ shows the selection and delamination of a single neuroblast from a
proneural cluster. ’NB patterning’ shows the arrangement of proneural clusters in a
single hemisegment (top image) and the arrangements of the neuroblasts that develop
from the proneural clusters (bottom image). ’NB specification’ shows how different
positional information leads to different cell fates within a single hemisegment. The
red, yellow and green proneural clusters correspond to the activity of medial (m),
intermediate (i) and lateral (l) columnar genes, respectively (top image). The colours
of neuroblasts correspond to different cell fates, and their names are shown in the
middle (bottom image). Figure taken from a review by Skeath (1999).
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et al. (2008) find that there is a particular point during neuroblast divisions where
Dichaete is switched off and that if this event does not occur, it is not possible for
neuroblasts to exit the cell cycle, indicating that the role of Dichaete in neuroblasts
is to maintain pluripotency, similarly to the known role of its mammalian homologue
Sox2 in stem cells.
Figure 1.10: A temporal sequence of transcription factors during neuroblast devel-
opment specifies cell fate. Figure taken from Maurange and Gould (2005).
In Drosophila, neuroblasts form in 5 distinct waves, with neuroblasts from different
waves being referred to as SI to SV neuroblasts, depending on during which wave they
form. In Dichaete null mutants, SI medial neuroblasts are not affected, but there is a
loss of later delaminating SII and SIII neuroblasts from both medial and intermediate
columns (Zhao and Skeath, 2002). The weakening of the neuroblast phenotype is
thought to be due to a functional redundancy with SoxN, which is also expressed in
medial and intermediate columns (Overton et al., 2002).
1.7 Structure of genes targeted by Dichaete
While studying identified direct Dichaete targets (in particular, referring to the primary
pair rule genes eve, h and run, the Dichaete midline target slit, ac in the neuroectoderm,
and hedgehog and dpp in the hindgut), Overton et al. (2002) observed that genes
identified as being Dichaete targets had complex structure and complex regulation,
with some of them having regulatory regions that extend over many kilobases. It
was suggested that the complexity of the regulatory regions that Dichaete targets is
linked to the variable phenotypes observed, with Dichaete perhaps having a structural
role facilitated through its ability to bend DNA. Nambu and Nambu (1996) observe
that in the case of the determinants involved in segmentation, there is a complicated
hierarchical network in place, and that this is reflected in the regulatory regions of
the genes involved: they are often very long and contain multiple binding sites for
the same transcription factors, allowing for different combinations of regulators giving
different outputs. If Dichaete is a master regulator and/or chromatin modifier involved
in a number of these complex networks, as appears to be the case, it is plausible that
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there may be a pattern in the structure of genes that such a master regulator targets.
For example, if it targets a range of other regulators and important developmental
genes, this might reflect in terms of the gene structure of Dichaete targets - genes
with complex, dynamic patterns of expression tend to have larger areas of non-coding
sequence, either in the form of long introns or surrounding sequence Nelson et al.
(2004), and this is something that could be a general feature of Dichaete targets, if this
is indeed the type of genes that Dichaete tends to target.
1.8 The role of Dichaete in larval development
Dichaete appears to be required for the growth and survival of imaginal cells in larvae.
Ectopic expression of Dichaete at this stage causes severe phenotypes in adults, in-
cluding truncated legs and antennae, and suppressed eye formation (Mukherjee et al.,
2000). Dichaete was shown to be required for the expression of engrailed and wingless
during larval development. There was also found to be a link between Dichaete ec-
topic expression morphological defects, and the altered expression of wingless, dpp and
bric-a-brac (Mukherjee et al., 2000).
1.9 Dichaete and SoxNeuro
1.9.1 SoxNeuro overview
In Drosophila, SoxNeuro is the Sox gene most closely related to Dichaete. However,
the majority of the sequence similarity is found in the HMG domain, with the rest of
the sequence being quite divergent, so it is likely that any similarity in function found
between the two is facilitated via the DNA binding domain (Overton et al., 2002).
SoxN is first expressed in the head region of the syncitial blastoderm, later followed
by expression in the ventral neuroectoderm, where it is first expressed slightly earlier
than Dichaete. It is therefore possible that SoxN regulates the initiation of Dichaete
expression in this area, however, the study by Overton et al. (2002) showed variable
effects: in approximately half of the SoxN null mutant embryos, the expression of
Dichaete was unchanged, whereas in the other half, Dichaete levels were reduced in
the anterior half of the neuroectoderm. It therefore appears that SoxN has a variable
and spatially restricted effect on Dichaete expression. As previously discussed, variable
phenotypes are observed to be a feature of Dichaete mutants (Russell et al., 1996), and
SoxN appears to follow the same pattern. As discussed, there are a few potential
reasons for this. It is possible that there is a variability intrinsic to their activity,
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for example if they have accessory roles and/or act as stabilisers of gene expression,
resulting in a variable range of changes in mutants. The other possible reason was
that if they are hub nodes in the middle of regulatory networks, it is possible that
the network can still partially function due to redundancy, but is destabilised and less
robust, resulting in a variable range of phenotypes.
From embryonic stage 8 onwards, SoxN is expressed in the developing central nervous
system (Cremazy et al., 2000). It is known to have a key role in determining the
positioning of the ventral neuroectoderm relative to the dorsal non-neural ectoderm.
The expression of SoxN is reported to be regulated maternally by Dorsal and zygotically
by Dpp, Sog, Brk, Twi and Sna (Figure 1.11). The presumptive neuroectoderm requires
Sog and Brk to exclude anti-neural Dpp activity. Based on their effects on SoxN,
it seems probable that the expression of SoxN establishes a positive feedback loop
increasing the expression of sog and brk and reducing the expression of Dpp, while
the opposite happens in regions outside the neuroectoderm, helping to establish sharp
tissue boundaries. However, the specific role of SoxN appears to be connected to
maintenance rather than original establishment of the differences in gene expression,
as the loss of SoxN was not observed to change the early expression levels of brk, sog
and Dpp (Buescher et al., 2002).
Figure 1.11: Genes regulating SoxN (data from Cremazy et al. (2000))
SoxN appears to be essential for neuroblast formation, with a reduction in lateral and
intermediate column neuroblasts observed in SoxN null mutant embryos (Buescher
et al., 2002). The ventral neuroblasts were found to be largely unaffected in the same
mutants, which is thought to be due to functional redundancy with Dichaete. SoxN,
like Dichaete, was found to genetically interact with Vnd and Ind, and it is thought
to act upstream and parallel to proneural genes (Buescher et al., 2002). There is also
evidence that SoxN is involved in later embryonic neuroblast cell fate specification
(Overton et al., 2002).
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1.9.2 Dichaete and SoxNeuro overlap
There is an overlap in the expression of SoxN and Dichaete in the neuroectoderm, but
the SoxN expression domain extends more laterally: while both proteins are present
in the medial and intermediate column, only SoxN is expressed in the lateral column.
There is also a difference in patterns of cellular localisation between the two - while
SoxN is always found in the nucleus, Dichaete displays both nuclear and cytoplasmic
localization in the neuroectoderm (Cremazy et al., 2000). Based on their position-
ing along the DV axis, waves of forming neuroblasts initiate either Dichaete on its
own, SoxN on its own, or Dichaete and SoxN together. They also colocalise in the
chordotonal organs of the peripheral nervous system (Cremazy et al., 2000).
1.9.3 Differential and redundant function
Overton et al. (2002) described the first evidence for both redundant and differen-
tial function of Dichaete and SoxN in the developing CNS in Drosophila. The CNS
phenotype of a SoxN null mutation was studied, and it was found that in the lateral
neuroectoderm where SoxN is expressed on its own, the expression of ac was reduced
and there was a reduction in the number of lateral neuroblasts. The same effects were
not observed in the medial neuroectoderm, where the expression of SoxN and Dichaete
overlaps; the phenotypes of both single null mutants were mild in this region. On the
other hand, Dichaete/SoxN double mutants showed severe phenotypes throughout the
CNS, including a loss of ac expressing neural clusters and medial neuroblasts, leading
to the conclusion that there is partial functional compensation.
It is interesting to note that, while Dichaete and SoxN appear to cooperate and display
partial functional redundancy in the medial column, Dichaete null mutants display
a partial derepression of ac in the intermediate column (Overton et al., 2002; Zhao
and Skeath, 2002), indicating that Dichaete and SoxN have distinct functions in this
particular region of the neuroectoderm and are capable of acting antagonistically. In
the double mutants, the observed effect on ac expression is additive: while there is a loss
of expression in the lateral column, occasional ectopic expression in the intermediate
column is also observed (Overton et al., 2002).
The severe neural hypoplasia observed in Dichaete/SoxN double mutants indicates
that both genes control neural specification at the level of the neuroectoderm. In
addition, the loss of neuroblasts in SoxN single mutants indicates that SoxN also has
a role in later cell fate specification in neuroblasts (Overton et al., 2002), which is also
the case for Dichaete (Maurange et al., 2008).
SoxN has also been implicated in epidermis development and there is reported partial
redundancy with Dichaete in this function (Overton et al., 2007). To explain their
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roles, I will first give a very brief overview of embryonic epidermis development in
Drosophila. At the end of embryogenesis, a highly patterned cuticle layer is secreted
by epidermal cells, with the ventral surface displaying a mixture of segmental denticle
belts and naked cuticle. Wingless (Wg), a growth factor belonging to the Wnt family,
regulates this process. In a wg null mutant, there is no naked cuticle separating the
denticle belts, whereas when wg is overexpressed the entirety of the ventral epidermis is
converted to naked cuticle (Noordermeer et al., 1992; Hays et al., 1997). SoxNeuro was
identified in a screen for mutations that suppress or enhance wg mutation phenotypes,
and it was found that SoxN negatively regulates Wg pathway activity in the embryonic
epidermis, likely cooperating with the repressor form of Tcf to achieve this (Chao et al.,
2007). Overton et al. (2007) found that SoxN is activated by Spi and repressed by Wg,
and that it is necessary and sufficient for regulating the expression of svb, which in turn
stimulates trichome formation, producing denticle belts. The same study shows that in
this context, Dichaete is coregulated with SoxN and has a redundant (though slightly
weaker) function in the regulation of svb and repression of the Wg pathway.
1.10 Conservation of structure, molecular and de-
velopmental functions
The closely matched DNA-binding domain sequence of Drosophila Dichaete and Sox2
from chick, mouse and human suggests that there may be functional conservation be-
tween the invertebrate and vertebrate proteins (Russell et al., 1996). Furthermore,
Dichaete was found to interact with the POU domain protein Ventral veins lacking in
the embryonic ventral midline (Soriano and Russell, 1998), in a manner analogous to
the way Sox2 interacts with the POU-domain protein Oct3 (Yuan et al., 1995). There
is a set of steps during neural development that is conserved across a wide range of
metazoan species. For example, during early neural determination there is antagonistic
action of positive and negative acting determinants that help establish the neuroecto-
derm: the positive action of Sog and negative action of Dpp in Drosophila very much
mirrors the action of BMP and Chordin in vertebrates. It has been suggested that
Sox genes also have a conserved function within this context (Buescher et al., 2002).
Based on sequence, Sox1, Sox2 and Sox3 are the closest vertebrate relatives of Dichaete
and SoxN, and these were also found to overlap in the developing nervous system and
to display partial functional redundancy during neural development (Nishiguchi et al.,
1998). It is therefore possible that the function of Sox genes during neural development
is highly evolutionarily conserved.
The regulation of SoxN and Sox2 appears to be conserved in Drosophila and Xeno-
pus : both are negatively regulated by Dpp / BMP4 and positively regulated by Sog
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/ Chordin (Sasai et al., 2001; Buescher et al., 2002). Furthermore, Sox2 appears to
have a role in the maintenance of neural tissue (Kishi et al., 2000), which is similar
to the observed role of SoxN in the neuroectoderm (Buescher et al., 2002). However,
experiments indicate that when expressed in the midline, Sox2 from mouse rescues the
Dichaete null mutant phenotype (Soriano and Russell, 1998). It has also been reported
that mouse Sox1 can rescue SoxNeuro lateral neuroblast phenotypes, while SoxN and
Sox1 are both incapable of rescuing the Dichaete phenotype in the midline (Overton,
2003). This appears to be contrary to the idea that SoxN and Sox2 are conserved and
closely related, and instead suggests specific functional conservation between Dichaete
and Sox2, as well as between SoxNeuro and Sox1. It is possible that while there is some
conservation from the original ancestral Sox genes, there has also been some reshuﬄing
of functions between closely related Sox genes, leading to only a partial conservation
between individual genes in vertebrates and invertebrates.
1.11 Dichaete: a genome-wide view
When I first began my PhD, no genome-wide data was available for Dichaete, so one
of the main aims of my project was to generate such a dataset, in order to gain insight
into the genome-wide action of Dichaete. In the meantime, three Dichaete ChIP-chip
datasets have been published as part of large scale studies. Two datasets were gener-
ated by the modENCODE project (Celniker et al., 2009; Negre et al., 2011), a large
scale international effort whose aim is to elucidate a range of genomic regulatory mech-
anisms in the model organisms C. elegans and D. melanogaster. A third dataset was
generated by the Berkeley Drosophila Transcription Factor Network Project (BDTNP)
(MacArthur et al., 2009), a smaller high throughput project whose aim is to study the
genomic regulation of Drosophila development. Both projects are reviewed in more
detail in Chapter 6. The existence of a range of genomic datasets has been enormously
helpful in progressing my thesis work and at various points in my thesis I draw data
from these two projects, focusing on transcription factors, insulators, histone modifi-
cations and DNA accessibility (MacArthur et al., 2009; Negre et al., 2011; Li et al.,
2011).
1.12 The aims of my project
Previous developmental biology studies have identified the roles of Dichaete in early
Drosophila embryonic development based on phenotypic analysis and gene expression
patterns, identifying a number of individual targets and genetic interactions in the pro-
cess. The first few Dichaete genome-wide binding data sets have also recently become
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available, but have focused more on the general patterns observed in the data from a
large number of transcription factors, rather than specifically on what the genome-wide
data can tell us about Dichaete action in development. In my project, I draw on the
data available from previous studies, as well as generating new genome-wide binding
and expression profiles, with the aim of answering the following questions:
• Where in the genome does Dichaete bind in vivo?
• Which of the genes associated with binding are likely to be direct targets?
• Which cofactors does Dichaete interact with?
• How do Dichaete and its cofactors act together to regulate gene expression during
development?
These are specific questions aimed to improve and expand our understanding of Dichaete
action in particular, and from there, the action of Sox genes and transcription factors
in general. As covered in this chapter, Sox proteins are an interesting and highly
conserved family of transcription factors whose presence spans all across the metazoa.
Because of the conservation of their domain structure and the apparent conservation
of their function across relatively distantly related species, further understanding of
their action in the genome is generalisable in the sense that mechanisms of action ob-
served for one Sox protein may well apply to other Sox proteins too. Since a number
of Sox proteins are of medical importance, further insight into their action is therefore
of general interest. There is also the broader underlying theoretical question of how
transcription factors in general work together to regulate changes in gene expression.
Studying specific parts of important transcriptional regulatory networks can lead to
broader insights into transcription factor action in general. Finally, the developmental
processes that Dichaete is involved in are interesting and fundamental ones, and un-
derstanding Dichaete action within processes such as segmentation and nervous system
development also furthers our understanding of those processes.
I address these questions experimentally using genomics methods such as generating
genome-wide binding data and gene expression profiling. I then use a range of bioinfor-
matics methods to glean the underlying mechanisms of Dichaete action in the genome,
and draw on a number of published high-throughput datasets to try and further eluci-
date the genetic network that Dichaete is involved in during early embryogenesis, with
a particular focus on nervous system development.
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Chapter 2
Materials and Methods
2.1 Fly work
2.1.1 Fly husbandry
Fly stocks were maintained long-term at 18◦C. The stocks used in experiments were
reared and maintained at 25◦C. All fly stocks were fed standard cornmeal agar medium
prepared by the fly media facility in the Department of Genetics, University of Cam-
bridge. Virgin collections were performed within 8 hours after eclosion at 25◦C, or
16 hours after eclosion at 18◦C, as described in Greenspan (2004). Embryo collection
crosses were set up in collection cages and fed fresh yeast on apple juice agar plates.
All embryo collections were performed at 25◦C.
2.1.2 Fly stocks
The balancers used are described in Flybase (Gelbart et al., 1997). Unless otherwise
specified, the stocks were obtained from Cambridge Fly Stock Collection, Department
of Genetics, University of Cambridge. An Oregon-R stock was used as the default wild
type strain. The list of fly stocks used is shown in Table 2.1.
2.2 Immunohistochemistry
2.2.1 Fixation
Embryos were collected in Nytex baskets, washed with water and dechorionated for
5 mins in 50% commercial bleach. After washing thoroughly with water, they were
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transferred to a glass scintillation vial. The embryos were fixed with 0.5 ml 37%
Formaldehyde, 4 ml fixing solution (100 mM Hepes, 2 mM MgSO4, 1 mM EGTA) and
5 ml Heptane, while being shaken vigorously at room temperature for 20 min. The
lower phase was removed with a glass Pasteur pipette, 5 ml MeOH was added and the
vial was vortexed vigorously for 30 sec. The embryos were left to sink to the bottom of
the vial and were then moved to a 1.5 ml Eppendorf tube using a glass Pasteur pipette.
They were washed 3 times with 1 ml MeOH, then 3 times with 1 ml PBT (PBS with
0.1% Triton-X100). They were then washed 3 times with 1 ml PBT, including a gentle
rotation at room temperature for 20 min after each wash.
2.2.2 Immunohistochemistry
The antibodies used are shown in Table 2.2. The Dichaete polyclonal antibody was
first preabsorbed by incubating with fixed embryos (well washed with PBT) for 2-3
hours at room temperature with gentle rotation. The BP102 monoclonal antibody,
which targets the axons of the nervous system, was used without preabsorption.
Antisera Source / Reference Host species Concentration
BP102 DSHB Mouse 1:100
Dichaete Soriano and Russell (1998) Rabbit 1:1000
Table 2.2: Antibodies used
Fixed embryos were left to incubate overnight at 4◦C in 100 µl of PBT with the
appropriate dilution of primary antibody. The primary antibody was then removed
and the embryos were washed 4 times with 1 ml PBT, each time for 10 mins at room
temperature with gentle rotation. The embryos were left to incubate for 2 hours in
0.5 ml PBT with 10 µl of the appropriate biotinylated secondary antibody (Vector
laboratories). The incubation was stopped with 4 times 10 min washes in 1 ml PBT.
The biotinylated secondary antibody was detected using the Vectastain ABC Elite
Kit (Vector Laboratories) at a 1:50 dilution in 0.5 ml PBT, left to incubate with the
embryos for 30-60 min. The embryos were washed 4 times for 10 min in 1 ml PBT, then
transferred to a glass box in 0.5 ml PBT. 20 µl of 10 mg/ml DAB (diaminobenzidine,
Sigma) was added and left to incubate for 10 min. The staining was started by adding
5 µl of 1% hydrogen peroxide diluted in PBT, monitored under a microscope and
stopped with 6-8 washes in PBT.
For mounting, the embryos were rinsed once in 1 ml PBS, once in 1:1 PBS/glycerol,
then stored in 70% glycerol mountant. Sellotape was added to the sides of the slide
before mounting to prevent the glass cover slip from damaging the embryos.
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2.3 Dominant negative crosses
Some Dichaete dominant negative UAS constructs were available from previous work
(Shen, 2006). One was UAS dnDichaete HMG− (from here referred to as HMG−),
the Dichaete protein missing its active High Mobility Group domain. The other was
UAS dnDichaete Enrep (from here referred to as EnRep), a Dichaete protein with the
engrailed repressor domain attached. The third construct included in the study was
UAS Dichaete (from here referred to as DWT), which is a wild type protein, driven by a
UAS promoter and is therefore significantly overexpressed compared to the endogenous
protein. All the constructs contain an in-frame N-teminal GFP fusion and they were
each compared to flies expressing UAS GFP.
Because the dominant negative constructs are driven by a UAS promoter, and are thus
activated wherever the Gal4 protein is expressed: consequently they are convenient for
gene expression studies in specific tissues. I performed two such studies: one using
the simGal4 driver (expressed in the ventral midline) and a second using the prosGal4
driver (expressed in neuroblasts). In both cases, female virgins from the Gal4 strains
were crossed to males from UAS strains, and stage 8-9 embryos (3.5 to 4.5 hours old)
were collected. The control sample for the gene expression experiments was a UAS
GFP strain crossed to the same Gal4 drivers. Since all the constructs used were GFP
tagged, the embryos were inspected under a confocal microscope (Biorad MRC 1024)
to ensure that they were expressed in the correct tissues. For further validation, the
embryos were stained with BP102 and the structure of the nervous system inspected
for phenotypes.
2.4 Dichaete null mutant
The Dichaete homozygous null mutants are embryonic lethal and homozygous D em-
bryos were obtained from crosses using balancer chromosomes containing GFP marker
- twiGal4 UAS EGFP. The earliest time when fluorescence could be reliably detected
was found to be stage 10, so a stage 10-11 embryo collection (5 - 7.5 hours) was used
for gene expression profiling.
Two Dichaete null alleles were used - Dr72, an EMS induced null allele (Soriano and
Russell, 1998) and Dr513, a small deletion in the coding sequence induced by P-element
excision (S. Russell, unpublished data). Alleles were first balanced over the fluorescent
balancer chromosome, crossed with each other and homozygous null mutants identified
by a lack of fluorescence. For the purposes of studying gene expression changes, the
homozygotes were compared to a heterozygous null allele. The heterozygous null allele
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embryos were obtained by crossing Dr513/twiGal4 UAS EGFP to the isogenic wildtype
stock, again identifying the embryos based on lack of fluorescence.
2.5 Gene expression experiments
2.5.1 RNA extraction
The RNA extractions were performed using the Trizol method (details available at
the FlyChip website: www.flychip.org.uk) and on ice to prevent RNA degradation.
Embryos were collected in PBS, then the PBS was removed and 300 µl TRIzol was
added. The embryos can at this stage be stored for about a month at −20◦C if required.
The embryos were homogenised for 30-60 seconds using a disposable polypropylene
pellet pestle. Another 700 µl of TRIzol was then added and the sample was centrifuged
at 13,000 rpm (16,000 g) for 10 min. The supernatant was transferred to a fresh 1.5 ml
Eppendorf tube. 200 µl of chloroform was added and the sample was vortexed for 30
sec, followed by centrifugation at 13,000 rpm (16,000 g) for 15 min. The upper phase
was transfered to a new 1.5 ml tube, while taking care not to touch the interphase,
as this would contaminate the RNA sample. The lower phase and interphase were
discarded, 0.8 volumes of Isopropanol (around 320 µl) added and the contents mixed
gently then left to precipitate for 1 hour at −20◦C. The RNA was then pelleted by
centrifugation at 13,000 rpm (16,000 g) in a microfuge for 15 min and the supernatant
was discarded (being careful not to disturb the pellet). The RNA was washed with 500
µl of 70% ethanol/DEPC H2O, then centrifuged at 13,000 rpm (16,000 g) for 10 min.
The ethanol was discarded and the pellet was left in an open tube to dry for up to 10
min to remove any residual ethanol. The RNA was resuspended in 30 µl DEPC H2O.
The quality of RNA was verified by electrophoresis in a 1% agarose gel followed by
ethidium bromide staining and quantified using a Nanodrop spectrophotometer (paying
particular attention to the 260/230 ratio, to monitor contamination).
2.5.2 RNA amplification and labelling
Klenow labelling was used for all gene expression experiments performed. In brief,
the procedure involves reverse transcribing RNA to cDNA, second strand synthesis,
precipitating and purifying the DNA, incorporation of dCTP conjugated Cy3 and
Cy5 dyes using a Klenow fragment, and finally, paired competitive hybridisation to
microarrays. The standard FlyChip protocol was used for this (details available at
www.flychip.org.uk).
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Up to 5 µg of RNA per sample was used for the reverse transcription reaction. The
volume was made up to 11 µl with DEPC H2O and 1 µl of oligo-dT was added. The
sample was heated for 10 min at 65◦C, followed by incubation on ice for 5 min. A
master mix containing the following quantity of reagents per sample was prepared: 4
µl of 5x 1st strand buffer, 1 µl of 10mM dNTPs, 2 µl of 0.1M DTT, 0.25 µl RNAsin
and 0.75 µl of 200U/µl Superscript III. 8 µl of the master mix was added to each
RNA sample, pipetting gently up and down to mix. The samples were then incubated
at 46◦C for 2 hours, at 65◦C for 15 min, followed by snap cooling on ice for a few
minutes.
For second strand synthesis. a premix was prepared on ice, containing 9.15 µl H2O, 7.5
µl 5x second strand buffer, 0.75 µl 10 mM dNTPs, 2 µl of 10U/µl DNA Polymerase I,
0.1 µl of 5U/µl RNaseH and 0.5 µl of 10U/µl E. coli ligase per sample. 20 µl of premix
was added to each sample, followed by incubation at 16◦C for 2 hours.
The double strand cDNA was purified over Sephadex G50 columns: the samples were
made up to 100 µl by the addition of 60 µl DEPC H2O. Phase Lock Gel (PLG) tubes
were centrifuged at 13,000 rpm (16,000 g) in a microfuge for 30 seconds to prepare
them, then each sample was added to a PLG tube with an equal volume (100 µl) of
pH 8.0 Phenol/Chloroform/Isoamyl alcohol. The tubes were shaken by hand for 15
seconds to mix them, followed by centrifugation for 5 min at 13,000 rpm (16,000 g) in
a microfuge. The upper phase was removed to a new 1.5 ml Eppendorf tube and the
volume reduced to 30 µl in a Speed Vac concentrator. The samples were then loaded
on to prepared Sephadex G50 columns and centrifuged for 1 min at 5000 rpm (2,400
g) in a microfuge. The samples were then made up to 100 µl by the addition of 70 µl
DEPC H2O, followed by 3.5 µl of 5M NaCl, 0.5 µl of LPA and 220 µl of 100% EtOH.
Samples were incubated for 2 hours at −20◦C, then centrifuged for 30 min at 13,000
rpm (16,000 g) in a microfuge. The supernatant was removed and each sample was
washed with 500 µl of 70% EtOH, the pellet air dried then dissolving in 10 to 20 µl
DEPC H2O, depending on pellet size. The sample concentration was measured using
a Nanodrop spectrophotometer.
cDNA was labelled using the random priming method: up to 1000 ng cDNA per sample
was made up to 25 µl using MilliQ water. 20 µl of 2.5x Random Primer reaction buffer
was added and the samples were incubated at 100◦C for 5 min in a PCR (polymerase
chain reaction) block, then placed on ice to cool. A premix was prepared containing 1
µl of 10x low-C dNTP, 2 µl of the relevant fluorescent dye (dCTP conjugated Cy3 or
Cy5) and 1 µl of 40U/µl Klenow per sample. 4 µl of pre-mix was added to each sample,
pipetting up and down gently to mix. The samples were incubated at 37◦C for 2 hours
and the reaction stopped by adding 5 µl of stop buffer (0.5 M Na2EDTA, pH 8.0).
The Cy3 and Cy5 labelled sample and control pairs were combined in 1.5 ml tubes
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and the volume was reduced to 25-30 µl in a SpeedVac concentrator. Sephadex G50
purification, with two G50 columns per sample, was used to eliminate unincorporated
dyes. The resin in the G50 columns was resuspended by vortexing and the column was
placed in a 1.5 ml tube and pre-spun in a microfuge for 1 min at 5000 rpm (2,400 g).
The cap was then removed and the column was placed in a new 1.5 ml tube, ready for
use. Half the sample was pippeted onto the centre of the column and centrifuged in a
microfuge for 1 min at 5000 rpm (2,400 g): the process was repeated for the other half
of the sample with a new column. The volume of the sample was then reduced to 2-5
µl using a SpeedVac concentrator. 2 µl of 10 mg/ml sonicated salmon sperm DNA was
added, along with 140 µl of Ambion Hybridisation Buffer 1. The sample was heated
at 100◦C for 2 min, spun in a microfuge at 13,000 rpm (16,000 g) for 1 min, then kept
at 65◦C until ready to load on a slide.
2.5.3 Gene expression microarrays and hybridisation
The Flychip in-house printed FL002 and FL003 gene expression arrays were used (GEO
Platform Accession numbers GPL5135 and GPL14121, respectively). Four biological
replicates were performed for each expression study. Dye swaps were incorporated into
the experimental design to correct for bias, with two out of four from each replica group
dye swapped.
The samples were hybridised to arrays in a Genomic Solutions Hybridisation Station:
135 µl of sample was loaded onto each array, and they were left to hybridise for 16 hours
at 65◦C with agitation. After the hybridisation, the slides were washed to rinse off non-
hybridised samples. For the rinsing, two wash solutions were used - wash solution 1
(0.2x SSC, 0.2% SDS) and wash solution 2 (0.2x SSC). 400 ml of wash solution 1 and
800 ml of wash solution 2 were preheated to 55◦C in a water bath. A black staining
box was filled with warm wash solution 1, with the rest poured into a glass staining
dish. The hyb cassette was submerged into wash solution 1 in the glass dish, and the
slides were carefully lifted and transferred into a wash rack (maximum 12 slides per
rack), which was put into the black wash box and submerged in warm wash solution 1.
It was then left to incubate on a shaker with gentle agitation (50 rpm, 0.24 g) for 20
mins at room temperature, keeping the lid on the wash box to shield them from light.
The slides (still in the wash rack) were then transferred into a fresh staining box, and
gently dipped up and down for 1 min at room temperature. The 1 min dipping was
then repeated another two times using fresh wash solution. The slides were then rinsed
by dipping the wash rack into MilliQ-water for 3 seconds at room temperature. The
slides were transferred into a slide box lined with tissue paper, dried in a centrifuge at
1000 rpm (96 g) for 5 mins, and transferred into a dry slide box, using an AirDuster
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to remove any water droplets. The slides were then scanned using an Axon GenePix
4000B scanner.
2.5.4 Data processing
In the case of the dominant negative experiments, the standard FlyChip data analysis
pipeline was used (www.flychip.org.uk): Dapple (Buhler et al., 2000) was used for spot-
finding (manually checking for any spot-finding mistakes and areas of high background)
and variance stabilizing normalisation (vsn) (Huber et al., 2002) was performed. In
brief, vsn uses an affine transformation followed by a log2 variance-stabilising transfor-
mation to normalise the data. The final results were analysed using CyberT to assess
statistical significance (Baldi and Long, 2001). The thresholds used to find differen-
tially expressed genes were average M-value < −0.5 or > 0.5 (where the M-value is the
log2 of the ratio of sample vs control intensities), and p-value < 0.05.
In the case of the Dichaete mutant experiment, problems were encountered during
the normalisation step, due to the large number of genes that changed expression.
Standard normalisation methods tend to assume that 50%-75% of genes studied will
not be differentially expressed and this was an inaccurate assumption for this particular
experiment. To address this problem, a previously published invariants normalisation
method (Pradervand et al., 2009) was suggested by Stewart MacArthur (CRUK) and
implemented by Bettina Fischer. The later stage of the analysis was again performed
using limma (Smyth, 2005), a more stringent alternative to CyberT. The thresholds
used to find differentially expressed genes were average M-value < −1 or > 1, and
p-value < 0.01, in order to filter the large number of positive hits.
2.6 DamID
As part of a PhD project by Riaz (2009), E. coli Dam Methylase was fused to Dichaete
and inserted into a vector under the control of a standard UAS promoter. Thus any
areas of the genome bound by the Dichaete-Dam fusion will be methylated, with the
weak expression from the uninduced UAS promoter limiting the amount of fusion
protein expressed, thus preventing saturation (van Steensel et al., 2001). As a control,
DNA was prepared in parallel from embryos carrying an unfused Dam Methylase under
the control of the same UAS promoter. The protocol used here is based on the original
Vogel et al. (2007) method, with some minor adjustments.
The method involves first extracting DNA from embryos expressing the Dam methylase-
Dichaete fusion (and also from control embryos only expressing Dam methylase), fol-
lowed by digestion with a restriction enzyme that only cuts methylated sites (DpnI ),
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a ligation of adaptor DNA sequences to DNA overhangs left from the digestion, fol-
lowed by a further digestion by a restriction enzyme (DpnII ) that targets the same
sites as DpnI, but only if they are unmethylated. From there, the sequences contain-
ing adaptors are amplified using PCR to generate sufficient material for labelling and
hybridisation to Nimblegen genome tiling arrays (minimum material required is 1.5 µg
DNA), followed be fluorescent labelling and hybridisation. Three biological replicates
were performed. There is a potential for bias to be introduced during the amplification
step, which is why both the sample and the control were treated the same - if bias
is introduced, it should be similar for both sample and control, and therefore not a
concern, since we only look at the ratios, rather than absolute values. Further to that,
systematic shifts in intensity values that are different between samples and controls
should show up on QC scatter plots, so there is a check in place to look for this.
2.6.1 Embryo collection and DNA extraction
The fly stocks used were the DED3 strain containing a UAS Dichaete-Dam methylase
fusion protein, and the ED2A strain containing a UAS Dam methylase, originally pro-
duced by Riaz (2009). Embryos between 0-12 h were collected (stage 1 - 15) and DNA
extracted using a Qiagen DNeasy Blood and Tissue kit following the manufacturers
recommendations. Up to 50 mg of embryos were placed in a 1.5 ml tube, 50 µl of PBS
and 1 µl of RNase added, and the sample homogenised with a disposable polypropylene
pellet pestle. 130 µl of PBS, 20 µl proteinase K and 200 µl of Buffer AL (lysis buffer
purchased from Qiagen) was added to the sample, which was then mixed thoroughly by
vortexing and incubated at 56◦C for 10 min. After the incubation, 200 µl of 96-100%
ethanol was added to the sample, which was mixed thoroughly by vortexing. The sam-
ple was then pipetted into a DNeasy Mini spin column and centrifuge in a microfuge
at 8000 rpm (6,100 g) for 1 min. The flow through was discarded and the column
placed in a new collection tube. 500 µl of Buffer AW1 (wash solution 1, purchased
from Qiagen) was added, and the column was again centrifuged in a microfuge at 8000
rpm (6,100 g) for 1 min. The flow through was discarded, 500 µl of Buffer AW2 (wash
solution 2, purchased from Qiagen) was added to the column followed by centrifugation
in a microfuge for 3 min at 14,000 rpm (19,000 g). 100 µl of MilliQ water was added
to the column, incubated for 1 minute, then the DNA was eluted into a new 1.5 ml
collection tube by centrifugation in a microfuge at 8000 rpm (6,100 g) for 1 min.
2.6.2 DNA precipitation
The concentration of each DNA extract was determined using a Nanodrop spectropho-
tometer. Two volumes of 100% ethanol and 0.1 volume of 3M sodium acetate (pH 5.5)
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were added and mixed with the sample. The DNA was precipitated by storing on ice
for 30 min, followed by centrifugation for 30 min at 4◦C in a refrigerated microfuge to
pellet the DNA. The supernatant was discarded and the DNA washed by adding 500
µl of 70% ethanol. The sample was then centrifuged for 5 min (4◦C, 16,000g), after
which the supernatant was removed. The pellet was left to air-dry for 5-10 min, to
evaporate any residual ethanol. The DNA was dissolved in pH 7.5 T10E0.1 (TE buffer
with reduced EDTA - 10mM Tris-HCl, pH 7.5, 0.1mM EDTA) prewarmed to 55◦C, at
a concentration of 1 µg/µl, based on the original Nanodrop measurement. The concen-
tration was verified using the Nanodrop (and a 1:10 sample dilution, in order to save
as much sample as possible). 500 ng of DNA was then used for the next step of the
experiment.
2.6.3 Digestions
Two negative controls were included: one where a Dichaete-Dam sample was processed,
but with the DpnI enzyme excluded, and the second where the DNA ligase was omitted.
The double stranded adaptor oligonucleotide (dsAdr) was prepared from two oligonu-
cleotides - ”AdRt” (5’-CTAATACGACTCACTATAGGGCAGCGTGGTCGCGGCCGAGGA-
3’) and ”AdRb” ( 5’-TCCTCGGCCG-3’). AdRt and AdRb were both dissolved in
water. A 50 µM stock of dsAdr was prepared by combining equal volumes of 100 µM
AdRt and 100 µM AdRb, placing the tube to float in a beaker of water at 90◦C, and
leaving it until the water cooled to room temperature, so that the adaptors can anneal
slowly.
The DpnI digest was set up using 0.5 µl of DNA sample (500 ng), 1 µl 10x Buffer 4
(NEB) 0.5 µl of 20 U/µl DpnI (NEB) and 8 µl H2O, and left to incubate overnight at
37◦C. DpnI was then heat-inactivated for 20 min at 80◦C.
The ligation was set up in the same tubes using the 10 µl of DpnI digested gDNA, 2 µl
10x ligation buffer (Roche), 1 µl of 5 U/µl T4 ligase (Roche), 0.8 µl of 50 µM dsAdr and
6.2 µl H2O, and left to incubate overnight at 16
◦C. Ligase was then heat-inactivated
for 10 min at 65◦C.
The DpnII digestion was set up in the same tubes using the 20 µl ligated DNA, 5 µl
10x DpnII Buffer (NEB), 1 µl of 10 U/µl DpnII (NEB) and 24 µl H2O, and left to
incubate for 1 hour at 37◦C.
2.6.4 PCR amplification
The Adr-PCR primer is an oligonucleotide (5’-GGTCGCGGCCGAGGATC-3), with
both the 5’ and 3’ ends left unphosphorylated.
39
Reagent Amount
DpnII digested DNA 10 µl
10x cDNA PCR buffer (Clontech) 5 µl
Primer Adr-PCR (50 µM) 5 µl
dNTPs (10 mM) 1 µl
PCR advantage enzyme mix (Clontech, 50x) 1 µl
H2O 31.75 µl
Total volume 50 µl
Table 2.3: PCR reagents.
The digested DNA was amplified by PCR with the reagents shown in Table 2.3. The
reaction conditions were as follows: 68◦C, 10 min, for 1 cycle; 94◦C for 1 min, 65◦C for
5 min, 68◦C for 15 min, for 1 cycle; 94◦C for 1 min, 65◦C for 1 min, 68◦C for 10 min,
for 4 cycles; 94◦C for 1 min, 65◦C for 1 min, 68◦C for 2 min, for 17 cycles. The samples
and PCR controls were then analysed on a 1% agarose gel. Provided the DNA was
visible on the gel and the controls came back negative, the remainder of the sample
was then purified using a Qiaquick PCR purification kit, and the concentration was
measured using a Nanodrop.
2.6.5 Labelling and microarrays
NimbleGen Drosophila melanogaster 2.1M Whole Genome Tilling Arrays from Roche
were used. The labelling protocol using the Invitrogen BioPrime Kit was followed.
The recommended quantity of DNA for use with NimbleGen arrays is 3-6 µg, but the
protocol has been successfully performed in FlyChip with as little as 1.5 µg. Two
labelling reactions, each with 1 µg of DNA each, were performed for each sample and
control: 1 µg of DNA was made up to a volume of 32.1 µl by adding MilliQ water
and 30 µl of 2.5x Random Primer Reaction Buffer was added. The samples were
incubated at 100◦C for 5 min in a PCR machine, then placed on ice. A master mix
was made up with 7.5 µl of 10x low-C dNTP, 4.5 µl dCTP conjugated Cy3 or Cy5 dye
(as appropriate) and 1.8 µl of 40U/µl Klenow. 13.8 µl of the master mix was added to
the DNA, pipetting up and down gently to mix. From this point on, the samples were
protected from light at all times, because the dyes are light sensitive. The samples
were then incubated at 37◦C for 2 hours. The reaction was stopped by adding 7.5 µl
of stop buffer.
The two same dye sample reactions were combined in a 1.5 ml tube, and 17.25 µl 5M
NaCl and 165 µl isopropanol was added. The samples were vortexed and incubated at
room temperature, followed by centrifugation in a microfuge at 13,000 rpm (16,000 g)
for 10 min. The supernatant was removed and the pellet rinsed with 500 µl 80% ice-
cold EtOH, spun at 13,000 rpm (16,000 g) for 2 min, drained and air dried. The dried
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pellet was resuspended in 50 µl water, vortexed, pulsed in a microfuge, left to incubate
for 5 min, vortexed and pulse centrifuged again. The concentration was measured using
a Nanodrop.
34 µg of test sample was combined with 34 µg of the matching control sample. The
contents were dried in a speed vac, then resuspended in 12.3 µl of MilliQ water and
vortexed. A Hybridisation Solution master mix was prepared by mixing 29.5 µl of 2x
hybridisation buffer, 11.8 µl of hybridisation component A and 1.2 µl of the alignment
oligo. 31.7 µl of the master mix was added to each sample pair, followed by vortexing
and spinning. The samples were incubated at 95◦C for 5 min, then at 42◦C for a
minimum of 5 min. The microarrays were prepared and placed into the hybridisation
station (NimbleGen Hybridization System 4), after which 41 µl of the sample was
loaded onto the array. The arrays were hybridised for 20 hours at 42◦C, washed and
then scanned using an Axon GenePix 4000B scanner.
2.6.6 Microarray data processing
The spot-finding and generation of pair files was carried out using the Roche propri-
etary software NimbleScan. The remainder of the data processing was performed using
the TiMAT pipeline (http://bdtnp.lbl.gov/TiMAT/) using standard settings. The nor-
malisation method used was quantile normalisation on samples and controls separately,
since their signal distributions were quite different. Quantile normalisation on all of
them together appeared to normalise away the entirety of the signal for the experi-
ment. Peak-finding was performed as part of the TiMAT pipeline at FDR values 1%,
5%, 10% and 25%.
2.7 Bioinformatics methods
All analysis, except where indicated otherwise, was performed using custom written
Perl and R scripts, with data stored in mySQL databases. Perl version 5.8.8, R version
2.12.2 and mySQL version 14.12 were used. Genome visualisation was performed using
the Affymetrix Integrated Genome Browser version 5.12 (Nicol et al., 2009). Drosophila
melanogaster Release 5 genome sequence version, and Genome Release 5.26 annotation
are used consistently throughout this thesis. Significance of overlap between different
binding datasets was determined using a resampling-based method implemented in the
Cooccur package (Huen and Russell, 2010).
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2.7.1 Gene list analysis
Gene associations for binding intervals were found using a custom method. If there was
direct overlap of a gene with a binding interval, the gene or genes in question would
be classed as associated. If no direct overlaps were found, the closest gene within a
10 kb region would be classed as associated with the intervals. All gene lists were
subsequently uploaded into FlyMine (Lyne et al., 2007). From there, FlyMine widgets
such as the ones for GO enrichment, domain enrichment and publication enrichment
were routinely used for gene list analysis.
2.7.2 GO enrichment analysis
All GO enrichments were found using FlyMine (a hypergeometric test combined with
a Holm and Bonferroni correction for multiple testing), unless otherwise indicated in
the text. Specific analysis methods are detailed in the relevant chapters. In the case
of GO enrichments performed on gene lists generated from binding data, a bias is
introduced because longer genes are both more likely to be hit by binding intervals and
have specific functions. The standard analysis method does not account for this bias,
and it has not been corrected for anywhere in this thesis. This problem is highlighted
in the relevant analysis sections, and the basis of the problem, the available solutions
and the impact on the analysis in this thesis is discussed in detail at the end of Section
4.5.2 in Chapter 4.
2.7.3 Motif analysis
The NMICA software was used for motif searching (Down and Hubbard, 2005). Binding
intervals were ranked according to the highest scoring window and between 100 and
200 top scoring intervals were selected (as indicated in the relevant results sections).
The searches were performed for a 6-10bp long motif, using Markov background order
1 and 6 background classes. 15 motifs were retrieved from each search. The motif
scanning with the Dichaete motif was performed using nmscan, a part of the NMICA
package, with the cut-off score 5. A Monte Carlo method was used for estimating
the overrepresentation of motifs in individual intervals, by reshuﬄing the columns of
the existing motif and scanning the intervals with the new randomized motifs. When
comparing a number of motifs of different lengths, matrix scan, a part of the RSAT
package (Thomas-Chollier et al., 2008), was used, with Markov background order 1
and a score cutoff between 4 and 6, as indicated. STAMP was used for searching for
matches with already known motifs (Mahony and Benos, 2007).
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2.7.4 Visualisation
The software Cluster 3.0 was used for hierarchical clustering (de Hoon et al., 2004),
with the default settings used being uncentered correlation and centroid linkage. The
clustering output was subsequently visualised using Java TreeView (Saldanha, 2004).
Cytoscape version 2.6.2 was used for network visualisation (Shannon et al., 2003).
Where indicated, GO enrichments were performed and visualised using Ontologizer
(Bauer et al., 2008).
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Chapter 3
Dichaete genome-wide binding
The cis-regulatory systems that mediate regional specification are thereby the keys to
understanding how the genome encodes development of the body plan. (Davidson,
2001)
In his treatise on genomic regulatory systems, Davidson (2001) argues, as others have
done, that understanding the regulatory logic of the genome is a cornerstone of our
efforts to understand the way the information in the genome is used to generate bi-
ological diversity. Whether we seek to understand the way organisms have evolved,
how organisms grow and develop or how biological processes can go wrong leading to
diseases such as cancer, there is a unifying thread: the combinatorial activity of tran-
scriptional regulators at defined locations in the genome to control where and when
genes are expressed. A key component of the effort to understand this process is to
define where transcription factors are active in the genome, in order to identify the cis-
regulatory modules controlling gene expression. The recently developed techniques for
characterising in vivo protein-DNA interactions across entire genomes, such as ChIP
and DamID, are powerful tools which are beginning to yield genome-wide views of
transcription factor activity. This chapter focuses on an in-depth comparative analy-
sis of 4 Dichaete genome-wide binding data sets generated from developing embryos.
The aims of the chapter are to assess the quality of the available datasets, investigate
the possible routes of approaching a genome-wide functional analysis and generate a
preliminary set of results with respect to Dichaete biology, to be further investigated
in ensuing chapters.
3.1 Introduction
Organismal development is controlled on a genetic level by the combinatorial binding
of transcription factors to precise locations in the genome, allowing for transcription
complexes to form and facilitating the control of gene expression. Research suggests
that few, if any, transcription factors act alone (Davidson, 2001). Instead it is through
their presence/absence and the cooperative action between them, coupled with exter-
nal signals and the orchestration of a precise cascade of events, which brings about
the complex process of development (Mann and Carroll, 2002). Studying the binding
patterns of individual transcription factors that are known to have developmental roles
is an important part of solving this puzzle. High-throughput genomics methods have
provided a new and powerful tool for studying the binding location of transcription
factors in vivo. This has the potential to lead to insights into the action of the individ-
ual regulators studied as well as a broader understanding of the general principles of
transcription factor action. What follows is an overview of the available experimental
techniques, their individual pros and cons, and where they fit into what is already
known about Dichaete during development.
3.1.1 ChIP-chip
While in vitro experiments can provide a useful starting point for the analysis of
protein-DNA interactions by, for example, defining consensus DNA sequence motifs, a
realistic picture of what happens inside living organisms can only emerge from study-
ing interactions in vivo. Chromatin immunoprecipitation (ChIP) has emerged as a
powerful technique that takes a snapshot of protein-DNA interactions in vivo, opening
up new avenues for understanding aspects of transcriptional regulation (for a review,
see Buck and Lieb, 2004). Provided that an appropriate antibody or tag for the pro-
tein of interest is available, ChIP provides a rapid way to gather data on where in the
genome a protein is bound. This versatile technique has been used for mapping histone
modifications, transcription factor binding, DNA methylation and the association of
chromatin-modifying enzymes with the genome (Lieb et al., 2001; Iyer et al., 2001; Ren
et al., 2000; Kwong et al., 2008; Celniker et al., 2009; MacArthur et al., 2009; Bernstein
et al., 2002; Ng et al., 2002). The preparation of samples can often be adapted to allow
the analysis of tissue or developmental stage specific interactions (Wilczynski and Fur-
long, 2010), facilitating a detailed analysis of the changing patterns of protein-DNA
interactions underpinning developmental processes.
The first step in a ChIP analysis is the crosslinking reaction, which fixes proteins at
whatever position in the genome they occupy upon crosslinking. Formaldehyde is the
agent most commonly employed today, though other methods such as UV-crosslinking
have been used (Walter and Biggin, 1997). Crosslinked nuclei are purified and the
chromatin is randomly fragmented, usually by sonication, to produce chromatin frag-
ments less than 1 kb long. With the bound DNA still attached, the protein of interest
is enriched using an appropriate antibody. Crosslinks are reversed by heat treatment
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and the DNA is then purified. A variety of methods can be used to identify some or
all of the enriched DNA fragments: these include cloning and sequencing (Fullwood
et al., 2009), specific polymerase chain reaction (PCR), Southern blotting (Solomon
et al., 1988), array hybridisation (Ren et al., 2000; Iyer et al., 2001) and next generation
sequencing (Robertson et al., 2007; Johnson et al., 2007). Since some regions of the
genome will be unspecifically enriched by the immunopurification, a control reaction
using IgG, preimmune sera or mock purification is carried out in parallel. A compar-
ison of the specifically enriched and control samples identifies genomic regions that
were crosslinked to, and by inference bound by, the protein of interest. Input DNA
is kept, and can be used to help normalize the signal, based on how much DNA from
each genomic region was present in the sample in the first place. As the IP reaction is
known to be very noisy and to result in false positives, the presence of controls and a
sufficient number of replicates is crucial to ensuring that the experimental data gained
is of a high quality (Birch-Machin et al., 2005).
In the pioneering work of Solomon et al. (1988), a Southern hybridisation assay was used
to identify protein-DNA interactions at specific genomic locations and this was later
most commonly assayed by specific PCR reactions. ChIP entered the post-genomic era
when microarray technology was first used to infer the identity and genomic location of
enriched DNA (Ren et al., 2000; Iyer et al., 2001). By hybridising the enriched DNA to
a microarray containing probes representing all intergenic sequences or even an entire
genome, a comprehensive view of DNA binding is produced from a single assay. While
the costs of such assays were initially high and the array densities limited, the prices
have dropped over time and there are now a number of tiling microarray platforms
available for several model organisms, including Drosophila. Perhaps more importantly,
there are also a variety of well-developed and freely accessible data analysis pipelines
for processing ChIP-chip data.
3.1.2 ChIP-seq
The ChIP-seq technique uses the same ChIP protocol, but identifies the enriched DNA
using sequencing (instead of microarrays or PCR). In brief, the ChIP-seq method in-
volves sequencing short reads from each end of the ChIP-enriched DNA fragments,
mapping the sequence reads back to a reference genome and using the frequency of
sequence reads in a particular region to assess enrichment. The basic concept behind
ChIP-seq has existed for some time, since using sequencing to identify the composition
of a mixture of DNA fragments is an obvious course of action. However, the approach
only became a viable alternative to array-based methods once the available sequenc-
ing technologies were fast enough and cheap enough. The newly developed ChIP-seq
approach uses second generation massively parallel DNA sequencing platforms, which
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can produce several orders of magnitude more sequencing reads directly from ChIP
enriched DNA at a fraction of the time and cost of traditional Sanger sequencing.
The method is extremely high-throughput with, for example, the Illumina 1G Genome
Analyser producing more than a gigabyte of sequence in a single run (for a review of
next generation sequencing technologies, see Holt and Jones, 2008). While relatively
new, initial studies using the ChIP-seq method look very promising and the method
is rapidly gaining popularity for a variety of applications including studying transcrip-
tion factor binding (Robertson et al., 2007; Johnson et al., 2007), histone modifications
(Mikkelsen et al., 2007; Barski et al., 2007) and DNA methylation (Pomraning et al.,
2009).
While ChIP-seq is a fast and powerful technique, there was no compelling rationale for
using it to achieve the aims of this thesis. ChIP-seq is invaluable when dealing with
large genomes containing a high proportion of repetitive DNA (which can confound
array analysis) and where tiling arrays are expensive since multiple arrays are needed.
However, Drosophila has a small compact genome and available tiling arrays are of
sufficient density to provide high resolution genome coverage on a single array. The
limiting factor in this case is likely to be the size of the sonicated DNA fragments rather
than the microarray platform (Aleksic and Russell, 2009). Additionally, methods and
analysis pipelines for ChIP-chip have been systematically tested and are well developed
(Johnson et al., 2008), whereas the biases inherent in ChIP-seq are only just starting
to emerge and be corrected (Cheung et al., 2011). It was therefore concluded that
a combination of cost and technical reasons indicated using tiling arrays would be
optimal for the purposes of this project.
3.1.3 DamID
DamID is an alternative to ChIP for studying transcription factor binding in vivo
and is of particular use in instances where an antibody for the protein of interest is
unavailable or unreliable, making ChIP-chip difficult. Originally developed by van
Steensel (van Steensel and Henikoff, 2000; van Steensel et al., 2001), it uses adenine
methylation to label locations at which a protein of interest is bound. A fusion protein
is created, where E. coli DNA adenine methyltransferase (Dam) is attached to the
transcription factor of interest and subsequently expressed ubiquitously at low levels
in vivo. Thereafter, the transcription factor fusion protein leaves a methylation tag
whenever it binds to DNA in the genome. While low levels of 5-methylcytosine are
reported to be present at specific stages during Drosophila development (Lyko, 2001),
no adenine methylation is found in the Drosophila or any other eukaryotic genome,
meaning that any adenine methylation tags detected must have been produced by the
fusion protein. A necessary control is a Dam only protein to account for unspecific
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methylation that occurs due to the inherent Dam affinity for DNA. While DamID
is mostly performed in cell lines (De Wit et al., 2008; Greil et al., 2007; Pindyurin
et al., 2007; Filion et al., 2010), a number of studies have also been performed in
whole organisms (Choksi et al., 2006; Pym et al., 2006). While at first sight it may
appear that the DamID technique requires direct binding of the fusion protein to DNA
and therefore might be unsuitable for studying features such as histone modifications
or chromatin associated proteins that do not have direct access to DNA, a range of
proteins including ones not directly binding to DNA has been studied in cell lines. This
implies that bringing Dam into the vicinity of DNA is sufficient to allow methylation
so this limitation may not be too severe in practice. Another potential limitation of the
DamID technique is its reported lower resolution compared to ChIP (Holland et al.,
2005). However, the reports on this are mixed: Moorman et al. (2006) use both ChIP
and DamID, and do not observe a notable difference in resolution. An advantage of the
DamID approach is that the ChIP-chip protocol is complex, can often be very noisy
and requires many individual protocol modifications depending upon the antibody and
tissue source. In contrast, the DamID protocol is comparatively straight-forward, and
is reported to perform quite robustly.
3.1.4 Origin of the binding signal
The signal from a ChIP-chip reaction is generated by analysing the fragments of
DNA crosslinked to the protein of interest. The bulk of the covalent links formed
through formaldehyde crosslinking in a ChIP reaction are thought to be protein-protein
(Schmiedeberg et al., 2009). This means that, for example, in cases of DNA looping,
DNA will be captured and registered as ’bound’ if it happens to localise near the protein
of interest. This will also happen with pieces of DNA that happen to be packaged in a
way that brings them close to the protein of interest. This is why it has been possible
to successfully map chromatin associated proteins such as Polycomb and Mod(mdg4)
using ChIP, despite the fact that they interact with DNA indirectly (Kwong et al.,
2008; Negre et al., 2010).
In any ChIP reaction there is therefore an unknown quantity of genuine signal that is
not indicative of direct DNA binding and this may account for some of the variability
reported for immunoprecipitation reactions. It has also been reported that formalde-
hyde crosslinking fails to capture transient interactions (ones where the protein binds
for less than 5 seconds) that are detected using fluorescence techniques in live cells
(Schmiedeberg et al., 2009). This is not a problem if the functional role of a protein
requires it to stay in one place for a while, but might be problematic if the biologically
interesting protein-DNA interactions happen to be transient.
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It is therefore inevitable that even with appropriate controls, in every ChIP-chip reac-
tion there will be at least some false positives detected (pieces of DNA in the proximity
of, but not bound by, the protein of interest) and some false negatives (transient inter-
actions not picked up by the crosslinking). Furthermore, in contrast to chromatin from
homogeneous sources such as cell lines, when using whole animals, such as Drosophila
embryos, there is a mixture of tissues, and thus the final signal from a ChIP-chip
reaction will be averaged over developmental time and across multiple tissues.
A DamID reaction involves isolating and amplifying the methylated DNA labelled by
the Dam methylase enzyme fused to the protein of interest. This is likely to mean
that some degree of direct physical proximity is required for methylation to take place,
perhaps reducing some of the spurious signals from neighbouring but unbound regions.
The protein being studied does not need to directly bind DNA, and DamID, much like
ChIP, has also been successfully applied to Polycomb (Tolhuis et al., 2006). However,
it still seems plausible that because the Dam methylase does need direct access to
DNA, the signal might be more selective compared to a ChIP reaction where a range
of proteins can be crosslinked to each other. However, in the absence of systematic
studies, this is purely speculative, and to date, only a small number of appropriate
ChIP-chip and DamID datasets have been available for comparison. The data were
found to match well for GAGA factor and Polycomb group proteins (Negre et al., 2006;
Tolhuis et al., 2006; Moorman et al., 2006), but a more in-depth analysis of ChIP and
DamID differences would be of general interest.
E. coli Dam methylase is extremely processive (Urig et al., 2002), meaning that high
levels of the Dam protein can result in substantial tracts of methylated genomic DNA
and thus in poor resolution (van Steensel et al., 2001). To compensate for this, the
Dam-protein fusion construct is generally regulated by an inducible promoter, such
as UAS or Hsp70, with the construct used under uninduced conditions. The leaky
expression from the uninduced promoter provides a suitably low quantity of enzyme
to leave a specific methylation signal: induced expression results in rapid methylation
of substantial portions of the genome (van Steensel and Henikoff, 2003).
The sensitivity of the enzyme may be an advantage; it has been suggested that the
transient interactions not captured by ChIP may be identified with DamID (Wolffe
and Leblanc, 2000). However, this has not been tested to date. On the other hand, the
inability to drive the construct in a tissue-specific manner means that the signal might
be unusual. The construct is expressed ubiquitously, in a range of cells and with a
range of partner TFs that the target TF might be capable of interacting with, but may
normally never encounter in wild type embryos: the effects of this on binding patterns
are unknown. In addition, even under low level expression conditions the processivity
of the enzyme means that methylated regions can be quite broad, possibly having a
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negative impact on the resolution of the experiment. Another compounding factor is
that the enzyme methylates the GATC sequence, which may not be evenly distributed
across the genome, resulting in varying probabilities of methylation.
3.1.5 Controls
A control commonly used for ChIP-chip is an antibody that does not specifically inter-
act with any specific Drosophila protein, such as β-galactosidase or IgG. This should
pick up chromatin regions that are particularly prone to unspecifically binding to any
antibody and provide a general picture of the stochastic noise inherent in an immunop-
urification. The importance of this control has been demonstrated in a number of
studies (Johnson et al., 2008; Birch-Machin et al., 2005). The controls are also crucial
because antibody specificity is generally not known - in a recent study of over 200
commercially available histone modification antibodies, it was found that more than
25% failed specificity tests by dot blot or western blot (Egelhofer et al., 2010). This
highlights the importance of including specificity controls as part of ChIP experimental
design. However, while the presence of this control undoubtedly improves data qual-
ity by removing a number of false positives, it does not remove the other previously
discussed sources of noise inherent in ChIP data.
The control for DamID experiments is a Dam only protein not fused with a TF, which
should leave methylation tags in areas that are likely to be unspecifically methylated,
again eliminating some of the false positives. It is known that some parts of DNA
will be more accessible than others and also that the fusion protein will sometimes
bind to unspecific locations. However, it is thought that the methylase only control
successfully cancels out these effects. It is unclear whether the methylation tags stay
attached permanently after the DNA is tagged, or whether their occupancy can change
more dynamically over time. This could have an impact on the signal but, in theory,
as long as the developmental time periods are the same for the sample and the control,
the control should still be effective. However, this is another area where a systematic
study of DamID could prove helpful.
For both ChIP-chip and DamID, an equal amount of labelled DNA is used for both
sample and control to make them comparable. This assumes that the quantity of DNA
pulled down in an IP (or methylated, in the case of DamID) is similar for both samples
and controls. In cases where, for example, the control has a lot less signal (a likely
scenario for proteins which display large amounts of specific binding), whatever sig-
nal is present in the control will become saturated from amplification, and will cancel
out any sample signal in those regions. While already an issue for some more active
transcription factors, this is likely to be an even bigger problem in the case of histone
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modification domains, which tend to display broader patterns (Liu et al., 2011). How-
ever, this is still the optimal method of matching sample and control DNA quantities.
Since both the sample and the control are subject to PCR amplification, differences in
amplification efficiency mean that combining the sample and control without matching
the DNA quantities would produce an unknown amount of variability. Though poten-
tially introducing false negatives due to signal saturation, the currently used technique
is unlikely to result in an increase in false positives, as it is the control rather than the
sample signal that is being potentially oversaturated. Ideally, a minimum of 3 repli-
cates is used for both techniques, which allows for reliable statistical analysis and also
means that dye swaps can be performed for two colour arrays, countering the different
dye incorporation and detection efficiencies.
3.1.6 Experimental noise
Some of the potential sources of experimental noise for ChIP-chip and DamID have
been discussed above. Human error can also have a significant impact on results; results
are variable for the same experiments performed by different people or even by the same
person at different times. It is therefore helpful in the case of Dichaete that several
datasets are available, since while some experimental variability is expected, trends
occurring consistently across datasets are likely to be genuine. Different tiling arrays
have been used for different experiments, which could be another potential source of
variability, though the best systematic study done to date suggests that this is not
a major contributor to variability (Johnson et al., 2008). The variability in the data
analysis output of different pipelines and from different starting analysis parameters is
also an issue.
A difficult choice is therefore presented: either to use very stringent thresholds to
eliminate false positives but generate a large number of false negatives, or to make the
threshold less stringent, which introduces a number of spurious peaks. The advantage
of using ChIP and DamID in combination is that the assays are fundamentally different.
Therefore, while both the techniques are expected to show noise, it is also reasonable
to expect that the noise profile will differ between techniques. There is no reason to
suggest that the regions of chromatin that non-specifically interact with antibodies
should be the exact same regions that get non-specifically methylated by the Dam
fusion but not removed by the Dam only control. Therefore there is potential to
use these complementary techniques in combination to identify genuine patterns of
Dichaete action across the genome.
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3.1.7 A systematic comparison
The situation of having multiple binding datasets available for a single protein is an
interesting and fortunate one. First of all, it allows us to cross-validate, checking which
binding regions are likely to be genuine and which ones are variable, and potentially
a product of experimental noise. This makes multiple datasets helpful for extracting
biological insights from data. The quality of the individual datasets as a whole can also
be assessed by comparison with the other datasets, and by the presence or absence of
expected patterns in different types of analysis. Furthermore, a systematic comparison
of ChIP-chip from different labs in combination with DamID is valuable in assessing the
utility of such mixed datasets in general, making an interesting technical comparison
possible. In addition, results from the same analyses performed on developmental
time windows of different lengths could be interesting for determining what type of
ChIP-chip experimental design is most suited for future genomics studies. The main
motivation for this chapter is to assess the quality of the available data, with the
intention of figuring out the best way to use it for the purpose of further elucidating
Dichaete biology. A variety of genomics analyses were therefore performed using all 4
datasets, partly for purposes of comparison and partly as a pilot screen to see which
analysis paths are likely to be worth pursuing.
The existence of high throughput data generation initiatives such as modENCODE
(Celniker et al., 2009) means that smaller labs and individual researchers worldwide
have access to a large number of genome-wide datasets to use alongside the ones they
generate themselves. In addition, a large number of genome-wide datasets from indi-
vidual studies exist in the public domain, and this number is likely to greatly increase
in years to come. Therefore the question of how to integrate and effectively use such
datasets is a timely and relevant one.
3.1.8 Chapter overview
This chapter discusses the results derived from my Dichaete DamID experiment, com-
paring and contrasting it to 3 available Dichaete ChIP-chip datasets. For this analysis
I discuss the properties of each dataset as a prelude to generating a high confidence
set of Dichaete targets, which is discussed in the next chapter. I first focus on the
genome-wide patterns of binding: whether the Dichaete binding sites are likely to hit
genic or intergenic regions, introns or exons, and how far away they are from transcrip-
tion start sites. The Dichaete sequence specificity is then studied in more detail, using
motif finding and scanning tools. In the final section, Dichaete data is compared with
some common genomic markers, the involvement of Dichaete in polymerase pausing is
investigated, some potential coregulators are identified from enriched sequence motifs,
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and the impact of chromatin accessibility on Dichaete binding is assessed.
3.2 The DamID experiment
When I first began my PhD, while some individual ChIP-PCRs had been done, no
genome-wide binding datasets were available for Dichaete. Therefore, one of the initial
aims of my project was to perform both ChIP-chip and DamID. However, multiple
attempts at ChIP-chip yielded very noisy and unusable data due to the quality of
the antibody. In the meantime, 3 separate ChIP-chip datasets became available for
Dichaete, as generated by BDTNP and modENCODE (MacArthur et al., 2009; Cel-
niker et al., 2009). Consequently, I instead focused on generating a DamID dataset,
then using it together with the existing ChIP-chip datasets for an analysis of the role
of Dichaete during early embryonic development.
3.2.1 Experimental design
For the DamID experiment, two genetic constructs were used. For the sample signal,
Escherichia coli Dam methylase was attached to the Dichaete protein and for the
control the Dam methylase on its own was included in the same vector. Both the
vector constructs and the fly strains were created by Riaz (2009) as part of his PhD
work in the Russell lab. The pUAST vector was used in both cases (Phelps and Brand,
1998), putting the transgenes under the control of a UAS promoter. A schematic of the
constructs used is shown in Figure 3.1. A Drosophila melanogaster full-length kayak 3-
untranslated region (3-UTR) was incorporated into the transformation constructs with
the hope that its destabilizing influence will reduce the half-life of the transcripts and
accordingly the total quantity of methylase present. The motivation for this was that
reducing the quantity of methylase present at any one time should ameliorate the effects
of Dam processivity, potentially improving the data resolution and specificity.
The fly strains UAS-D-ED-3, with the Dichaete-Dam fusion inserted on chromosome 3,
and UAS-ED-2a, with the Dam methylase control construct inserted on chromosome 2,
were used. Since the flies were homozygous for the construct, no crosses were required,
and instead embryos were collected directly from the fly strains in question.. Embryos
between 0 - 12 hours old (stage 1-15) were collected for the experiment. This was
considered to be an interesting developmental period, covering several periods during
which Dichaete is thought to be developmentally active, such as segmentation and
embryonic nervous system development. It also complemented well the existing ChIP-
chip datasets, all of which were generated from embryos at ages somewhere within this
developmental window. DNA was extracted and specific restriction digests were used
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Figure 3.1: Schematic of constructs used in the DamID experiment, figure from Riaz
(2009).
to enrich the methylated fragments of the genome as described in Chapter 2. The
DNA was then amplified, labeled with fluorescent Cy3 and Cy5 dyes, and hybridised
to NimbleGen Drosophila melanogaster ChIP-chip 2.1M Whole-Genome tiling arrays.
The data was processed using NimbleScan and the TiMAT pipeline, using quantile
normalization separately on the samples and the controls. The data was quality checked
using a variety of diagnostic plots (R scripts written by Bettina Fischer).
3.2.2 Results
The raw data scatterplot (Figure 3.2) shows that the 3 Dichaete biological replicates
are very similar to one another and that the 3 methylase only control replicates are
also very similar to one another, which is encouraging. It also shows that the Dichaete
samples are very different from controls, which is as expected: an active transcription
factor leaving a specific trail in the genome should look quite different from unspecific
methylation.
As shown in the density plot in Figure 3.3, the sample and control have quite distinct
data distributions. The motivation for using normalization that deals with the sample
and the control signals separately, is that one that normalizes them together presents
a danger of normalizing away too many of the genuine differences between the two
signals: as seen in the bottom part of Figure 3.3, the method used normalizes the two
signals, while keeping their distinct distributions intact.
The number of intervals found (Table 3.1) is comparable to the Dichaete data from
other studies (MacArthur et al., 2009), confirming the view that Dichaete binds to
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Figure 3.2: Dichaete DamID raw data scatterplot
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Figure 3.3: Dichaete DamID raw (above) and normalized (below) data density plot.
Data from all 3 biological replicates is shown separately in the raw data plot. During
normalization, the data from the different replicates is combined, with the data from
the 3 samples treated together, and separately from the 3 controls. Thus the bottom
chart shows two lines - one for the combined ’sample’ data, the other for the combined
’control’ data.
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thousands of locations across the genome. The comparison of the numbers and lengths
of intervals found in different Dichaete binding datasets is presented in detail in Section
3.3 of this chapter (Table 3.3 gives an overview of the figures). Encouragingly, the
resolution of the DamID experiment seems to be excellent and very much comparable
to ChIP-chip studies that use similar platforms, and shows an improvement to the
resolution of comparable DamID studies performed in the past. For comparison, a
whole embryo DamID experiment performed by Choksi et al. (2006) using a Prospero-
Dam fusion was reanalysed using the same analysis settings that were used for Dichaete
DamID, and the average interval length was found to be 2606 bp for FDR 1% and
3279 bp for FDR 25% - a resolution much lower than the Dichaete DamID one. The
comparative improvement in resolution may be due to the addition of the destabilising
kayak 3’-UTR region, or by the use of an improved tiling array platform (the Prospero
paper uses a custom-made tiling array, with a 60-mer every 300 bp). Further analysis
of the Dichaete DamID dataset will be presented later in the chapter, alongside the
analysis of the Dichaete ChIP-chip datasets.
False Discovery Number of Average interval
Rate (%) intervals length
1% 4342 1688 bp
5% 5989 1835 bp
10% 7437 1940 bp
25% 12301 2359 bp
Table 3.1: Dichaete DamID dataset overview
3.3 Integration of Dichaete binding datasets
3.3.1 Data used
The following data (shown in Table 3.2) was used for further analysis. In the case of
Dichaete, 3 different ChIP-chip datasets have already been published. Dichaete ChIP-
chip data was generated from 2-3h old embryos by the Berkeley Drosophila Transcrip-
tion Network Project (MacArthur et al., 2009), and with chromatin from 0-8h and
0-12h old embryos by the modENCODE project (Celniker et al., 2009). The Dichaete
DamID data generated using 0-12h old embryos provides a fourth dataset.
3.3.2 Processing methods
The Dichaete DamID (D Dam) was run on NimbleGen arrays, processed first using
NimbleScan (version 2.4) for spot-finding, then the TiMAT pipeline for peak finding,
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using quant2 normalization, a 675 bp scanning window, min 5 probes and a 200 bp
maximum gap. The BDTNP Dichaete ChIP data (D Berk), generated using Affymetrix
arrays, was downloaded from the BDTNP website - the intervals at FDR 1% and FDR
25% found using symmetric-null test normalization were used. The analysis method
is described at length in the associated publication (MacArthur et al., 2009). For
the modENCODE data (D08 and D12), also generated using Affymetrix arrays, the
original plan was to use the intervals as processed by the modENCODE consortium.
However, for each of the two datasets, while the raw data was available, only one
interval file existed, with ambiguous labelling (it was unclear how the intervals were
obtained, and whether the threshold was FDR 1% or FDR 5%). The modENCODE
data was therefore reanalysed, in order to obtain binding intervals with more certainty
regarding the data processing method and the contents of the interval files. Starting
from the raw data (.CEL files), the modENCODE datasets were reanalysed using the
TiMAT pipeline, using default window size of 675 bp, number of oligos in a valid
window of 10, and maximum gap of 200 bp. The normalization method used was
quant (quantile normalization across samples and controls together). The BDTNP
data was not included in the reanalysis, and was instead used as processed in the
original publication. The reason for this was that the data processing method used for
the dataset in question was robust, well tested and well documented, so the resulting
final data was deemed trustworthy enough to processed with as is. In contrast, the
modENCODE data processing was badly documented, so the reanalysis was performed
in order to know with certainty what methods and thresholds were used, before basing
extensive downstream analysis around the processed data.
3.3.3 Parameter sensitivity analysis
For the modENCODE data, the default TiMAT settings were used: quant normal-
ization, a 675 bp scanning window, min 10 probes (because Affymetrix rather than
NimbleGen arrays were used, there is a larger number of shorter probes present) and
Dataset Name Method Development Source
time
D ChIP 2-3h D Berk ChIP-chip 2-3h embryo BDTNP
(MacArthur et al., 2009)
D DamID 0-12h D Dam DamID 0-12h embryo My data
D ChIP 0-8h D08 ChIP-chip 0-8h embryo modENCODE
(Celniker et al., 2009)
D ChIP 0-12h D12 ChIP-chip 0-12h embryo modENCODE
(Celniker et al., 2009)
Table 3.2: Dichaete datasets used for analysis
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a 200 bp maximum gap. It was then thought that analysing all the datasets using the
same pipeline and the same settings would be helpful in terms of making the different
datasets more comparable. However, reanalysing the DamID data using quant instead
of quant2 normalization unexpectedly resulted in 0 instead of the 4000 - 12000 binding
intervals previously identified. The way quantile normalization works in general, is by
ordering the intensity values on each array from lowest to highest, then changing the
values at each rank position into an average for that rank (Russell et al., 2009). If done
across all arrays, this means that the intensity distribution of all the arrays becomes
identical. The difference between quant and quant2 is that quant applies the normal-
ization across all arrays, whereas quant2 applies quantile normalization to samples and
controls independently. If the sample and control signals are expected to have a similar
distribution, it makes sense to normalize across all arrays. However, this is not the case
with the DamID data, so quant normalization appears to normalize away much of the
genuine signal. The DamID data shows high similarity between biological replicates,
so it was not thought that the data quality was in question. Also, quant2 normalized
data finds binding intervals with a high overlap with other Dichaete datasets and an
overrepresentation of genes considered to be likely Dichaete targets. It was therefore
concluded that the normalization method chosen for a particular data set is dependent
upon the characteristics of the data and it is prudent to explore different methods with
each data set generated.
Out of the 3 datasets reanalysed, the dramatic difference in intervals found due to
alternative normalization methods was only observed with the DamID data. However,
other parameters were also found to affect the number of intervals found by the pipeline.
The maximum gap parameter is normally set to the default 200 bp, and it was found
that varying it only results in minor fluctuations to the number of intervals found. The
same was found for the minimum number of oligos, with the results of these analyses
shown in Figure 3.4.
On the other hand, the size of the sliding window was found to have a large effect on
the number of intervals found (as shown in Figure 3.5), most likely because using a
small window results in the identification of a large number of small clustered intervals,
whereas a large window registers these clusters as a single large interval.
Unfortunately, while it is clear that the initial TiMAT parameters do influence the
result of the analysis, determining which parameters give the more genuine signal is
not possible due to the lack of further experimental data about verified Dichaete binding
sites. In addition, as previously discussed, datasets with different distributions may
require different analysis tools and parameters to extract the best results. Therefore a
single set of optimal settings for all datasets is unlikely to exist, and in any event it may
be hard to tell which results should be considered the best. As a pragmatic solution,
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Figure 3.4: Influence of TiMAT maximum gap and minimum oligo parameters on
the number of binding intervals found
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Figure 3.5: Influence of TiMAT sliding window size on the number of binding intervals
found
the default settings were used wherever possible, adjusting the minimum oligo number
according to the microarray platform (10 for Affymetrix, 5 for NimbleGen), and using
quant2 instead of quant for DamID.
3.3.4 Processed data overview
The number of intervals identified in each dataset is shown below in Table 3.3. The
high stringency intervals were found at FDR 1% for all datasets except D08, where
FDR 5% data was used because no peaks were found at FDR 1%. The low stringency
results for all datasets were found at FDR 25%. The high numbers of peaks found in
D Dam and D Berk datasets, while striking, are comparable to other developmentally
important transcription factors such as Kru¨ppel and hunchback (Li et al., 2008). The
modENCODE datasets (D08 and D12) give fewer peaks than the DamID and the
Berkeley data, but this is thought to be due to lower signal strength (perhaps due
to lower quality antibodies) rather than an abundance of false positives in the other
datasets (as the high overlap between D Dam and D Berk suggests that they both give
a reliable picture of Dichaete binding).
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dataset FDR Number of Average interval % of genome covered
intervals length (bp) by binding intervals
D Berk 1 6452 1885 10.1
D Dam 1 4342 1688 6.1
D08 5 1366 1002 1.1
D12 1 208 1025 0.2
D Berk 25 16501 1989 27.4
D Dam 25 12301 2359 24.2
D08 25 6493 1225 6.6
D12 25 538 1160 0.5
Table 3.3: Dichaete binding intervals
Interval lengths
The interval lengths for the 4 available Dichaete datasets at different FDRs are shown
in Table 3.3. While there are reasons described above why DamID may generate lower
resolution data than ChIP-chip, in this instance this does not appear to be the case
at more stringent thresholds. Although the DamID does give the broadest intervals
at FDR 25%, they are comparable to the length of the Berkeley ChIP-chip data at
the same FDR (with differences possibly due to the use of different arrays/analysis
pipelines, rather than a major difference in the resolution of the techniques). At the
FDR 1% threshold, the resolution of DamID even appears to be slightly higher than
that of Berkeley ChIP (though, again, differences could be due to arrays/analysis
pipelines and a direct comparison is difficult because of potential differences in binding
patterns at different developmental stages). The modENCODE datasets have a much
narrower interval length than the Berkeley and DamID datasets, but this may be due to
the fact that the signal is generally weaker and thus the peaks appear narrower.
Overlap
Because of the slightly different stages of development and different methods used,
some difference in binding intervals identified is expected. However, there should still
be a significant overlap between the datasets if they represent bona fide Dichaete
binding locations, and this was indeed found to be the case. The resampling-based
significance test implemented in the Cooccur package (Huen and Russell, 2010) was
used to determine the significance of overlap between the different Dichaete datasets.
All the datasets with significant overlap (p-value < 0.05) are shown as connected
in Figure 3.6. All the datasets with comparable numbers of intervals were found to
significantly overlap. The D12 dataset has much fewer intervals compared to all other
datasets, so a possible reason for the absence of significant overlap with the other
datasets is simply a lack of statistical power. A look at the actual overlap numbers
62
shows that between 77% and 85% of D12 overlap with D Berk, which confirms that the
lack of statistical significance is caused by the small number of intervals rather than
a lack of overlap. This seems to indicate that the D12 dataset is likely to be specific
to Dichaete, but just has a signal so weak that most Dichaete sites are not registered.
Nevertheless, all 4 datasets were used for further analysis, with caution applied when
interpreting the results from the D12 dataset.
3.4 Genome-wide view of Dichaete binding
3.4.1 Distance from transcription start sites
The 5’ end of genes, as annotated in FlyBase (Gelbart et al., 1999), was used as an
approximation of where the transcription start site is expected to be. The middle of
the highest scoring window from each interval was used as the binding site coordinate.
The analysis was only done for the high stringency intervals (FDR 1% for all datasets
except D08, for which FDR 5% was used), as the low stringency intervals were thought
to introduce too many false positives. On the graph, upstream locations are shown
as negative values and downstream locations are shown as positive values (Figure
3.7).
The distance of the peaks from the closest transcription start site found within 5 kb
is shown in Figure 3.7. Since histograms can be misleading depending on the number
of bins used, the density curve is also shown. All 4 datasets show a similar trend,
with peaks found close (within 500 bp) to transcription start sites, but the trend is
more pronounced in the D Berk and D08 datasets. None of the datasets are normally
distributed (p-value between 9E−5 and 2.2E−16 for all datasets, Shapiro-Wilk test), so
non-parametric tests were used to compare their similarity. First, the Kruskal-Wallis
test was performed to find out whether the data distributions are the same for all
datasets. This was found to not be the case (p-value < 2.2E-16). The Mann-Whitney
U test was then used for pairwise comparisons of the datasets. The datasets that were
found to be significantly different from one another were D Berk and D12 (p-value
= 0.04), and D08 and D12 (p-value = 0.01), with the D Dam and D12 having the
borderline p-value of 0.06. This matches the previous conclusion that the D12 dataset
is significantly different from the other datasets, and may be unreliable. However, after
correction for multiple testing (Benjamini-Hochberg), none of the p-values are below
the 0.05 cutoff threshold, so the results were in the end not found to be significantly
different for different datasets.
The mean distances from the transcription start site for the D Berk, D Dam and D08
site were between 100 and 150 bp, suggesting that Dichaete frequently binds slightly
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Figure 3.6: Significance of overlaps of Dichaete datasets. Datasets significantly over-
lapping (p-value < 0.05) according to a resampling based test are shown as connected.
Dataset 1 Dataset 2 Dataset 1 Dataset 2
% overlap % overlap
D Berk FDR 1% D Dam FDR 1% 38% 60%
D Berk FDR 25% D Dam FDR 25% 50% 64%
D Berk FDR 1% D08 FDR 5% 17% 86%
D Berk FDR 25% D08 FDR 25% 26% 80%
D Berk FDR 1% D12 FDR 1% 2% 77%
D Berk FDR 25% D12 FDR 25% 3% 85%
D Dam FDR 1% D08 FDR 5% 15% 49%
D Dam FDR 25% D08 FDR 25% 31% 72%
D Dam FDR 1% D12 FDR 1% 2% 47%
D Dam FDR 25% D12 FDR 25% 3% 72%
D08 FDR 5% D12 FDR 1% 4% 27%
D08 FDR 25% D12 FDR 25% 5% 54%
Table 3.4: Interval overlap for different Dichaete datasets.
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downstream of the transcription start site. The median values were even smaller: 69,
29 and 73 bp, respectively. In the case of the D12 data, the mean was 406 bp, and the
median 268.
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Figure 3.7: Probability distribution of the distance to the closest transcription start
site
It is possible that, because the Drosophila genome is quite dense and gene rich, the
distance to the closest transcription start site would be short by chance. The same
analysis was therefore rerun to look at the distances from all transcription start sites
present within the 5 kb region (Figure 3.8). The graphs flatten out somewhat but there
still appears to be a trend with Dichaete binding close to the transcription start site,
particularly visible in the case of the D Berk and D08 data. The mean distance was
between 100 and 200 bp for the D Berk, D Dam and D08 data sets, and 350 bp for
the D12 dataset, with the median values being slightly smaller (between 110 and 160
bp for D Berk, D Dam and D08 data and 300 bp for D12).
The traditional model of transcription factor binding expects the TF to bind to a cis-
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Figure 3.8: Probability distibution of the distance of Dichaete peaks from all tran-
scription start sites within a 5 kb region
regulatory module upstream of the gene. The apparent tendency of Dichaete to bind
slightly downstream of the transcription start site may suggest a different regulatory
role, for example forming loops to bring other regulatory elements together, affecting
chromatin accessibility or facilitating RNA polymerase pausing. In the case of binding
very close downstream of the transcription start site, this may help keep the polymerase
poised, or might be targeting a genic enhancer element.
3.4.2 Gene hits
For each of the intervals, all directly overlapping genes were counted as gene hits. If
no direct overlaps were found for an interval, the closest gene within a 10 kb region
upstream or downstream was found and registered as a gene hit instead. The complete
list of Drosophila melanogaster genes (genome annotation version 5.26, downloaded
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from FlyMine) was used and the FBgn numbers were used as identifiers. It has been
observed that changes in gene names and genome annotation can lead to statistical
errors, which is why the most up to date version and the most stable identifiers were
selected.
dataset % FDR Total number Number of
of intervals genes hit
D Berk 1 6452 6258
D Dam 1 4342 2872
D08 5 1366 1529
D12 1 208 206
D Berk 25 16501 10726
D Dam 25 12301 8271
D08 25 6493 5517
D12 25 538 498
Table 3.5: Numbers of genes hit by Dichaete bound intervals
Further analysis was restricted to the high stringency intervals (FDR 5% for D ChIP 0-
8h, FDR 1% for all the other ones) in order to minimise the number of false positives:
with the FDR 25% intervals, particularly in the case of the Berkeley data, the major-
ity of the genes in the Drosophila genome are hit, and while this is likely to capture
most Dichaete targets, it is also likely to have too many false positives to be informa-
tive.
The gene list overlap for the high stringency datasets is shown in Figure 3.9 below
(graphic generated using the Venny tool. Oliveros, 2007). In total, 6918 genes were
flagged in at least 1 of the 4 datasets. 3026 genes were hit by intervals from 2 or more
datasets, 829 by 3 or more, and 92 by all 4 datasets.
Figure 3.9: Gene list overlap
While the list of genes hit by all 4 datasets is obviously too stringent, it nonetheless
gives an interesting list of candidate targets. Out of the 92 genes, 25 are annotated
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as putative transcription factors in FlyTF (Adryan and Teichmann, 2006) (p-value
<2.2E-16, Pearson’s χ2 test) and 30 are involved in nervous system development (p-
value = 1.1E-10, as calculated by FlyMine, after Benjamini-Hochberg correction for
multiple testing).
It is likely that the list of genes hit by all 4 datasets is far too stringent, and that the
list of genes hit by only 1 dataset contains false positives. Nonetheless, 149 of the same
GO terms were found to be statistically significantly enriched (p-value < 0.05 after
correction with Holm-Bonferroni, FlyMine) in all 4 individual gene lists. The details
of the GO enrichments found are shown in Table 1, Appendix 1.
In order to provide a more simplified and general overview of the processes in which
Dichaete is involved, the 4 gene lists were evaluated against the subset of GO terms
provided by the Panther database (Mi et al., 2005) GO slim list using Ontologizer
(Bauer et al., 2008) for analysis and visualisation. Resulting p-values were corrected
for multiple testing using Benjamini-Hochberg. The GO enrichments for genes hit by
at least 3 of the 4 data sets are shown in Figure 3.10.
The overrepresentation of genes involved in transcriptional regulation is expected, given
the high number of transcription factors hit by all of the Dichaete datasets. The
overrepresentation of genes involved in developmental processes is also expected, given
the known Dichaete mutant phenotypes. Genes for localization and cell communication
could be some of the targets through which Dichaete exerts control during development.
The presence of apoptosis and cell cycle regulation is particularly interesting given
the role Sox2 plays in mammals to maintain stem cell pluripotency. It appears that
Dichaete may perform a similar function at some point during fly development.
It has been reported that differences in gene length and the genomic spacing around
them result in biases in gene assignments derived from binding data, featuring for
example more transcription factor and nervous system genes, because these are on
average longer and easier to hit (Taher and Ovcharenko, 2009). Since these are exactly
the processes identified in this analysis, this means that the p-values presented here
are certainly overinflated. However, it is still certain that these are high confidence
gene hits, as they are identified a number of times in independent Dichaete datasets.
Further to that, they seem to constitute a reasonable proportion of the total hits of the
same stringency - about a third of the total list are nervous system development genes,
and about a quarter are transcription factors. However, it is important to note that
because of the gene length bias, the relative importance of transcriptional regulation
and nervous system development compared to other processes that Dichaete is taking
part in is likely overestimated.
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3.4.3 Genomic features hit
The mean length of the regions of enrichment in each dataset was, even at stringent
FDR values, still between 1 and 2 kb, which means that the span of each interval
tends to encompass a range of genic and intergenic regions. Therefore for this analysis
individual nucleotide positions were used instead of the whole interval. In order to use
a point that is more likely to be representative of Dichaete binding site locations, the
middle of the highest scoring window in each interval was used.
It was found that Dichaete binding is mostly associated with genic regions (Figure
3.11). Of the peaks mapping to genic regions, the majority were located within introns.
While the traditional transcription factor binding location is just upstream of genes,
it is possible that Dichaete binding in the middle of introns also has a regulatory
role. A further two pieces of analysis were conducted: one to determine whether there
is a link between the quantitative information from ChIP-chip experiments and the
location of binding, as suggested by BDTNP (MacArthur et al., 2009), and the second
to determine whether different Dichaete binding profiles clearly correspond to different
classes of genes.
3.4.4 Quantitative binding information
MacArthur et al. (2009) report that high scoring peaks correlate with intergenic and
intronic hits, which they claim are more likely to be functional regulatory sites. An
analysis was performed to verify that the reported trend exists for the D Berk data, and
to see whether a similar phenomenon can be observed for the other available datasets.
For the Berkeley data, the scores for each symmetric null analysed primary peak were
used for ranking. For all the other datasets, the score of the highest ranking 675 bp
window from each interval was used. The points were used in rank order to determine
which genomic features were hit, with the highest scoring intervals having the lowest
rank numbers. To determine whether trends for binding to particular genomic features
differ based on rank, probability densities were plotted for all 4 datasets, using a window
of 100 rank places for smoothing. Only features that could be unambiguously mapped
to one ’type’ were used for the analysis.
For the D Berk, D Dam and D08, the datasets do indeed show the reported trend -
the higher ranking intervals are more likely to land in intergenic regions (Figure 3.12).
There also appears to be a prevalence of intervals bound to genic regions in ’middle-
ranking’ (rank 1500-2500) peaks for D Dam. The D12 dataset does not display the
same trend, possibly because the small number of peaks and general weakness of the
signal mean that the quantitative peak data is not as informative as it is for the other
datasets. To support the conclusions drawn from the graphs, Wilcoxon tests were
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Figure 3.11: Genomic features hit by different Dichaete datasets
71
performed to verify whether there is a significant difference between the distributions of
peak ranks for genic and intergenic regions, and the p-values were corrected for multiple
testing using an estimate of FDR. The results support the conclusions drawn from the
graph patterns - D Berk, D Dam and D08 all show significant differences between the
rank distributions for genic and intergenic regions (with corrected p-values of 0.004,
0.004 and 0.01, respectively). These results mean that there may be some form of link
between quantitative ChIP information and in vivo binding patterns.
The Berkeley data does display the reported trend of more highly ranked peaks binding
in introns and intergenic regions, and the lower-ranking peaks binding to exons, as does
D Dam, and to a much smaller extent D08 (Figure 3.13). Interestingly, while Figure
3.12 shows significant differences between the ranks of peaks hitting genic and intergenic
regions, Figure 3.13 suggests that most of the difference is due to the exon hits having
much lower scores, and contributing to the lower rank of genic hits as a whole category,
while the difference between the intron and intergenic hits does not appear significant.
Statistical tests verify the latter observation - the only dataset showing a significant
difference between intron and intergenic hits is D Berk (Wilcoxon test, Bonferroni
adjusted p-value = 0.0002). In the case of D Berk, the trend is interesting - while the
very top ranked intervals are intergenic hits, a number of the slighty lower (but still
high scoring) intervals appear to be intronic hits.
What these trends mean is unclear. Assuming that exon hits are unlikely to be func-
tional sites (an assumption that may or may not be valid), the fact that most exon
hits come from low scoring peaks perhaps suggests that higher scoring peaks are more
reliable ’hits’, and the lower scoring peaks are false positives. If the peaks in question
are not in fact false positives, then it is possible that they correspond to sites that
are not of functional significance and are only occasionally bound by Dichaete when
they are accessible, while higher scoring peaks correspond to more strongly preferred
sites that are more frequently bound in different cells and at different developmental
times. However, while we could potentially filter out non-functional hits based on low
scores, it is unclear that this strategy is based on a solid premise. In terms of the
difference between intronic and intergenic binding - this difference for the most part
seems to be non-existent. It is clearly a significant difference in the D Berk dataset,
and this could hypothetically correspond to different profiles of binding sites generating
different ranges interval scores, with the D Berk dataset perhaps picking up on these
because of the tight developmental time window used for the experiment.
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Figure 3.12: Probability density of the genomic features hit by different Dichaete
datasets, based on the rank of the intervals in question. The highest scoring intervals
in a set have the lowest rank numbers - for example, the highest scoring interval in each
set has the rank ’1’. Note that the axes are different between the different graphs -
because both the numbers of intervals and the probability distibutions are very different
between datasets, the axes were adjusted to visualise clearly what’s happening within
each individual dataset. From the graphs we can see that D Berk, D Dam and D08
all show the same trend, where the higher ranking intervals are more likely to land in
intergenic regions. The D12 dataset does not display the same trend.
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Figure 3.13: Probability density of the genomic features hit by different Dichaete
datasets, based on the rank of the intervals in question. Only peaks that could be
unambiguously mapped to one particular type of genomic feature were included in
the analysis. The highest scoring intervals in a set have the lowest rank numbers -
for example, the highest scoring interval in each set has the rank ’1’. The axes are
different between the different graphs, because both the numbers of intervals and the
probability distibutions are very different between datasets, the axes were adjusted to
visualise clearly what’s happening within each individual dataset. From the graphs we
can see that in D Berk and D Dam , and to a lesser extent in D08, exon hits tend
to be associated with very low scoring peaks, compared to intergenic and intron hits.
While the intergenic hits still appear to be the highest scoring, the difference between
intergenic and intronic hits does not appear to be that large. The D12 dataset does
not display any differences in trends for the different feature types.
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3.4.5 Genes targeted by Dichaete binding to different genomic
features
The peaks from each dataset were divided into 3 categories - intergenic, introns and
exons. The peaks with ambiguous assignments, hitting both introns and exons, were
ignored. Gene lists were then generated for each of the categories and GO enrich-
ment analysis was performed to determine whether different genomic binding locations
correspond to different classes of genes.
The GO enrichment data for D12 exon hits is not shown because no significant enrich-
ment was found (likely due to the small number of genes in the category). For the other
datasets, the heat map of enrichments is shown in Figure 3.14. The clustering and heat
map results are ambiguous. The D Dam and D Berk datasets show similar profiles for
introns and intergenic hits, with genes with intron hits performing more roles, such as
cell cycle regulation and cell communication. In addition, it seems to be specifically the
genes with Dichaete exon hits from these 2 datasets that perform cellular component
organisation and biogenesis. For the other two datasets (D08 and D12), their introns
also show a profile similar to each other, but distinct from the Berkeley and DamID
data (and more similar to their intergenic hits profile). On the whole, very few genes
are hit in exon regions in 3 out of 4 datasets, and therefore they show few or no GO
enrichments. In the case of the Berkeley data, large numbers of exons are bound, giving
a distinct enrichment profile. This raises the possibility that some blastoderm-specific
regulation is happening through Dichaete exon binding. Alternatively, exon binding
may be transient and tissue specific and therefore not picked up in datasets looking at
longer time periods of development.
Cell cycle genes seem to be specifically targeted in D Berk data, specifically with in-
tergenic or exon rather than intron binding. Transient exon binding might be related
to regulating transcription through PolII pausing, or perhaps to bringing regulatory
elements together through DNA looping. Cellular component organisation genes seem
to be targeted by both D Berk and D Dam exons, though the reason for this pattern
is unclear. On the other hand, transcription related genes seem to be hit specifi-
cally in intronic and intergenic regions rather than in exons, suggesting that perhaps
Dichaete is regulating them in a more traditional fashion via upstream regulatory re-
gions and/or through facilitating PolII poising. Cell cycle regulation genes seem to be
targeted specifically through intronic regions, as do genes for regulation of translation
and ectoderm development. It is worth noting that one of the few verified Dichaete
targets, the slit midline enhancer, is located in an intron.
It is interesting that the D Berk and D Dam datasets show more similarity to one
another, than the D Dam dataset shows to D08 and D12, which were done on a much
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more similar time scale. This suggests that the different collection times, while perhaps
contributing to, are not the main determinant of the differences between the datasets.
As far as the ChIP-chip datasets go, they appear to cluster somewhat by lab - this might
be due to the antibody used in each case, or to different labs using different fixation
times or other distinct protocol modifications, or to variability caused by different
researchers performing the experiments. The similarity between D Berk and D Dam
is extremely encouraging, particularly given both the different techniques used and the
different developmental periods studied. While it is difficult to assess the validity of any
one data set without a larger pool of solid validated reference points, this nonetheless
seems to suggest that D Berk and D Dam are reflective of bona fide Dichaete binding
patterns.
Figure 3.14: GO enrichments for Dichaete intervals hitting different genomic features
(significant p-values are shown in red)
3.5 Dichaete sequence specificity
3.5.1 De novo motif finding
Dichaete is a sequence specific transcription factor and a binding motif sequence from
a bacterial 1-hybrid experiment was already available in the JASPAR database (Bryne
et al., 2007). De novo motif searching was also performed using the NMICA software
(Down and Hubbard, 2005) with the available Dichaete datasets. NMICA is a highly
sensitive but computationally intensive algorithm for finding overrepresented sequences,
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so a selected subset of binding intervals was used in order to keep the computational
time reasonable. The motif searches were run twice, using the best 100 and the best
200 peaks from each dataset at FDR 1% (FDR 5% in the case of D08). A subset of
the peak intervals, 300 bp around the highest scoring window within each interval, was
used. The top 15 motif hits of length of 6 - 10 bp were found in each search. One of
the searches using the D Berk dataset revealed a position weight matrix very similar
to the reported JASPAR motif, adding validation from in vivo data to the bacterial
1-hybrid experiment: the two motifs are presented in Figure 3.15. This is therefore
likely to be a genuine Dichaete binding motif.
Figure 3.15: The Dichaete motif found from the top 200 peaks of the D Berk ChIP-
chip dataset, compared to the known one from JASPAR
While the motif found is very similar to the previously known sequence, which is
encouraging, it is also notable that nothing at all similar to the Dichaete motif was
found through searches with the other 3 datasets. There are several potential reasons
for this. As previously noted, the D Berk dataset reflects a tight developmental time
and could therefore be more indicative of precise Dichaete binding sites rather than
broad patterns of binding. This becomes more important when only a small selection
of peaks is used: the Dichaete motif needs to be overrepresented in a 300 bp region of
the selected highest scoring peaks in order to be found. Location shifts of the binding
position during development may result in the peak ’centre’ moving and the Dichaete
motif not being found. To an extent it is also a matter of chance since NMICA has a
stochastic element and the quantitative information used for selecting the top intervals
may not be indicative of their reliability and functionality. Therefore, while finding a
motif is encouraging, not finding one may or may not mean anything.
3.5.2 Overrepresentation of the Dichaete motif in Dichaete
binding regions
It is known from literature that while transcription factors often have sequence-specific
binding preferences, these are not always clearly causally connected to functionality.
Indeed, there are reported examples of functional conservation despite an absence of
sequence conservation. An example of this is the stripe 2 enhancer of eve, where
it has been demonstrated that both the binding site sequences and the location of
the enhancer sites have undergone a considerable degree of reshuﬄing between species,
77
with new mutations arising to keep the expression of eve constant (Ludwig et al., 2000),
demonstrating that sequence conservation and the presence of a particular binding site
sequence are not necessary for the conservation of enhancer function. Typically, while
the motif of a particular transcription factor will be highly represented in genome-wide
binding data, there will nonetheless be many regions where binding is detected despite
the absence of the transcription factor’s preferred sequence.
One explanation for these observations is that sequence specificity is not always required
for the binding of a particular transcription factor, but because of the increased affinity
of the TF for a particular sequence motif, it is more likely to end up in genomic locations
that contain the motif. Thus, if the presence of a particular TF was required in a
particular part of the genome for a critical function during development, while it is not
guaranteed, it is nonetheless expected that there would be an overrepresentation of the
TF binding motif at that location. On the other hand, the regions where the TF plays
a less critical role may have less of an overrepresentation of the binding motif.
Dichaete is a transcription factor that binds in the minor groove, which means it does
not have a physical ’view’ of the bases (i.e. the specific array of hydrogen bond donors
and acceptors) in the way that major groove binding transcription factors do (Tullius,
2009). Instead it is thought to rely on the electrostatic potential of the DNA backbone,
which varies due to the shape of the backbone being altered by the sequence of bases
attached (Rohs et al., 2009). Thus it is perhaps even more likely in this case that the
presence of the motif is an aid for location-finding rather than a crucial component of
Dichaete functionality. Nonetheless, looking at the patterns of motif occurrence might
give an indication of the reliability of the data and their presence might also highlight
some of the more important areas of Dichaete function.
Because in vivo data is thought to be more reflective of genuine transcription factor
biology than in vitro studies, the motif found from the D Berk data was used for
further analysis, rather than the JASPAR one. The motif scanning software nmscan
(part of the NMICA package) was used for scanning the interval regions for motif hits
(at the threshold -5, which was thought appropriate for this length of motif). In order
to assess the statistical significance of the overrepresentation of the Dichaete motif at
each interval, the columns of the Dichaete motif were randomly shuﬄed 10,000 times,
making sure they did not match the original motif, and the randomly generated motifs
were used to scan the intervals at the same settings. The numbers were then compared
to those for the original Dichaete motif and the p-values and z-scores were calculated.
(p-value of an interval was calculated as the proportion of random motifs that have
the same or greater number of ’hits’ in that interval as Dichaete).
The summary of results is shown below in Table 3.6. Notably, the method used to
simulate the ’background’ in order to assess the significance is likely to massively un-
78
derestimate the actual significance of the Dichaete motif overrepresentation - many of
the randomly generated Dichaete motifs are expected to be very similar to the original
motif, and therefore are expected to be similarly overrepresented in the binding regions
(giving unnecessarily low p-values). This does however mean that the intervals that
are flagged as significantly enriched for the Dichaete binding motif are certain to have a
substantial number of high quality matches (rather than that the intervals not flagged
as significant having none or few sites).
Dataset Total number Number of intervals Number of intervals with the D
of intervals with the D motif motif significantly enriched
D Berk 6452 5957 (92%) 1031
D DamID 4342 4001 (92%) 668
D08 1366 1206 (88%) 187
D12 208 181 (87%) 7
Table 3.6: Numbers of intervals with the Dichaete binding motif found
In total, 1473 genes are associated with at least one interval significantly enriched for
the Dichaete binding motif. The list includes usual targets, such as Hox genes, ac,
sim, prospero, miranda, cas, dpp, kuz, a range of transcription factors and other genes
involved in segmentation and nervous system development. The list contains 224 genes
involved in nervous system development (p-value 7.2948E−38), 104 genes involved in
cell fate commitment (p-value 1.348E − 28), 217 genes involved in the regulation of
gene expression (p-value 7.3101E−21) and 78 genes involved in segmentation (p-value
1.5141E−14), amongst others. In total, 30 genes have 5 or more (to a maximum of 7)
overlapping or nearby Dichaete binding intervals. This group of genes with Dichaete
binding clusters contains several transcription factors and is quite specific for nervous
system development: 6 of the genes in question are involved in neuroblast differentiation
and 14 are involved in regulation of gene expression. A network view is shown in Figure
3.16.
Interestingly, the majority of intervals hit intergenic regions in the cases of all 4
datasets, which was not the case for the datasets as a whole. It is therefore possi-
ble, accepting the caveats discussed above, that the binding locations containing an
overrepresentation of the Dichaete binding motif are active, functional binding sites,
whereas a subset of the binding sites that show no significant motif overrepresentation
might be non-functional sites.
3.5.3 Sequence specificity
The GC content of Dichaete binding peaks and surrounding regions was studied to
determine whether there are clear patterns in sequence composition associated with
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Figure 3.16: Genes hit by clusters of Dichaete binding. The genes associated with
5 or more Dichaete binding sites were uploaded to FlyMine (Lyne et al., 2007) and
imported into STRING 9.0 (Search Tool for the Retrieval of Interacting Genes/Proteins
Von Mering et al., 2005), the tool with which the network figure was generated. The
different line colours represent the types of evidence for the association, with the legend
shown in the top right corner.
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Dichaete. Only the high stringency binding intervals were examined: values were
found for 200 bp windows in a range of 5 kb upstream and downstream of the centre
of the highest scoring window of the interval (Figure 3.17).
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Figure 3.17: GC content of areas surrounding Dichaete binding peaks
Surprisingly, each of the datasets shows distinct but different GC profiles. The D Berk
and D12 datasets show the most similarity, with a rise in the % GC content at the
estimated binding site location and dips in GC content immediately adjacent to the
binding site. Interestingly, the D08 dataset shows the exact opposite trend, with a dip
in the GC content right in the middle of the binding site. The DamID GC profile looks
very unusual. It does not appear that the problem is in estimating the binding site
location, as the profile clearly shows a distinct pattern around position zero. However,
the pattern is unclear. It is possible that Dichaete binding sites at different stages have
different, distinct binding profiles, with some low and some high in GC content, and
the mixture of those profiles could conceivably give a graph such as that generated for
DamID GC content. As previously mentioned, there is a bias in the DamID signal, in
that for a signal to occur at all, GATC sites need to exist in the sequence around the
location in question. However, while this may explain a bias in the GC content of the
DamID data, it does not explain why different ChIP-chip experiments - D Berk and
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D08 - give very different results for GC content.
Looking at the level of variability in the data, it is also questionable whether just
looking at the mean is really fully informative, since it does not capture the range of
sequence variance. The collection of raw data for each interval is shown in Figure 3.18,
with the GC content of each interval plotted individually (200 bp window, within a
5 kb range). While looking at the raw data suggests that there does appear to be a
trend at the zero position compared to the remainder of the analysed interval, it is
also clear that just taking the average flattens much of the information. Consequently,
box plots were generated for each 200 bp window for each of the datasets, in order to
better visualise the sequence content trends.
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Figure 3.18: GC content of areas surrounding Dichaete binding peaks - raw data
It appears that the variance of the sequence GC content next to the binding site in data
sets B Berk, D Dam and D08 is visibly lower than that of the surrounding sequence
(Figure 3.19), suggesting sequence constraint in areas of the genome that Dichaete
binds. However, the exact specificity seems to vary from dataset to dataset, with
D Berk and D12 exhibiting a peak of higher GC content in areas of Dichaete binding,
but the D08 and D Dam apparently showing a drop in GC content (though in D Dam,
it is not obvious that the median is significantly different from that of surrounding
sequence). So while there appears to be a difference in the GC content of genomic
DNA in the vicinity of Dichaete binding sites compared to the surrounding sequence,
a clear trend cannot be deduced from these data.
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Figure 3.19: GC content of areas surrounding Dichaete binding peaks, with the
coordinate of the Dichaete binding peak labelled with a red line.
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3.5.4 Conservation
It has been suggested that the binding locations of important transcriptional regulators
are highly conserved across closely related species, as exemplified in the case of Twist
(He et al., 2011). An alternative hypothesis is that the reshuﬄing of transcription factor
binding sites is a driving force for evolution, so some transcription factors are expected
to have highly divergent binding site locations in closely related species. Examples of
this have been convincingly demonstrated in mammalian genomes (Odom et al., 2007).
Ludwig et al. (2000) look in depth at an example of this divergence - the enhancers
regulating the stripe 2 expression of eve. While the expression of eve is strongly
conserved in Drosophila, the enhancer sites appear to have undergone a considerable
degree of reshuﬄing between species. Ludwig et al. (2000) experimentally show that
reshuﬄing the enhancer sites in D. melanogaster has an impact on gene expression.
From there, they propose that there is stabilising selection acting on the expression of
eve across species, and that the reason the enhancer sites can move around is that new
mutations arise to stabilise the effects of the reshuﬄing on eve expression.
If we assume that transcription factor binding is causally connected to the underly-
ing genome sequence, which for sequence specific transcription factors appears to be
broadly correct, then in the absence of binding data for different species, looking at the
sequence conservation may act as a predictor of binding conservation. In addition it
may potentially highlight the functionality of the binding sites in question. However,
given the evidence for enhancer site evolution described above, the inverse is not the
case - a lack of conservation does not necessarily imply non-functionality.
The phastCons scores for multiple alignments of Drosophila melanogaster with 14 other
insects, downloaded from UCSC for Genome Release dm3, were used for this analysis.
The average phastCons scores were found for 100bp windows in a range of 5 kb around
the middle of the highest scoring window of each binding interval (Figure 3.20).
Dichaete peaks do not appear to be any more conserved than their surrounding regions.
In fact, slightly in the D Dam and strikingly in the D08 data, the Dichaete peak areas
in fact seem to have a drop in conservation compared to the surrounding sequence.
The D Berk and the D Dam datasets also seem to have a drop in the conservation of
the surrounding sequence, which is interesting. The shapes of the graphs bear a strong
resemblance to the ones for GC content, and it seems likely that GC content and
conservation are connected. This may be due to the fact that the highest GC content
in Drosophila is found in the coding regions of genes (Zhang et al., 2004), which are
also the areas showing the most conservation. In terms of Dichaete conservation, it
does not appear that Dichaete binding sites are more conserved than their surrounding
genomic sequence. On the contrary it appears that, if anything, Dichaete and the
nearby sequences tend to be significantly less conserved. This could mean that Dichaete
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Figure 3.20: Average phastCons scores of areas surrounding Dichaete binding peaks
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binding sites are fast-evolving between species (a series of ChIP-chip experiments with
different Drosophila species could resolve this), or that binding sites perhaps stay the
same between species, but are not completely determined by exact sequence specificity,
but rather via some other property, such as for example the overall flexibility of the
stretch of DNA in question.
3.6 Dichaete and other factors
3.6.1 Dichaete and transcriptional pausing
Looking at the Dichaete binding profile raises an interesting question - what is the
purpose of apparent preference for binding in intronic regions. A plausible hypoth-
esis would be that, as well as regulating gene expression the ’traditional’ way via a
cis-regulatory module, it may also have a role in influencing gene expression through
regulating transcript elongation by causing or assisting RNA polymerase pausing. Al-
ternatively, it is possible that this pattern reflects the fact that Dichaete tends to bind
to developmental genes with large introns, which may contain enhancer elements: this
possibility is investigated in the next section.
Transcriptional pausing has been previously reported as a regulatory mechanism for
a number of developmentally important genes in Drosophila (Zeitlinger et al., 2007a;
Muse et al., 2007). In particular, it is known that regulation of transcriptional elonga-
tion is crucial in the regulation of slp1 (Wang et al., 2007), a gene that the binding data
suggests is also regulated by Dichaete. Polymerase pausing may be an effective way of
ensuring immediate transcriptional response by keeping the polymerase docked at the
start of a gene until it is needed. Additionally, it may facilitate precise regulation of
transcript quantity through slowing down the progress of polymerase along the gene
when required. The reported effects of disrupting the polymerase pausing are varied.
The obvious effect is a lowering of expression due to pausing and therefore overexpres-
sion when pausing is interrupted. However, it has also been reported that polymerase
stalling can enhance gene expression (Gilchrist et al., 2008). This is thought to be be-
cause in the absence of factors that facilitate polymerase pausing, chromatin structure
switches from an open to a closed configuration, resulting in apparent downregulation
when pausing is disrupted.
Genes can be classified according to 3 distinct types of polymerase binding profile:
actively transcribed (with no stalling), non-transcribed and genes with a stalled poly-
merase which show clear binding peaks in pausing positions (Zeitlinger et al., 2007a). If
Dichaete were involved in facilitating polymerase pausing, a correlation between peaks
of polymerase binding within genes and Dichaete binding within the same regions is
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expected. While for the purposes of pausing, there is no difference between exons and
introns - the polymerase can pause at any position along the transcript - the sequence
of exons tends to be highly conserved due to functional constraints on the protein.
Introns, on the other hand, can potentially be shaped by evolution specifically for the
purpose of gene expression regulation, so they are likely to be the more promising
feature to investigate.
To start with, the RNA polymerase II Drosophila 0-12 h embryo ChIP-chip dataset
was downloaded from modENCODE and reanalysed using the TiMAT pipeline with
standard settings (quant normalization, 675 bp window, 200 bp gap, 10 oligo mini-
mum). The FDR 1% peaks were then compared with the high stringency Dichaete
datasets. The rationale for using the polymerase FDR 1% data was that the peaks of
interest for this analysis are the very pronounced ones, rather than general regions of
low level PolII binding. Datasets for narrower time periods (0-4 h, 4-8 h) were also
available, but upon visual inspection, these were found to be lower quality and noisier
so only the 0-12 h dataset was used for analysis.
As an initial analysis step, a resampling-based significance test (Huen and Russell,
2010) was performed to determine whether there is a statistically significant overlap
between the polymerase data and the Dichaete datasets. The only one that was flagged
as significant was the overlap with D Berk (p-value = 0.001), possibly because it corre-
sponds more closely to specific open chromatin regions than the other 3 datasets that
are an average over a longer developmental window.
The next step of the analysis was to determine whether there is anything special about
Dichaete intronic binding that corresponds with spikes of PolII binding. A trend was
found: the Dichaete sites in genic regions are much more likely to overlap with PolII
than sites in intergenic regions (not at all surprising, given the expected location of
PolII within and just upstream of transcribed regions). In the case of D Berk data,
61% of Dichaete genic intervals overlap with PolII intervals, compared to only 43%
of intergenic intervals (p-value < 2.2E-16, χ2 test). The numbers are 51% of genic
intervals vs 25% of intergenic ones for D DamID (p-value < 2.2E-16, χ2 test), and
86% genic vs 64% intergenic in the case of D08 data (p-value < 2.2E-16, χ2 test). A
significant difference was not found in D12, possibly due to the low number of peaks
present in these data.
Out of the genic sites, Dichaete sites in exons were much more likely to overlap with
PolII than Dichaete sites in introns. In D Berk data, 72% of the Dichaete intervals
associated with exons overlap with PolII, as opposed to 49% of intervals that bind
introns (p-value < 2.2E-16, χ2 test). The same trend was also present in the D DamID
and D08 datasets, with 68% of exon-binding intervals and 44% of intron binding ones
overlapping with PolII in the case of D DamID (p-value < 2.2E-16, χ2 test), and 93%
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exon vs 81% intron intervals overlapping in the case of D08 (p-value < 8.8E-6, χ2
test).
Next, the distance of the PolII peak (the highest scoring window of each interval) to
the Dichaete peaks was examined for all the Dichaete peaks within 1 kb of PolII sites.
If more than 1 PolII site was within 1 kb of a Dichaete peak, that peak was counted
multiple times. While many Dichaete peaks are found within 1 kb of a PolII peak,
the trends are quite different for the different datasets (Figure 3.21). While the D08
dataset shows a clear tendency for Dichaete peaks to land right next to PolII peaks,
and the D Berk dataset shows a slight trend in that direction, the other two datasets
do not show such trends at all, making the analysis inconclusive.
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Figure 3.21: Histograms of the distance of Dichaete binding sites from PolII binding
sites
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3.6.2 Dichaete and enhancers
As mentioned, an alternative hypothesis for the tendency of Dichaete to land into
introns is that it is targeting large introns containing enhancers. This is a difficult
hypothesis to verify, since a full genome-wide dataset of enhancer regions at present
does not exist, and using cloning and molecular biology, while potentially interesting,
was considered outside the scope of this project. Two analyses were nonetheless run,
which were thought to be, if not fully conclusive, at least informative about whether
this hypothesis is worth pursuing further in the future.
Intron size
There are a number of examples from single gene studies of enhancers found in par-
ticularly long introns in Drosophila (Kohler et al., 1996; Hauck et al., 1999; Meredith
and Storti, 1993; Markstein et al., 2004; Stathopoulos et al., 2002). Also, interest-
ingly, it has been found that long introns are more evolutionarily conserved than short
ones, implying that they commonly contain important regulatory elements (Haddrill
et al., 2005). Since a typical metazoan enhancer is about 500 bp in length (Erives and
Levine, 2004), it is possible that the length of the introns needs to be above a minimum
threshold to provide enough space for the presence of enhancers.
Based on the assumption that intron length is indicative of the potential presence of en-
hancers in the region, an analysis was done to verify whether the introns that Dichaete
binds within are particularly long, compared to those in the rest of the genome. Highest
scoring windows within Dichaete binding intervals were used to estimate the Dichaete
binding site location, and those mapping to introns were selected for this analysis. In-
tron coordinates were downloaded from UCSC (Rhead et al., 2010) for all Drosophila
genes. Introns from the transcript with the greatest number of introns were used for
this analysis. Alternative transcripts for the same genes were ignored to avoid counting
the same introns multiple times. The comparison of the length of introns hit by peaks
in different Dichaete datasets, compared to the rest of the genome, is shown in Table
3.7. The length of introns bound by Dichaete is strikingly different from the genome-
wide average in all 4 data sets, with the average length of introns hit by Dichaete
being in all cases significantly larger on average. While this is not direct evidence,
these data are consistent with the hypothesis that Dichaete binds to intronic enhancer
regions.
This result may also be a reflection of the fact that longer introns are more likely to be
hit at random, and would therefore be more represented in the datasets. However, this
assumes that the occurrence of binding intervals in question is indeed that - random.
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Answering whether this is the case is tricky. Certainly, if Dichaete is just landing non-
specifically to whatever regions are accessible at the time, they could be considered
to be random within the constraints imposed by chromatin accessibility. Further to
that, for this analysis only one specific nucleotide coordinate is chosen for each binding
interval (based on the highest window score in that interval), and it is possible that
the coordinate chosen is more likely to land in a large intron than a small one, just
by virtue of their size. The argument against the completely random model is that
there is consistency across datasets in terms of binding interval location, despite the
differences in the experimental conditions used, indicating that the experiments are
picking out locations that are Dichaete specific, rather than random. However, picking
out a single coordinate out of the interval may still introduce bias. For this reason,
while the broad observation that Dichaete lands in long introns is likely to be correct,
the extremely high p-values might be a result of a length bias.
Dataset Mean length of introns Mean length of introns Wilcoxon rank sum
hit by Dichaete peaks in the rest of the genome test p-value
D Berk 9199 bp 826 bp 2.2E-16
D DamID 9372 bp 851 bp 2.2E-16
D08 9428 bp 1027 bp 2.2E-16
D12 11480 bp 1081 bp 2.2E-16
Table 3.7: Size of introns hit by Dichaete peaks compared to the rest of the genome
Overlap with known CRMs
To further verify whether it is plausible that Dichaete interacts with enhancers, a list
of 997 known Drosophila cis-regulatory modules, associated with a total of 325 genes,
was downloaded from the REDfly database (Halfon et al., 2007). The locations of the
known CRMs were compared to the available Dichaete datasets (Table 3.8). Assessing
the significance of overlap proved to be unexpectedly difficult. Using something like
a t-test or a hypergeometric test gives implausibly low p-values for almost any degree
of overlap, by assuming that binding to any site in the genome is equally likely (an
assumption that is demonstrably false). On the other hand, using the resampling-based
signicance test implemented in the Cooccur package (Huen and Russell, 2010) does not
indicate any significance of overlap, which might be an underestimate - the numbers
of sites are very different for the Dichaete data and the CRM sites, and the collection
of CRMs is incomplete and non-random. Certainly, the number of CRMs overlapped
by Dichaete intervals appears high in the cases of D Berk and D Dam data, with 55%
and 43% of known CRMs being hit, respectively. Also, because the CRMs stored in
REDfly regulate a range of different genes, it is not reasonable to expect a complete
overlap, as we might for binding profiles of cooperating transcription factors. Despite
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the thousands of binding sites, we do not actually expect Dichaete to regulate every
existing CRM in the genome. Therefore the analysis outcome seems to be plausibly
consistent with the hypothesis that Dichaete regulates transcription by binding to
enhancer regions.
There is almost certainly a bias in what sorts of genes are studied enough to have
multiple experimentally characterised enhancers, so gene list analysis in this case is
not very informative - as expected both due to gene length bias and bias of being
interesting enough to be studied, a number of transcriptional regulators and other
important developmental genes feature. The list does contain overlaps with CRMs of
genes that are expected to be targeted by Dichaete based on previous literature, which
is encouraging. In particular, Dichaete overlaps the CRMs of Dichaete targets during
segmentation - eve, ftz and run, the AS-C complex genes ac and sc, the Dichaete
cofactors ind and vvl, as well as the known direct Dichaete target slit. It also overlaps
the CRMs of interesting nervous system targets, such as bl, ey, hb, Kr, nub, grh and
sim. The list also includes Dichaete’s own CRMs, suggesting it self-regulates.
Dataset Number of CRMs Percentage of known CRMs
overlapping with Dichaete overlapping with Dichaete
D Berk 549 (from 185 genes) 55%
D DamID 427 (from 158 genes) 43%
D08 98 (from 51 genes) 10%
D12 5 (from 4 genes) 0.5%
Table 3.8: Overlap of Dichaete data with verified CRMs from REDfly. The total
number of genes associated with the CRMs in question is shown in brackets.
3.6.3 Matches to other TF position weight matrices
It is expected that any direct Dichaete cofactors will have binding sites physically
close to a Dichaete site. For example, the distance between the Dichaete and Vvl
binding sites in the slit regulatory region was proposed to be between 50 and 70 bp
(Ma et al., 2000). In the case of mammalian Sox2 and Oct4, their crystal structure
shows a distance of 3 bp between the 7 bp Sox2 and 8 bp Oct4 binding site, though
distances may vary for different sites and binding partners (Remenyi et al., 2003).
Cofactor motifs, if present, should therefore also be flagged as overrepresented in the
NMICA searches. First motif searches were performed for each binding dataset using
the NMICA tool. Two sets of 15 motifs each were acquired for each dataset - one
found using a 300 bp region of the top 100 peaks, and the other one for the top 200
peaks. The search was performed for motifs that are 6-10 bp long, and all motifs found
this way were used for subsequent analysis. The STAMP motif matching tool (Mahony
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and Benos, 2007) was used to compare the NMICA results to the existing transcription
factor position weight matrices from the JASPAR database (specifically, only the non-
redundant matrices available for insects) (Bryne et al., 2007), and also to the sequences
from FlyReg (Bergman et al., 2005). The default settings were used - the Pearson
Correlation Coefficient was used for comparing the columns, the ungapped Smith-
Waterman method was used for alignment, iterative refinement was used for generating
multiple alignments and the UPGMA algorithm was used for tree building.
For each pair of motifs, an e-value was given as an approximation of the significance
of the match, with the e-value representing the number of times the match is expected
to occur at random given the sequence profiles of the inputs. The lower the e-value,
the more significant the match. The e-value takes into account that matches to shorter
sequences are more likely to be found, scaling the value accordingly.
In total, matches for 75 sequence-specific DNA binding proteins were found, with 5
of these (SuH, Sna, Adf1, Dl and BEAF-32) enriched in all 4 Dichaete data sets.
The top 10 motif matches, sorted by e-value, include the strongly matching Dichaete
motif, as well as motifs for Top2, Aef1, Cf2, Mad and multiple matches to the BEAF-
32 motif. Two matches to Vvl, a known Dichaete cofactor, were found, though the
matches were not particularly high quality (7.54E−03 for a match to the DamID data,
and 2.43E − 02 for a match to the D08 data). This may be a reflection of the poor
quality of the known Vvl binding motif. Since not all the matches found were actually
high quality, a threshold was applied to produce a selection of the matching motifs
considered to be reliable.
Only matches with an e-value of < 1E − 04 were further examined. The filtered list
consists of 35 DNA-binding proteins, one of them being Dichaete itself. The rest of the
list is represented as a cloud in Figure 3.22, with the word size corresponding to the
number of different Dichaete data sets that contained hits to the motif (minimum 1,
maximum 4). The presence of Vnd is encouraging and can be associated with coopera-
tion during CNS patterning. Dichaete is reported to physically interact with Vnd, with
potential Dichaete and Vnd binding sites previously identified together in the achaete
regulatory region (Zhao, Boekhoff-Falk, Wilson and Skeath, 2007). The presence of
Grh and Hb motifs may reflect a role for Dichaete during neuroblast division.
This analysis, while not conclusively proving any direct interactions, nonetheless suc-
cessfully identified some potential cofactors that could be studied in more detail in the
future. The strong presence of the BEAF-32 motif is intriguing and may hint at an
interaction between Dichaete and particular insulator regions. BEAF-32 is reported to
be a marker of hotspots, regions of high transcription factor occupancy in the genome,
where it is proposed to potentially facilitate their creation (Roy et al., 2010). Dichaete
frequently binds in hotspot regions (on average, it is reported to bind in the same
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Figure 3.22: TFs with motifs flagged in NMICA searches of D binding data. Only
the motif matches with an e-value < 1E − 04 are shown. The size of the gene name is
proportional to the number of Dichaete datasets that the motif for the gene was iden-
tified in. The list of genes, along with the number of Dichaete datasets the associated
motifs were identified in, is shown in Table 5 in Appendix 2.
regions as 6.9 other transcription factors at a time (Roy et al., 2010)), so it is possible
that this hotspot region connection is why the BEAF-32 motif is observed to be en-
riched so frequently in Dichaete binding intervals. The presence of binding motifs for
Vnd, Grh, Hb and Ey in particular, are likely to be connected to the action of Dichaete
during nervous system development. A number of transcription factors whose motifs
were identified are active in the blastoderm and thus may cooperate with Dichaete
during early development. For example, Bc, Hb, Kni, Run and Slp1 all play a role in
the early establishment of the anterior-posterior axis and, at least in the case of the
first 4, Dichaete may cooperate with them and target the same cis-regulatory modules
(Russell et al., 1996).
3.6.4 Association with known genomic element markers
The modENCODE project has generated a large number of ChIP datasets for a range
of DNA binding proteins and histone modifications. Much of this data was generated
from embryos between 0-12 hours old, and is therefore comparable to the Dichaete
data. Therefore, by looking at markers associated with different genomic features
and comparing their binding profiles to that of Dichaete we can answer questions
such as whether Dichaete is commonly associated with insulators, enhancers, actively
transcribed genes or heterochromatin. A caveat when using these data for comparison
is that it is not clear at which exact developmental point and in which tissue the
observed enrichment originates from, so it is possible for regions of enrichment to
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overlap perfectly, but for the proteins in question to never actually be present in the
same set of cells in vivo. Nonetheless, this is still an interesting screen for potential
associations, but one where the results should be approached with some caution.
In order to test the association of Dichaete with different genomic features, datasets for
the following histone modifications and insulator associated proteins were used:
• H3K4me3 - active transcription start sites
• H3K36me3 - actively transcribed exons
• H3K4me1 - enhancer marker (as studied by modENCODE). H3K4me1 has a
very different distribution pattern to the other histone methylations. While it is
enriched around active genes, its distribution is broader (scattered about 1-2kb
upstream and downstream of the TSS).
• H3K9me3 - transcriptionally inactive heterochromatin
• H3K27me3 - Polycomb-directed silencing
• Insulator proteins CTCF, Su(Hw), Mod(mdg4), Beaf-32 and CP190
The binding intervals (in Genome Release 5) were downloaded from the modENCODE
website. 0-12 hour embryo datasets were used for comparison to all the Dichaete data,
and, where available, 0-4 or 2-4 hour datasets were also used, because they closely match
the 2-3 hour collection period of the D Berk data. If multiple datasets were available
for the same time period, they were fused to create one dataset for comparison. The
full list of datasets used for analysis is shown in Appendix 1, with the original data
used shown in Table 2, the unions performed shown in Table 3, and the final data used
for analysis shown in Table 3.
The datasets that significantly overlapped with Dichaete (p-value < 0.05) are shown in
network form in Figure 3.23. No significant overlaps were found with the D12 dataset,
but as discussed, this dataset is quite different from other Dichaete data in that it
has much fewer peaks. Of the other 3 datasets, D Berk shows the largest overlap with
different genomic markers - possibly reflecting the fact that data derived from a broader
developmental window gets averaged out over time and space, whereas the smaller time
interval appears to give a sharper signal. The less specific data sets are certainly not
likely to capture all the details of Dichaete action at every point in development, and
thus it is likely we may miss what may otherwise be significant overlaps. Only one
genomic marker, H3K4Me1, shows a significant overlap with all 3 reliable Dichaete
data sets. Since H3K4Me1 is a marker for both active genes and broader enhancer
regions (Roy et al., 2010), this fits well with the observed patterns of Dichaete binding
in various genomic regions, and suggests that globally, Dichaete acts by binding to
enhancer regions.
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Figure 3.23: Genome-wide histone modification and insulator location datasets with
a significant degree of overlap with Dichaete binding datasets (p-value < 0.05), as
determined using the resampling based test Cooccur.
Interestingly, both D Dam and D Berk display significant overlap with H3K9me3 and
H3K27me3, the markers for transcriptionally inactive heterochromatin and Polycomb-
directed silencing, respectively. Polycomb group proteins are known to be regulators
of Hox genes (Beuchle et al., 2001) and act by remodelling chromatin in a way that
brings about gene silencing (Lund and van Lohuizen, 2004). Binding data suggests
Dichaete also has a regulatory interaction with Hox genes, and it is not clear whether
Dichaete acts antagonistically to or cooperatively with Polycomb. Interestingly, it
has been found in humans and mice that when Polycomb group genes responsible for
H3K27me3 methylation are disrupted, embryonic stem cells lose the ability to maintain
themselves in an undifferentiated state (Lee et al., 2006; Boyer et al., 2006). This is
a phenotype that is reminiscent of the role that Sox2 (a mammalian Dichaete ortho-
logue) plays in stem cell biology, which suggests that Dichaete action and Polycomb
silencing may, in the context of stem cells, have the same function. Judging by the
overlap between H3K27me3 and Dichaete, it is possible that Dichaete and Polycomb
may cooperate in particular genome regions, possibly through jointly altering over-
all chromatin architecture. An alternative hypothesis is that Dichaete and Polycomb
silencing are mutually exclusive with a given genomic location occupied by Dichaete
or Polycomb and the binding profiles reflecting differential occupancy in different cell
populations in the embryo.
There were several other significant overlaps specific to the D Berk dataset, includ-
ing the markers of active transcription H3K4Me3 and H3K36Me3, and the insulator
proteins BEAF-32 and CP190. The action of Dichaete may be context dependent -
it is possible that it can bring about both activation and repression, depending on
the cofactors it partners up with. In the midline, Dichaete enhances the activation
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of slit (Ma et al., 2000), whereas ac is derepressed in the intermediate column of the
neuroectoderm in Dichaete mutants (Overton et al., 2002). It is unclear whether the
latter is a direct or indirect effect, but it opens the possibility that Dichaete may be
capable of facilitating repression. From the data overlap it appears likely that, at least
in the blastoderm, Dichaete frequently acts as an activator, a view supported by an
analysis of pair rule gene expression in Dichaete loss and gain of function conditions
(Russell et al., 1996). It is also possible that this is true throughout development, but
that the interactions are transient, and/or stage and tissue specific, so may be lost in
the broader time period used to generate the other datasets.
The association with insulator proteins is interesting, particularly in the case of BEAF-
32, since the BEAF-32 binding motif was consistently found to be overrepresented in
a subset of Dichaete binding peaks from all 4 available data sets, supporting the view
that there is an interaction between the two (or at least, that their activity is required
in the same genomic regions). It is therefore possible that Dichaete in some way affects
or interacts with insulator functions. While insulator functions are poorly defined at
the level of the whole genome, one model proposes they are involved in chromatin
looping or architecture, intriguing in light of the known DNA bending activity of Sox
proteins. The connection between Dichaete, BEAF-32 and regulatory hotspots (Roy
et al., 2010) is also intriguing and potentially worth investigating further.
3.6.5 Open vs closed chromatin
It is likely that Dichaete, like other transcription factors, binds to available areas of
accessible chromatin (Li et al., 2011). However, it is not yet clear what determines
which areas of chromatin are open at any one time. On the one hand, it is possible
that transcription factors bring about the chromatin accessibility state. Alternatively,
TFs may just congregate at open regions once they become available. Perhaps the
most likely explanation is that there is feedback between the two, where once the tran-
scription factors associate with regions of the genome they help maintain an accessible
state. Regardless of which of these explanations is correct, accessibility has been used
before as a powerful predictive tool for modelling transcription factor binding (Kaplan
et al., 2011). Therefore chromatin accessibility data can be helpful in understanding
and predicting transcription factor action, even without a full understanding of the
causal relationship between them.
To verify whether Dichaete tends to bind to open chromatin regions, genome-wide
DNaseI chromatin accessibility data was downloaded from the Berkeley Drosophila
Transcription Network Project (Thomas et al., 2011). Time course data was available
for embryonic stages 5, 9, 10, 11 and 14. These data were converted to Genome Release
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5 using the UCSC LiftOver tool (Rhead et al., 2010). Cooccur software was then used
to compare the significance of overlap between the accessible regions and Dichaete
binding. It is ideal to match the developmental stages of the embryos used to generate
the accessibility data as closely as possible to the development times used for the ChIP-
chip studies. Therefore, for an initial screening, the D Berk (2-3 h, stage 4-5) data was
compared to the stage 5 accessibility data, the D08 data (0-8 h) was compared to a
union of stage 5, 9, 10 and 11 data, and the 0-12 h Dichaete datasets (D Dam and
D12) were compared to a union of all the available accessibility data.
In all cases, there was found to be significant overlap between Dichaete datasets and the
relevant DNaseI datasets (p-value < 0.001). The percentage of overlap was found to be
very high - between 90% and 98% of Dichaete intervals from the different datasets over-
lapped with DNaseI intervals. This confirms the expected hypothesis that Dichaete,
like other transcription factors, is consistently found in open chromatin regions during
development.
While some regions of chromatin appear to be accessible throughout development,
many regions exhibit distinct and dynamic accessibility profiles during different stages
of embryogenesis. Given the highly significant overlap with Dichaete, and also the
predictive power that these types of data have for other transcription factors (Thomas
et al., 2011), it is possible that the accessibility time course data could be used to
computationally estimate what genes Dichaete is targeting at different points in devel-
opment. Indeed this approach may be generally helpful for transcription factors where
ChIP-chip data is only available for relatively broad time periods.
3.7 Conclusions
3.7.1 A systematic data comparison
The initial difficulties with comparison of the datasets were encountered very early
in the data processing stage. It is known that using different data analysis pipelines
can result in very different output results (Johnson et al., 2008). However, what the
parameter sensitivity analysis concluded is that, even using the same pipeline, it is still
possible to get highly divergent results from the same dataset by altering the analysis
parameters. Also, while intuitively it makes sense that using the same parameters for
all the datasets would reduce variability, in practice it seems that, for example, different
normalization methods are optimal for different datasets, depending on the data profile.
It is also possible that different peak finders and analysis pipelines are more appropriate
for different data types - with, for example, some being better at recognising small sharp
peaks, and others being more suited to recognising broad regions of binding. While
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it is true that using different analysis methods for different datasets is introducing
an unknown amount of variability, it was nonetheless concluded that matching your
data analysis methods to suit your data type, rather than using a fully standardised
pipeline, is optimal for the purpose of extracting the maximum biological signal from
the data. However, this does also mean that independent validation becomes essential.
Having multiple matched datasets is therefore recommended - it makes it possible to
optimize parameters, and extract high confidence binding regions from the data, while
making it easier to filter out the noise from the signal.
The consistency of replicates within individual binding studies presented is good, and
the high overlap between 3 out of 4 datasets suggests that these are high quality and
genuinely reflective of Dichaete binding sites in vivo rather than products of noise. The
data quality, particularly in the case of D Berk, but also to a great extent in the case of
D Dam, appears to be excellent. The datasets are both extensive, showing thousands of
peaks across the genome, and specific, exhibiting various features expected of Dichaete
targets. The D08 and D12 datasets seem to do well in terms of specificity, showing a
lot of overlap with the other datasets, but the signal appears to be much weaker and
consequently the sensitivity is much lower compared to the other two datasets. This is
particularly evident in the case of D12, though the overlaps imply that the binding sites
are genuine, the dataset only captures a few hundred Dichaete binding sites, compared
to thousands captured by D Berk and D Dam.
The DamID data shown here is clearly of a comparable resolution to ChIP-chip datasets,
showing a high degree of overlap in terms of both the genomic binding coordinates and
the genes hit. The high overlap between the D Berk and D Dam datasets and their tar-
get genes is particularly encouraging since these are different experimental techniques
used over different embryonic time periods, yet for the most part they give remarkably
consistent results for most types of downstream analysis. It therefore appears that
ChIP-chip and DamID are very much comparable and complementary, and can be
used in unison as powerful tools for identifying genome-wide binding patterns.
The most interesting analysis results, including a high quality Dichaete binding motif,
seemed to arise from the D Berk dataset, probably because of the tight developmental
window of the experiment - this is useful to know in general for ChIP-chip experimental
design. However, it is also possible that some of the increased data quality of D Berk
compared to D08 and D12 is due to a better quality antibody and/or more optimized
ChIP-chip conditions used by the laboratory. It is highly encouraging that all 4 datasets
appear to have good specificity - this opens up the possibility of using all 4 datasets
jointly to create a core high confidence set of Dichaete intervals, that would be both
highly specific due to independent validation and highly sensitive due to the large
quantity of data available.
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The interval ranking method used by BDTNP only gave good results for D Berk data
- possibly because the data is sharper and more time-specific, meaning that the quan-
titative information from the ChIP-chip was more meaningful. However, based on the
results for the other datasets, the use of this method is not widely recommended. On
the other hand, differentiating between target genes based on whether they have single
or multiple binding peaks (a method similar to the one used by Choo et al., 2011)
was only briefly explored, but since it seemed to successfully pick out an interesting
network of genes, it seems worth testing out further in the next chapter.
The extremely high overlap of all the datasets with open regions of chromatin (as
assessed by a DNaseI assay) is as predicted from previous work associating TF binding
with chromatin accessibility, but is nonetheless interesting as it seems to suggest that
chromatin accessibility is one of the main determinants of Dichaete binding locations.
As such, it should be possible to deconvolve Dichaete binding data into binding at
specific stages, according to whether the chromatin was accessible at the time or not.
Time series experiments are extremely interesting and informative, but also difficult,
expensive and time-consuming. As we see from the D Berk data, various features such
as the Dichaete motif, and the tendency to bind to exons, were only possible to glean
from the data with a tight developmental time. However, in practice, perfect time
courses are not always available. Deconvolving data for different developmental times
based on chromatin accessibility profiles, if proven to be reliable, could potentially
provide a cheap and easy alternative when time-course experiments are not possible to
perform. It is also worth noting that the data quality is not solely determined by the
specificity of the time period used - while the D Berk data does reveal some features
that the other datasets do not show, the D Berk and D Dam datasets were in many
respects very similar, which seems to suggests that it is possible to have datasets for
broad developmental time windows, that are both sensitive and specific.
There were also some differences between the analysis outcomes for the different datasets.
In particular, the GC profile of the surrounding sequence varied highly from dataset
to dataset. A further look at the source of the differences concluded that the GC pro-
files of the bound regions and surrounding genome sequence was highly variable, and
that perhaps the usual method of looking at the mean is in fact inadequate for this
analysis in general. Looking at the whole range of data points was much more informa-
tive, and perhaps a more elaborate statistical approach would make this analysis more
worthwhile. However, looking at the differences in profiles raises the question of how
consistent GC profiles are in general, though there might plausibly exist sub-types of
GC profiles that are in some way biologically relevant. Similar differences were found
with the analysis of phastCons scores, so potentially some of the same conclusions
apply.
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Some differences between ChIP-chip and DamID can most likely be accounted for
because DamID requires the presence of a non-randomly distributed sequence (GATC)
that it methylates, whereas ChIP does not. However, figuring out the way in which
this affects the results is not straight-forward - what it is likely to mean is that certain
areas of the genome might be invisible to the DamID technique, due to the absence
of the appropriate sequence in those regions. Since restriction enzymes are then used
to isolate it, this also means that the fragment lengths should be fixed rather than
continuous, which may also affect the outcome of the experiment (possibly shifting the
peak centres). Analysing the consequences of these differences is beyond the scope of
this work, but would make an interesting future project.
3.7.2 Dichaete biology
Previous investigations identified a number of developmental functions and potential
target genes for Dichaete. However, it has only recently become possible to gain a
genome-wide view of Dichaete action during Drosophila embryonic development. The
exciting thing about looking at genome-wide data is the ability to look for broader
patterns, not possible to glean from small scale experiments on individual genes.
From the binding data, it is apparent that the action of Dichaete is broad: ChIP-chip
and DamID both indicate that Dichaete has thousands of binding sites spread through-
out the genome. About a third of the binding sites are located in the more ’traditional’
regulatory regions outside genes, whereas two thirds are located within genes, mainly
within introns. This perhaps should not come as a surprise, as the verified site of
Dichaete action within the slit CRM is located in an enhancer within the first slit in-
tron (Ma et al., 2000). Dichaete does seem to show a tendency to bind just downstream
of transcription start sites, suggesting a possible role in facilitating PolII pausing or
enhancer action, but there is also generally a broad spread of Dichaete locations in
relation to genes, suggesting a range of functions during transcriptional regulation.
The overlap with H3K4me suggests that Dichaete binds to enhancer elements, and
perhaps its DNA bending properties are used to bring more distant elements together
into physical proximity, allowing a variety of regulatory functions to take place from
there.
A distinct Dichaete binding motif was found, which matches previous experimental
data. However, broader patterns in GC content surrounding the binding sites are less
clear, and in fact seemed mixed or contradictory in different datasets. Minor groove
binding proteins, which Dichaete is one of, do not have direct access to bases, and
instead they rely on the differences in the electrostatic properties of the DNA backbone.
While Dichaete does appear to have a clear sequence preference, it is likely that, in
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principle, it can bind to any piece of DNA with its specific preferred sequence being
more likely because of a higher affinity. Therefore, as well as being determined by the
sequence specificity, the Dichaete binding patterns at different stages may primarily
be determined by chromatin accessibility, and so the GC content patterns for Dichaete
would vary in concordance with the way GC patterns of regions of open chromatin
would, explaining the variability and some of the unusual graph patterns seen.
Looking at other sequence motifs found in Dichaete binding intervals reveals some
interesting potential regulator partners. For Dichaete’s role in segmentation, there
are Kni, Hb and Bcd, a set of TFs known to regulate, as Dichaete does, the primary
pair-rule genes. In terms of nervous system development, some proteins that appear
interesting are Ey, Ttk, Hb, Grh and Vnd. The presence of SuH suggests a connection
to the Notch signalling pathway. Also, the presence of the BEAF-32 binding motif in
all data sets, as well as the overlap found with the BEAF-32 binding data, suggests a
possible role in insulator function and a connection with regulatory hotspots.
3.7.3 Conclusions
All 4 Dichaete genome-wide datasets were found to have an encouraging degree of
specificity and therefore will be used together in the next chapter, for generating a
core high confidence Dichaete binding dataset. Because DamID is a method indepen-
dent from ChIP-chip, regions of binding found using both methods can be considered
highly rigorous. At the same time, because of the large amounts of data available, it
is possible to build up a sensitive and extensive profile of Dichaete binding in early
development.
Some methods for analysing the data further were also explored. Using the presence
of accessible regions as a rough guide to which binding sites are present during which
developmental times, seemed like a promising approach. The use of clusters of binding
as an indicator of active regulation was also thought to be promising.
The preliminary analysis of Dichaete biology based on binding data yielded some
promising starting points, including potential cofactors, an extensive catalogue of po-
tential target genes, a high quality Dichaete motif and several possible hypotheses
about the nature of Dichaete action. All of these will be explored further in the next
chapter.
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Chapter 4
Dichaete high confidence
intervals
4.1 Introduction
As discussed in the previous chapter, chromatin immunoprecipitation (ChIP) is a pow-
erful technique for studying in vivo protein-DNA associations. However, it is also
known to be noisy and to generate false positive results, even when the experiment is
designed accurately and a sufficient number of replicates are performed. There is po-
tential to use DamID as an independent validation method to generate high confidence
binding data, though this combined approach has not been used much in practice to
date, perhaps in part due to time and cost constraints.
The early comparisons of ChIP and DamID suggested that ChIP gives significantly
better resolution and that therefore the two techniques are not particularly suited
to being used as complementary tools (Holland et al., 2005). However, subsequent
comparisons suggest that the binding profiles are much more comparable than probe-
based correlations suggest (Figure 4.1) and can be used for independently verifying each
other (Negre et al., 2006; Moorman et al., 2006; Tolhuis et al., 2006). The evidence
presented in Chapter 3 supports this conclusion.
High throughput binding assays are a common tool used for a number of exciting
genomics projects, such as the large scale international ENCODE (Feingold et al., 2004)
and modENCODE (Celniker et al., 2009) projects. The success of such projects and
the biological insights drawn from them depend on the reliability of the experimental
data generated. One of the things becoming apparent from such studies is that many
transcription factors have thousands of binding sites across the genome (Li et al.,
2008; MacArthur et al., 2009). However, there can be considerable variability between
different IPs for the same transcription factor, as well as variability in results obtained
Figure 4.1: ChIP vs DamID comparison performed by Negre et al. (2006). The graph
shows GAF binding in the Adh region obtained by ChIP at the embryonic stage (upper
panel in blue) and with DamID in cultured Kc cells as described in Sun et al. (2003)
(lower panel in red). Pearson’s correlation coefficient between the two distributions is
shown at the bottom of the graph.
using different analysis pipelines (Johnson et al., 2008). The parameter sensitivity
analysis in the previous chapter highlights this problem.
It is therefore virtually inevitable that a proportion of the ’thousands’ of binding sites
represent false positives caused by experimental noise or biases associated with different
analysis parameters. Increasingly, a number of independent datasets are becoming
available for the same transcription factors, providing the potential to integrate data
and produce more stringent, reliable genome-wide binding sets. While this can be done
with different ChIP-chip datasets to increase reliability, ChIP-chip and DamID together
are particularly well suited to the purpose, since they are completely independent
experimental methods. This chapter explores the integration of ChIP and DamID
data to generate a set of very high confidence intervals for Dichaete binding during
embryogenesis.
Furthermore, of the thousands of binding sites, it is believed that only a subset of them
are ’functional’ - i.e. have an active effect on the transcription of associated genes.
However, at present it is not possible to reliably differentiate between functional and
non-functional binding. While a simple solution to this problem may not currently
exist, this chapter explores potential strategies for filtering binding data to obtain a
more meaningful collection of functional associations.
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4.1.1 Chapter overview
One of the aims of this project was to develop a method for integrating different
binding datasets. This chapter provides an overview of the method used and the
reasoning behind it. It presents the Dichaete high confidence core binding interval
dataset, followed by an analysis of the biological conclusions that can be drawn from
it. I also present some ways in which the dataset can be filtered further to extract
more biological information from it.
4.2 Combining datasets
When looking at peaks found at different FDR values, it is unclear which overlaps
are the most meaningful to use for further analysis. Certainly, when looking at an
individual data set, stringency might win out over inclusiveness, so an FDR of 1%
would be preferable to an FDR of 25%, due to the latter introducing a larger number
of false positives. However, it is not as intuitively clear whether this is the case when
using more than one data set. For example, selecting overlapping peaks at random
from two different FDR 25% peak sets, the chances of landing a ’double false positive’
are 1/4 * 1/4, i.e. 1/16, so the effective FDR of two combined FDR 25% data sets
is 6.25% (probability 1/16). Thus fusing 2 relatively non-stringent sets results in a
data set with a reasonable FDR. On the other hand, merging an FDR 1% dataset
and an FDR 25% dataset yields an FDR of 0.25% (1/100 * 1/4 = 1/400, i.e. 0.25 %)
and merging two FDR1 data sets is extremely reliable (1/100 * 1/100 = 1/10000, i.e.
0.01%). The underlying assumption with these assessments is that false positives are
randomly distributed, which may not be the case if all the experiments have the same
experimental noise. However, combining ChIP and DamID data sets should satisfy
the random noise assumption, since the noise from each technique is expected to be
different. Based on this, it was thought that the FDR 1% to FDR 25% fusion of
datasets would be optimal, as it gives a highly reliable FDR value, while not making
it so stringent that the sensitivity of the experiment is compromised.
4.3 The high confidence Dichaete embryonic data
set
4.3.1 Background
With the advance of high-throughput experimental methods, it has now become much
easier to quickly obtain genome-wide binding data for transcription factors. However,
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there is some concern about the reliability of these data sets. ChIP, the most commonly
used experimental method for studying in vivo binding, is an inherently noisy experi-
mental technique with the variability in data output from different analysis pipelines
and from different starting analysis parameters compounding the issue. Thus, when
using a single ChIP study there is a limit to our ability to determine how many of
the identified binding sites, even at high confidence intervals, are artifactual. How-
ever, since many ChIP studies can be performed relatively quickly, and alternative
techniques such as DamID are available, it is possible to independently verify binding
locations using several data sources.
In the case of Dichaete, three different ChIP-chip data sets have already been pub-
lished: from 2-3h embryos by the Berkeley Drosophila Transcription Network Project
(MacArthur et al., 2009), and for 0-8h and 0-12h embryos by the modENCODE
project(Celniker et al., 2009; Negre et al., 2011). As described in the previous chap-
ter, I generated Dichaete DamID data for 0-12h old embryos, providing a fourth data
set. Since ChIP and DamID are independent methods it is expected that, while both
will generate false positives due to noise, they will be different in each case. Because
of the different stages of development and different experimental methods used, some
difference in identified binding intervals is expected, however there may also be a sub-
stantial overlap of direct targets. I therefore combined the available data sets described
in the previous chapter into a single high confidence core Dichaete binding set. The
acquisition and processing of the ChIP data were discussed in Chapter 3.
4.3.2 Creating the high confidence intervals set
Reiterating the results from the data processing performed in Chapter 3, the number
of binding intervals in each dataset is presented in Table 4.1.
Data set High stringency cut-off Low stringency cut-off
D ChIP 2-3h 6452 16501
D DamID 0-12h 4342 12301
D ChIP 0-8h 1366 6493
D ChIP 0-12h 208 538
Table 4.1: Number of binding intervals in each data set. High stringency = FDR 1%
for all except D ChIP 0-8h (FDR 5% data was used because no peaks were found at
FDR 1%). Low stringency = FDR 25%.
Based on the thought experiment presented above, FDR 1% peaks from each ChIP-chip
dataset were compared to FDR 25% peaks of the DamID dataset and vice versa, fusing
the resulting intersects together. In the case of the Dichaete 0-8h modENCODE data,
no peaks were found at FDR 1%, so the FDR 5% data set was used instead. Once all
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the overlaps were found, they were merged to generate the core set of Dichaete binding
intervals. A diagram of the intersection and union schema is shown in Figure 4.2. Once
this was completed, it was found that some of the resulting intervals were very small
(as little as 3bp long) and were not considered meaningful overlaps. Therefore, as a
final step, the intervals were filtered to remove intervals that were shorter than 100bp,
reducing the set to the final 6227 intervals in total.
Figure 4.2: A representation of how the Dichaete core set was created from the
original datasets. To start off with, the DamID dataset was compared to each of
the 3 ChIP datasets in turn, taking the intersections of the two FDR 1% to 25%
comparisons. Next, the two FDR 1% to 25% comparisons were unioned. After that,
the results from all 3 ChIP to Dam comparisons were unioned to create the final set
(which was subsequently filtered to remove intervals smaller than 100 bp).
4.3.3 Data strengths and weaknesses
Because of the timings of the data sets used, the core Dichaete data set generated
is specific to the first 12 hours of embryonic development, with a possible bias for
registering more binding in the 0-8h period (the Dichaete 0-12h ChIP data has very
few peaks). It is expected that during the first 12 hours of development, binding sites
change while the current data only provides a static picture of binding sites. In order
to construct precise and finely dissected transcriptional networks, more detailed and
precisely timed binding data is required. However, we argue that the amalgamated
binding data presented here is rigorous and independently verified by two different
experimental techniques, and while it is unlikely to give exact answers as to the precise
mechanisms of transcriptional regulation during particular points in development, it
is nonetheless a solid starting point for exploring the genome-wide action of Dichaete,
identifying potential co-factors, identifying target genes, and analysing causal factors
such as chromatin architecture and their potential impact on Dichaete action.
4.4 Genome-wide view of Dichaete core intervals
4.4.1 Binding interval summary
There were 6473 intervals in the unfiltered data, of which 6227 overlapped by more
than 100bp and these were used for further analysis. The mean interval length is 1.6kb
(1.2kb median), while the maximum length is as high as 16.8kb, with the majority of
the peak intervals less than 3kb long. Thus these data show a relatively narrow binding
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interval as would be expected for a transcription factor. The distribution of interval
sizes is shown in Figure 4.3.
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Figure 4.3: Distribution of interval sizes in the core Dichaete data set
4.4.2 Genes hit
The method described in Chapter 3 was used to identify genes hit. For each of the
intervals, all directly overlapping genes were counted as gene hits. If no direct overlaps
were found for an interval, the closest gene within a 10 kb region upstream or down-
stream was identified and registered as a gene hit. The most up to date version of the
complete list of Drosophila melanogaster genes (annotation release 5.26) was used and
the FBgn numbers were used as identifiers. The 6227 intervals were associated with
4750 genes (about a third of the total genes present in the Drosophila genome) and of
these, 4043 genes were directly overlapping with a binding interval. As discussed in
Chapter 3, two out of four datasets suggest that Dichaete has thousands of binding sites
across the genome, and this is comparable to results for other developmental transcrip-
tion factors. This method of finding gene associations was not used for benchmarking
using the Twist and Snail data, because it was important for the gene hits there to be
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unambiguous. However, this method is recommended for doing gene associations for an
exploratory genomics analysis because, while it is less stringent, it takes into account
the possibility of binding sites being bound to enhancers far upstream or downstream
and still controlling gene expression.
Out of the 4750 genes associated with Dichaete binding intervals, a large proportion
(1224 genes, p-value=2.1E−111) are involved in developmental processes, more specif-
ically: in segmentation (165 genes, p-value=1.8E−22), the development of imaginal
discs (348 genes, p-value=4.5E−63), the nervous system (558 genes, p-value=2E−87),
sensory organs (292 genes, p-value=2.1E−43), the respiratory system (137 genes, p-
value=1.9E−18) and muscle structures (158 genes, p-value=3.6E−14). Since Dichaete
is not expressed in the mesoderm, the latter is somewhat unexpected. It is possible that
there is either an overlap of genes involved in mesoderm development that perform other
functions during development, or that Dichaete is repressing some mesoderm genes in
the developing neuroectoderm. A significant number are implicated in the regulation
of gene expression (583 genes, p-value=3.9E−53), and 294 of the genes are annotated
as encoding sequence specific DNA binding transcription factor activity (p-value =
4.7E−46) with a particular enrichment for proteins containing homeodomain-like do-
mains (107 genes, p-value = 5.1E−18). There are also a number of genes involved
in the cell cycle (380 genes, p-value=6.4E−20) and cell fate commitment (201 genes,
p-value=8.3E−39), perhaps connected to the role of Dichaete in neural stem cells.
The genes associated with Dichaete binding were evaluated against the subset of GO
terms provided by the Panther (Mi et al., 2005) GO slim list using Ontologizer (Bauer
et al., 2008) for analysis and visualisation. Resulting p-values were corrected for mul-
tiple testing using the Benjamini-Hochberg method. The GO enrichments are shown
for molecular functions (Figure 4.4) and biological processes (Figure 4.5). Looking at
the molecular functions of the genes, it is clear that many of the genes associated with
Dichaete play a role in some form of transcriptional regulation, variously through DNA,
mRNA and chromatin binding. Another highlighted major role is protein modification,
with various structural and post-translational molecular activities featured.
In terms of the biological processes, the enrichment of genes involved in cell cycle regu-
lation and apoptosis is exciting, because it hints at an involvement of Dichaete in stem
cell pluripotency, reminiscent of the role of Sox2 in mammals. Genes involved in local-
ization and cell communication may be the facilitators of some of the developmental
signals regulated by Dichaete. It also seems possible that Dichaete plays a role as a
global regulator, controlling a host of genes involved in transcriptional regulation and
modifying chromatin architecture to facilitate broad regulation of biological processes
at relevant times during development. The enrichment of genes involved in protein
modification supports the results from the GO enrichment for molecular functions,
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and suggests that this may be another level of regulation that Dichaete is indirectly
involved in. The enrichment of developmental processes is as expected, and the enrich-
ment of genes for neurotransmitter secretion may be connected to a role for Dichaete
in later stages of nervous system development.
The list of targets in the high confidence binding data suggests that Dichaete is a
global regulator, with thousands of binding sites present across the genome. Judging
by the gene associations, the high confidence dataset appears to be both extensive
and specific. However, the scale of the data presents a challenge: while the associated
558 genes involved in nervous system development, for example, probably provide an
extensive catalogue of Dichaete nervous system targets, it is not immediately clear
where to go from there. While such lists are a useful resource for anyone doing further
experiments on specific Dichaete targets, or trying to validate pre-existing hypotheses,
jumping from a list of thousands of genes to biological insight is challenging to say the
least. For this reason I attempted to perform some filtering and deconvolution steps
in an attempt to narrow down the list, allowing a more precise biological focus. The
further analysis is described later in this chapter.
4.4.3 Genomic features hit
In the absence of raw binding profiles for a dataset that is a union of other datasets, the
centres of the binding intervals were used as an approximation of where the Dichaete
binding sites are likely to be. While this may not necessarily be the most accurate
method, it was considered to be a valid pragmatic approach. The results were very
similar to the ones found using the individual Dichaete datasets in Chapter 3 with the
majority (59%) of the binding intervals found in genic regions. Also, as found with
the individual Dichaete binding sites, most of the binding intervals mapping to genic
regions are found within introns (Figure 4.6).
In the previous chapter it was found that the size of the introns containing Dichaete
binding intervals was significantly larger than the average intron size for the rest of
the genome. I verified that this trend holds true for the Dichaete core binding dataset.
Transcripts with the greatest number of introns were used for the analysis and alter-
native transcripts for the same genes were ignored to avoid counting the same introns
multiple times. The same trend is still present, with the mean length of the introns
containing Dichaete binding intervals (8.3 kb) significantly higher than the 840 bp
genome average (p-value < 2.2E-16, Wilcoxon rank sum test). As discussed in Chap-
ter 3, long introns frequently contain regulatory regions, so the mapping of Dichaete
to long introns may be an indication of a tendency to bind to enhancers.
109
F
ig
u
re
4
.4
:
G
O
en
ri
ch
m
en
t
m
ol
ec
u
la
r
fu
n
ct
io
n
s
fo
r
ge
n
es
as
so
ci
at
ed
w
it
h
D
ic
h
ae
te
b
in
d
in
g
(p
-v
al
u
e
<
0.
05
),
w
it
h
th
e
b
ri
gh
te
r
ye
ll
ow
co
lo
u
r
co
rr
es
p
on
d
in
g
to
an
in
cr
ea
se
in
si
gn
ifi
ca
n
ce
110
F
ig
u
re
4
.5
:
G
O
en
ri
ch
m
en
t
b
io
lo
gi
ca
l
p
ro
ce
ss
es
fo
r
ge
n
es
as
so
ci
at
ed
w
it
h
D
ic
h
ae
te
b
in
d
in
g
(p
-v
al
u
e
<
0.
05
),
w
it
h
th
e
b
ri
gh
te
r
gr
ee
n
co
lo
u
r
co
rr
es
p
on
d
in
g
to
an
in
cr
ea
se
in
si
gn
ifi
ca
n
ce
111
Figure 4.6: Genomic features associated with Dichaete binding sites
4.4.4 Distance from transcription start site
The middle of each core binding interval was used as an estimate of where the Dichaete
binding site is likely to be and the distances from transcription start sites within a 5 kb
range were analysed (Figure 4.7). Looking at the positioning of the closest transcription
start site, there appears to be a trend for the majority of Dichaete binding sites to be
located very close to transcription start sites, as well as both upstream and downstream.
Even looking at all transcription start sites present within the 5 kb interval (to ensure
the result is not accidentally caused by the high gene density of some parts of the
Drosophila genome), the trend for Dichaete binding sites to be located within 1 kb
upstream or downstream of a transcription start site remains.
Figure 4.7: Distance of binding sites from the nearest transcription start site (left)
and from all transcription start sites within 5 kb (right) expressed as a probability
density function
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4.4.5 GC content
The GC content around the binding sites was investigated (Figure 4.8). The first
interesting observation is that there is a trend around the estimated binding site, which
is different from that of the surrounding sequence. This is encouraging, as it suggests
that while picking out the centres of binding intervals is arguably not the most precise
way of estimating binding site location, it nonetheless seems to provide a reasonable
approximation since the result is similar to those obtained using the more meaningful
highest scoring windows described in Chapter 3. The actual trend resembles that found
for the D DamID dataset in Chapter 3 and may indicate that there is an increase in
flexibility on the outsides of regions bound by Dichaete.
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Figure 4.8: Genomic features associated with Dichaete binding sites
4.4.6 Transcriptional pausing
The potential role of Dichaete in transcriptional pausing was discussed previously and
I examined this with the core dataset. Using Cooccur, the PolII 0-12h embryo ChIP-
chip data set from modENCODE was found to significantly overlap with the Dichaete
core 0-12h data set (p-value = 0.001). It is therefore still a plausible hypothesis that
Dichaete, at least in part, regulates transcription by modulating polymerase pausing.
However, further conclusions are difficult to draw without performing more specific
experiments to test the hypothesis.
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4.4.7 Enhancers
To verify whether it is plausible that Dichaete interacts with enhancers, the list of
997 known Drosophila cis-regulatory modules from the REDy database was compared
to the Dichaete core dataset. It was found that 533 enhancers (53.5%) overlap with
Dichaete binding intervals. Compared to the results from Chapter 3, this is slightly less
than the number overlapping with D Berk (549) but more than the number overlapping
with DamID (427), and significantly more than the number overlapping with D08 (98)
and D12 (3). The number of overlaps with CRMs seems to correspond fairly linearly
to the number of binding intervals present in each dataset in the first place. The high
percentage of overlap between the Dichaete core dataset and known enhancers supports
the hypothesis that Dichaete acts by binding to enhancer regions in the genome.
4.5 Filtering binding data for functional analysis
As previously discussed, the collection of binding sites found in any one genome-wide
binding assay can often be large. Even assuming that the dataset is perfectly reliable
and that there are no false positive intervals present, that still leaves the question of
which binding sites are likely to be actively regulating transcription, and which ones
might be due to non-functional binding. Here I explore a few strategies for filtering
and deconvolving the Dichaete dataset to focus in on more biologically meaningful
hits.
4.5.1 Motif scanning
The Dichaete binding motif identified from ChIP-chip data in Chapter 3 was used
to scan the binding intervals for the presence of Dichaete binding motifs. The soft-
ware nmscan (part of the NMICA package) was used at threshold 5 (a medium level
stringency threshold). The results for each interval were compared to the results for
10000 random motif simulations (obtained by reshuﬄing the columns of the existing
Dichaete binding motif) and the intervals with a p-value < 0.05 were considered to
have a significant enrichment of the Dichaete binding motif.
A total of 906 intervals passed this test and were found to be significantly enriched.
Considering that the test used for statistical significance is extremely stringent (many
of the randomly generated motifs are very similar to the genuine one), I consider this
to be a high number of positives. The intervals in question were found to be associated
with 917 genes. The list of genes included a number of Hox genes, as well as ind
and comm, Notch, kuz, engrailed, several POU domain proteins, the nervous system
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transcription factors bancal, eyeless, SoxN and prospero, and the known Dichaete target
slit. Under the threshold used, 5354 of the original 6227 intervals (86%) were found to
have at least one binding motif, but it should be noted that the number of motif hits
relies heavily on the chosen threshold and should not be considered a reliable indication
of the presence of actual binding sites.
The overall GO enrichment results are quite similar to the ones found for the entire
Dichaete core dataset, with many of the same terms enriched. However, in some ways,
the list enriched for the Dichaete binding motif is more specific - while 1224 out of
4750 (26%) genes in the original dataset are involved in developmental processes, 326
out of 917 (36%) are in the motif enriched set. The same is true for genes involved,
for example, in nervous system development (18% compared to 12%) and cell fate
commitment (8% compared to 4% in the original dataset). It is possible that these
particular categories of genes are more prominent than other ones because of a gene
length bias - the tendency of developmental genes and transcription factors to be long
genes and/or to have a lot of genomic space around them, combined with the increased
likelihood that binding intervals will be associated with long genes, compared to short
ones (Nelson et al., 2004; Taher and Ovcharenko, 2009). However, what we are looking
at here are extremely high confidence Dichaete intervals - ones generated from multiple
independent experiments, which also contain a statistical overrepresentation of the
Dichaete binding motif. The gene association method used is sensible, therefore saying
that a proportion of the genes associated with the intervals are nervous system genes
is merely a factual statement. However, while nervous system genes really are bound,
what might be happening is that other categories of genes are, for example, short genes
masked by the presence of direct Dichaete overlaps with very large genes in the same
region. It is therefore possible that some additional relevant categories are being missed
out here.
It is inevitable that some real functional binding sites are lost when using site enrich-
ment (as opposed to the presence of a Dichaete site) as a filter for binding intervals,
and while it appears to somewhat improve the signal to noise ratio it also filters a large
number of potentially interesting targets. I concluded that filtering for enrichment of
Dichaete binding sites is therefore not suitable for an exploration of genome-wide pat-
terns of Dichaete binding. However, in cases where stringency is desired, for example
when planning experimental verification of specific targets, this may well be a help-
ful filter to use as it is likely to more precisely zoom in on likely functional Dichaete
binding sites.
In terms of the genomic features hit, the proportion of introns hit remained roughly the
same as the average for the whole set (it went from 38% to 36%), but the proportion
of intergenic hits increased from 41% to 48% and the proportion of exon hits decreased
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from 18% to 13%. This is perhaps an indication that looking at the enrichment of
the Dichaete binding motif is correctly identifying active regulatory regions, which are
more likely to be situated in introns or intergenic regions than in exons.
4.5.2 Single vs multiple binding clusters
The analysis strategy which compares genes with single vs multiple associated binding
sites was successfully used by Choo et al. (2011), who found that, while the genes
associated with single Ubx peaks showed very few GO enrichments, the genes with
multiple peaks had a set of specific GO enrichments similar to the ones found for the
full set of Ubx bound genes. The approach was briefly described in Chapter 3 and
identified some interesting associations in the genetic network, but here I describe a
more in-depth analysis with the entire set of Dichaete associated genes. An initial
screen found that of the 4750 genes associated with Dichaete binding, the majority
(3476 genes, 73%) were associated with a single binding peak. Of the remainder, 682
genes (14%) had 2 associated binding peaks, 259 (5%) had 3 and 333 genes (7%) had
4 or more, up to a maximum of 25 associated binding peaks.
Hotspots of Dichaete binding
Only 22 genes were identified with 10 or more associated binding peaks (Table 4.2)
and these were individually examined in detail, with the interesting potential targets
described below. In the case of the gene with 25 binding sites associated, FBgn0052816
(CG32816), it was found to be an unannotated gene spanning a very large region
(chrX, 201,609:364,670), encompassing the entirety of the Achaete-Scute region on
chromosome X. Since Achaete-Scute Complex (AS-C) genes are known to be regulated
by Dichaete from previous studies (Zhao and Skeath, 2002), it is likely that the binding
peaks correspond to AS-C regulatory regions. This gene was therefore removed from
further analysis. A second gene associated with 19 associated binding peaks - CG1677
(FBgn0029941) - comprises a long transcript (around 125 kb), which runs across a very
gene rich region containing 13 other smaller genes, including the transcription factor
brk. In this case, CG1677 was left as part of the gene list, but the analysis was also run
without it to see which of the encompassed genes associate with these Dichaete binding
peaks. Another potential ambiguous assignment is the gene kirre, which is adjacent to
Notch in the genome, and while the 11 Dichaete peaks may be associated with kirre
they may also be part of the Notch regulatory region. These observations highlight the
general problem of associating transcription factor binding peaks with the genes they
regulate.
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Other approaches exist for assigning target genes based on transcription factor binding
sites. For example, Sandmann et al. (2006) used BGDP in situ data to assess the gene
expression patterns of the genes close to binding sites, as well as looking at distance
from binding sites and differential expression in mutants. Unfortunately, this approach
was considered not to be appropriate for Dichaete. Firstly, Dichaete can act context-
dependently both as an activator and a repressor, so an absense of a similar expression
pattern might in fact be a sign that Dichaete is doing its job, rather than that the
gene in question is not a direct target. Secondly, as discussed, a number of the genes
Dichaete targets are large genes with complex expression patterns, so it is unlikely
that the presence of Dichaete binding sites is a sole determinant of their expression
pattern, making it difficult to predict what a ’promising’ expression pattern would
look like. Some approaches also use functional annotations of surrounding genes to
pick out the likely candidates. However, while this approach might be appropriate for
picking out specific targets in a particular tissue, it is definitely inappropriate for a
genomic analysis where the function of the genes identified as targets is used to draw
conclusions about the roles of the transcription factor in question - picking out nervous
system genes, and thus concluding that the transcription factor in question is involved
in nervous system development, is definitely based on circular logic. This is why, for
the purposes of this analysis, a simplistic approach for gene assignment was used - it
was considered to be the best option given what we know about Dichaete and what
the purpose of the analysis was.
Encouragingly the gene slit, which is known to be a direct Dichaete target in the
developing midline, is one of the multiply bound genes and has 11 Dichaete binding
peaks associated with it. This means that it is possible that multiple Dichaete binding
may be an indication of direct regulation, bearing in mind that this class represents a
tiny fraction of the genes associated with Dichaete binding.
A number of Hox genes were also found to be associated with multiple Dichaete binding
peaks, including Antennapedia (18 peaks), Ubx (14 peaks) and Abd-A (10 peaks), as
well as the Hox cofactor homothorax (15 peaks). All of these are interesting potential
regulatory targets, with involvement in important developmental processes such as
segmentation and neurogenesis. Since several genome-wide binding analyses of Ubx and
Homothorax have recently been published (Choo et al., 2011; Slattery et al., 2011) and
binding data is available, a detailed comparison of the relationship between Dichaete
and Hox proteins would be interesting to explore in the future.
Other transcriptional regulators are also present in this gene subset. The transcrip-
tion factor jing (associated with 19 peaks) is amongst other things involved in various
aspects of central nervous system development and tracheal development (source: Fly-
base (Gelbart et al., 1999)), and there are no other genes in the same region, making
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Flybase ID Name Number of D hits
FBgn0037153 olf413 10
FBgn0026239 gukh 10
FBgn0000014 abd-A 10
FBgn0024308 Smr 10
FBgn0261570 CG42684 10
FBgn0086364 rdx 11
FBgn0028369 kirre 11
FBgn0085403 Rapgap1 11
FBgn0003731 Egfr 11
FBgn0003425 sli 11
FBgn0016797 fz2 12
FBgn0051163 SKIP 12
FBgn0086901 cv-c 12
FBgn0040071 tara 13
FBgn0003944 Ubx 14
FBgn0001235 hth 15
FBgn0011224 heph 15
FBgn0250867 CG42238 16
FBgn0260642 Antp 18
FBgn0029941 CG1677 19
FBgn0086655 jing 19
FBgn0052816 CG32816 25
Table 4.2: Genes with 10 or more Dichaete binding sites
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jing an interesting potential direct regulatory target. The gene taranis is involved in
wing disc dorsal/ventral patterning and transcription maintenance and has 13 associ-
ated Dichaete binding peaks.
It is intriguing that a number of the genes associated with a large number of Dichaete
binding peaks are transcriptional regulators involved, amongst other things, in wing
development. Since the most famous Dichaete dominant phenotype is a defect in
wing development (Russell, 2000) perhaps this should not come as too much of a
surprise. While Dichaete itself is not normally expressed in the wing disc, many of
the transcription factors that are expressed in the wing also have other functions in
different tissues during development and it is likely that Dichaete normally regulates
these genes elsewhere. In this view, ectopic expression of Dichaete in the wing results
in defective development by missregulating genes it normally regulates elsewhere in the
fly.
The list also features a number of receptors and other proteins involved in signalling
pathways. The Wnt-receptor Frizzled 2 is involved in various aspects of nervous system
development. The gene cv-c encodes a GTPase activator with a range of developmen-
tal roles, including activity at the syncytial blastoderm stage and an involvement in
synaptic transmission and hindgut development. The growth factor receptor Egfr is
active in the blastoderm and involved in the development of sensory organs. The gene
heph is involved in the Notch signalling pathway.
There were several other developmentally important genes, such gukh, involved in pro-
tein localization and axon guidance. The apoptosis gene roadkill might be connected to
maintenance of pluripotency vs differentiation, and Smrtr is a cell cycle regulator.
The results of this crude analysis look very encouraging. Virtually all of the genes
associated with multiple Dichaete binding peaks are developmentally important, and
the known Dichaete target slit is included in this set of genes. Of course, since most
of the identified genes have multiple roles at various stages during development, the
structure of their cis-regulatory regions is complex. It likely includes multiple CRMs,
with each CRM containing binding of multiple factors, and the complete cis-regulatory
region associated with the gene potentially containing multiple binding sites for each
factor. These genes are likely to be direct regulatory targets of Dichaete and could
be investigated further in studies focused on individual Dichaete targets. The strong
connection with Hox genes that this analysis suggests is an interesting feature which
may constitute an interesting topic for a future study.
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GO enrichment
For this part of the analysis, the genes associated with only 1 Dichaete binding site
(a total of 3474 genes after the analysis modifications described above) were classified
as ’single’, and the genes with 4 or more Dichaete binding sites (a total of 340 genes)
were classified as ’multiply bound’. The genes with 2 or 3 Dichaete binding sites were
considered unclassified and were therefore left out. As discussed in the Materials and
Methods chapter and the later part of this chapter, GO enrichments are biased because
longer genes tend to both belong to particular categories, and get hit more often by
chance (Nelson et al., 2004; Taher and Ovcharenko, 2009). The p-values associated
with these enrichments are therefore likely to be significant overestimates.
The GO enrichment profiles for the two groups of genes are very distinct. In the case
of the genes bound by single peaks, while a mixture of different genes is present due
to the large number of genes, the terms that are significantly enriched are cellular
processes (1845 genes, p-value = 1.3E−28) such as cell cycle processes (236 genes,
4E−11), cellular metabolic processes (1163 genes, 3.6E−14), microtubule cytoskeleton
organization (154 genes, 4.7E−10) and nucleic acid metabolic processes (488 genes,
9E−8). While 651 genes involved in developmental processes do feature on the list, the
p-value is comparatively high (0.000016), a reflection of the fact that this is a relatively
small subset (19%) of the whole gene list.
On the other hand, the multiply bound gene list is massively enriched for genes in-
volved in developmental processes (196 genes, 1.9E−63), composing the majority (58%)
of the entire gene list. 123 of the 340 genes are involved in nervous system develop-
ment (2.3E−55), 97 of the 340 are involved in imaginal disc development (p-value =
2.4E−53), 139 in cell differentiation (p-value = 3.5E−52) and 205 in biological regula-
tion (p-value = 6.4E−47), with 106 regulating transcription (p-value = 6.5E−42).
Potential analysis biases
There are several potential explanations for the observed patterns of gene enrichment.
One explanation is that multiply bound genes are a distinct subset from single peak
genes and are more likely to be directly regulated. Binding information is insufficient
to determine whether this is the case or not, but this hypothesis will be revisited in
Chapter 6, where binding data is compared with gene expression data from Dichaete
mutants. The same pattern could be random, due to the fact that long genes cover
a relatively large fraction of the genome and could therefore overlap many Dichaete
binding peaks by chance. This might be the case for a few of the examples described
in detail above, specifically those that have transcripts encompassing a region densely
populated with smaller genes. However, this was not the case for most of the genes
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observed. Another possibility is that the differences in GO enrichment are not due to
specific subgroups in the Dichaete binding set but reflect the fact that longer genes
in the Drosophila genome have particular properties, for example, they encode devel-
opmental regulators with complex cis-regulatory modules, sometimes including long
introns containing enhancers. A further analysis of Dichaete binding and gene length
was performed in order to shed further light on this possibility.
The first noticeable trend is that, overall, genes associated with Dichaete binding are
significantly longer than genes in the rest of the genome (p-value < 2.2E-16, Wilcoxon
rank sum test). The mean length is 9481 bp for Dichaete associated genes, and 3916
bp for genes in the rest of the genome. This does not appear to be a by-product of a
bias introduced by a small number of Dichaete bound genes, the maximum gene length
for the rest of the genome is 396 kb and is much larger than the 172 kb average for
the Dichaete associated class. The medians show the same trend as the means (the
median is 3304 bp for Dichaete bound genes and 1556 bp for the rest of the genome).
It was then investigated whether similar trends held true for different subgroups of
genes bound by Dichaete. Each of the Dichaete groups, genes associated with 1, 2,
3 or multiple (4 or more) Dichaete peaks, was compared with the remainder of the
genome (genes not associated with any Dichaete binding). It was found that all of
the subsets contained genes significantly longer than the genome average (p-value <
2.2E-16 in all cases, Wilcoxon rank sum test). However, the difference in size ranged
from only slightly larger (average gene length 5.5 kb compared to the 3.9 kb genome
average) in the case of genes with single Dichaete binding peaks, to the much larger:
12.2 kb average for genes with 2 peaks, 19.5 kb average for genes with 3 peaks and 35.3
kb average for genes 4 or more peaks. This is an almost exact linear trend, with on
average 1 Dichaete binding peak occurring every 6 kb of gene length. The numbers of
genes in each group are quite different, with the majority being associated with just one
Dichaete binding peak and a much smaller total number of genes being associated with
more than one peak. In order to make the comparison of the gene size distributions
easier, they are shown as probability densities (Figure 4.9). It is clear both from the
graphs and from the statistics that there is a correlation between an increased number
of Dichaete binding peaks and an increase in gene size. However, there is also a lot of
variance within this - the scatterplot in Figure 4.10 visualises this more clearly. While
there does appear to be a trend, the correlation found was 0.53.
Further analysis
While the results of this analysis are clear, the conclusions are less certain. First of
all, it is not obvious that the Dichaete peaks associated with long genes are really
functionally relevant for gene expression or whether they have various chromatin func-
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Figure 4.9: Distribution of gene sizes based on the number of Dichaete binding sites
associated with the genes
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Figure 4.10: Number of associated Dichaete binding sites vs gene length
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tions in different parts of the genome and large genes just happen to associate with
more Dichaete peaks by chance. While the functional annotations of genes with a large
number of Dichaete peaks indicates that this is unlikely to be the case for all of them,
however, for genes situated in gene dense areas, a random association may be the case.
Several multiple peak genes are the only annotated genes in a particular genome region
and are therefore considered to be the most likely direct Dichaete targets.
An obvious question is whether there is something specific about the pattern of Dichaete
binding to genes with multiple peaks or whether there are particular general features
about the way long genes are regulated in the genome. It is plausible that, for ex-
ample, long genes may have enhancer regions situated within introns and generally
more complex cis-regulatory modules. In some developmentally important genes, the
transcribed region itself may not be particularly long but there are relatively large up-
stream and downstream regions that contain a variety of complex regulatory modules,
examples here include the primary pair-rule genes eve, hairy and runt. It is therefore
possible that the different GO enrichments observed with the single vs multiple peak
genes are due to the different modes of regulation for dynamically expressed temporally
specific genes, which require complex regulation, compared to single peak genes with
more mundane housekeeping functions that are likely to have more basic regulatory
sequences. Indeed, this was found to be the case - Nelson et al. (2004) report that genes
with complex functions and dynamic expression are flanked by significantly more non-
coding DNA than genes with housekeeping functions and simple expression patterns.
It is therefore possible that the correlation between gene length and number of binding
peaks is caused by a subset of genes, whose complex regulation is mediated through
intron-based regulatory regions. Alternatively, what may also be contributing to this
is that not all binding regions are functional, and the longer genes are, the more likely
they are to be bound at random. It is therefore possible that some of the increase in
the frequency of Dichaete binding intervals associated with longer genes is a chance
occurrence.
From a Dichaete-specific perspective, a few more questions can be investigated. One is
whether the extent of correlation between multiple binding and gene length found here
is Dichaete specific, or whether it is typical of most transcription factors. Looking at
a few other transcription factor binding site profiles and rerunning the same analysis
could potentially answer this. In addition, looking specifically at total intron and total
exon length and assessing the correlation with the number of Dichaete binding peaks
could indicate whether the association is due to regulatory regions within introns.
Similarly, looking in more detail at where exactly within the multiply bound genes the
Dichaete binding peaks are located, could provide similar indications. A brief analysis
of these factors was thought to be instructive.
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Binding patterns of other TFs based on gene length
To see whether the pattern of clusters correlated with gene length was Dichaete spe-
cific, several other embryonic genome-wide data sets were analysed. In order to be
comparable with Dichaete data, the binding data sets were selected on the basis of
the number of intervals present at FDR 1%, which were then used for the analysis.
The data sets selected were the Kruppel 0-8h set (union of a Berkeley 2-3 h set and a
modENCODE 0-8 h set, 4553 intervals), the Chinmo 0-12 h set (modENCODE data,
7054 intervals), the Daughterless 2-3h data set (Berkeley, 5534 intervals), the hairy
0-8 hour data set (union of a Berkeley 2-3 h set and a modENCODE 0-8 h set, 5145
intervals), the Medea 2-3 h data set (Berkeley, 5458 intervals) and the Twist 2-3 hour
data set (Berkeley data, 7674 intervals). These data sets are also representative of a
number of different DNA binding domains and regulatory functions (Table 4.3).
Transcription factor DNA binding domain Regulatory function
Kruppel C2H2 zinc finger A-P early gap, neurogenesis
Chinmo C2H2 zinc finger Neurogenesis
Daughterless bHLH D-V maternal
Hairy bHLH A-P pair rule
Medea SMAD-MH1 D-V zygotic
Twist bHLH D-V zygotic
Table 4.3: Transcription factors used for comparison with Dichaete
The results (Table 4.4) clearly show that the trend Dichaete displays is very much
a typical pattern, at least compared to other embryonic transcription factors with a
similar number of binding sites. This leaves the question of whether the observed
association occurs by chance purely because the genes are long, or whether it reflects
the fact that genes of different lengths have a distinct set of functional properties.
Transcription factor 0 1 2 3 4+
Dichaete 3.9 5.5 12.2 19.5 35.3
Kruppel 3.7 7.5 17.2 25.6 44.8
Chinmo 3.4 5.7 15.3 23.2 43.9
Daughterless 3.7 6.1 14.3 23.2 41.2
Hairy 3.7 7.3 14.9 23.7 42.5
Medea 4.2 5.0 12.3 25.8 41.8
Twist 3.3 4.9 11.0 21.3 42.9
Table 4.4: Mean gene lengths (kb) associated with different numbers of binding peaks
Dichaete binding and intron size
To assess whether clusters of Dichaete binding specifically associate with genes con-
taining long introns, the number of Dichaete binding peaks associated with a gene
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was compared to the total exon and total intron length of each gene. The exon and
intron coordinates from the longest transcript for each gene were used. In order to get
the most up to date gene models, relevant genome annotation release 5.26 data was
downloaded from FlyMine. Small discrepancies in size compared to the Dichaete gene
lengths are present, due to some of the gene models changing between the two analyses,
however, it was thought that the effect of this on the overall trend was negligible.
Dichaete binding sites 0 1 2 3 4+
Total average intron length 2.3 3.3 9.3 16.4 31.3
Total average exon length 1.7 2.3 3.1 3.7 4.4
Table 4.5: Mean total intron and exon lengths (kb) associated with different numbers
of binding peaks
It was found that an increased number of Dichaete binding peaks appears to coincide
with a significant increase (Wilcoxon test, p-values between 0.0003 and 2.2E−16) in
both the intron size and the exon size (Table 4.5). However, it is clear from the data
that, while the exons do increase in size slightly, most of the difference in size comes
from a large increase in total intron length. Therefore, while it is possible that multiple
Dichaete binding sites are present at random in larger genes, it is also possible that
the presence of multiple binding peaks can be explained by a tendency for Dichaete
to bind at multiple locations within intron regulatory regions: for example, intronic
enhancers.
Gene length and gene function
One possible hypothesis is that longer genes have distinct functionality, for example
that developmental genes are more likely to be longer because of complex regulatory
regions sometimes present within their introns, whereas ubiquitously expressed house-
keeping genes are on average shorter because their regulatory regions do not need to
be as complex. This is indeed exactly what was found by Nelson et al. (2004) in their
study on the subject. Here I present a short piece of analysis looking only at gene
length, with the purposes of relating the conclusions of the Nelson et al. (2004) study
to the currently available genome and functional annotations. The gene length infor-
mation for all genes in Drosophila melanogaster, genome annotation release 5.26, was
downloaded from FlyMine, with the gene length considered to be the length of the
longest transcript.
In order to look at differences in GO enrichments of the different lengths of genes, the
set of all Drosophila genes was divided into subsets by length. The first idea was to
partition the gene set into equally divided size ranges - e.g. length from 0 to 50 kb,
from 50 to 100 kb and so on. However, looking at the size distributions of the genes
126
revealed that the distribution is extremely skewed, with most genes falling within the
0 - 5 kb range, with the much larger genes (going up to a maximum of 396 kb) being
extreme outliers. In order to have equally sized subsets of genes for comparison, the
data was instead split into 4 groups using quartiles, with the ranges being 31 bp to 992
bp for the ’very small’ genes, 993 bp to 1914 bp for the ’small’ genes, 1915 to 4373 bp
for the ’medium’ genes, and 4374 to 396000 bp for the ’large’ genes. This resulted in
4 subsets containing between 3719 and 3725 genes each. There is nothing specifically
biologically meaningful about these cutoff points but any cutoff based on gene length
alone will always be arbitrary. GO enrichments were obtained through Flymine and all
p-values were corrected for multiple testing using the Holm-Bonferroni method. Any
p-values of less than 0.01 after correction were considered significant.
In the case of the very small genes, about 20 GO terms were found to be enriched,
most of them connected to macromolecule metabolism/biosynthesis (631 of the genes
were found to be involved in macromolecule metabolic processes, p-value 5.6E−7).
Interestingly, the very small subset also shows an enrichment for genes involved in
gene expression (430 genes, p-value 3.1E−25) and chromatin organisation (118 genes,
p-value 2.8E−29). Virtually all of the chromatin organisation genes in question were
histones, which are required ubiquitously and tend to contain no introns. Many of the
genes involved in gene expression are associated with mRNA processing and translation,
processes that, while essential, are also likely to be required ubiquitously and not in
any particularly temporal or tissue-specific fashion.
The small gene set showed comparatively little GO enrichment, with only 10 GO
terms passing the statistical cut-off. Many of these genes are involved in metabolic
processes (1291 genes, p-value 1.2E−11); other enriched functions are connected with
either sensory perception (125 genes, p-value 1.1E−14) or spindle elongation (42 genes,
p-value = 0.00005). Similarly, the medium length genes are not enriched for many
specific GO annotations. A total of 13 GO terms were enriched, with p-values that,
while significant, are not particularly low. Again, metabolic processes feature (1520
genes, p-value 0.001) and within this group, metabolic processes of small molecules
appear to be particularly enriched (289 genes, p-value 2.6E−6). The other enriched
biological processes are connected to transport (497 genes, p-value 9.1E−6) and the
establishment of localization (511 genes, p-value 1.5E−5).
The large genes, on the other hand, show completely different trends compared to
the other 3 groups. Two striking features immediately apparent are an abundance of
enriched GO terms (over 400 biological processes were found to be enriched) and the
high degree of specific enrichment, with some of the p-values as low as 2E−130. A
large number of the genes are involved in developmental processes (1116 genes, p-value
4.9E−126), specifically in the development of anatomical structures (1024 genes, p-
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value 2.3E−130). Many of the genes are also involved in the regulation of biological
processes (1285 genes, p-value 6E−113). This group contains a large number of genes
involved in cell differentiation (667 genes, p-value 9.3E−97), nervous system develop-
ment (514 genes, p-value 7.1E−91) and various other specific developmental processes.
In conclusion, in agreement with the Nelson et al. (2004) study, it was found that gene
length is strongly correlated with gene function: smaller genes are more likely to have
general housekeeping roles and ubiquitous expression, and large genes are more likely
to have very time-specific and developmentally important roles, associated with dy-
namic expression patterns. This pattern is likely to be connected to the role of introns
in the precise temporal regulation of transcription.
Analysis conclusions
The overall analysis of genes associated with Dichaete binding found that some genes
in the genome are associated with single Dichaete binding sites, while others are as-
sociated with clusters of binding peaks. There is a clear difference in the functional
enrichment between these two classes, with the multiply bound genes mostly associated
with developmental processes. An analysis of gene length showed that the number of
binding peaks associated with a gene is strongly linked with gene length, with roughly
1 Dichaete binding peak on average for every 6 kb of gene length. An analysis of other
transcription factor binding data revealed that this pattern is typical of a number of
different developmentally important transcription factors. It was also found the ma-
jority of the increase in target gene size can be accounted for by the size of the introns
present within these genes. As previously found by Nelson et al. (2004), and redone
here using the current GO enrichments, it is clear that there is a massive difference in
the functional profiles of long genes, which were found to be mostly developmentally
important genes, or genes involved in biological regulation.
Taken together, the conclusion of these analyses is as follows. Genes that are devel-
opmentally important, or for other reasons need to be expressed dynamically and at
precise times in the organism, tend to be large, and specifically, they tend to have long
introns. In addition, large genes tend to attract multiple binding peaks for a variety
of transcription factors, including Dichaete. The likely explanation for this is that the
presence of a large number of regulatory modules, possibly reusing the same transcrip-
tion factors in different configurations, is capable of executing precise and dynamic
temporal expression programmes. In contrast, shorter genes tend to be involved in
housekeeping processes and are associated with a smaller number of binding sites, pre-
sumably because their regulation is more straightforward and likely to be dependent
upon relatively simple regulatory elements. While Dichaete appears to be one of the
transcription factors associated with multiple binding peaks within large genes, it is
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likely that this is a more general trend in the regulation of gene expression during de-
velopment. However, the other possibility is that longer spaces in the genome are more
likely to be bound purely by chance. This does not appear to be the likely scenario
for the majority of the genes in question - while one or two binding intervals could be
non-functional, and located in particular genome areas by chance, this seems less likely
to be the case for genes that are associated, for example, with 11 different Dichaete
binding intervals. Nonetheless, this is a possibility worth bearing in mind. Perhaps an
ideal method of gene association would take this into account, and for example involve
a Monte Carlo simulation to assess the significance of the gene to binding interval
association.
Addressing GO enrichment bias
As pointed out to me by Dr Casey Bergman, the fact that function correlates with
gene length introduces a bias into GO enrichment analysis, which a number of papers
describe in detail (Stanley et al., 2006; Taher and Ovcharenko, 2009; McLean et al.,
2010). A consequence of this difference in regulatory locus size described by Nelson
et al. (2004) is that, since high complexity genes have much bigger non-coding regions
around them, it is much more likely that by chance, binding peaks will be found in
these regions. Since particular ’types’ of genes, such as developmentally important
transcription factors, tend to have more complex gene expression patterns, and thus
also bigger regulatory loci, this introduces a bias in terms of the GO terms found to be
significantly enriched for genes associated with binding peaks using standard analysis
tools. Judging by the observation above about the increasing size of complex regulatory
loci in more complex animals, it is likely that this bias gets worse in, for example, large
mammalian genomes.
Taher and Ovcharenko (2009) studied this bias in the human genome, by randomly
sampling non-coding genomic locations, and assigning their functions based on the lo-
cation of the nearest gene. While with a random search like this, you would expect
no specific over- or under-representations, they found that the random search yielded
significant enrichments of categories such as ’nervous system development’ and ’tran-
scription factor activities’. This is not a problem for gene lists generated from gene
expression experiments, as these are not biased according to the surrounding regulatory
regions - all genes are in theory equally likely to feature, based on the presence/absence
of mRNA. However, it’s a major problem for functional analysis of genome-wide bind-
ing experiments such as ChIP, because there, the availability of ’landing space’ for the
factors in question can greatly bias the GO analysis. In such cases, it is important to
correct for the bias, in order to get an accurate assessment of GO enrichment. It is
worth noting in general that care should be applied when choosing appropriate statis-
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tical tests, based on what type of experiment the data comes from in the first place.
While a hypergeometric test, the statistic usually applied to obtain GO enrichment
p-values, is appropriate for data from gene expression studies, it becomes entirely in-
appropriate for gene lists generated from binding data, where the assumption of equally
probable discrete data categories is violated.
While the GO enrichment bias caused by differences in gene length is definitely im-
portant (and remarkably underreported in the literature on GO enrichment), actually
correcting for it turned out to be non-trivial. The study by Taher and Ovcharenko
(2009) developed the theoretical framework for correcting GO enrichment biases based
on the location of genes in the genome, but this method would then need to be actually
implemented as software for Drosophila, ideally also customising the input to account
for the fact that different methods and maximum distances used for gene association
assignment also impact the probabilities of different GO categories being represented.
While this would definitely constitute interesting future work, due to time constraints
it is beyond the range of this thesis. There were also two software packages already
available - GONOME (Stanley et al., 2006) and GREAT McLean et al. (2010). While
GONOME is a standalone package (including a web interface) that corrects for gene
length bias and works for Drosophila, unfortunately it is extremely out of date and no
longer maintained - the last version uses a genome release dating back to 2005. GREAT
looks like an excellent package that is recent enough and uses solid methods, but is un-
fortunately currently only implemented for human, mouse and zebrafish. Thus, while
not correcting for gene length as part of a GO enrichment analysis is definitely an
error, the GO enrichment analysis in this thesis was still performed using the standard
methods which do not correct for this, with the caveat that therefore, the conclusions
that can be drawn from GO analysis in this thesis are relatively limited.
Specifically, while counting the numbers of genes in a gene list that have a particular GO
term associated with them is merely a factual statement - e.g. out of 1000 genes, 400 are
annotated as having ’nervous system development’ functions - what GO enrichment
analysis aims to do is pick out the functionally relevant GO terms by statistically
testing whether they are over- or under-represented than would be expected given
the size of the gene list and the proportion of all the genes in the genome that are
annotated with the function in question. So, while 400 nervous system genes might
seem like a lot, it might not be if, say, 12,000 out of the total 14,000 genes in the
genome have nervous system functions - in fact, there would then be a significant
underrepresentation of them in the gene list in question. Since the p-values might be
skewed because of gene length, it is likely that the presence of developmental genes and
transcriptional regulators is deemed much more significant than is actually the case,
while for example housekeeping genes are more underrepresented. If the function of
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a transcription factor was being determined for the first time purely on the basis of
a gene list, this would be a huge problem. In essence, all transcription factors would
end up supposedly involved in the same range of developmental processes, likely purely
by chance. However, with studying Dichaete specifically, I have the good fortune of
drawing on a number of years of phenotypic analysis Russell et al. (1996); Soriano and
Russell (1998); Sanchez-Soriano and Russell (2000); Overton et al. (2002); Shen (2006);
Maurange et al. (2008). So, for example, we know from phenotype-based experiments
that Dichaete is involved in nervous system development - specifically in midline and
neuroblast development. Therefore, starting from a global gene list for Dichaete and
identifying the subset involved in aspects of nervous system development is inherently
interesting because of what we know about Dichaete function, irrespective of whether
’nervous system development’ as a term is overrepresented and underrepresented. With
this in mind, GO enrichment analysis results are still presented throughout this thesis,
with the caveat that the p-values are biased and should not be relied on as the sole
basis for further work.
4.5.3 Deconvolution for different developmental times
It was found in the previous chapter, that there is an extremely high overlap between
accessible regions of chromatin (as found by the BDTNP) and Dichaete binding. This
is not unexpected, as literature on transcription factor binding suggests that the ac-
cessibility of chromatin, combined with sequence specificity, is one of the strongest
determinants of transcription factor binding locations (Li et al., 2011; Kaplan et al.,
2011). While the correlation does not resolve the question of what comes first, chro-
matin accessibility or transcription factor binding, it does open up the possibility of de-
convolving binding profiles collected during broad time periods into more stage-specific
views, by using the available detailed chromatin accessibility time-course data. Though
unlikely to be as precise as a detailed time course experiment on specific transcription
factors of interest (since chromatin accessibility profiles reveal where transcription fac-
tors might be binding rather than where they actually are binding at the specified
time), this method nonetheless has the potential to save time and money, in situations
where a detailed time course is not readily achievable.
Method
The DNase I assay accessibility data (Li et al., 2011) was downloaded from the BDTNP
website, and converted to Genome Release 5 using the UCSC LiftOver tool (Rhead
et al., 2010). Data were available for stage 5, 9, 10, 11 and 14 embryos, overlapping
with the 0-12 h developmental time frame of the Dichaete core binding dataset. An
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intersect between the Dichaete data and the accessibility data was found for each of
the available stages, and used as an estimate of where Dichaete is likely to be binding
in the embryo during that developmental time. Stages 5 and 9 were of particular
interest, as this is when Dichaete is likely to be active in segmentation and neurogenesis,
respectively. Similarities and differences in the binding patterns between the stages,
and the potential associated target genes, were then studied.
Overlap found
First of all, the Dichaete core dataset was compared to the union of all available DNase
I data in the same time period to check whether the same strong correlation observed
with the individual Dichaete binding datasets described in Chapter 3 was present.
This was indeed found to be the case - 90.4% of the Dichaete core intervals showed an
overlap with the accessibility data (p-value = 0.0009, resampling based significance test,
Cooccur (Huen and Russell, 2010)). The overlap is not perfect and potential reasons for
this could be: the presence of false positives in the Dichaete data (considered less likely
since the binding intervals detected by independently methods); the presence of false
negatives in the accessibility dataset (possibly because the accessibility of some regions
changed too quickly to be captured, or because the DNase I assay is not a perfect
bias-free predictor of accessibility); the possibility that Dichaete does not always bind
to accessible regions; or because the accessibility datasets do not cover the entire time
period that the Dichaete dataset covers. The last reason was thought to be the most
likely, however, if this were the case, the D Berk dataset from Chapter 3 would be
expected to have the highest overlap, due to being the most closely temporally matched
to the corresponding DNaseI dataset. This was not found to be the case: the D08 and
D12 datasets display the highest overlap (96% and 98%, respectively), with D Berk
and D Dam both showing a 90% overlap. D08 and D12 have much fewer peaks than
D Berk and D Dam, perhaps indicating that the strongest Dichaete peaks only appear
in accessible regions. If the problem is in the datasets, it is more likely to be due to the
incompleteness of the DNaseI datasets (single experiment, 2 replicates, FDR 5%) than
due to false positives in the Dichaete dataset (multiple experiments, between 2 and 3
replicates at FDR 1% in at least one of the experiments). Nonetheless, the overlap
found was considered to be high enough to proceed with the rest of the analysis.
Time specific Dichaete datasets
The Dichaete core dataset was split into 5 stage specific datasets, by taking the intersect
of the Dichaete dataset with the DNaseI dataset at each stage. To start with, previously
identified potential Dichaete targets (Shen, 2006), such as the genes in the Achaete-
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Scute complex, were visually inspected to verify what the deconvolved data looks like
(Figure 4.11). The patterns that emerge are interesting, with some regions being
continually bound throughout the 5 different stages while others appear more dynamic.
A pattern that seems to emerge from looking at this subset of genes, is that positions
near the transcription start site are frequently continually bound, whereas sites that are
further away tend to be more dynamic, perhaps priming a gene for expression, then
regulating expression at particular stages more precisely via interactions with other
factors at more distant cis-regulatory modules. While this is clearly too small a subset
of genes to base solid conclusions on, it is nonetheless an interesting hypothesis.
Static vs dynamic Dichaete binding
First of all, the Dichaete binding peaks present at different stages (based on the presence
of DNaseI accessibility tracks in that location at the appropriate stage) were categorised
into static or dynamic binding sites. The five datasets were merged, with any clusters of
partially overlapping intervals treated as one large interval for the purposes of counting.
The intervals in the fused dataset with overlaps at each of the developmental stages were
tabulated to indicate the presence or absence of each interval at different developmental
times. The fused dataset contained a total of 8140 intervals, all of which were accessible
and bound at least once during the 5 stages that accessibility data is available for. The
number of intervals is greater than the original 6473, because some of the original
intervals got split into a number of smaller intervals based on the location of accessible
regions within them. These were then split up according to the total number of stages
they were bound at (Figure 4.6).
Total stages interval Number of Percentage of
is bound at intervals total intervals
1 1433 17.6%
2 947 11.6%
3 805 9.9%
4 1121 13.8%
5 3834 47.1%
Table 4.6: An overview of static vs dynamic Dichaete binding, as estimated from
DNase I accessibility data for different embryonic stages. The data was available for a
total of 5 different stages and the table shows in how many of those stages the interval
in question is bound.
Overall, a large number of intervals (47%) were found to be ’static’ - i.e. bound at all
stages. The intervals bound at only 1 out of 5 (constituting 18% of the total number)
were classified as ’transient’. The intervals bound in between 2 and 4 stages (35% of the
total) were classified as ’dynamic’ (Figure 4.7). I then looked for differences between
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Figure 4.11: Dichaete temporal binding profiles. The diagram shows estimated
Dichaete binding intervals for 5 different stages (stage 5, 9, 10, 11 and 14), with the
location of Dichaete binding at each stage estimated based on the overlap with DNaseI
accessibility interval locations during the stage in question.
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the gene sets associated with each group, caluclating GO enrichments for each groups
with Ontologizer, using the Parent-Child union method and the Benjamini-Hochberg
correction for multiple testing.
Classification Number of Percentage of Number of
intervals total intervals genes hit
Static 3834 47% 3780
Dynamic 2873 35% 1557
Transient 1433 18% 899
Table 4.7: An overview of static vs dynamic Dichaete binding, as estimated from
DNase I accessibility data. The intervals are classified as static (bound at all 5 stages),
dynamic (bound during 2-4 stages) or transient (bound during 1 stage).
A number of genes were associated with more than one type of binding since they are
close to multiple binding clusters (Figure 4.12). Very few genes were associated with
transient binding intervals alone - instead they were frequently also associated with
static or dynamic intervals, or both. The few genes only associated with transient
binding show no significant enrichment and do not feature particularly interesting
developmental genes. While the total set of genes associated with transient binding
has a lot of interesting GO enrichments, including developmental processes (p-value
3.95E − 59, 355 genes) and regulation of gene expression (p-value 2.75E − 31, 175
genes), these enrichment classes are also found for genes associated with either static
binding, dynamic binding or both. It is therefore possible that transient binding has a
role in stage-specific regulation of particular genes, but it seems unlikely that transient
binding is a unique feature. Rather, it is likely that transient binding sites act in unison
with other more long-lasting binding regions to modulate gene expression.
Figure 4.12: Numbers of genes hit by particular types of binding intervals.
The set of genes associated with static binding alone appears more interesting. It con-
tains a range of genes involved in cellular (p-value 1.4E-79, 1521 genes) and metabolic
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processes (p-value 1.04E-21, 1139 genes), and biological regulation (p-value 2.93E-22,
722 genes). This includes a range of cell cycle genes (p-value 2.31E-06, 251 genes),
genes involved in various aspects of cytoskeleton organisation and genes involved with
cell death (p-value 1E-4, 82 genes). While a large number of developmental genes are
present, the enrichment for developmental processes is not particularly strong (p-value
0.01, 532 genes), and specific enrichments for particular developmental processes such
as neurogenesis is notably absent in this set. It appears that static binding on its own
is associated with basic cellular processes and is perhaps important in implementing
some levels of Dichaete-facilitated regulation. However, it does not appear that this
set is the causative factor in bringing about different developmental processes.
The genes associated with dynamic binding alone only display a small number of very
weak enrichments, connected to localization (81 genes, p-value 0.42) and CNS devel-
opment (15 genes, p-value 0.46), presumably because of the small number of genes
featured in this group. However, the connection of these processes to development and
differentiation is notable.
The set of genes associated with 2 or more different types of binding appears to be
the developmentally interesting group since it is highly enriched for developmental
processes (539 genes, p-value 8.6E-97) and biological regulation (562 genes, 4.5E-85),
including the regulation of gene expression (253 genes, p-value 5.2E-37). It contains
genes involved in signalling (271 genes, p-value 1.1E-34) and growth (96 genes, p-value
3.8E-29). It also contains genes involved in both embryonic (205 genes, p-value 4.6E-
11) and post-embryonic development, and involved in specific developmental processes
such as nervous system development (294 genes, p-value 1.7E-10). This finding makes
sense since the presence of some form of temporally specific binding would be expected
in order to facilitate the temporally specific expression of developmental regulators.
An interesting observation is that a many of these regulators are associated with static
Dichaete binding throughout development as well as multiple binding sites, some of
which are dynamic. This raises several possibilities. The static binding sites may be
effector sites that are ready to act on the nearby genes, but require particular cofactors,
the presence of which is triggered by the dynamic binding sites. Alternatively, there
may be some degree of non-functional binding, where Dichaete is just docking close to
the genes that it will regulate later in development. Of course, these speculations rely on
the datasets being considered accurate, and though they do provide an approximation
of where Dichaete binding may be occurring at different developmental times, they are
not actually from an experimental time course.
It was then investigated how the interval occupancy changes over different stages of
development (Figure 4.13). It is interesting to note that the total number of binding
intervals is fairly constant, around 6000 intervals in total during Stages 5-11, but then
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drops off to approximately 4900 intervals during Stage 14, when Dichaete is thought
to have less of an active developmental role. Interestingly, the numbers of static and
transient binding sites remain about the same throughout the different stages, whereas
the number of dynamic intervals changes dramatically, dropping from over 2000 to
around 800 at Stage 14. It is possible that this is due to dynamic binding intervals
being important as particular developmental triggers at set times, and then no longer
being needed during later stages of embryogenesis.
Figure 4.13: Overview of numbers of Dichaete binding sites. The total number of
binding sites (left) drops off during later stages. When broken down by type of binding
(right), the numbers of static and transient binding sites remain similar over time,
whereas the drop in the number of dynamic binding sites causes the overall drop in the
interval number.
In conclusion, the DNaseI accessibility data can be used for deconvolving ChIP-chip
data into more temporally specific datasets, and the dynamically bound intervals might
be of particular interest to study, as they may have the most significance in terms of
developmental biology.
4.6 Conclusions
The main contribution of this chapter was the development of a method for integrating
multiple genome-wide binding datasets to generate a single high confidence interval
set. While simple, it is thought that this method it both useful and widely applicable.
Genome-wide binding studies are becoming extremely common and using methods to
increase the amount of reliable biological signal extracted from them is considered
useful due to the noise levels inherent in techniques such as ChIP-chip. In terms of
contribution to Dichaete biology - there is now a highly reliable binding dataset for
Stages 1-15 of embryogenesis, which should be helpful for future studies.
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The biological conclusions about Dichaete largely match those from Chapter 3: Dichaete
binds mainly within either intergenic or intronic regions and tends to be found next
to or within 1 kb upstream or downstream of transcription start sites. It is likely
that it acts by binding to enhancer regions, although there is also a suggestion that it
may facilitate aspects of transcriptional pausing: the binding data is consistent with
both hypotheses and it is possible that Dichaete is doing both in different locations or
contexts.
One of the ultimate aims of my PhD is to identify functional Dichaete sites in the
genome and determine how they facilitate regulation of gene expression. One of the
puzzles presented by binding data is that a lot of the binding sites present in the
genome may not necessarily be functional. Therefore identifying filters for finding
likely functional binding sites is extremely useful.
Using the overrepresentation of the Dichaete binding motif as a filter for function-
ality showed some very promising results. It is known that binding motifs do not
perfectly correlate to functionality, indeed it is possible to have conservation of func-
tionality without conservation of sequence (Hare et al., 2008). However, this seems
like a promising method for isolating at least a subset of functional binding peaks, and
may be a useful filter for selecting particular regions for individual validation.
Distinguishing between single and multiple binding peaks does not appear to clearly
identify functional binding regions, however, it does identify interesting target genes. It
appears likely that the genes associated with multiple binding peaks have complex reg-
ulation, in part facilitated by Dichaete, and are likely to be both direct and interesting
targets.
The preliminary analysis of data deconvolved by time via DNAse accessibility data
allows the identification of binding sites that are likely to be dynamically bound by
Dichaete, and suggests that this particular class of binding sites might be functionally
important. The other use of these data is in cases where other functional data, such
as a gene expression profiling, is available for a particular stage of development. Here
the binding data filtered by accessibility can be used as a substitute for a time course
binding experiment, in order to more closely match the binding profile with the other
available data. While of course time course experimental data would be preferable, this
is a cheap and easy alternative that might be practical in cases when obtaining a time
course is not a possibility. These filtering methods will be used alongside functional
data in Chapter 6.
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Chapter 5
Dichaete gene expression studies
5.1 Introduction
In Chapter 4, I presented a high confidence Dichaete binding dataset and the insights
drawn from it about Dichaete biology. However, looking at binding data alone does
not answer the question of which binding sites have a functional role in regulating
gene expression, exactly what this role is, and what genes are being regulated. A
computational analysis can go some way towards identifying potential targets, but to
verify the generated hypotheses, further evidence is required.
5.1.1 Microarrays and gene expression
Gene expression studies are a commonly used tool in functional genomics. In a genome-
wide gene expression study, two samples are compared; for example, cancerous and
non-cancerous cells, or cells carrying a mutation vs those with a wild type gene. In
the context of Drosophila developmental biology, genome wide expression profiling
has been successfully employed to identify genes involved in a variety of processes,
including mesoderm development (Furlong et al., 2001), early embryonic patterning
(Stathopoulos et al., 2002) or aspects of CNS development (Altenhein et al., 2006) as
well as studying the activity of particular transcription factors (Montalta-He et al.,
2002; Hueber et al., 2007). While the main direct purpose of this type of experiment is
to identify transcription factor target genes and the genetic networks they are involved
in (Altenhein et al., 2006; Stathopoulos et al., 2002), further analysis can also use these
data as a starting point for dissecting transcriptional regulation underlying biological
processes, as was the case with uncovering the specificity and hierarchy of Hox gene
action (Hueber et al., 2007). Gene expression experiments can also be designed to
test evolutionary conservation between either specific genes or broad patterns of gene
expression by, for example, comparing results from the same tissues from different
species (Chan et al., 2009) or seeing the effects of a transcription factor from another
species on the model system of interest (Montalta-He et al., 2002). Temporal expression
profiles related to the action of different transcription factors can also be obtained and
can lead to new insights into biology (Furlong et al., 2001).
There are a number of different types of microarrays employed for different purposes:
for gene expression, probes are commonly designed from genome annotations or se-
quenced cDNA libraries and only cover genic regions, whereas tiling arrays are avail-
able for use in experiments that require whole genome coverage. In general 2 types of
microarray platform are in common use, the Affymetrix GeneChip, a single channel
technology (Lockhart et al., 1996), and the spotted or synthesised platforms based on
the cDNA array concept developed in the Brown lab, which are generally used in 2
channel studies (Schena et al., 1995). The principal difference is that for single channel
microarrays, the sample and control are hybridised to different arrays, and the differ-
ences in intensities are only compared during post-processing, whereas for dual channel
microarrays, both the sample and the control are labelled with different fluorophores,
combined and hybridised to the same array. However, while the platforms are differ-
ent, a systematic analysis indicates that the choice of microarray platform does not
have a significant impact on experiment outcomes (Johnson et al., 2008). While next-
generation sequencing is becoming more popular, microarray technology still offers a
cost effective and convenient platform for rapidly comparing transcriptomes, partic-
ularly in species with compact genomes, where it is possible to provide high density
genome coverage on a single tiling array (Aleksic and Russell, 2009). In addition, for
many species gene expression arrays are readily available, comparatively inexpensive
and reliable.
Here I take advantage of the long oligonucleotide platform developed by the Interna-
tional Drosophila Array Consortium (INDAC) (Sykacek et al., 2011), which has been
shown to perform well in a number of previous studies (Choksi et al., 2006; Zeitouni
et al., 2007; Meadows et al., 2010). In brief, RNA from each of the samples being com-
pared is extracted, reverse-transcribed, sometimes amplified and then labelled with
fluorescent dyes before hybridising to a microarray. After washing and scanning, the
ratio of intensities for each spot on the array is quantified, providing a relative mea-
sure of the abundance for each mRNA sequence assayed by each specific array probe.
Relative differences between two samples, i.e. sample and control, are calculated as
the intensity ratio of each spot. In the case of dual channel arrays, which employ
different fluorescent dyes for each channel, dye incorporation and detection efficiencies
are known to be different and a standard experiment normally includes dye swaps to
control for these effects (Russell et al., 2009).
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In order to account for natural occurring gene expression variability between samples,
as well as to control for technical variability, a number of different biological replicates
are included in the same experiment. While the number of replicates employed will
depend upon the degree of statistical power one wishes to achieve, FlyChip commonly
use four biological replicates (with 2 dye swaps providing a balanced design), how-
ever, on occasion where large differences in the magnitude of expression changes are
observed, three replicates may yield sufficient data and statistical power (Russell et al.,
2009). Once the raw images are recorded and the intensities quantified, microarray
data must be normalized within and between arrays to eliminate some of the technical
variability associated with the method. There are a variety of techniques employed,
depending upon the experimental design and type of data collected, ranging from rel-
atively simple techniques, normalising the intensity distribution across arrays, to more
sophisticated approaches that take into account spot intensities and utilise linear re-
gression or probabilistic methods to better deal with the peculiarities of microarray
data. After normalization, the reliability of the gene expression ratios across the repli-
cates is assessed statistically allowing thresholding and selection of gene lists for further
analysis (Russell et al., 2009).
5.1.2 Mutants used for gene expression
In biomedical research it is common to compare cells from diseased tissues with those
from control normal individuals: alternatively, if the genes implicated in a particular
disease are already known, they can be individually mutated or knocked-down to study
the specific effects on gene expression. In more basic biology research that focuses on
understanding, for example, the developmental processes shaping particular organs or
tissues, a common study design involves disrupting a specific gene and comparing the
mutant state to the wild type tissue or cell type. While whole organisms are frequently
used in such studies, more specific experiments can also be performed by isolating
particular tissues or single cell types. In the case of Drosophila, while some larval
or adult tissues are relatively easy to isolate for expression studies (Pavlopoulos and
Akam, 2011), the embryo is more difficult to deal with and it is only very recently that
methods for isolating specific cell populations from the embryo have been developed
(Salmand et al., 2011). In my studies I have used whole embryos for expression profiling.
While it is clear that deconvolving data from across the entire embryo is difficult, as
previous studies have shown, it can still be useful to catalogue gene expression changes
across the entire animal (Hooper et al., 2007; Papatsenko et al., 2010).
There is a wealth of genetic tools available for the fly, including null alleles being avail-
able for many genes, which facilitates the identification of expression changes in the loss
of function condition. If possible, it is desirable to combine two different null alleles or
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to examine a null allele in combination with a deletion since chromosomes can contain
other mutations that may confound the microarray analysis. Alternatively, approaches
such as RNAi can be used to disrupt the expression of a specific gene in particular
tissues. The Gal4 driver system available in flies makes tissue-specific expression of
constructs straightforward and the availability of a variety of tissue or cell-specific
drivers provide a very powerful research tool (Brand and Perrimon, 1993). Another
tissue-specific approach that utilises the Gal4 system involves creating dominant nega-
tive alleles that in some way compete with and/or disrupt the action of a transcription
factor of interest, for example by attaching a repressor domain to an activator or by
mutating a transactivation or interaction domain of the protein (Margolin et al., 1994;
John et al., 1995). In my work, I utilise both the loss of function and the dominant
negative approach.
5.1.3 Chapter overview
This chapter presents the results of a set of gene expression studies I performed for a
number of Dichaete mutant conditions. The gene expression results are both a stand-
alone study in their own right as well as a useful functional validation for the Dichaete
embryonic DNA binding data presented in Chapters 3 and 4. For this reason, the
gene expression data will first be presented on its own, followed by a brief comparison
with binding data. More in-depth integration with the binding data and the functional
conclusions drawn from that will be explored in Chapter 6. During the course of the
gene expression experiments, questions arose about the exact mechanisms of function
of some of the dominant negative alleles used and this was investigated further. A
pilot study exploring this issue is presented in this chapter, along with suggestions for
future work.
5.2 Method
5.2.1 Dichaete null mutants
For expression profiling Dichaete loss of function embryos I took advantage of two
characterised null alleles: Dr72 and Dr513. Dichaete null mutants display severe seg-
mentation and nervous system phenotypes, and do not hatch from the egg. To obtain
Dichaete null embryos, each allele was balanced over TM3, twi-Gal4 UAS-eGFP and
the homozygous mutants identified by the lack of eGFP fluorescence. However, it
should be noted that this was not an ideal solution: while it was desirable to per-
form the gene expression study during the early stages of CNS development, the eGFP
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construct takes some time to be expressed and is not visible until 4.5-5 hours of devel-
opment (late stage 9). The earliest time when fluorescence could be reliably detected
was found to be towards the end of stage 10, so a stage 10-11 embryo collection (5
- 7.5 hours) was performed and individual eGFP− embryos hand picked from timed
collections. As a control population, heterozygous embryos with a single functional
Dichaete allele were selected since it was thought that comparing homozygous null
allele embryos to the wild type would poorly control for genetic background and envi-
ronmental conditions. Heterozygous control embryos were collected by crossing Dr513 /
TM3, twi-Gal4 UAS-eGFP to wild type flies and heterozygotes were identified by the
lack of eGFP. The samples were stored in Trizol and frozen, with the RNA extraction
performed once a sufficient number of embryos was collected, followed by amplification,
labelling and hybridisation to INDAC FL003 microarrays. 4 replicates were performed,
and a dye swap was incorporated into the experimental design.
5.2.2 Dominant negative mutants
For this study, the dominant negative Dichaete constructs created by Shih-Pei Shen as
part of her PhD work were used. The constructs are inserted into the pUAST vector and
thus under the control of the Gal4 UAS promoter. Two different types of dominant
negative Dichaete proteins were created: one (EnRep) has the engrailed repressor
domain fused to the C-terminal of the wild type Dichaete protein, in theory turning
it into a repressor wherever it binds. The second construct (HMG−) has a deleted
HMG DNA-binding domain, meaning that it should no longer bind to DNA but might
still be able to compete with endogenous Dichaete for co-factors. A third construct,
DWT, is the wild type Dichaete protein in the same vector. While this construct
does not result in appreciable embryonic phenotypes compared to embryos expressing
the dominant negatives, it was still thought that it might be interesting to examine
gene expression when Dichaete is overexpressed. All of the constructs were tagged in
frame with GFP, making visualisation, and potentially chromatin immunoprecipitation,
straightforward.
5.3 Construct validation
Before embarking upon the microarray analysis, it was considered prudent to validate
the dominant negative stocks by checking that they produce the expected phenotypes.
For the Dichaete dominant negative constructs, the validation was performed by Alek-
sandra Mandic, a summer student in the lab working under joint supervision of Bettina
Fischer and myself. There were two components to the validation. The first was to
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verify the fly stocks, whether the Gal4 drivers were working as expected and to check
that each of the constructs was still present in the stock. The second involved veri-
fying that previously reported nervous system phenotypes were present, i.e. that the
dominant negative constructs were having the expected developmental effect.
5.3.1 Gal4 driver validation
Since all the constructs were eGFP-tagged, their expression could be easily validated by
fluorescence microscopy without the need for immunostaining. The expression patterns
were found to be as expected, with the simGal4 crosses clearly showing fluorescence in
cells of the ventral midline and prosGal4 crosses displaying fluorescence in the neuroec-
toderm and developing neuroblasts (Figure 5.1). An interesting observation emerged
from these experiments: while fluorescence was strong and correctly located with the
prosGal4, UAS-DWT cross, it was much weaker in the prosGal4, UAS-HMG− and
EnRep crosses. There are two possible explanations for these observations: either the
reduction results from the general nervous system phenotype induced by the dominant
negatives or, since we have evidence that Dichaete regulates prospero, the constructs
might in fact be switching off the prosGal4 driver by interfering with normal Dichaete
function. Since the nervous system phenotypes do not result in a severe loss of CNS, the
latter is considered more likely. A UAS-GFP strain included as a control demonstrates
that GAL4-driven expression was in the expected tissues, indeed the GFP signal in
this case was very strong compared to the Dichaete constructs. Some of the difference
may be due to the fact that the constructs are randomly integrated into the genome
via a P-element vector (a more modern approach would insert each construct at the
same location using an integrase or recombinase). However, this is considered less likely
since the SimGal4 crosses show much less variability.
5.3.2 Phenotype validation
Having verified by fluorescence that the constructs were present and expressed in the
expected tissues, phenotypes were checked to ensure the dominant negatives disrupted
Dichaete activity as expected by examining major axon tracts of the embryonic CNS
with the BP102 antibody (Figure 5.2. The phenotypes observed in the dominant neg-
atives were concordant with the Dichaete loss of function (Soriano and Russell, 1998).
Expression of the EnRep construct resulted in a strong phenotype, with thinning and
breaks of the longitudinal tracts as well as commissure fusion. The HMG− construct
was also found to have a visible CNS phenotype, although not as severe as those
observed with EnRep. As expected, expression of DWT and the GFP control did
not result in appreciable CNS phenotypes, though occasional commissure breaks were
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Figure 5.1: Fluorescence observed in the dominant negative crosses. Fluorescence is
observed in the neuroectoderm (yellow arrows) in the prosGal4 crosses (a-d) and in the
midline (yellow arrowheads)in simGal4 crosses (e-h), as expected. Interestingly, the
prosGal4 dominant negatives (b, c) display less clear fluorescence than the wild type
controls (a, d). This is also, to a lesser extent, observed for the simGal4 dominant
negatives (f, g).
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found in embryos expressing wild type Dichaete in the midline (arrowhead in Figure
2c). Taken together, the validation experiments reveal the expected phenotypes and
confirm that the genotypes are suitable for further gene expression analysis.
Figure 5.2: Embryonic CNS phenotypes of the dominant negative crosses, visualised
with BP102 axon staining. The EnRep dominant negative (b, e) displays the most
severe phenotypes, with the collapsed commisures (arrowheads) and breaks in longitu-
dinals (arrows) clearly visible. HMG− (a, d) displays a milder, but still clearly visible
phenotype. simGal4 DWT (c) displays slight thinning of the longitudinals, whereas
prosGal4 DWT (f) appears wild type.
Microarray analysis
Two sets of experiments were performed using the dominant negative constructs: ex-
pressing each in the midline using a simGal4 driver and in neuroblasts using a prosGal4
driver. In each case, HMG−, EnRep and DWT were crossed with the relevant driver:
sufficient embryos were collected to analyse four biological replicates per cross. In order
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to keep the genetic background of the embryos as similar as possible, virgin females were
always collected from the Gal4 driver stock and males taken from the dominant nega-
tive strain. A UAS GFP construct crossed in parallel with the Gal4 drivers was used
to collect control embryos. Roughly 150 embryos per sample were collected between
3.5 and 4.5 hours after egg laying and stored frozen in Trizol. Following RNA extrac-
tion, reverse transcription, Klenow amplification and labelling (Chapter 2), samples
were hybridised to INDAC FL002 or FL003 Drosophila gene expression arrays. Four
biological replicates were performed for each experiment, with 2 dye swaps incorpo-
rated into the experimental design to control for bias due to different dye incorporation
efficiencies.
5.4 Data processing
For all the gene expression datasets, Dapple was used for spotfinding and the arrays
were quality checked manually, removing any spots that appeared to be affected by high
levels of background or artefacts. The signal intensities were quantified with Dapple
prior to normalization and subsequent processing. Differentially expressed genes were
selected on the basis of p-values and average M values. An M-value is the log2 ratio of
sample vs control for the probe in question on the array (with each probe being mapped
to one particular gene). In cases where multiple probes hit the same gene, the average
M value for that gene was calculated as an average across the different probes that
were flagged as significant. In these cases the values from the different probes tended
to be extremely similar, supporting the reliability of the INDAC microarray.
In the case of the dominant negative constructs, the standard FlyChip data analysis
pipeline was employed, using the Variance Stabilisation and Normalization (vsn) pack-
age in R followed by CyberT to assess statistical significance. The thresholds used to
identify differentially expressed genes were average M-value of < −0.5 or > 0.5 with
a p-value < 0.05. When the limma package was used for assessing statistical signif-
icance, it filtered the majority of differentially expressed genes that CyberT finds to
be significant. While limma uses a more stringent statistical test, it was thought that
in this case it was too severe for an exploratory analysis. The rationale here is that
the gene expression studies are not only intended as stand-alone experiments, but also
to be examined together with other data and act as a screen for potential interesting
targets. Therefore, while there are certainly false positives within the sets of genes
identified with CyberT, these data were used with this knowledge and awareness that
the reduced statistical threshold weakens evidence from each individual study. How-
ever, this approach makes it easier to compare results across studies, and it is likely
that a gene flagged in multiple experiments is a strong candidate target. In addition, it
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is known that Dichaete phenotypes are variable (Russell et al., 1996) and it is possible
that this will also be reflected in variable effects on gene expression between biological
replicates. If this is indeed the case, the direct Dichaete targets may end up with less
significant p-values because of the variability between biological replicates despite be-
ing real targets. Taken together these arguments support the view that a less stringent
statistical test for exploratory analysis of the Dichaete data is more appropriate for
looking at Dichaete biology.
In the case of the Dichaete null mutant experiment, the data processing proved to be
more complex. Most commonly used microarray normalization methods rely on the
majority (50%-75%) of genes not showing significant expression changes in any given
experiment (Russell et al., 2009). However, such a large number of genes changed ex-
pression in the Dichaete homozygous null embryos that standard normalization meth-
ods failed. To deal with this a previously published invariants normalisation method
(Pradervand et al., 2009) was used (suggested by Stewart MacArthur and implemented
by Bettina Fischer). In this method, the subset of genes whose expression is constant
across arrays are identified and used to normalize the rest of the set. The invari-
ant genes are identified by the invariant normalization method in question, by using
mixture models of the mean and variance distributions to identify probes that have
medium-high mean intensity and low variance across arrays. The later stages of the
analysis were performed using limma. This normalization method seemed to work bet-
ter than the standard methods (Figure 5.3), identifying 9120 differentially expressed
genes using the thresholds employed for the dominant negative constructs. Since such
a large number of genes were found to be differentially expressed, and because it was
uncertain how accurate the normalization method was, given the small number of in-
variant genes, more stringent thresholds were applied to obtain a smaller number of
more reliable hits. The new thresholds used to find differentially expressed genes in
the Dichaete mutant were average M-value < −1 or > 1 and a p-value < 0.01.
5.5 Dichaete null mutant gene expression
As described above, the normalisation of the Dichaete mutant data was made difficult
by the large number of genes that changed expression in this experiment. Indeed,
if the statistical thresholds used for the dominant negatives data are applied a total
of 9120 genes are found to be differentially expressed (65% of the total genes in the
Drosophila melanogaster genome!). When more stringent cutoffs are applied a total of
4518 genes were found to be significantly differentially expressed (the data for the 4518
genes is shown in Table 8, Appendix 3). The vast majority of these, 92.6% (4182),
are downregulated, with only 7.4% (336) found to be upregulated. While in a null
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Figure 5.3: Comparison of different normalization methods applied to the Dichaete
null mutant expression data. Each of the 4 panels corresponds to 1 biological replicate
performed on an individual array, and dye swaps are present in 2 out of 4 replicates
(and visible in the overall trends of the graphs). The gene spots are shown in black.
For the raw and invariant normalized data, the controls are shown in green, and the
spikes are shown in orange (hidden for the other two). For the invariant normalization,
invariant genes are shown in blue. A successfully performed normalization is expected
to center the data around M-value 0, which VSN and L-quant fail to do.
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mutant experiment it is impossible to disentangle immediate gene regulation targets
from downstream effects, these results nonetheless highlight the central role Dichaete
plays in genetic regulatory networks during development. Encouragingly, one of the
genes flagged as differentially regulated in this screen is the known Dichaete target
slit.
The differentially expressed genes were analysed using the Genomewide Expression
Maps (GEMs) tool at Fly Express (Kumar et al., 2011; Konikoff et al., 2011) and a
heatmap was generated for the genes for which in situ data are available from the
BDGP. Encouragingly, the majority of the genes identified have an expression pattern
very similar to that of Dichaete (Figure 5.4). This indicates that, despite the large
numbers of genes flagged in the gene expression analysis, many of them appear to be
specific and constitute plausible Dichaete targets.
Figure 5.4: Heatmap of genes differentially expressed in the Dichaete null mutant
experiment. (a) Dichaete in situ, stage 9-10, taken from BDGP, (b) Heatmap of ex-
pression of genes from the Dichaete mutant study for which BDGP in situ data was
available. Generated using the GEMs tool at Fly Express
5.5.1 GO enrichment
Despite the large number of genes flagged in the Dichaete mutant gene expression ex-
periment, the GO enrichments indicate that the genes are to a large extent very much
specific to the reported roles of Dichaete during development. The GO enrichments
found include developmental processes (802 genes, p-value 7.00E − 06), nervous sys-
tem development (329 genes, p-value 1.00E − 04), cell fate commitment (129 genes,
p-value2.00E−06), embryo development (226 genes, p-value 6.00E−04) and digestive
track development (49 genes, p-value 8.00E − 04): all of these are biological processes
which Dichaete is expected to be involved in (Russell et al., 1996; Nambu and Nambu,
1996; Soriano and Russell, 1998; Sanchez-Soriano and Russell, 2000). Another process
that was found to be enrichment is open tracheal system development (96 genes, p-
value 1.60E − 03), possibly because a number of genes are involved in both tracheal
development and neurogenesis. It was also found that 58 of the differentially expressed
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genes contain a Homeobox domain (p-value 4.00E − 05). Out of the 296 genes present
in the FlyTF ’trusted’ list of transcription factors, 152 were found to be differentially
expressed in the Dichaete null mutant, even with the more stringent cutoffs applied.
On the whole, the GO enrichment analysis looks very encouraging and suggests that de-
spite the very broad effects on gene expression observed, the experiment is nonetheless
successfully picking out genuine components of the Dichaete genetic network.
5.5.2 Upregulation and downregulation
One of the immediate striking things about the results of this experiment is that
the great majority of differentially expressed genes were found to be downregulated.
The set of downregulated genes still has a very similar GO enrichment profile to the
one described for the complete set of differentially expressed genes, as expected since
it constitutes around 93% of the complete set. The upregulated gene set was only
found to have a few biological processes significantly enriched, connected with sexual
reproduction (40 genes, p-value 3.00E − 03) and macromolecule catabolic process (20
genes, p-value 7.00E−03). However, this set does still contain a number of interesting
developmental genes such as bicoid and Su(H), so the absence of GO enrichments may
be due to a smaller number of genes present resulting in a lack of statistical power,
rather than necessarily because the upregulated genes are fundamentally different to
the downregulated genes. From the overall profile, it nonetheless appears likely that
Dichaete is mainly functioning as an activator, and possibly driving a number of other
activators during development, whereas the upregulated genes are likely to be affected
by downstream effects. However, it is thought that Dichaete can affect gene expression
context-dependently (Phochanukul and Russell, 2009), so while this experiment gives
a rough general picture of what is happening, the specifics are likely to be significantly
more complex.
5.5.3 Potential direct targets
As described above, the known Dichaete target gene in the midline, slit, is found to be
downregulated in the Dichaete null mutant. There are a number of other interesting
targets that Dichaete may be regulating or interacting with at different stages during
development: some during segmentation and axis establishment, such as engrailed,
bicoid and knirps, and some during nervous system development, such as huckebein,
Kruppel, achaete, grh and sim, as well as a number of Hox genes, including Abd-A,
Abd-b, Ubx, along with the Hox gene cofactor hth.
On one hand, the list of genes obtained from this experiment is intriguing: it includes
a large number of interesting developmental genes, including a considerable number of
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transcription factors which have a range of roles at various points during development.
On the other hand, this makes the analysis difficult since many interesting potential
targets are highlighted in this screen and many of the affected transcription factors
are known to be involved in development from early embryonic stages. This means
that there are likely to be considerable downstream effects from disrupting these reg-
ulators. Thus, while the experiment is likely to identify the general genetic network
that Dichaete acts within, it is impossible to determine those effects that are direct
and those that are a result of the entire network being disrupted. In addition, for the
transcription factors involved in a range of processes, it is not immediately clear from
the data at which stage they are likely to interact with Dichaete.
In spite of these concerns, these data do provide an interesting starting point for study-
ing the genetic network that Dichaete is involved in, particularly when analysed in
combination with the high confidence Dichaete binding data, providing preliminary
evidence for functional interactions. A brief comparison between binding and expres-
sion data is described below, which will be further explored in Chapter 6. A major
conclusion from the whole embryo experiment is that to gain a more detailed un-
derstanding of specific Dichaete functional interactions, more focused, tissue-specific
experiments are required. For these reasons I chose to focus on the nervous system, and
performed a number of tissue-specific gene expression experiments using Gal4 drivers
and dominant negative constructs in the hope that these studies would point to direct
Dichaete targets and provide insights into the specific action of Dichaete in different
tissues rather than giving a global overview.
5.5.4 Overlap with binding data
Out of the 4518 genes found to be differentially expressed in a Dichaete null mutant
at stage 10-11, 1519 (33.6%) were also found to be associated with high confidence
Dichaete binding intervals. While the majority of the genes are not associated with
Dichaete binding, this is expected since much of the differential expression is likely to
be due to indirect downstream effects rather than direct Dichaete action. The binding
data helps identify a subset of genes that may be direct Dichaete targets and it is likely
that the subset of bound and regulated genes are more focused than the entire set of
differentially expressed genes. The subset includes, for example, 262 genes involved
in nervous system development (p-value 1.1E − 49), which constitutes slightly over a
1/6th of the entire gene set. It also contains most of the transcription factors found
in the original Dichaete null mutant dataset, with 131 of the FlyTF ’trusted’ set of
transcription factors bound and affected by Dichaete (compared with 152 TFs identified
in the entire gene expression list). The overlap list also includes the known Dichaete
target slit.
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Interestingly, a reasonable proportion (144 out of 336, 43%) of the upregulated genes
were found to be associated with Dichaete binding. In comparison, only 1375 out of
4182 (33%) downregulated genes are found in the high confidence Dichaete binding
set. This may suggest that Dichaete action is less straightforward than simply acting
as a transcriptional activator and that it is possible that Dichaete acts as a repressor
in certain contexts. Alternatively, it is possible that some genes are regulated by both
Dichaete and a number of other transcription factors within the Dichaete network,
in these cases it is unclear which part of the network perturbation is responsible for
the observed direction of expression change. Of course this is also the case for all
the downregulated genes. The GO enrichments found for the upregulated genes were
again mostly connected to sexual reproduction and oogenesis. The GO enrichments for
downregulated genes are as expected from Dichaete phenotypes and contain a number
of developmental processes including nervous system development.
5.6 Dichaete in the ventral midline
When the dominant negative mutants were expressed in different parts of the CNS,
the ventral midline and all neuroblasts, a number of differentially expressed genes
were detected (Table 5.1). Expression of the wild type Dichate construct also induced
some changes in gene expression, presumably because the action of Dichaete is dosage-
dependent. Focusing first on the ventral midline: 214 genes in total changed expression
in at least one of the 3 screens (the data is shown in Table 6, Appendix 3). The total
of differentially expressed genes was 169 for the HMG− mutant (50 upregulated, 119
downregulated), 48 for the EnRep mutants (13 upregulated, 35 downregulated) and 45
for wild type (17 upregulated and 28 downregulated). Clearly this is a relatively small
number compared to the total number of Dichaete binding peaks in the genome or to
the results obtained in the Dichaete mutant study. However, it is worth bearing in
mind that the ventral midline is a very small tissue (around 500 cells per embryo) and
that the changes in gene expression were assessed using mRNA extracted from whole
embryos. Thus only very pronounced changes in gene expression are expected to be
detected in this particular study.
5.6.1 Dataset overlap
The overlap between the datasets (Figure 5.5) is reasonable: in the case of wild type
and EnRep, 64% and 58% of genes flagged, respectively, are also found in at least one
of the other two datasets, In the case of HMG−, the proportion of shared genes is
smaller, since expression of this dominant negative identifies a large number of genes
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Construct used Number of Number of
upregulated genes downregulated genes
simGal4 UAS HMG− 50 119
simGal4 UAS EnRep 13 35
simGal4 UAS DWT 17 28
prosGal4 UAS HMG− 66 533
prosGal4 UAS EnRep 119 154
prosGal4 UAS DWT 18 66
D null mutant 336 4182
Table 5.1: Overview of numbers of genes differentially expressed in different screens
not flagged in the other two screens. The reason for this is not immediately obvious:
while it is possible that the HMG− protein disrupts gene expression more than the other
two constructs, this seems curious since the strongest CNS phenotypes are observed in
EnRep expressing embryos. However, focusing only on genes that overlap in more than
one dataset did not seem to meaningfully filter results to more likely targets, therefore
all genes were considered further as possible targets with the obvious caveat that the
genes featuring in more than one dataset are more likely to be actual targets.
Figure 5.5: Overlaps between genes flagged in different midline gene expression
datasets
One potential explanation for the extra genes disrupted by HMG− is that the Dichaete
HMG− construct competes for cofactors, but since the Dichaete DNA binding domain
is missing, the cofactors end up binding to DNA in different locations and disrupting a
set of genes that the cofactors can affect but that Dichaete does not normally regulate
in the midline. In addition, HMG− could also be sequestering the cofactors required by
other transcription factors as well as Dichaete, thus disrupting several genetic networks
at once. If the genes disrupted are not required for the development of the midline,
this may not show up as a severe phenotype, despite considerable differences in gene
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expression.
5.6.2 Functional analysis
When looking at the set of all genes changing expression in at least one of the simGal4
experiments, no GO enrichments are found. This is possibly because the number of
genes flagged in the study is quite small. The known Dichaete target in the midline,
slit, was not flagged in any of the studies, possibly because of sensitivity issues or
because the dominant negatives used failed to disrupt its expression. In all cases
where there was an overlap in differentially expressed genes between experiments, the
change in gene expression was always in the same direction, for example, upregulated
in all three. This is not an obvious finding since we would expect the consequences of
Dichaete overexpression to be different, potentially opposed to the effects of attaching
a repressor domain. This highlights the fact that the exact action of the dominant
negatives used is not well understood and consequently a precise interpretation of the
data gained from these constructs is difficult. On the other hand, these studies may
provide a degree of validation for functional relationships inferred from the loss of
function studies. Out of the 214 genes found to be differentially expressed, 65 were
found to be upregulated and 149 downregulated. However, the two categories did not
show clear functional enrichment, and it is not clear that there is a distinct difference
between them.
5.6.3 Potentially interesting direct targets
Only three transcription factor genes, ’trusted’ as defined by FlyTF, were found to
be differentially expressed: nejire, mTTF and slbo. Of these, nej is particularly in-
teresting as it is involved in both segmentation and neuron differentiation, which it
facilitates through histone modification and transcription cofactor activity. This gene
is also bound by Dichaete in the core binding interval dataset, with several upstream
Dichaete binding peaks, and it is therefore an interesting potential direct target, per-
haps a potential cofactor. Its expression is only disrupted using the HMG− construct,
where it is slightly upregulated, suggesting that perhaps Dichaete normally acts as a
repressor here, and that the HMG− construct disrupts its expression by competing for
cofactors.
The gene bancal, which is reported to have transcription factor binding activity and to
be involved in mRNA splicing, was found to be downregulated in all three experiments.
There are four Dichaete binding intervals associated with bancal, which suggests it
may be a direct target. However, it is unclear exactly how this gene is regulated; the
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downregulation upon increased expression of wild type Dichaete suggests that it is being
repressed, but the dominant negative alleles should disrupt rather than increase the
usual action of Dichaete. In the case of the EnRep allele, the expectation is that targets
normally activated by Dichaete should be downregulated and thus we would conclude
that bancal should be an indirect target. However, experiments using similar Sox2
constructs in zebrafish suggest that what might be happening is that the En repressor
domain is not affecting the Sox2 activation domain, but instead further repressing
already repressed targets (Paul Scotting, personal communication): this may also be
the case with our Dichaete-EnRep construct. As described above, the effect of the
HMG− allele is the least straightforward of the three to interpret but as before we
assume that it acts through sequestration of co-factors.
5.6.4 Overlap with Dichaete binding data
Out of the 214 genes identified in the midline gene expression screens, 61 are also
associated with core Dichaete binding intervals. Of these 61, 24 are upregulated and 37
are downregulated, which is not significantly different from the proportions in the total
set of genes (χ2 = 1.37 , p-value = 0.24). The set of upregulated genes shows weak GO
enrichment for the cell fate commitment of R3/R4 photoreceptors (p-value = 0.027),
but this is only based on the presence of 3 genes (nej, fz and Rala). However, given
the extreme eye phenotype associated with Sox2 in mammals, these may constitute
interesting direct targets. The downregulated set contained several genes of interest
such as bl and Kr-h1, but no clear enrichment patterns were found. The list of potential
targets identified in this screen is varied and not all of the genes have an obvious
connection with Dichaete function: in particular, a number of genes connected with
chitin/cuticle development are present in the list. Some of the more interesting genes
include those described above (bl and nej ) as well as the Wnt receptor frizzled, the
transcription factor Kr-h1, the Notch signalling pathway genes BobA and Rala, baf,
which encodes a DNA-binding protein with an embryonic nervous system phenotype,
and pip, which is involved in DV axis specification.
5.7 Dichaete in neuroblasts
837 genes in total changed expression in at least one of the three screens using the
prosGal4 driver (the data is shown in Table 7, Appendix 3). The total of differentially
expressed genes was 599 for the HMG− mutant (66 upregulated, 533 downregulated),
273 for the EnRep mutants (119 upregulated, 154 downregulated) and 84 for UAS
Dichaete wild type (18 upregulated and 66 downregulated). This experiment affects
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about 4 times as many genes as the midline experiment does, but this is to be expected
since the tissue targeted is larger and it is easier to pick up more subtle changes in
gene expression. The HMG− strain again causes the largest number of gene expression
changes, the reasons for which, as described above, are unclear. For the most part,
the effects on gene expression were the same for all three constructs. However, there
is a small subset (22 genes) which were downregulated in HMG−, but upregulated in
EnRep. The reason for this is unclear. It is possible that the repressor domain does
not work on activated genes and that the EnRep construct is mimicking the action of
Dichaete overexpression, whereas HMG− is disrupting Dichaete action. Alternatively,
it is possible that these are indirect targets - only 3 out of the 22 genes are associated
with Dichaete binding peaks, and none of them are clearly connected to Dichaete
developmental functions.
5.7.1 Dataset overlap
The overlap between the three prosGal4 datasets is reasonable but not particularly
high. 39 out of 84 genes from DWT (46%) overlap with other datasets, 88 out of 273
for EnRep (32%) and 86 out of 599 for HMG− (14%). As with the simGal4 data, there
is a large subset of genes from HMG− that is not identified in any other dataset. There
is a large degree of overlap between the effects of the two dominant negatives, which
is greater than the overlap of either of them with the Dichaete overexpression results.
This could be because the effects of the dominant negatives are stronger, and it is
therefore possible to identify more targets. The differences in the genes targeted could
be accounted for by the dominant negative alleles having very different modes of action.
The Dichaete binding data indicates that there are potentially thousands of direct
targets in the genome and it is possible that the different constructs identify different
targets. However, as before, potential targets are considered to be more reliable if they
are identified in a minimum of two different gene expression screens.
5.7.2 GO enrichment
The neuroblast experiment provided a much larger list of differentially expressed genes
than the midline experiment. However, despite this, and although a number of individ-
ual interesting targets were found, very few significant GO enrichments were identified
in the total set of 837 genes. There were no GO enrichments with a p-value lower than
0.01: the enrichments found included female gamete generation (55 genes, p-value
0.017), embryonic pattern specification 932 genes, p-value 0.017), cellular process in-
volved in reproduction (58 genes, p-value 0.019) and oogenesis (54 genes, p-value 0.022).
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Figure 5.6: Overlaps between genes flagged in different neuroblast gene expression
datasets
Embryonic pattern specification is very relevant to Dichaete function in early develop-
ment, and this subset includes the genes hunchback and Delta, which are involved in
nervous system development, a process associated with Dichaete function. The other
results appear similar to the enrichments for the genes upregulated in a Dichaete mu-
tant, and may be connected to the reported function of Dichaete in developing oocytes
(Mukherjee et al., 2006). Interestingly, Dichaete does not localise in the nucleus during
oogenesis, and its role appears to be performed entirely through RNA binding, so if
there is indeed a connection and similar effects are being seen in prosGal4 dominant
negative experiments, this raises the question of where the dominant negative proteins
localise and how such effects are being facilitated. The imaging data presented earlier
suggests that wild type and EnRep constructs are predominantly nuclear, however the
HMG- protein may also be present in the cytoplasm (Figure 5.1).
Taking a look at the HMG− study individually also yielded some interesting results:
with prosGal4 a number of GO enrichments, mostly connected to appendage mor-
phogenesis (32 genes, p-value 0.002) and wing disc morphogenesis (28 genes, p-value
0.01), were found. Cell cycle regulation was also highlighted (29 genes, p-value 0.047).
While Dichaete does not appear to play a direct role in wing development, the original
Dichaete phenotype is a change in wing structure caused by the ectopic expression of
Dichaete (Russell, 2000). It is possible that the HMG− dominant negative is pairing
up with Dichaete cofactors, causing expression changes to genes that the cofactors reg-
ulate independently of Dichaete. It is therefore possible that Dichaete interacts with
proteins expressed in neuroblasts that are also involved in wing morphogenesis, possi-
bly one or more Hox genes. The individual results from expressing the wild type and
EnRep constructs yielded no enrichment.
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5.7.3 Upregulation and downregulation
In total, 194 genes were upregulated, and 687 genes downregulated. The upregulated
genes displayed specific GO enrichments, including cellular process involved in repro-
duction (24 genes, p-value 0.001), positive regulation of cellular metabolic processes
(13 genes, p-value 0.017), cell differentiation (36 genes, p-value 0.012), gamete genera-
tion (26 genes, p-value 0.008) and anatomical structure development (50 genes, p-value
0.013) among others. Interestingly, some of these are similar to the enrichments found
for genes upregulated in the Dichaete null mutant, so while they could be indirect tar-
gets, it is also possible that Dichaete acts as a repressor on the subset of genes involved
in reproduction when they are not required, but potentially acts as an activator in
other tissues where they do need to be expressed. As described above, Dichaete has
a reported role in oogenesis (Mukherjee et al., 2006), and it is unclear whether the
expression experiments may be picking up on some of the same functions. While the
downregulated gene list does feature a number of factors involved in neurogenesis and
development, there were found to be no statistically overrepresented GO terms for this
set of genes.
5.7.4 Potential direct targets
The gene bancal was identified in all three midline experiments and in all three neurob-
last experiments, which combined with the binding data (four Dichaete core binding
intervals upstream and within the gene) suggests that bancal is a high confidence di-
rect target. The transcription factor hunchback was upregulated by wild type Dichaete
in the neuroblast study, which is interesting given its role in the temporal sequence
of neuroblast division (Maurange et al., 2008). This suggests that, as well as being
expressed together in neuroblasts at the same time, there may be a regulatory loop
between them. Since hunchback was not identified as differentially expressed in the
midline experiments, this regulatory relationship may be specific to neuroblasts, al-
though there is a caveat regarding the sensitivity of the midline screen. A number
of other developmentally important genes were identified in the screens, including the
transcription factors bicoid, charlatan, Mad, the insulator mod(Mdg4), and a number of
genes involved in neurogenesis, including lola and midline, the neuropeptide hormone
Nplp4, and the Notch signalling pathway genes Delta and Notchless. Dichaete itself was
also differentially expressed in both HMG− and EnRep expressing embryos, suggesting
potential self-regulation in neuroblasts. However, since it was found to be upregulated
in both, it is also possible that this is an indirect effect caused by a feedback loop
between Dichaete and some of its direct targets.
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5.7.5 Overlap with Dichaete binding data
Out of 837 genes found to be differentially expressed in the prosGal4 study, 352 genes
(42%) are also associated with Dichaete binding. The GO enrichments found for these
targets are highly specific, including embryo development (44 genes, p-value 0.000024),
segmentation (25 genes, p-value 0.0002), cell differentiation (66 genes, p-value 0.0002)
and nervous system development (49 genes, p-value 0.005) among others. This is
very encouraging and it appears that, while some of the genes identified the prosGal4
study may be downstream effects not directly related to Dichaete function, combining
the expression data with binding data appears to give much more focused results,
identifying a reasonable set of potential direct targets.
5.8 Comparison of gene expression studies
Looking at the individual analyses, the different expression datasets show some common
features, for example the majority of the differentially expressed genes are downregu-
lated in all three studies. There are also some similar GO enrichments found between
sets, although judging by these, the dataset that is most reflective of global Dichaete
biology is that derived from the Dichaete mutant. This is perhaps to be expected,
as tissue-specific experiments zoom in on one particular role of a transcription factor,
rather than necessarily reflecting a global picture. The purpose of this section is to
take a more systematic look at the similarities and differences between the datasets,
to suggest the best way of using them together to gain insights into Dichaete biology,
or indeed to decide whether combining the datasets is sensible at all.
5.8.1 Overlap between datasets
The overlap found between the different gene expression datasets is reasonable (Figure
5.7): 49% of the genes differentially expressed in a prosGal4 study are also found to
be differentially expressed in other studies, and the percentage is even higher (59%)
for simGal4. In the case of the Dichaete mutant, 431 out of 4518 genes (9.5%) are
also differentially expressed in other studies. Due to the different nature of the gene
expression experiments a perfect overlap was not expected and the level of overlap
found is encouraging.
The 32 genes that are differentially expressed in all three studies seem most likely to
be potential direct targets. However, a more detailed look at the list suggests that this
may not be the most informative set since most of the genes have unknown functions or
belong to gene families seemingly unrelated to Dichaete phenotypes (with the potential
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Figure 5.7: Overlaps between genes flagged in the 3 different gene expression studies
exception of the cell cycle gene wisp). This could be because with the dominant
negative experiments, the set of genes that appear in at least one study is large and
may be unspecific (as discussed before, the HMG− dominant negative in particular
may be causing a range of effects not directly related to Dichaete function).
Looking at these data as seven individual experiments rather than three studies was
explored. However, taking all the genes that are differentially expressed in at least one
of the seven studies gives a large set of 5069 genes, which is likely to include a high
number of false positives. Filtering the dataset by looking at genes flagged in at least
two out of seven studies narrows down the set to a more manageable 520 genes and
means that each potential target is supported by at least two gene expression studies.
However, the list of genes obtained in this way appears somewhat haphazard and as a
whole not particularly specific to known Dichaete functions. It is therefore questionable
whether the intersects of these datasets are particularly meaningful. While the fact
that there is some overlap is encouraging, I concluded that taking the overlap as a
guide to identifying the most reliable targets is not the optimal strategy. Looking
at the individual studies suggests that the most meaningful filter for genes related
to Dichaete function is actually to identify the overlap between gene expression and
Dichaete binding: this strategy will be further explored as a way of finding direct
Dichaete targets in Chapter 6. Prior to this however, there are a few other potential
filtering methods that highlight some interesting features in the expression data.
5.8.2 Clustering
Looking at the subset of genes flagged as differentially expressed in at least four out of
seven studies (31 genes; Figure 5.8) shows that, with a few exceptions, the majority of
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genes change expression in the same direction. At a superficial level, it appears that
interesting targets such as bl and phr are mainly found in the downregulated subset.
The majority of the genes flagged in the expression experiments are downregulated,
possibly because Dichaete mainly acts as an activator and thus the upregulated genes
are not direct targets. However, it is also possible that Dichaete is sometimes acting
as an activator and sometimes as a repressor. If this is indeed the case, some of
the upregulated genes may also be direct targets. If Dichaete were acting differently
dependent on the spatial context, it would be expected that certain genes would for
example be consistently upregulated in the midline and downregulated in neuroblasts,
but looking at the data, this does not appear to be the case. It is possible that this
is because we are looking at two tissues where Dichaete acts similarly, or perhaps
because the differences are more precisely tuned and arise, for example, in a specific
subset of neuroblasts and are thus averaged out and not identified by this particular
experimental design. Most of the differences shown here where a particular gene is
sometimes upregulated and sometimes downregulated raise questions about the mode
of action of particular dominant negatives, rather than providing support for a tissue-
specific model of Dichaete action. While the identification of direct targets from this
data alone is not possible, it is nonetheless a useful screen for targets that are connected
to the Dichaete genetic network in the developing nervous system, directly regulated
or otherwise.
5.8.3 Differences in expression fold-change
To explore the possibility that some of the constructs cause greater fold-changes in
gene expression and hence identify larger gene lists, the average M values for each
set were compared (Table 5.2). For the most part, the fold-change of downregulated
genes was higher than that of the upregulated genes. In the case of the prosGal4
data, this is particularly striking with the DWT construct where very few genes are
upregulated and when they are the fold change is low. A much larger number of
genes are downregulated with much larger fold changes. At first glance, this seems
to indicate that, in the context of neuroblasts, Dichaete mostly acts as a repressor
and that overexpression of Dichaete results in further repression, whereas upregulated
genes are barely affected and may be indirect targets. This pattern is less clear in the
context of the midline, possibly either because of the lower sensitivity of the screen or
because the action of Dichaete in the midline is different from that in neuroblasts. For
the Dichaete mutant, the thresholds used were more stringent in the first place, which
is why the average M values are much higher. It is interesting to note that the averages
are almost identical for upregulated and downregulated genes.
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Figure 5.8: Hierarchical clustering of genes differentially expressed in at least 4 stud-
ies. Uncentered correlation, centroid linkage.
Construct used Number of Average Number of Average
upregulated genes M value downregulated genes M value
simGal4 UAS HMG− 50 0.74 119 -0.95
simGal4 UAS EnRep 13 0.90 35 -0.67
simGal4 UAS DWT 17 0.63 28 -0.69
prosGal4 UAS HMG− 66 0.72 533 -0.78
prosGal4 UAS EnRep 119 0.71 154 -0.91
prosGal4 UAS DWT 18 0.56 66 -1.07
D null mutant 336 1.28 4182 -1.27
Table 5.2: Average M value of genes differentially expressed in different screens
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Using the average M value for finding direct targets
Following from this I investigated whether larger changes in expression are indicative
of genuine Dichaete targets. The Dichaete null mutant data was ranked by average M
value and split into 2 sets of 2259 genes each: the ’top’ set (higher absolute average
M values) and the ’bottom’ set, corresponding to absolute values above and below
1.2, respectively. A higher average M value does indeed appear to be indicative of a
greater potential to be a direct target. The top set features a large number of genes
involved in developmental processes (510 genes, p-value 1.2E−15) and nervous system
development in particular (231 genes, p-value 1E−13), alongside a host of enrichments
for other specific developmental processes. In contrast, the bottom set only features two
GO enrichments with p-values less than 0.01: proteolysis (157 genes, p-value 0.0009)
and sensory perception (72 genes, p-value 0.005). Thus, a higher average M value does
indeed appear to be indicative of a greater potential to be a direct target. Overlap
with Dichaete binding data indicates a similar result: while 945 genes from the top
set (42%) overlap with Dichaete binding, only 575 (25%) from the bottom set do so.
These results indicate that, while all differentially expressed genes should be considered
potential targets and it is unwise to filter datasets too soon in the analysis, the absolute
average M value can, if required, be used as a filter to determine which genes are more
likely to be direct targets.
5.8.4 Comparison to binding data
Taking all the gene expression experiments together, I conclude that while gene ex-
pression studies are a useful functional assay, on their own they are of limited utility.
For example, it is difficult to determine whether overexpression of Dichaete changes
the expression of genes that are already Dichaete-controlled in the tissue of interest
or whether an increased concentration of Dichaete affects new targets not normally
regulated. The other obvious issue that arises is whether differentially expressed genes
are direct targets or whether some expression changes are due to downstream effects.
This is of particular concern for the Dichaete mutant study since Dichaete is involved
in many processes early in development and disentangling direct from downstream ef-
fects in an experiment performed as late as stage 10-11 is difficult. On the face of it,
this may be less of an issue with the dominant negative experiments, since they are
localized to particular tissues. In these cases it is more likely that at least some of the
gene expression changes reflect direct targets, while the others may be indirect but in
the same genetic network as Dichaete.
Because of the difficulty in interpreting the gene expression results it is clear that the
high confidence binding data presented in Chapter 4 can provide a crucial extra piece of
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the puzzle for unravelling the genome-wide action of Dichaete. Since one of the aims of
my project was to uncover new direct Dichaete targets in the genome this approach will
be further explored in Chapter 6. As a prelude to this, and to act as a preliminary filter
for a further exploration of the expression data, the overlap between the expression and
binding data was identified (Figure 5.9). This analysis identifies a reasonable number of
potential direct targets (1519 genes overall during embryogenesis, and more specifically,
61 in the midline and 352 in neuroblasts) and there are a number of further areas that
can be investigated from here. The binding patterns in the vicinity of genes with
affected expression may be different from genes with seemingly unaffected expression.
The underlying sequence and presence or absence of particular binding motifs may also
play a role. The presence of binding by other transcription factors that are thought to
be cofactors would also be interesting to investigate.
Figure 5.9: Overlap between different gene expression studies and Dichaete binding
data
5.9 Variability
The phenotypic variability observed in Dichaete mutants (Russell et al., 1996) is un-
usual. One possible interpretation is that Dichaete acts as a stabilizing factor for
transcriptional regulation and that when it is mutated or disrupted it leaves the whole
system more open to chance and fluctuations. It was thought that one way of verifying
this would be to look at whether genes that are likely to be direct Dichaete targets
(i.e. those associated with Dichaete binding) display more variance in expression in
a Dichaete null mutant than genes not associated with Dichaete binding. To obtain
an estimate of expression variability the standard deviation of M values from each of
the 4 replicate microarrays was calculated for each gene. If multiple probes target a
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single gene the variance for each probe was used individually, rather than calculating
an average for each gene. There was found to be a significant difference between the
two sets (Wilcoxon rank sum test, p-value < 2.2E − 16), with the Dichaete bound set
on average showing a higher standard deviation (mean 0.32, median 0.27) than the set
of genes not bound by Dichaete (mean 0.29, median 0.23). The distribution of values
is shown in Figure 5.10.
Figure 5.10: Distribution of standard deviations of differential gene expression in a
Dichaete null mutant
This is an interesting result: if increased variability is an effect of disrupting Dichaete,
it makes it more difficult to reliably identify direct targets from gene expression ex-
periments, since higher variability between replicates is normally interpreted as an
indication that data are less reliable. However, it is possible that this variability is in
fact a reflection of Dichaete biology. These data are consistent with a model where
Dichaete acts as a stabilising factor for gene expression, possibly required for gene ex-
pression maintenance (Soriano and Russell, 1998). Unfortunately, high variance can
be caused by a number of factors, some of which are experimental noise, so on its own
cannot be used as a reliable predictor of which genes are direct targets. Nonetheless,
this was considered an interesting observation.
5.10 Dominant negatives as a tool for functional
genomics
Dominant negative mutations such as the ones used in this study are a common tool for
inferring functional relationships between transcription factors and their target genes
(John et al., 1995; Margolin et al., 1994). However, it is currently not entirely clear
what their precise mechanism of action is, making data analysis challenging. A pilot
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study was therefore performed by Aleksandra Mandic, under the supervision of myself
and Bettina Fischer, in order to shed light on the exact mechanism of action of the con-
structs used in this study. The HMG−, EnRep and Dichaete wild type constructs were
expressed in developing neuroblasts with the prosGal4 driver and ChIP-chip experi-
ments performed to determine where they bind in the genome. Since all the constructs
were GFP-tagged, an anti-GFP antibody was used for the immunopurification and an
anti-β−galactosidase antibody used on the same chromatin as a mock-IP control.
For the wild type and EnRep experiments technical difficulties meant that it was only
possible to obtain 1 replicate each in the available time. The EnRep array identified
a small number of bound regions (14 at FDR 5% and 57 at FDR 25%). With the
wild type, between 211 (FDR 1%) and 6409 (FDR 25%) bound regions were identified.
Obviously, a single replicate does not give a reliable enough dataset to draw any solid
conclusions, however, a number of the genes associated with these bound regions were
involved in various developmental processes including neural development and one of
the genes associated with EnRep binding was slit, which is a known bona fide Dichaete
target. Thus it was thought that these were encouraging preliminary results.
With the HMG− construct a more complete dataset was generated, with three bio-
logical replicates performed. The binding profiles found in each biological replicate
were quite different, but the QC plots show that the microarray data was high quality
(Figure 5.11), suggesting the possibility that the differences in binding profiles between
the replicates are a genuine reflection of biological variability with this construct. Sep-
arating the replicates and analysing each one individually yielded a variable number of
peaks; 3, 27 and 887 at FDR 25% for each of the replicates. Again, the genes associated
with the binding were involved in various developmental processes, suggesting the data
are at least plausible. However, overlap with the gene expression data is very limited.
For the replicate that produced 887 binding intervals, these were found to be associ-
ated with 856 genes, but only 53 of these genes matched the 599 genes differentially
expressed in the prosGal4 HMG− experiment. Obviously, with only one replicate at
FDR 25%, a very large number of noise and false positives would be expected, which
might account for the difference in datasets.
The overlap with Dichaete high confidence binding data was in general low, approxi-
mately 10% on average for each of the available datasets. However, it was observed in
the case of HMG− that much of the binding was in the vicinity, but not overlapping
with, wild type Dichaete binding intervals. This led to the hypothesis that HMG−
affects Dichaete action by competing for cofactors and associating with different DNA
sequences, depending on where the cofactor is bound. This hypothesis also accounts for
the variability of the data: competing for cofactors with an existing wild type protein
is likely to be a stochastic, variable process, especially since the Dichaete protein with
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Figure 5.11: Histogram of the HMG− data from 3 biological replicates. The grey area
shows the experimental noise and the red area shows the signal. The data is thought
to be high quality because the signal clearly stands out from the noise, rather than
overlapping with it.
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its HMG domain removed is likely to be a lot less efficient at this than its wild type
counterpart. In fact, the likely reason that any phenotype at all is observed with this
particular mutant construct is because it is expressed much more strongly than the
wild type protein, giving it a competitive advantage.
The same experiment was also performed in the midline using the HMG− and wild
type constructs using the simGal4 driver, by Louis Chauviere under my supervision.
While the HMG− construct did not yield any binding intervals, the wild type con-
struct yielded much better binding data. Three replicates were performed, identifying
between 740 (FDR 1%) and 5751 (FDR 25%) binding intervals. These preliminary ob-
servations suggests that even in a restricted tissue Dichaete can bind to a substantial
number of genomic locations, albeit under conditions where it is overexpressed. The
FDR 1% peaks from this experiment were compared to the available data from the
prosGal4 experiment and the overlap was found to be extremely low, possibly because
the constructs are expressed in different tissues or because the datasets are unreliable.
Binding studies with these dominant negative constructs are ongoing since they are
likely to yield some interesting insights into the mechanisms of action of these widely
used approaches.
5.11 Conclusions
The binding data and the Dichaete null mutant expression study indicate that Dichaete
binds thousands of locations in the genome and has a knock-on effect on a similar
number of genes by stage 11 of embryonic development. This makes sense, considering
that Dichaete is involved in a number of crucial developmental processes (Russell et al.,
1996; Soriano and Russell, 1998; Sanchez-Soriano and Russell, 2000; Overton et al.,
2002; Zhao and Skeath, 2002; Zhao, Wheeler and Skeath, 2007). While the large
number of binding locations and target genes is unusual, it is certainly not unique
amongst transcription factors: Kr, Hairy, Daughterless, Dorsal, Mothers-against-dpp
and Twist all display similar binding profiles (MacArthur et al., 2009). In addition,
the GO analysis suggests that the Dichaete null mutant expression data appears to be
reliable and quite specific to Dichaete function despite the large number of genes that
change expression and the expected abundance of downstream effects. The overlap
between the Dichaete binding data and the Dichaete null mutant expression data
provide an interesting list of possible direct targets genes across the entire genome.
The binding patterns associated with these genes and sequence underlying them will
be explored in detail in the next chapter.
Looking at the overlaps between the three gene expression studies did not appear to
give particularly illuminating results due to the confounding issues described above.
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After exploring the experimental data together, I decided that it would be more effec-
tive to treat each study separately in order to answer a set of different questions. The
Dichaete null mutant study provided insights into the broader patterns of Dichaete ac-
tion, supporting the view from the binding studies that Dichaete regulates many genes
in the genome. The tissue-specific experiments performed with the dominant nega-
tive constructs allowed a preliminary focus on particular areas of Dichaete influence.
However, it became clear that the use of dominant negative constructs raised more
questions than were answered, since the direction of gene expression changes observed
did not necessarily concur with the activity expected of each dominant negative. This is
certainly a useful thing to bear in mind for future studies using such approaches.
One interesting observation to emerge from the gene expression studies was that a
high average M value for a gene appeared to be quite a strong indicator of whether
a gene is likely to be a direct target or not. This could potentially be used to filter
the strongest candidates for specific verification studies. It was intriguing to note that
genes associated with Dichaete binding also appeared to display a higher variability in
expression measures across replicates, which is consistent with some of the preliminary
results from the dominant negative studies and supports a model of Dichaete as a factor
that stabilises gene expression at specific points in development.
While Dichaete does appear to bind to a large number of different locations in the
genome, the tissue-specific gene expression studies indicate that the action of Dichaete
in particular tissues is much more small-scale, with a suggestion that it may switch
from a being a master regulator of global phenomena, such as segmentation, to micro-
managing the expression of specific neural genes in different parts of the developing
CNS. Unfortunately, a precise tissue-specific binding map for Dichaete is currently un-
available, although the experiment expressing wild type protein in the midline with the
Gal4 system hints that Dichaete can bind to many genomic locations in a restricted
tissue. There are new experimental approaches becoming available to generate tissue-
specific binding profiles (for example, ChIP with chromatin from FACS-sorted nuclei
or DamID approaches using the GAL4 system to drive specific expression of reduced
activity methylase constructs), but these have only recently become available and while
they are technically challenging and beyond the scope of this thesis, they provide an
exciting future extension to this project. In the meantime, the Dichaete core binding
set generated as part of this project can be used as an approximation of where Dichaete
is likely to be binding and finding overlaps between these data and tissue-specific gene
expression studies appears to provide useful preliminary insights. For a more in-depth
analysis, it will be interesting to take temporal chromatin accessibility data (Li et al.,
2011) into account in an attempt to make the binding profile more specific to the time
windows used for the gene expression analysis
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The preliminary data for the dominant negative ChIP was encouraging, and this may
be an interesting project to carry on with in the future. While having proper binding
data for the mutant proteins would make it easier to interpret the Dichaete expression
data presented here, it also has much broader relevance to research, as dominant neg-
ative constructs are frequently used in a range of model organisms, but to date their
mechanisms of action are poorly understood.
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Chapter 6
An integrative analysis of Dichaete
genomic data
6.1 Introduction
In the era of rapid second generation sequencing and widely available genome-scale
microarrays, the possibility of obtaining a detailed global overview of genome biology is,
for the first time, becoming a real possibility. In particular, two large scale international
projects have been launched with this aim in mind; the ENCODE project to catalogue
functional elements in the human genome (Feingold et al., 2004) and modENCODE to
analyse the genomes of the model organisms C. elegans and D. melanogaster (Celniker
et al., 2009).
The modENCODE project is of particular interest to researchers working on the model
organisms in question. The advantages of the project are two-fold: first, it broadens
our current understanding of a range of genomic processes, from a broad integrative
analysis of functional elements for both organisms (Gerstein et al., 2010; Roy et al.,
2010; Negre et al., 2011) and full transcriptome sequencing (Graveley et al., 2010;
Spencer et al., 2011), to shedding light on more specific aspects of genome regulation
such as trans-splicing (Allen et al., 2011), microRNAs and mirtrons (Berezikov et al.,
2011; Chung et al., 2011), transcriptional diversity of cell lines (Cherbas et al., 2011),
the role of chromatin architecture in a range of processes (Eaton et al., 2011; Ercan
et al., 2011; Kharchenko et al., 2010; Liu et al., 2011; Riddle et al., 2011), a genome-wide
look at promoter architecture (Hoskins et al., 2011) and transcription factor binding
(Niu et al., 2011).
The second advantage is that, because all the data is publicly available, a range of
high quality genomics data becomes accessible worldwide, allowing smaller labs and
individual researchers to do comparative analysis using datasets that would otherwise
be difficult to obtain for individual labs in terms of the time and cost required to gen-
erate them. This means that as well as providing interesting research conclusions in its
own right, modENCODE enables genomics research in the wider scientific community.
My own PhD project has certainly benefited from this, in particular from the ChIP-
chip and ChIP-seq datasets available for a range of transcription factors and histone
modifications studied during different time periods of Drosophila embryogenesis.
Another note-worthy project with a more specific focus, but similar aims, is the
Berkeley Drosophila Transcription Factor Network Project (BDTNP) (Li et al., 2008;
MacArthur et al., 2009), which has amongst other things produced very high quality
ChIP-chip data for a range of developmentally important transcription factors during
early stages of Drosophila embryogenesis. There have also been a number of smaller
scale efforts by individual labs to generate genomic data for their transcription fac-
tors of interest (Choksi et al., 2006; Schwartz et al., 2006; Zeitlinger et al., 2007b;
Adryan et al., 2007; Holohan et al., 2007; Kwong et al., 2008; Southall and Brand,
2009). There is considerable potential for using this large quantity of available data
for mapping out the key genetic networks and pathways active during different points
in development.
When looking at transcription factor binding, while determining their overlap is trivial,
getting a measure of statistical significance of overlap is a much more complex problem.
The question is a relevant one, as it is extremely useful to be able to look at multiple
binding profiles and determine which ones may be overlapping by chance and which
ones are likely to be acting in unison or antagonistically. This problem, along with
a number of potential methods for solving it, is reviewed in detail by Fu and Adryan
(2009). The main question being addressed is whether two transcription factors bind in
the same location more commonly than would be expected by chance, and the difficulty
in answering it stems from the measure of significance being highly reliant on choosing
the correct null distribution model. For example, assuming a null distribution where
all transcription factors can bind anywhere in the genome does not reflect existing
biological constraints that limit transcription factor binding to a subset of possible
genomic locations, thus this approach massively overestimates the significance of any
overlap found. Failure to account for the non-random nature of transcription factor
binding can result in a large number of false positives (Haiminen et al., 2008; Huen
and Russell, 2010).
Resampling tests are one method of dealing with this problem, as they generate a null
distribution from known binding sites, thus producing a profile that is more closely
matched to specific protein binding preferences. However, Huen and Russell (2010)
find that the success of this approach is highly sensitive to the manner in which the re-
sampling is done. The standard recommended resampling method reshuﬄes the labels
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of the binding intervals present in the datasets. This strategy is flawed as it means that
the original number of overlaps is the maximum number of overlaps that can possibly
be achieved after reshuﬄing. It therefore massively overestimates the significance of
the overlaps compared to simulations. Huen and Russell have developed a hybrid re-
sampling method for pairwise comparisons of binding profiles, which performs well and
appears to be applicable to real world data. The hybrid resampling method involves
splitting the sites into two groups: one group are the overlapping sites and the other
group are the singleton (non-overlapping) sites. With the overlapping sites, each site
gets assigned at random to one transcription factor only. With the singleton sites,
they can be randomly assigned to one or both transcription factors, resulting in new
overlaps. This method has been implemented as an R package (Cooccur) by David
Huen, and is used extensively in this chapter.
6.2 The search for direct Dichaete targets
In previous chapters, a range of evidence was presented to address the question of
where Dichaete binds in the genome and what effects its absence or disruption has
on gene expression. One of the aims of my PhD was to generate a list of candidate
direct targets, so the aim of this section is to combine the binding and gene expression
data in order to achieve this aim. As discussed previously, the gene expression studies
yielded quite different results from one another, so it was thought that they would be
best treated separately, looking individually at potential direct Dichaete targets in the
midline, in neuroblasts, and more globally throughout embryogenesis.
6.2.1 Dichaete targets in the midline
The transcriptome analysis in Chapter 5 revealed 61 potential Dichaete targets in the
midline - genes that change expression in at least one of the simGal4 expression studies,
as well as showing an overlap with Dichaete core binding data (Table 11, Appendix 5).
These were already discussed in the previous chapter, but it was thought that a further
look at Dichaete binding patterns around them and a more selective choice of direct
targets would be interesting. This list is clearly not extensive, as the known Dichaete
target in the midline, the gene slit, is not captured in this analysis. It was though that
the reduced sensitivity was due to the midline contributing only a small fraction of the
total embryo, thus all but the strongest changes in gene expression would be averaged
out.
First, the gene expression data was compared to the genes associated with Dichaete
binding intervals at stage 9 (estimated according to DNaseI accessibility data). Out
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of the 4372 genes associated with this Dichaete dataset, 56 overlapped with expression
data (Table 12, Appendix 5). The 5 genes lost were all genes of unknown function
(except for Gasp, which is involved in chitin production), so it does not appear that
much, if any, of the signal from the experiment was lost by using this filter. Instead
it is likely that this filter narrowed down the list further into more likely functional
targets, as these are genes where Dichaete is likely to bind at the appropriate stage of
development.
Out of the 56 genes bound at stage 9, 38 are associated with a single Dichaete binding
site, 5 are associated with 2 sites, 6 are associated with 3 sites, and 7 are associated
with 4 or more (Table 6.1). Potentially, all 18 genes associated with more than one
Dichaete binding interval at Stage 9 constitute interesting direct targets.
Number of Associated genes
binding peaks
2 Cpr100A, BG4, Kr-h1, Rala, fne
3 bl, CG14688, Hsc70-3, l(3)neo38, CG8965, CR42862
4 or more olf186-F, BobA, fz, Glut4EF, CG42574,Sema-5c, fog
Table 6.1: Genes that change expression in dominant negative mutants and are asso-
ciated with multiple Dichaete binding intervals at Stage 9 of embryonic development
Examining the gene expression patterns in detail reveals some interesting observations
(Figure 6.1). First of all, the strongest direct target gene associated with nervous sys-
tem development is bancal. This gene is significantly downregulated in all 6 dominant
negative experiments. Further to that, while it does not get flagged as differentially
expressed in the Dichaete mutant when the very stringent filtering is applied, it should
be noted that its average M value in this experiment was −0.82, with a p-value of
0.009, so it does appear to be downregulated in all 7 experiments performed. This
gene is also associated with three Dichaete binding intervals at Stage 9 (Figure 6.2),
all of which are intragenic and predominantly located in intronic regions. bancal en-
codes a functionally conserved homologue of the vertebrate hnRNP K gene, and is
reported to act in imaginal discs, promoting apoptosis to ensure the correct size of
adult appendages (Charroux et al., 1999), so it is possible that it employs a similar
mechanism in the nervous system. This would give it an important developmental
role, given that temporally regulated apoptosis is essential for correct nervous system
development (Wheeler et al., 2011). While it is definitely considered a high confidence
direct target, the exact action of Dichaete on bancal is unclear. The downregulation
in response to Dichaete overexpression in both the midline and neuroblasts suggests
that Dichaete is acting as a repressor and the data from HMG− and EnRep studies
are consistent with this hypothesis. The fact that bancal is also downregulated in a
Dichaete mutant seems to run contrary to this hypothesis, but this could be due to
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downstream effects from various transcription factors being disrupted, and may not be
indicative of direct Dichaete action. The model of Dichaete acting as a repressor of a
gene promoting apoptosis is consistent with the idea of Dichaete being a factor that
maintains cells in a pluripotent dividing state.
Figure 6.1: Clustering of genes differentially expressed in the midline, which are asso-
ciated with 2 or more Stage 9 Dichaete binding intervals, as estimated from accessibility
data.
Another interesting target from this analysis is the gene Rala, which is upregulated in
all experiments in the midline, but not affected in any of the neuroblast experiments or
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the Dichaete mutant. This appears to be an interesting midline-specific direct Dichaete
target. It is known to be involved in regulation of the Notch signalling pathway (Eun
et al., 2007) and cell fate commitment of R3/R4 photoreceptors. In an early paper,
Sawamoto et al. (1999) report that Rala is expressed ubiquitously throughout em-
bryogenesis and only develops specific spatial and temporal expression during larval
development and later. However, the in situ data in Fly Express suggests more specific,
though weak, expression in the embryonic neuroectoderm (Konikoff et al., 2009; Kumar
et al., 2011), perhaps as expected, if it is indeed being repressed by Dichaete in the
nervous system. It is therefore unclear whether it has any midline specific functions, or
whether Dichaete merely has the potential to specifically activate it, but normally does
not because it is not present in sufficient quantities. This is nonetheless an interesting
general target of Dichaete, particularly in view of the severe eye phenotype observed
in vertebrates with Sox2 loss of function.
It is interesting to note that in the case of bl, which appears to be repressed, Dichaete
binding is mainly intronic, whereas with Rala, which appears to be activated, Dichaete
binding is in intergenic regions (Figure 6.2). While the evidence from two genes only is
merely anecdotal, it would be interesting to investigate whether this is a genome-wide
trend.
Figure 6.2: Dichaete binding patterns during embryonic Stage 9 around the direct
Dichaete targets in the midline. A) bancal is thought to be repressed by Dichaete. B)
Rala is thought to be activated by Dichaete.
6.2.2 Dichaete targets in neuroblasts
Out of 837 genes differentially expressed in the prosGal4 study, 352 were found to over-
lap with Dichaete high confidence binding intervals. 325 of these genes are associated
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with Dichaete Stage 9 binding, all of which can be considered potential direct Dichaete
targets in neuroblasts (Table 13, Appendix 5). A large portion of these are involved
in developmental processes (111 genes, p-value 0.005), and in particular in embryonic
pattern specification (26 genes, p-value 2E-6) and organ development (66 genes, p-value
6E-6). Particular developmental processes that are flagged are generation of neurons
(39 genes, p-value 0.004), segmentation (24 genes, p-value 3.3E-4) and female gamete
generation (34 genes, p-value 0.003). The list of genes involved in neuron generation
includes SoxN, Delta, lola, mid, hb, ac and hkb (the complete list is included in Table
14 in Appendix 5).
Out of the 325 genes in question, 209 are associated with single Dichaete binding
intervals at Stage 9, 50 genes are associated with 2 Dichaete binding intervals, 23 with
3 intervals, and 43 with multiple (4 or more) intervals (the genes bound by 4 or more
intervals are shown in Table 15, Appendix 5). Despite containing the greatest number
of genes, the gene set associated with single Dichaete binding intervals displays no
significant GO enrichments. The set associated with 2 intervals is weakly enriched for a
single term (regulation of cellular component biogenesis: 6 genes, p-value 0.03) and the
set associated with 3 genes contains no enrichments (possibly due to the small number
of genes included). In contrast, the set of 43 genes associated with multiple Dichaete
binding displays a striking level of enrichment for a range of important developmental
processes, many of them related to transcription, segmentation and nervous system
development (Table 16, Appendix 5). This set of potential direct targets is clearly
very stringent and likely misses some high probability targets, such as the gene bancal,
which has 3 associated Dichaete binding intervals and is flagged in all gene expression
studies. However, the stringency and specificity of this gene set is also an advantage
for further studies verifying Dichaete action in neuroblasts, providing a high confidence
candidate list (the full set of genes is listed in Table 15, Appendix 3). For a slightly
less stringent, but nonetheless high confidence set of targets, the set of genes with 2 or
more associated Dichaete intervals could be used.
When looking at the gene expression patterns of the multiply bound genes (Figure 6.3,
these display some unusual patterns compared to other differentially expressed genes.
First of all - while in the whole neuroblast dataset genes are mostly downregulated,
with this particular subset the number of upregulated genes is roughly equal to the
number of downregulated genes. It is possible that this reflects the fact Dichaete can
both upregulate and downregulate its direct targets, whereas its overall effect at a
whole genome scale is to activate a large portion of the developmental network, thus
resulting in mainly downregulated genes, not all of which are direct targets. Very few
of the selected genes change expression when Dichaete is overexpressed, potentially
because if the sites next to them have high affinity for Dichaete, they may already
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be maximally occupied, and overexpresion of Dichaete does not alter this. Another
interesting observation is that most of the dominant negative constructs caused gene
expression changes in the opposite direction from those observed in the Dichaete null
mutant, a trend contrary to the genome-wide observation.
For the few genes for which a Dichaete overexpression effect is available to indicate
which way they may be regulated, a similar pattern holds to the one found in the
midline: an activated gene, (hb), shows mainly intergenic binding, whereas repressed
genes, (mod(mdg4) and Jupiter), show mainly intragenic, specifically intronic, binding
(Figure 6.4). A further examination reveals that for repressed genes, particularly in
the case of mod(mdg4), Dichaete binding intervals closely correspond to Polymerase II
binding peaks from 0-12 h embryo ChIP-chip (Figure 6.5), consistent with the hypoth-
esis that Dichaete is attenuating gene expression by facilitating Polymerase pausing at
a set of intragenic sites.
6.2.3 Global Dichaete targets during embryogenesis
Of the 4518 genes found to be differentially expressed at stage 10-11 in the Dichaete
null mutant, 1519 were found to be associated with high confidence Dichaete binding
intervals. This particular dataset is difficult to precisely deconvolve by time, since
all 1519 genes in question are potentially direct targets and in principle their change
in gene expression could have been caused by downstream effects from events that
happened at any point before or during stage 11. Therefore identifying specific target
genes in particular tissues is difficult from this dataset. Rather, these data provide
more of a global look at the broad transcriptional network Dichaete is involved in
during development. The purpose of this section is to identify a more narrow high
confidence set of Dichaete targets, based on filters developed in previous chapters. A
brief look at the binding patterns around the identified targets is also presented.
High confidence direct targets
As discussed in Chapter 5, it is possible to use the absolute M value for filtering
these data meaningfully and the analysis indicated that a higher absolute M value is
indicative of genes more likely to be related to Dichaete function. Accordingly, the
top half of the differentially expressed genes in terms of absolute M value (2259 genes
in total) were used for this part of the analysis. Of these, 176 were upregulated and
2083 were downregulated, and 945 of the genes overlap with Dichaete high confidence
binding intervals. 133 of the Dichaete bound genes were associated with multiple (4 or
more) Dichaete binding sites and these were considered to be a high confidence set of
Dichaete targets (Table 17, Appendix 3). 83 of the genes in question were associated
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Figure 6.3: Clustering of genes differentially expressed in neuroblasts which are asso-
ciated with 4 or more Stage 9 Dichaete binding intervals (as estimated from accessibility
data).
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Figure 6.4: Dichaete binding during Stage 9. The gene hb, which is thought to
be activated by Dichaete, is associated with intergenic Dichaete binding (A), whereas
mod(mdg4) and Jupiter, which are thought to be repressed, show a lot of intronic
Dichaete binding (B, C).
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Figure 6.5: Dichaete binding during Stage 9. Dichaete binding within genes corre-
sponds closely to Polymerase II peaks (from a 0-12h ChIP-chip) in mod(mdg4) (A),
and partially in Jupiter
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with binding intervals statistically enriched for the Dichaete binding motif (method
discussed in Chapter 4), providing further evidence that these are indeed direct targets.
Encouragingly, the known Dichaete midline target slit is amongst these 83 genes.
The set of 133 multiply bound genes displays a large number of significant and highly
specific GO enrichments: 76% are involved in developmental processes (101 genes, p-
value 5.9E-32), with specific processes highlighted including imaginal disc development
(55 genes, p-value 8.7E-35), pattern specification (49 genes, p-value 6.2E-28) and ner-
vous system development (64 genes, p-value 4.3E-19). A number of genes are involved
in transcriptional regulation (56 genes, p-value 3.3E-56) and interestingly, 21 of the 133
encode a homeobox domain (p-value 2.1E-14 or a ’homeodomain-like’ domain. This
highlights the likely interaction of Dichaete with a number of Hox genes, and may be
key to some of the regulatory activity of Dichaete during development.
33 of the genes have been flagged in a microarray screen for neural precursor genes
(Brody et al., 2002), and 27 were identified in a screen profiling gene expression in
CNS midline cells (Kearney et al., 2004). 16 genes were also featured in a study on
direct responses to Notch activation (Krejci et al., 2009), and 33 were highlighted in
a study examining the genetic network influenced by the Notch effector Mastermind
(Kankel et al., 2007). mastermind is a particularly interesting target: it has a reported
role in Drosophila midline development (Zhang et al., 2011), and since other direct
targets are in the same genetic network, it is likely that Mastermind and Dichaete work
closely together during nervous system development. While this gene was not flagged
in the midline gene expression study, the lack of sensitivity of that particular screen has
already been noted. Further to that, 12 genes are connected to nerve cord development
(Skeath and Thor, 2003) and 14 were identified in a screen for genes regulating the
specification of abdominal neurons (Gabilondo et al., 2011). 12 are identified as factors
regulating segmentation (Noyes et al., 2008). Taken together, these overlaps with gene
sets identified in screens for neural function highlights the specific nature of the filtered
gene set in relation to Dichaete functions during development, specifically emphasizing
a key role in CNS development.
Patterns of Dichaete binding at high confidence targets
The Dichaete binding data deconvolved by time (described in detail in Chapter 4) was
used to look at the patterns of binding around a selection of the direct targets (Figure
6.6). The direct targets examined display a number of different binding peaks, some
static and some dynamically bound at specific developmental stages. The quantity of
binding present at different targets is variable, ranging from only a few peaks (minimum
4 for the high confidence set of targets, because of the selection process), to numerous
peaks both upstream and within the gene, particularly striking in the case of Delta.
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Figure 6.6: Dichaete binding at different stages of development in the vicinity of a
number of selected targets. Rows in descending order show Dichaete binding at stages
5, 9, 10, 11 and 14. All targets show multiple dynamic binding, with the binding
decreasing at later stages. Some binding persists at stage 14 for sli, Antp and Dl (A,
C, D), but disappears completely in the case of ac (B).
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There is also a trend for the genes to be more highly bound during earlier stages of
development and for some of the binding to disappear by stages 11 and 14, which
makes sense given the very active role of these genes during early embryogenesis in
particular.
6.3 Dichaete and its cofactors
Since it is known that transcription factors rarely, if ever, act alone (Davidson, 2001),
and that Sox genes in particular can change their mode of action depending on the
cofactors they are paired up with (Kamachi et al., 2000), one of the main aims of my
PhD was to determine which transcription factors are likely to be Dichaete cofactors
during embryogenesis. Measures of genome-wide binding co-occupancy at different
developmental times can be used as an indication of potential interactions between
factors, since it stands to reason that if factors are binding the same targets at the
same time, they may be acting in unison. The interaction can be direct, with proteins
physically interacting with one another, or indirect, with different factors acting at
the same cis-regulatory modules. Simply looking at factor overlap is likely to yield
false positives, since it is known that transcription factors can bind non-specifically
to exposed pieces of DNA. Thus it is critical to assess the statistical significance of
genome-wide overlap, rather than solely focusing on individual CRMs using data from
genome-wide studies. For this part of the analysis, embryonic transcription factor
ChIP datasets from modENCODE (Celniker et al., 2009; Negre et al., 2011), BDTNP
(Li et al., 2008; MacArthur et al., 2009) and an individual study on Prospero (Choksi
et al., 2006) were used. The resampling-based method implemented by David Huen
in the Cooccur R package was used for assessing the statistical significance of overlaps
(Huen and Russell, 2010).
6.3.1 Data collection and parsing
There were a number of difficulties in analysing the modENCODE data from scratch.
In particular, the original raw data files were often ambiguously labelled and my reanal-
ysis would frequently generate very different numbers of peaks from that reported on
the modENCODE website: the reasons for this were not immediately obvious. Com-
pounding this problem, as discussed in Chapter 3, datasets can be sensitive to specific
parameters used for analysis and optimal parameters can vary between datasets. This
makes a complete reanalysis of a large number of datasets non-trivial. Therefore I de-
cided that, for the initial analysis, a pragmatic approach would be to use the intervals
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generated by modENCODE and subsequently reanalyse a selection of data highlighted
during the initial screen.
Datasets with less than 10 peak intervals were ignored since independent replicates of
the ChIP studies in question showed thousands of binding intervals: thus the datasets
with a small number of binding intervals were considered uninformative and likely to
be noisy and unreliable. In total 126 datasets were downloaded from the modENCODE
website: all data was in gff3 format and all the coordinates were in Drosophila Genome
Release 5. The complete list of datasets, along with the number of peak intervals
present in each file, is shown in Table 9 in Appendix 4.
Along with the modENCODE data, 36 ChIP-chip datasets from 2-3h of embryonic
development were downloaded from the Berkeley Drosophila Transcription Network
Project and remapped to Genome Release 5 using the UCSC LiftOver tool and custom-
written Perl scripts. Raw Prospero embryo DamID data were taken from Choksi et al.
(2006), reanalysed with TiMAT and used in the analysis.
When multiple datasets were available for a particular transcription factor or protein
modification and time period (e.g. HDAC1, 0-12h), the union of all available intervals
was used. This was done with both modENCODE and Berkeley data. After the
unions were performed, there were a total of 102 unique datasets, used for further
analysis.
6.3.2 Gene associations
The modENCODE and Berkeley datasets were used to construct a genetic interaction
network. The list of all 14833 currently known Drosophila melanogaster genes was
downloaded from Flymine (including the start and end coordinates, FBgn number,
gene name and strand orientation). The genes encoded by the mitochondrial genome
were excluded, leaving 14795 genes. It was verified that all FBgn numbers in the list are
indeed unique identifiers, and these were used as gene names for further analysis.
The gene associations were then determined for each binding dataset using the method
described in previous Chapters. If there were 1 or more genes directly hit by the
interval, all of those were counted as hits (as it is impossible to disambiguate between
’meaningful’ and ’non-meaningful’ hits in this scenario). A direct hit is defined as the
gene coordinates and the binding intervals overlapping by 1 nucleotide or more. If an
interval had no direct gene hits, the nearest gene was found and counted as a hit, up
to a maximum distance of 10kb. If both a gene upstream and a gene downstream were
at exactly the same distance from the interval, the downstream gene was chosen as
more likely to be regulated. All the results were then tabulated, with each row being
a gene and each of the columns a ChIP dataset (list detailed above). ’1’ signifies that
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the gene is hit in the dataset, ’0’ signifies that it is not. This is considered a useful
resource for studying binding clustering at individual genes.
6.3.3 Overlap analysis
The resampling-based Cooccur software was used to do a series of pairwise comparisons
to assess the probability that the binding patterns of particular transcription factors
significantly overlap. A list of transcription factors was selected for the initial analysis,
with the datasets used shown in Table 10, Appendix 4. The focus of the analysis is
on Dichaete, for which the high confidence dataset covers 0-12 hours of embryogenesis,
so it was thought that, at least for the initial analysis, keeping the more precise time
points for the other datasets was not necessarily useful. Therefore when multiple
datasets falling within the 0-12 hour period were available for the same transcription
factor they were unified into a single dataset. Multiple datasets were only available
for a minority of the transcription factors (6 transcription factors, 13 datasets in total:
Cad, Hairy, Hkb, Kr, Run and Ubx), so the merging process should not significantly
change the analysis.
6.3.4 The Dichaete regulatory network
Figure 6.7: The network of transcription factors whose binding profiles significantly
overlap (p-value < 0.05), as determined by a resampling based test. This particular
figure shows only the network in the proximity of Dichaete - 4 significant overlaps were
left out to increase the clarity of the figure.
Initially, a number of transcription factors were found to significantly overlap (Table
6.2, Figure 6.7). It is worth noting that this summary of results was obtained by doing
all pairwise comparisons between transcription factors, rather than just comparing their
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binding profiles to Dichaete. Therefore the presence of a number of significant overlaps
between Dichaete and other factors is a reflection of Dichaete sharing a high degree of
significant cooccupancy with other factors, rather than being biased towards identifying
Dichaete-specific results. Once the p-values were corrected for multiple testing (using
an FDR based p-value adjustment), the number of significant overlaps decreased from
19 to 12. It was decided that the original list of 19 would still be interesting to proceed
with for the purposes of this analysis. The argument for this was that, while the p-
values are not stringent enough to properly prove a significance of overlap in a statistical
sense, these were still highly overlapping datasets, and the fact that they were initially
flagged in the screen indicates that they were (more significantly so than the other 542
combinations of pairs of datasets tested). Using the more stringent set of candidate
interactions is more solid proof, but is done at the danger of filtering out potentially
interesting interactions by increasing the stringency of the scan. Instead, the initial 19
interactions were used as a starting point for an exploratory analysis, with the caveat
that not all of them are statistically significantly overlapping in a strict sense.
Interestingly, the list of significant overlaps includes Hb and Kr (also included in the
more stringent list using corrected p-values), which are the first two transcription
factors active in a temporal series of transcription factors active in neuroblasts to give
rise to a diverse set of neurons/glia. Since Dichaete is also expressed in neuroblasts
during this period it is likely that it may interact with Hb and Kr in the modulation
of neuroblast identity. The Hb dataset used for analysis is from a different period of
development (blastoderm, rather than the developing neuroblasts), so it is possible that
the pattern of binding is actually quite different in the neuroblasts, but nonetheless
it seemed like an interesting connection worth investigating. The proteins encoded by
prospero (pros) and senseless (sens) also have a role in developing neuroblasts, but
specifically during differentiation, and the connection between them and Dichaete is
also interesting, suggestive of an interaction in the developing nervous system that may
be cooperative or antagonistic.
Of the datasets found to significantly overlap with Dichaete, Prd is a strong candidate
for directly physically interacting with Dichaete. Prd is a member of the Pax gene
family, and Pax6 has been shown to interact with Sox2 in mammals (Kamachi et al.,
2001). Additionally, it has been found that the Sox/Pax interaction is conserved be-
tween Drosophila and chicken: it was found that the same enhancer region regulated
by Sox2 and Pax6 in chicken can successfully be activated by SoxN and the Drosophila
Pax2 homologue Shaven (Blanco et al., 2005). Thus it is possible that a similar inter-
action is taking place between Dichaete and Prd, most likely during segmentation in
the blastoderm.
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6.3.5 The role of Dichaete during neuroblast divisions
It is known that one of the mechanisms for specification of neuroblast fates is the tem-
poral sequence of transcription factor expression that different neuroblasts go through
(Maurange and Gould, 2005; Maurange et al., 2008). The first two transcription factors
in the sequence are Hb and Kr, which were found to significantly overlap with Dichaete
binding (Figure 6.8). While binding data is not available for Pdm (a.k.a. Nubbin), the
third factor in the sequence, this is a POU protein which has a reported interaction with
Dichaete and is likely to be a genuine cofactor (Ma et al., 1998; Mace et al., 2010).
In the larval brain, which appears to generate neuroblasts using the same temporal
mechanism as the embryo, Maurange et al. (2008) report that Dichaete is present dur-
ing the first three neuroblast divisions and is then switched off by Cas. They also find
that unless Dichaete is switched off, neuroblasts keep on dividing instead of exiting the
cell cycle. This is consistent with Dichaete maintaining neuroblasts in a self-renewing
state, which is reminiscent of the role of Sox2 in vertebrate stem cells.
Figure 6.8: Temporal sequence of transcription factors in dividing neuroblasts and
its relation to Dichaete function. Dichaete is present during the first 3 divisions, then
is switched off by Cas. Original figure taken from Maurange and Gould (2005).
The presence in the same cells along with significant overlap of binding suggests that
Hb and Kr may be cooperating with Dichaete during early neuroblast divisions to
regulate the same genes. This is also likely to be the case for Pdm, though the data
is not currently available. One of the potential ways in which Dichaete may be acting
in neuroblasts is by regulating both differentiation factors and apoptosis genes (Figure
6.9). Since hb was one of the high confidence targets identified in neuroblasts, it is
also likely that there are feedback loops between Dichaete and the neuroblast temporal
transcription factors.
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Figure 6.9: Dichaete may act in neuroblast by binding to and regulating both apop-
tosis and differentiation genes. Dichaete binding to apoptosis genes hid and reaper and
differentiation genes prospero and miranda are shown.
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The initial involvement of Dichaete in neuroblast development likely starts quite early,
probably at the selection and delamination stage, due to its involvement with the
Notch signalling pathway. The role of Dichaete at this stage is already documented, as
it is known to act together with Vnd and Ind to establish differences in the positional
information along the DV axis (Zhao and Skeath, 2002). It is likely that additional
neurogenesis targets at this time help establish the exact positional information that
later specifies neuroblast identity.
Subsequently, since hb was upregulated when Dichaete was overexpressed in neurob-
lasts, it seems likely that Dichaete helps activate the first step of the transcription
factor temporal sequence in neuroblasts. It is then possible that Dichaete cooperates
with each of the transcription factors in turn to activate the next one in the sequence
- Kr and Pdm were both strongly downregulated (average M value < −1.5) in the
Dichaete null mutant. Dichaete may also help activate Svp, which facilitates the tran-
sition between hb and Kr expression in the temporal sequence.
6.3.6 The role of Dichaete in neuroblast differentiation
In terms of maintaining pluripotency, it is possible that Dichaete acts to maintain
the expression of miranda to ensure Prospero remains in the cytoplasm, since the
expression of miranda is strongly downregulated in the Dichaete null mutant (average
M-value < −2). It is likely that at the same time it blocks the expression of apoptosis
genes (Figure 6.9) to ensure that neuroblasts do not get a chance to exit the cell
cycle in any way. However, while this hypothesis makes sense in terms of the biology,
in the Dichaete mutant experiment, hid and rpr are both strongly downregulated,
contrary to the hypothesis. A number of possibilities exist. First of all, the hypothesis
may be incorrect and Dichaete might be activating apoptosis genes instead. However,
this seems unlikely given that Dichaete prevents neuroblast cell cycle exit rather than
promoting it. The other possibilities are that either the changes in expression are due
to downstream effects from a number of other key transcription factors factors being
affected in a Dichaete mutant, or that Dichaete is acting context-specifically and its
effect on apoptosis genes in neuroblasts is contrary to the global effect in the whole
embryo, and so is not picked up by the Dichaete mutant study. Verifying the changes
in expression of hid and rpr in neuroblasts of Dichaete mutant would resolve at least
the latter theory.
There is clearly a link between Dichaete and Prospero, given the high occurrence of
binding in the same genomic sites (Figure 6.10). However, it is unclear what the exact
relationship between them is. It is possible that Dichaete also activates prospero, but
makes sure that it is out of the nucleus by regulating miranda. Using the standard
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cut-offs discussed in the previous chapter, there are no significant changes of prospero
expression in the Dichaete gene expression experiments, despite multiple binding in
and around it. However, an expression change in the Dichaete mutant does exist, with
an M-value of −1.35 and a p-value of 0.02, which would count as significant other a
less stringent threshold. This leaves it unclear whether Dichaete is a main regulator
of prospero, and some further experiments would be useful here. Interestingly, the
immunostainings performed on Dichaete mutants using a Prospero antibody by Shen
(2006) find that the expression of prospero is stronger, contrary to the gene expression
data. The reasons for this difference may be similar to the ones already discussed for
apoptosis genes.
It is possible that Dichaete and Prospero act antagonistically at the same sites. It is
not known whether they are ever present at the same time in the same nucleus, but if
they are, it is possible that they compete directly for the same sites. It is also possible
that they act cooperatively (for example, by Prospero changing the mode of action
of Dichaete from a repressor into an activator at selected sites), but given the role of
Dichaete in maintaining pluripotency, this option seems less likely.
Figure 6.10: Examples of Dichaete and Prospero binding co-occurrence.
6.4 Investigation of Dichaete controlled cis-regulatory
modules
It was interesting to explore in more detail the binding patterns of Dichaete and its
proposed cofactors around high confidence direct targets. In particular, a list of high
confidence direct targets in neuroblasts has already been generated, so was explored
further. In case the sensitivity of that particular screen was doubtful, the same analysis
was also performed with the direct targets flagged in the genome-wide screen. Two
areas were considered of most interest: first, the interaction of Dichaete with Hb, Kr
and Pdm during early neuroblast divisions, and second, the interaction of Dichaete
and Prospero in the decision to self-renew or exit the cell cycle to differentiate.
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6.4.1 Dichaete targets in neuroblasts
For studying Dichaete interactions in neuroblasts, three different binding profiles were
available - the Dichaete core dataset, Kr 0-8 hour ChIP-chip and Hb 2-3 h ChIP-chip.
Of these, the Dichaete and Kr datasets cover the correct developmental time window,
whereas the Hb data is from earlier in development and may be considered an educated
guess at where Hb is binding at later stages. The original overlap numbers are shown in
Table 6.3. Since Hunchback has the smallest binding dataset, it shows the most overlap
with the other two (73% of Hunchback binding intervals overlap with Dichaete, and
76% overlap with Kruppel). A large portion of Kruppel binding intervals (61.5%) also
overlap with Dichaete. The percentage of Dichaete overlap appears relatively low, but
this is due to the greater total number of intervals than the other two datasets.
Dataset Overlap with Overlap with Overlap with
Dichaete Hunchback Kruppel
Dichaete (6227) 1598 (25.7%) 2889 (46.4%)
Hunchback (2180) 1674 (76.8%) 1596 (73.2%)
Kru¨ppel (4553) 2801 (61.5%) 1460 (32.1%)
Table 6.3: Binding overlap between Dichaete and temporal neuroblast transcription
factors Hunchback and Kru¨ppel
The overlap in binding between all 3 datasets was found by taking intersects of binding
intervals. There was a total of 1449 binding intervals present in all 3 datasets associated
with 1019 genes. As expected, the list of targets was highly enriched for genes involved
in developmental processes (460 genes, p-value 1.2E-74) and biological regulation (461
genes, p-value 1.7E-59), with 26% (268 genes) involved in nervous system development
(p-value 6.6E-46) and specific components of it such as neuroblast differentiation (27
genes, p-value 6E-18) and axon guidance (72 genes, p-value 7.3E-26).
This list was compared to the list of Dichaete neuroblast targets with 2 or more as-
sociated Dichaete binding peaks. It was found that 56 out of 116 direct Dichaete
targets in neuroblasts are also joint targets with Hb and Kr. This includes 4 of the
27 neuroblast differentiation genes (nkd, mid, hb and hkb) and the binding patterns
around these 4 genes was further investigated. In general, the binding intervals for all
3 datasets were quite broad, so it was considered useful to filter them based on accessi-
bility data, focusing only on regions that are likely to be bound at Stage 9. The genes
in question were found to have complex cis-regulatory modules, with some sites being
bound by all three transcription factors and other sites in the same region showing
varying combinations of one or two of them (Figure 6.11). It is likely that there are
specific enhancer regions being targeted at different times by different combinations of
transcription factors.
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Figure 6.11: Binding of Dichaete, Hb and Kr in the regions of the neural differenti-
ation genes mid (A), hkb (B), hb (C) and nkd (D). The transcription factor binding
intervals show significant overlap, as well as complex patterns of co-occurrence.
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6.4.2 hunchback regulation
Figure 6.12: (A) Dichaete core binding in the region of hb (shown in black) overlaps
with the HZ4 enhancer element (blue) which activates the expression of hb in neurob-
lasts and GMCs. (B) Dichaete temporal data indicates that the enhancer is specifically
bound at Stage 10 only.
For hb in particular, there is published data on specific enhancer regions and their
functions (Hirono et al., 2011), therefore I examined Dichaete binding at these en-
hancers and the co-occurrence of Dichaete and its cofactors. Originally there was a 4
kb enhancer element (the HZ4 element) discovered upstream of the hb gene (from co-
ordinates 4,527,893 to 4,532,199 on chromosome 3R) which conferred hb expression in
neuroblasts and GMCs, but not neurons (Margolis, 1992; Margolis et al., 1994, 1995).
Dichaete core binding is found around this hb region, and some of it overlaps directly
with the HZ4 element (Figure 6.12), thus this element may be associated with Dichaete
regulation in neuroblasts. Examining the estimated Dichaete temporal data (Figure
6.12) indicates that part of the HZ4 enhancer is only accessible and likely to be bound
at Stage 10 only. Looking at the overall pattern of binding, it does not appear that this
enhancer is the main regulatory target of Dichaete since there is apparently more bind-
ing both upstream and downstream to hb. However, because HZ4 is well characterised
and there is an overlap, this was thought worth investigating further.
A further study provided insight into the precise structure of the HZ4 enhancer by
looking at the expression of subfragments of the 4kb region (Hirono et al., 2011) and
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identifying a number of smaller regions with specific regulatory effects. Six different
constructs were created (selected based on conservation) and tested. HG4-7, the 691
bp construct found to be sufficient for driving hb expression in neuroblasts and GMCs,
partially overlaps with Dichaete core binding data. No overlap is found with Dichaete
temporal data, but that may be due to the incomplete nature of the temporal data.
The HG4-7 region bound by Dichaete contains a conserved binding site for Svp and a
conserved homeodomain core motif as well as Pou domain binding sites slightly further
upstream (the closest one being around 150 bp away from the end of the Dichaete
binding interval). It seems likely that Dichaete may be interacting with Nubbin close
to the Pou domain at some point, and it is possible that the Dichaete binding data
comes from a time period that is too broad, since there may be important transient
interactions taking place specifically in neuroblasts.
RSAT matrix-scan was used at weight threshold 4 to look for Dichaete binding sites
within HG4-7 using the Dichaete position weight matrix derived from ChIP-chip data.
Six consensus Dichaete binding sites were found within the region, four of them on
the − strand. The two highest scoring binding sites were both on the reverse strand
and had weight scores of 8.6 each. The first (coordinates 4,527,919 to 4,527,929) is
close to the beginning of the HG4-7 element and overlaps with a Dichaete core binding
interval. The second (coordinates 4,528,478 to 4,528,485) is identified as conserved in
at least 11 out of 12 Drosophila species (specifically, the ’AACAAT’ part of the motif)
and is situated next to and partially overlaps a POU motif. It is likely that Dichaete
and Pdm physically interact at this site to regulate the expression of hunchback.
The other Dichaete binding interval within the HZ4 enhancer fully overlaps with con-
structs HG4-1 and HG4-3, which are expressed in early born neurons, and very slightly
overlaps with HG4-5, which is expressed in late born neurons. This is the Dichaete
interval that the accessibility data indicates is only present at stage 10. It perhaps
stands to reason that the region required for expression in neuroblasts is bound in ear-
lier stages, whereas the region required for neuron development is bound slightly later
in development. Further to that, based on the positioning of predicted binding sites,
it seems possible that Dichaete is helping regulate the neuroblast expression enhancer
element by creating DNA loops in this region (Figure 6.14).
6.4.3 Motif searching
The binding motif for Dichaete generated from the Berkeley ChIP-chip study was
used, and the motifs for Hb, Kr and Nub (Pdm) were downloaded from the JASPAR
database (Bryne et al., 2007). At first, motif searching was attempted using nmscan,
a part of the NMICA software (Down and Hubbard, 2005). However, it was found
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that if the same threshold is used for all motifs, the number of binding sites found
varies greatly. As expected, the shorter and less specific motifs were found an order of
magnitude more frequently than the longer and more specific ones. Next a threshold
optimisation was attempted using experimentally validated binding sites from REDfly
(Halfon et al., 2007). Unfortunately, only hb had anywhere nearly enough known
binding sites (103 in total) to attempt this, so the strategy was abandoned. Therefore
I used a different motif search tool, matrix scan, part of the RSAT package (Thomas-
Chollier et al., 2008), which normalizes the output scores to take the motif length into
account (settings used were Markov Order 1 and the high stringency threshold >=
weight score 6). In the cases where two overlapping motifs were found, the higher
scoring one was selected.
Dichaete_ChIP
hb
Kr
nub
Figure 6.13: TF binding motifs used
To start with, just the hb HZ4 enhancer was scanned, as it was expected that there
may be some interaction between the four factors here. The HZ4 enhancer was found
to have 5 Dichaete, 3 Kr, 9 Hb and 5 Nub binding sites (Figure 6.14). The distance of
the nearest other transcription factor sites within a 1 kb range from either side of each
Dichaete site was assessed. As expected if this is indeed a cofactor, the Nub binding
sites were closest to Dichaete binding sites, with the closest one being 130 bp away.
This is actually much further away from Dichaete than the POU motif found by Hirono
et al. (2011), and this is because for this analysis, the Nubbin position weight matrix
from JASPAR was used. There were also some Hb binding sites relatively nearby,
with the closest one being 210 bp away, though this may simply reflect a high number
of potential Hb binding sites found due to the low specificity of the position weight
matrix for this factor. The Kr binding sites were far away, with the closest being 507
bp away.
The same analysis was repeated for the genes identified as high confidence targets in
neuroblasts, to see whether more general patterns emerge. The analysis was performed
using the Dichaete high confidence intervals associated with direct neuroblast targets.
The 116 genes associated with more than one Dichaete interval and also flagged in at
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Figure 6.14: A more detailed view of Dichaete action in the HZ4 enhancer region. The
top of the figure shows the predicted binding sites for Hb (green), Kr (blue), Nub (pink)
and Dichaete (black), as well as the position of the Dichaete core binding intervals
(black rectangles) and the HZ4 enhancer (blue rectangle). The different enhancer
regions investigated by Hirono et al. (2011) are shown below.
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least one neuroblast gene expression study were found to be associated with a total of
428 Dichaete intervals. These intervals were scanned with binding motifs for Hb, Kr,
Dichaete and Nub (Figure 6.13) using RSAT, with the settings described above. The
search identified 323 binding sites for Dichaete, 204 for Kruppel, 403 for Hunchback
and 260 for Nubbin. The distances of the other predicted binding sites from Dichaete
were then analysed, to check whether a particular distance tends to occur frequently.
For each Dichaete binding site, the closest sites within a 1 kb window on either side
were found (Figure 6.15). There appears to be a trend in site distances from Dichaete
for all 3 transcription factors, with all of them being most likely to be found roughly
100 bp away from Dichaete. Interestingly, the distance between the Dichaete and Vvl
binding sites in the slit regulatory region was proposed to be between 50 and 70 bp
(Ma et al., 2000), so the distances found here constitute plausible ones for cofactor
action.
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Figure 6.15: Distance of different transcription factor binding sites from Dichaete
binding sites. The sites were predicted using RSAT. Only the sites closest to each
Dichaete binding site are shown. There appears to be a peak about 100 bp away from
Dichaete binding sites for all 3 transcription factors.
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6.4.4 Dichaete and Prospero
Prospero is a transcription factor that facilitates the differentiation of neuroblasts into
neurons. In dividing neuroblasts, Prospero is kept outside of the nucleus by Miranda,
which anchors it to the basal cortex of the cell, resulting in asymmetric division in which
Prospero ends up in the ganglion mother cell. At that point, Prospero is released and
enters the nucleus, regulating gene expression to bring about differentiation (Choksi
et al., 2006). Dichaete and Prospero binding intervals were found to significantly
overlap, and the connection between them was thought to be potentially interesting.
Work so far indicates that they operate antagonistically: while the presence of Dichaete
ensures the continued proliferation of neuroblasts, the presence of Prospero in the
nucleus brings about neuron differentiation (Choksi et al., 2006). It is therefore likely
that they are targeting the same genes, but with opposite effects. However, direct
evidence for the relationship between Dichaete and Pros is currently lacking. For
example, it is not known currently known whether both factors are in the nucleus at
the same time at any point. It is possible that in the GMC, Dichaete expression is
quickly switched off, or that Dichaete is outcompeted by Prospero at relevant binding
sites. Alternatively, it is possible that Dichaete and Prospero in combination can have
the opposite effect from Dichaete paired with other transcription factors. This is an
interesting area to further research given the role of Sox2 and mammalian Prox proteins
in regulating neurogenesis (Torii et al., 1999). Here I present a preliminary analysis of
their relationship.
The connection between Dichaete and Prospero has been previously highlighted by
Shen (2006) in her PhD work on Dichaete. The effect of dominant negatives and a
Dichaete null mutant on prospero expression was characterised using immunohisto-
chemistry. It was found that in Dichaete null mutants, the expression of prospero is
much stronger, and the layer formed by neuroblasts and GMCs is much denser com-
pared to wild type, suggesting an increase in neuroblast proliferation. This is unusual
because a study of Dichaete expression specifically in neuroblasts found that Dichaete
promotes continued proliferation, and needs to be switched off in order for neuroblasts
to exit the cell cycle (Maurange et al., 2008). However, the phenotype could be due to
downstream effects, for example defects on the Notch signalling pathway in Dichaete
mutants. At stage 16, glial differentiation defects are present, including loss and disor-
ganisation of the longitudinal glia (Shen, 2006). When looking at dominant negatives,
both HMG− and EnRep display a loss of prospero expression. In the case of EnRep,
the repression makes sense and suggests that prospero is a direct target, which could be
either activated by Dichaete, or slightly repressed (and further repressed by EnRep).
In the case of HMG−, it is less clear why it would lead to a reduction of prospero ex-
pression, unless it is either normally activated by Dichaete, with HMG− sequestering
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away cofactors, or the reduction in expression is due to indirect effects. While the
precise effect of Dichaete on prospero expression is unclear, this combined with the
high confidence binding data strongly suggests that Prospero is a direct target.
In order to find out more about the possible interaction between Dichaete and Prospero,
their binding profiles were compared. The Prospero 4-7h embryo DamID binding data
from Choksi et al. (2006) was reanalysed using the TiMAT pipeline and remapped
to Genome Release 5 using the UCSC LiftOver tool. The FDR 1% dataset had very
few intervals (307 in total), so was thought to be too stringent. Instead, the FDR
25% dataset was used, which contained a total of 1478 intervals. This binding profile
was compared to the Dichaete core 0-12 hour dataset (6227 intervals). Intersecting
the two binding sets resulted in 1225 interval overlaps, associated with 642 genes.
The gene list is highly specific, with 292 genes involved in developmental processes
(p-value 1.8E−50), 146 in transcriptional regulation (p-value 1.8E−46) and 86 in cell
fate commitment (p-value 1.4E−43). 117 of the genes are involved in the generation of
neurons and this is likely to be an interesting target list (including Antp, Abd-A, hth,
ey, svp, hb, Kr, nub, cas, pros, mira, N, Dl, sim and sli). 27 out of 35 genes defined
as being part of a neural stem cell transcriptional network (Southall and Brand, 2009)
(Figure 6.16).
Figure 6.16: The figure, taken from Southall and Brand (2009), shows the neural stem
cell transcriptional network as determined from overlapping binding data for Asense,
Deadpan, Prospero and Snail. 27 out of the 35 genes are bound by Dichaete and
Prospero together in the same genomic locations are labelled with a black asterisk.
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Figure 6.17: The Dichaete gene expression data was compared to the prospero mutant
expression data from Choksi et al. (2006), looking specifically at genes identified as
being part of the neural stem cell transcriptional network by Southall and Brand (2009).
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It was thought interesting to further investigate the effects of Dichaete and Prospero
on the neural stem cell transcriptional network genes. The log2 fold-change for genes
in prospero mutants were taken from Choksi et al. (2006) and visualised alongside the
Dichaete gene expression experiments (Figure 6.17). While overall not enough genes
were differentially expressed to draw definite conclusions, it appears that the majority
of genes involved in neuroblast cell fate determination tend to be regulated antago-
nistically, whereas the two neuronal differentiation genes for which data is available,
zfh1 and Lim1, appear to be regulated in unison. This opens up the possibility that
Dichaete acts antagonistically to Prospero in neuroblast, maintaining pluripotency and
preventing differentiation, but then goes on to act in unison once Prospero enters the
nucleus of the GMC, with the two factors together facilitating correct neuronal differ-
entiation.
6.5 Conclusions
This chapter concludes the research part of my PhD. In previous chapters, I presented
a high confidence Dichaete binding dataset for the Stage 1-15 embryonic period, along
with a series of gene expression studies aimed at functional validation. Furthermore,
I developed a number of filtering methods for identifying direct targets and increasing
the signal to noise ratio of the data. In this chapter I have made use of these datasets
and methods to identify direct Dichaete targets in the hope that this will aid future
research on Dichaete and Sox genes
Further to that, I have made use of a large number of available binding datasets to
scan for cofactors, and identified links between Dichaete and the neuroblast temporal
sequence of transcription factors Hunchback and Kruppel, as well as a link with the
differentiation factor Prospero. It appears that Dichaete interacts and cooperates with
the first three transcription factors in the temporal sequence, as well as being an integral
part of the neural stem cell transcriptional network. This conclusion has a pleasing
similarity with the role of its homologue Sox2 in maintaining stem cell pluripotency
in vertebrates. The relationship of Dichaete with Prospero appears to be complex,
with Dichaete acting antagonistically to Prospero in neuroblasts in terms of preventing
cell cycle exit, but potentially acting cooperatively once the differentiation process has
begun in order to facilitate correct neuron differentiation.
One of the limitations of this work is that much of it is based on datasets from a range
of developmental time periods, so the next step would be to focus on specific stages of
development and parts of the nervous system, to more precisely determine the inter-
actions between Dichaete and the various transcription factors involved. It would also
be useful to do some validation, which can be performed using immunohistochemistry
204
and/ or in situs with interesting direct targets to determine the effects of Dichaete null
mutations and dominant negatives on specific transcription factors. What might be
of particular interest is that, while the results presented here have all been performed
using whole embryos, it is likely that the effects are non-uniform, so may vary for
example in particular neuroblast lineages.
In terms of computational work, further analysis can be performed using existing data
that, due to time constraints, I have been unable to complete. I have generated a
genome-wide network of binding with the available embryonic binding datasets: this is
a useful resource and could be further analysed by using, for example, clustering and
principal component analysis to determine clusters of genes that are co-regulated and
the extents to which different transcription factors influence gene expression together.
While much detailed analysis has already been published by BDTNP and the modEN-
CODE consortium, a similar analysis with a more specific focus on Dichaete has not
yet been perfomed. Motif searching could also be used further to predict binding sites
and do a more in-depth analysis of their occurrence patterns. However, such analy-
ses should ideally be followed up by in vivo validation, for example by using cloned
constructs attached to marker genes in wild type and mutants.
Part of what is interesting about the modENCODE data analysis presented in this
chapter is that a non-specific analysis with a large number of different transcription
factor binding datasets still points very clearly towards connections specific to CNS
development, neuroblasts and neuronal differentiation, processes Dichaete is known to
be involved in. The high degree of co-occurrence of Dichaete, Hb and Kr, as well as the
presence of their binding motifs, suggest that there are genuine interactions between
them. Dichaete and Prospero also appear to have a complex relationship that may be
interesting to investigate further. I hope that my work has created an initial roadmap
that can guide further Dichaete research.
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Chapter 7
Conclusions
The main objective of my PhD project was to provide the first in-depth genome-
wide view of the developmental and molecular action of Dichaete during Drosophila
melanogaster embryogenesis. Specifically, I set out to uncover the locations Dichaete
binds to in the genome; to assess the functionality of the binding using results from
gene expression studies; to use computational methods to predict potential cofactors
and their binding patterns and to gain an overall understanding of how Dichaete and
its cofactors act together to modulate gene expression. I believe that I have in part
been successful, and that this thesis presents the first rough roadmap of Dichaete
genomics.
7.1 Dichaete genome-wide binding during embryo-
genesis
The Dichaete in vivo binding profile was investigated using two independent genome-
wide approaches: ChIP-chip and DamID. While my own ChIP-chip studies did not
produce data with a sufficiently clear signal, several other Dichaete ChIP-chip datasets
had since been published and these I analysed as part of my thesis. The DamID data
I generated, on the other hand, is high quality and appears to specifically highlight
Dichaete activity. Since ChIP-chip and DamID are independent assays, they effectively
cross-validate each other, and this was used to create a high confidence binding dataset
for the 0-12 hour period of embryonic development. Since these high confidence bind-
ing intervals are validated by two methods and come from multiple highly concordant
datasets, I believe that this dataset provides a reliable general view of Dichaete action
during early embryogenesis. Additionally, the high concordance between the two dif-
ferent types of data is encouraging and means that these two techniques can be used
to complement each other and generate more robust binding datasets in general.
While looking at accessibility provides an approximation of where Dichaete may be
binding at specific developmental times, it was clear from the comparative analysis
that, as would be expected, having a tighter time window for a ChIP-chip experiment
has advantages. For example, the Dichaete binding motif was only successfully re-
trieved from D Berk ChIP data. While the high significance of overlaps between the
different Dichaete datasets suggests that they are performing well in terms of identi-
fying broad regions of Dichaete binding, the fact that a subsection of sequences close
to the estimated peak centre from D Berk were enriched for the Dichaete binding mo-
tif, while the others did not appear to, suggests that peaks in ChIP-chip data from a
tight developmental window may be more closely indicative of actual Dichaete binding
sites, rather than just correctly reflecting the general area of binding. Furthermore,
there appears to be signal in the quantitative information from this dataset, which may
have functional significance (Biggin, 2011). My analysis suggests that this correlation
between quantitative information and function is lost in datasets from broader devel-
opmental times, probably because the binding picture obtained is averaged out over
both time and multiple tissues.
As well as using narrow time windows, tissue specific profiles would be ideal where
possible, but this is currently technically challenging. While tissue specific ChIP where
dissection is not possible needs to involve, for example, sorting nuclei by fluorescence,
the development of a less active Dam methylase would make it possible to do tissue
specific DamID by driving the construct using tissue-specific drivers, making tissue
specific binding profiles much easier and more widely accessible to perform.
With or without access to these new technologies, the next logical step for the study of
Dichaete in neurogenesis would be to obtain a more specific binding profile, for example
at late stage 8-stage 9. A temporal series may also be interesting, to test whether
specific enhancers are only bound at particular points during development. My analysis
uncovered some interesting candidate targets and suggests that these can potentially be
identified from the Dichaete binding data deconvolved by using chromatin accessibility,
if only specific enhancers were studied. In particular, some of the CRMs documented
in REDfly (Halfon et al., 2007) which overlap with Dichaete data could be used.
Genes associated with multiple Dichaete binding intervals also showed increased en-
richment for involvement in a range of developmental processes. This is likely due
to the fact that complex CRM architecture makes it possible to integrate a range of
signals (Hermsen et al., 2006) and precisely control temporal expression. It would be
interesting to see whether the number of binding sites associated with a gene correlates
with the changes in gene expression in mutants, and also to try and dissect the pre-
cise functions of different components of multiply bound CRMs by creating reporter
constructs where individual binding sites are mutated.
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7.2 Dichaete mechanisms of action
While the data presented in my thesis is not sufficient to precisely determine the mode
of action Dichaete uses for transcriptional regulation, there were two hypotheses in
particular that are consistent with the evidence presented in this thesis. First, Dichaete
is likely to act by binding to enhancers: it frequently binds to long introns and overlaps
with a large proportion of known CRMs as characterised in REDfly (Halfon et al., 2007).
This is consistent with the limited previous evidence on Dichaete action, where it is
known to regulate the expression of slit in the midline together with the POU protein
Vvl and the PAS domain protein Single minded by binding to a 1 kb intronic enhancer
(Ma et al., 2000). The known CRMs Dichaete binds to could also provide a starting
point for further analysis of its action.
A second potential mechanism of action consistent with the available data is that
Dichaete facilitates Polymerase pausing. The majority of Dichaete binding peak cen-
tres land in genic regions, and there is a high degree of overlap with PolII binding inter-
vals, with some Dichaete intervals showing strong correspondence with PolII peaks, for
example in the region of the mod(mdg4) insulator protein gene. This is unlikely to be
the only mode of action of Dichaete, since it also binds to a large number of enhancers
and a sizeable portion of the binding peaks falls outside genic regions. However, it is
possible that for a subset of its regulatory targets, this is the mechanism Dichaete uses
for modifying their transcription rate. The fact that interrupting Polymerase paus-
ing sometimes results in repression and sometimes in derepression (Zeitlinger et al.,
2007a; Muse et al., 2007; Gilchrist et al., 2008) is consistent with the reported context
dependent effects Dichaete can have on gene expression (Phochanukul and Russell,
2009).
Dichaete, like other Sox genes, is known to bend DNA at a sharp angle (Werner,
Bianchi, Gronenborn and Clore, 1995; Ma et al., 1998), and it is possible that this
structural property is in some way integral to its function: for example with multiple
Dichaete binding sites bending DNA to create chromatin loops. This is consistent with
either of the two modes of action described above: Dichaete could be bending DNA at
enhancer regions to bring distant enhancer regions together. It is also possible that the
presence of bent DNA in the middle of a genic region slows down the progress of PolII,
resulting in pausing. This hypothesis is not possible to test from the currently available
data, but techniques such as chromosome conformation capture (3C) (Dekker, 2005)
could shed further light on the effect of Dichaete on local chromatin geometry and how
this may regulate transcription.
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7.3 Dichaete direct targets
For the functional analysis of binding intervals, data from a number of gene expression
studies were used. The analysis of Dichaete mutant embryos at stage 10-11 revealed a
very large number of differentially expressed genes, with the majority of the genes in
the genome changing expression. Despite the large number of genes flagged, the genes
in question nonetheless appear to be specific to known Dichaete functions, including
a number of genes involved in nervous system development, segmentation and the
regulation of gene expression, among other processes. The specificity of the list appears
to increase when filtered for higher fold-change values, which may reflect that genes
exhibiting more pronounced changes in gene expression are more likely to be direct
targets.
Several tissue specific gene expression profiles were obtained by using dominant nega-
tive constructs combined with appropriate Gal4 drivers. The effect of dominant nega-
tives was studied in the midline (using the simGal4 driver) and in neuroblasts (using
the prosGal4 driver) at developmental stages 8-9. The midline results only identified
a small number of differentially expressed genes, notably do not include the known
midline target slit, so this analysis clearly does not represent an extensive catalogue
of Dichaete midline targets. It is thought that this is because the gene expression
experiments were performed using whole embryos and since the midline is a relatively
small tissue, all but the strongest changes in gene expression are lost by being averaged
out over the rest of the embryo. However, the experiment still highlights a number
of interesting direct targets: for example, the gene bancal, which has a known role in
regulating apoptosis, and Rala, which is involved in the regulation of the Notch sig-
nalling pathway and cell fate commitment of photoreceptors. Clearly a future study
using newly developed methods for purifying specific cell populations from the embryo
(Salmand et al., 2011) will be of use here. Since the dominant negative constructs used
in my study are tagged with GFP, they may be of use in this type of study.
The neuroblast results provide a more extensive list of targets, with a total of 325
genes found to be associated with both Dichaete binding at stage 9 and differentially
expressed in the gene expression screen. A number of these were genes involved in
neurogenesis, including SoxN, Delta, lola, mid, nkd, hb, ac and hkb. The gene ac
in particular has already been shown to change in expression in proneural clusters
in bothDichaete and SoxN mutants (Overton et al., 2002), so the conclusion from
my analysis that it is a direct target is consistent with previous evidence. Previous
research suggests that Dichaete has a context-dependent effect. ac is derepressed in
some intermediate column proneural clusters in Dichaete mutants, suggesting that
Dichaete is acting as a repressor there, but it seems to be activated by Dichaete in
the medial column (Overton et al., 2002; Zhao and Skeath, 2002; Zhao, Boekhoff-
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Falk, Wilson and Skeath, 2007). SoxN mutants display a partial loss of ac expression
in the medial column, whereas a Dichaete and SoxN double mutant shows an almost
complete loss of ac expression. Further, more detailed experiments on binding patterns
and effects of SoxN around ac may shed some light on the partial redundancy between
Dichaete and SoxN.
The fact that SoxN was found to be a target makes sense: since Dichaete and SoxN
are both present in medial and intermediate column neuroblasts and share some func-
tionality, having a feedback loop between them seems logical. This has indeed already
been suggested by a previous study - Overton et al. (2002) report that in about half of
the SoxN null mutant embryos studied, the levels of Dichaete expression were reduced
in the anterior half of the neuroectoderm. Other genes identified as likely direct targets
in the CNS also show binding and expression effects that suggest it is likely that the
network of transcription factors in neuroblasts is highly interconnected. If this is the
case, it suggests a mechanism to facilitate precise tuning of different cell fate outcomes.
In this respect I note that Dichaete, Hb and Kr all bind to each others regulatory re-
gions, further emphasising the potential for a cross-regulatory network (Figure 7.1). It
is also interesting to note that the neuroblast differentiation genes nkd, mid, hb and
hkb are all associated with overlapping binding intervals for Dichaete, Hb and Kr, and
it is likely that these are some of the regulatory targets during the transcription factor
temporal sequence in neuroblasts.
7.4 The role of Dichaete in neuroblasts
Dichaete has been previously reported to have a role in maintaining the mitotic activity
of neuroblasts in the larval neuroectoderm, with downregulation of Dichaete necessary
for cell cycle exit (Maurange et al., 2008). The data from my PhD highlights this role
and provides some further insight into the details of its role. In particular, Dichaete
appears to interact with the first three transcription factors in the series (Hb, Kr and
Pdm) and may be preventing cell cycle exit by directly regulating both apoptosis and
differentiation genes. The presence of the Hb binding motif in the output from the
Dichaete motif searching I performed strengthens the evidence that the factors are
cooperating. In addition, Pdm is a POU protein with previously reported genetic
interactions with Dichaete (Ma et al., 1998). The occurrence of Hb, Kr and Pdm
binding motifs within Dichaete binding intervals suggests that the factors are frequently
located approximately 100 bp away from Dichaete binding. Although it is currently
not known whether at this distance they act as direct Dichaete cofactors, they at least
appear to be acting at the same general regulatory regions. It is also possible that the
motif occurence distances are connected to the structural properties of Dichaete and
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Figure 7.1: The binding in the regulatory regions of Dichaete, hb and Kr. It is
notable that all of the transcription factors in question bind multiple times to each
other’s regulatory regions, suggesting a complex cross-regulatory network.
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the angle at which it bends DNA. Establishing the resulting geometry of bound regions
will make an interesting further analysis.
Since hb has been highlighted in the analysis as a direct target of Dichaete, I performed
an analysis of the recently characterised hb enhancer HZ4 (Hirono et al., 2011). I
found some overlap between Dichaete binding data and the enhancer, in particular
in the regions controlling expression in neuroblasts and also in early neurons. Taking
into account the chromatin accessibility data for different time periods suggests that
Dichaete binds just upstream of (but not overlapping) the neuroblast regulatory region
at stages 5 and 9 only, and that it binds the early neuron regulatory region at stage
10 only. However, for this type of detailed analysis the limitations of the binding data
I present here becomes apparent and suggest that it is insufficiently detailed. While
my analysis provides a reliable overview of Dichaete binding during stages 1-15, it is
possible that there are more transient binding events occuring specifically in developing
neuroblasts, which this data is not sensitive enough to identify. This will be interesting
to investigate further, with particular focus on how the binding patterns change from
stage 9 to stage 11, and whether different parts of the enhancer are bound at different
times. A more focused study, using ChIP coupled with specific PCR assays, may be
helpful in this respect.
7.5 Dichaete and Prospero
Dichaete and Prospero binding profiles were found to significantly overlap, and in par-
ticular, joint Dichaete and Prospero binding regions were found to be associated with
27 out of 35 genes from the neuroblast transcriptional network identified by Southall
and Brand (2009) (Figure 7.2). This suggests the close involvement of both factors
in neuroblast transcriptional control. In particular, it was interesting that the expres-
sion results from Dichaete and prospero mutants show opposite changes for a number
of genes involved in neuroblast differentiation, but the same changes for two of the
genes involved in neuronal development (Figure 7.2). This opens up the possibility
that Dichaete and Prospero act antagonistically when it comes to neuroblast differ-
entiation, but possibly later cooperate to bring about correct neuronal development.
This conclusion stands up when we consider that Prospero is a differentiation factor
and Dichaete keeps neuroblasts in a pluripotent state. However, the involvement in
neuronal differentiation has not been investigated, and while solid conclusions cannot
be based on such a small number of genes, this will be an interesting area to further ex-
plore. Careful qRT-PCR or in situ analysis of relevant target genes in single and double
mutants will help clarify the regulatory inputs from Dichaete and Prospero.
My analysis and that of Maurange et al. (2008) suggests that Dichaete activates mi-
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Figure 7.2: (A) The neuroblast transciptional network, as identified by Southall and
Brand (2009), with the genes associated with overlapping Dichaete and Prospero bind-
ing labelled with a black asterisk. The majority of genes were found to be associated
with overlapping Dichaete and Prospero binding. (B) The clustering of gene expression
data is shown for the genes which have been flagged as differentially expressed in both
Dichaete and Prospero mutants. Dichaete and Prospero appear to have the opposite
transcriptional effect on the majority of neuroblast cell fate genes for which data is
available, but have the same effect on two of the neuronal differentiation genes.
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randa in neuroblasts, presumably to keep Prospero out of the nucleus and thus main-
tain neuroblasts in an undifferentiated state. However, it is unclear what happens
from there, including the issue of whether Dichaete and Prospero are ever located in
the same nucleus together. It would be interesting to resolve the question of whether
Dichaete persists in the nucleus of ganglion mother cell, and subsequently in its daugh-
ter cells. If the two colocalise together, it is possible that they cooperate to bring
about the later stages of neuron differentiation. If this is the case, it may represent a
switch in Dichaete function based on changing co-factors; for example, from the tem-
poral neuroblast TFs to Prospero. An initial analysis of Dichaete and Prospero using
immunofluorescence should help clarify the spatio-temporal relationship between these
to proteins as a prelude to further analysis.
7.6 Future work
Due to its importance as a developmental transcription factor and high degree of func-
tional conservation with relatively distantly related species such as mouse and chick
(Soriano and Russell, 1998; Blanco et al., 2005), Dichaete continues to be an interesting
subject of study. Further to that, the relationship between Dichaete and SoxNeuro as
yet remains unclear, and may serve as an interesting model for functional redundancy
between closely related Sox factors. Here I present some potential directions in which
to take the study of Dichaete further.
7.6.1 Further Dichaete in vivo binding studies
As discussed, there are a number of ways of improving our knowledge of Dichaete in
vivo binding. The most technically challenging would be to perform tissue specific
ChIP-chip using FACS, or tissue specific DamID using an improved construct that
can be driven in specific tissues. However, even without these methods, the data
would be much improved if it was collected from a tighter developmental window and
possibly as a time series. My analysis suggests that early developing neuroblasts will be
particularly interesting to focus on, and that there is a strongly interconnected network
of transcription factors that Dichaete is an integral part of. A different experiment that
could also be performed using currently available methods is ChIP-chip and DamID
using larval brains, to shed some light on the role of Dichaete in post-embryonic nervous
system development. At present such a dataset has not yet been published.
In terms of data analysis, our understanding of DamID data could possibly be im-
proved by studying the patterns of the GATC sequence occurring in the genome. The
technique relies on being able to methylate GATC sites in the genome, which are likely
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to be non-uniformly distributed, but this has as yet not been taken into account when
analysing DamID data. The strategy of using ChIP-chip and DamID data together
appears to be a promising one, and is likely to increase the reliability and reduce the
number of false positives from any data obtained.
7.6.2 SoxNeuro studies
Some particularly interesting questions regarding functional redundancy include how
Dichaete and SoxNeuro find their specific targets when present in the same tissues
(such as medial and intermediate column neuroblasts), to what extent they are func-
tionally redundant, whether as suggested they sometimes act antagonistically in a
context-dependent manner, and what the mechanism for their differential function is
in vivo. There is currently an ongoing PhD project by Enrico Ferrero in the Russell lab,
performing ChIP-chip, DamID and gene expression experiments on SoxNeuro similar
to the ones I performed on Dichaete, and hopefully with the joint data from our two
projects, some of the questions about the precise relationship between Dichaete and
SoxNeuro can finally be answered.
7.6.3 Molecular action of Dichaete
Dichaete belongs to the slightly unconventional group of transcription factors which
bind to the minor groove of DNA, and in the process of binding it is known to introduce
a sharp bend into the DNA. It is possible that the role of Dichaete is a structural one
and that the mechanism by which it contributes to gene expression regulation is by
forming structures such as chromatin loops. This hypothesis is experimentally testable
using chromatin conformation capture (3C) (Dekker, 2005). It will be interesting to
apply this method to the achaete-scute complex and potentially the regulatory regions
surrounding hunchback, as the binding patterns there have already been well studied
and contains probable bona fide Dichaete targets. This data may help shed light on
the question of the Dichaete mode of action, by comparing sites of intragenic bending
to the presence of corresponding PolII peaks, and also by identifying binding sites
through motif searches and studying in more detail how Dichaete-induced bending
alters enhancer geometry and binding site distances.
7.6.4 Conservation studies
A number of transcription factors have now been studied in closely related species,
including some in mammalian, yeast and Drosophila species (Odom et al., 2007; Borne-
man et al., 2007; Schmidt et al., 2010; He et al., 2011; Hemberg and Kreiman, 2011).
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The results are varied, and suggest that while some transcription factors have binding
sites whose locations are strongly conserved by evolution, other ones diverge rapidly be-
tween even very closely related species, perhaps providing a tool for evolution to shape
and optimise. It is unclear which group Sox genes in general and Dichaete in particular
belong to, but an evolutionary study of both Dichaete and SoxNeuro between closely
related Drosophila species may prove to be interesting and insightful. Sarah Carl, a
PhD student in the Russell lab, is currently beginning this project, which should offer
an interesting continuation of Dichaete research.
7.6.5 In-depth studies of Dichaete target expression patterns
The BDGP in situ database provides a major resource for studying the gene expression
patterns during embryonic development in Drosophila. This resource has not been used
very much in this thesis, primarily because Dichaete has been shown to act both as
an activator and as a repressor, and therefore the ’expected’ patterns of expression of
direct Dichaete targets could not be determined with certainty. However, a preliminary
analysis using the GEMs tool in Fly Express Kumar et al. (2011) revealed that the
predicted Dichaete targets do in fact show consistent patterns of expression in the
nervous system. Further to that, now that a large number of potential Dichaete targets
have been identified as part of this project, this provides a much more solid starting
point for drawing on this data. Future studies could use this to identify and filter for
direct targets, as well as doing an in-depth analysis of the expression patterns of known
targets during different stages of embryogenesis, to further dissect the potential action
of Dichaete at different times and in different tissues.
7.6.6 Dichaete and Sox2 binding conservation
There are now a number of ChIP-chip datasets available for Sox2 in mice, including
a fascinating study on the role of Sox2, Sox3 and Sox11 in neuronal lineage develop-
ment (Bergsland et al., 2011). A comparative analysis of the Sox2 binding in mice and
Dichaete binding in Drosophila may yield some interesting insights into the conserva-
tion of Sox binding between vertebrates and invertebrates. While genome alignments
are technically challenging even between mammalian species, and likely close to impos-
sible between mice and fruit flies, the level of homology between the genes associated
the binding intervals in each species should be relatively straight-forward to analyse,
and may yield some interesting insights into the functional conservation between the
two factors. The analysis may also be improved by including gene expression studies
from both species to facilitate comparisons between likely direct targets.
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7.6.7 The mode of action of Dichaete dominant negative con-
structs
Dominant negative constructs are a commonly used tool for studying transcription
factor function via gene expression studies. However, the mechanisms by which they
cause gene expression changes are often unclear, making the data analysis somewhat
ambiguous and inconclusive. In Chapter 5, I presented a pilot study of Dichaete dom-
inant negative protein binding in the genome, done in collaboration with Aleksandra
Mandic, Louis Chauviere and Bettina Fischer. The initial results were encouraging and
this is a promising project that could be taken further. The gene expression data using
the constructs is already available, and all the constructs are GFP-tagged, making the
project relatively straight-forward from a technical perspective.
7.7 Conclusions
In this thesis I present the first in-depth genome-wide study of Dichaete action. The
data I have generated, combined with data from other groups, gives a broad overview of
the role of Dichaete in Drosophila embryogenesis. While there is already an abundance
of available high throughput genomics datasets for Drosophila, and their number will
carry on increasing in the coming years, what is often lacking is an in-depth system-
atic analysis of the available data. Here I present such an analysis for Dichaete. The
Dichaete core binding dataset, as well as the direct targets identified using binding
data, gene expression and computational methods, are carefully constructed and will
hopefully form a foundation for future research. Further to that, during the course
of my project I believe I have developed several simple but effective analysis and fil-
tering methods, such as looking at clusters of binding to identify direct targets, and
using DNaseI sensitivity data to add a dynamic context to the available binding maps.
Finally, I identified a list of specific cofactors which link back to the Dichaete role
in the nervous system - specifically its interaction with Hb, Kr and Pdm in the neu-
roblast temporal series. Additionally, I highlighted an interesting connection between
Dichaete and Prospero in neuroblasts and GMCs, as well as suggesting a number of
potential future paths of enquiry that stem from my analysis. I believe that my work
makes a novel contribution to the field, and provides a useful stepping stone in our
understanding of Dichaete biology.
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Appendix 1
A GO enrichment of Dichaete targets
Table 1: GO enrichments for the four Dichaete binding datasets. Four gene lists were
created, for genes associated with between 1 and 4 datasets in total (named ’1 dataset’
to ’4 datasets’ according to the number of associations of the genes within it to different
datasets). The GO terms shown were found to be significantly enriched for all 4 of the
gene lists. The numbers shown are numbers of genes from each of the gene lists which
were found to belong to the GO category in question.
GO term 1 dataset 2 datasets 3 datasets 4 datasets
cell differentiation 862 574 236 36
positive regulation of cellular process 320 216 73 14
neuron development 372 252 118 22
negative regulation of transcription, DNA-
dependent
119 79 34 9
regulation of cellular component size 109 76 38 11
regulation of cellular component organization 228 138 55 13
negative regulation of biosynthetic process 181 119 47 11
cardiac cell differentiation 27 25 15 6
regulation of nucleobase, nucleoside, nu-
cleotide and nucleic acid metabolic process
693 423 152 29
cell division 155 101 40 10
biological regulation 1928 1073 391 58
regulation of multicellular organismal process 288 198 82 15
cellular component organization or biogenesis 1382 751 264 38
eye development 262 188 88 14
peripheral nervous system development 79 65 39 9
regulation of biological quality 513 299 116 21
transcription from RNA polymerase II pro-
moter
208 127 48 13
response to stimulus 1297 752 310 45
transcription, DNA-dependent 511 310 111 22
regulation of cellular macromolecule biosyn-
thetic process
651 401 146 30
oogenesis 347 218 90 17
nervous system development 640 442 204 30
cellular component organization at cellular
level
1177 653 233 34
cell part morphogenesis 326 214 103 19
chemotaxis 171 130 63 10
imaginal disc-derived wing morphogenesis 193 140 64 15
segmentation 194 136 60 13
organ morphogenesis 430 321 143 29
Continued on next page
Table 1 – continued from previous page
GO term 1 dataset 2 datasets 3 datasets 4 datasets
post-embryonic morphogenesis 323 241 109 22
cell growth 81 58 33 9
compound eye morphogenesis 200 143 71 11
transcription 641 391 142 29
imaginal disc-derived appendage development 217 162 75 19
organ formation 52 46 27 6
signal transduction 700 406 171 25
cell development 712 464 189 30
developmental process involved in reproduc-
tion
379 248 90 17
negative regulation of cellular macromolecule
biosynthetic process
180 118 47 11
imaginal disc development 367 279 124 25
open tracheal system development 154 116 57 10
negative regulation of cellular biosynthetic
process
181 119 47 11
positive regulation of biological process 349 234 81 16
developmental process 1464 933 366 57
regulation of macromolecule metabolic pro-
cess
831 495 181 31
cellular macromolecule biosynthetic process 1082 557 171 31
nucleic acid metabolic process 1114 569 191 30
axonogenesis 220 158 75 14
cell morphogenesis involved in differentiation 323 221 108 19
neurogenesis 501 347 160 26
regionalization 353 251 111 22
response to chemical stimulus 403 271 124 18
regulation of cellular process 1641 933 348 54
cell morphogenesis 360 236 119 21
system development 1066 726 314 51
regulation of nitrogen compound metabolic
process
694 423 152 29
negative regulation of RNA metabolic process 126 84 36 9
cellular component organization or biogenesis
at cellular level
1214 667 233 34
cellular component organization 1343 736 263 38
regulation of signaling 297 179 77 14
localization of cell 177 131 62 12
negative regulation of macromolecule biosyn-
thetic process
180 118 47 11
regulation of cellular biosynthetic process 679 415 148 30
growth 212 138 73 19
cell motility 173 129 61 12
gland development 157 118 59 10
cell fate commitment 227 180 88 15
regulation of gene expression 749 452 169 31
wing disc pattern formation 65 54 31 7
tube development 94 70 38 8
regulation of transcription from RNA poly-
merase II promoter
162 108 45 12
imaginal disc morphogenesis 254 197 87 18
cellular developmental process 882 580 240 37
wing disc morphogenesis 194 141 64 15
regulation of RNA metabolic process 535 333 119 23
neuron projection development 313 215 103 19
Continued on next page
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Table 1 – continued from previous page
GO term 1 dataset 2 datasets 3 datasets 4 datasets
imaginal disc-derived appendage morphogen-
esis
214 160 73 18
eye morphogenesis 211 153 74 13
wing disc development 249 181 81 18
multicellular organismal process 1641 1006 385 57
anatomical structure development 1318 855 343 55
signaling 825 472 190 28
negative regulation of biological process 508 310 131 21
regulation of growth 124 85 45 15
regulation of developmental growth 48 36 18 7
post-embryonic development 384 279 121 24
cell migration 169 126 61 12
cell fate determination 123 99 50 12
cell projection morphogenesis 326 214 103 19
cell morphogenesis involved in neuron differ-
entiation
309 211 102 19
circulatory system development 67 58 27 8
regulation of biosynthetic process 679 415 148 30
locomotion 350 255 116 20
anatomical structure morphogenesis 943 631 272 47
sensory organ development 326 237 106 20
instar larval or pupal development 366 264 116 24
regulation of metabolic process 918 539 189 32
post-embryonic appendage morphogenesis 206 153 71 18
negative regulation of nitrogen compound
metabolic process
160 106 44 10
appendage morphogenesis 220 165 74 18
compound eye development 248 175 84 12
generation of neurons 481 332 154 25
regulation of transcription, DNA-dependent 478 300 109 23
axon guidance 164 124 61 10
organ development 818 577 259 45
RNA biosynthetic process 513 311 111 22
neuron projection morphogenesis 309 211 101 19
regulation of cell size 89 62 36 11
pattern specification process 379 271 122 23
anatomical structure formation involved in
morphogenesis
312 210 86 15
cellular component morphogenesis 411 271 133 24
embryonic pattern specification 177 120 54 11
appendage development 223 167 76 19
female gamete generation 349 219 91 17
negative regulation of cellular process 451 282 116 21
cardiovascular system development 67 58 27 8
neuron differentiation 431 294 138 23
negative regulation of nucleobase, nucleoside,
nucleotide and nucleic acid metabolic process
160 106 44 10
post-embryonic organ morphogenesis 254 197 87 18
post-embryonic organ development 270 211 92 18
regulation of biological process 1753 981 366 54
regulation of cellular metabolic process 826 492 167 30
muscle structure development 192 130 64 13
regulation of multicellular organismal devel-
opment
217 151 65 13
blastoderm segmentation 162 110 50 10
Continued on next page
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Table 1 – continued from previous page
GO term 1 dataset 2 datasets 3 datasets 4 datasets
asymmetric cell division 60 44 24 8
heart development 67 58 27 8
sexual reproduction 478 289 109 18
metamorphosis 324 245 109 23
embryo development 430 300 136 23
regulation of cell communication 172 108 49 11
regulation of transcription 592 369 137 29
regulation of primary metabolic process 811 485 170 30
negative regulation of transcription 145 99 41 10
regulation of anatomical structure size 139 95 46 13
ovarian follicle cell development 150 112 52 11
cellular component movement 187 139 68 14
multicellular organismal development 1320 859 348 56
tissue development 413 296 145 19
respiratory system development 155 116 57 10
dorsal/ventral pattern formation, imaginal
disc
50 42 24 6
instar larval or pupal morphogenesis 314 236 104 22
gamete generation 467 283 107 18
behavior 275 188 93 17
developmental growth 130 88 48 12
regulation of developmental process 269 192 80 16
cellular process involved in reproduction 373 234 88 16
cell projection organization 367 243 114 19
regulation of macromolecule biosynthetic pro-
cess
651 401 146 30
macromolecule biosynthetic process 1087 557 171 31
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B modENCODE data used in Chapter 3
Original data used
BEAF32 0-12h ChIP-chip rel5.gff3
CP190 0-12h ChIP-chip rel5.gff3
CTCF C-term 0-12h ChIP-chip rel5.gff3
CTCF N-term 0-12h ChIP-chip rel5.gff3
H3K27Me3 0-12h ChIP-chip rel5.gff3
H3K27Me3 0-4h ChIP-chip rel5.gff3
H3K27Me3 0-4h ChIP-seq rel5.gff3
H3K36Me3 0-12h ChIP-chip rel5.gff3
H3K36Me3 2-4h ChIP-chip rel5.gff3
H3K4Me1 0-4h ChIP-chip rel5.gff3
H3K4Me1 0-4h ChIP-seq rel5.gff3
H3K4Me1 4-8h ChIP-chip rel5.gff3
H3K4Me1 4-8h ChIP-seq rel5.gff3
H3K4Me1 8-12h ChIP-chip rel5.gff3
H3K4Me1 8-12h ChIP-seq rel5.gff3
H3K4Me3 0-12h ChIP-chip rel5.gff3
H3K4Me3 2-4h ChIP-chip rel5.gff3
H3K9Me3 0-12h ChIP-chip rel5.gff3
H3K9Me3 0-4h ChIP-chip2 rel5.gff3
H3K9Me3 0-4h ChIP-chip rel5.gff3
H3K9Me3 0-4h ChIP-seq rel5.gff3
mod(mdg4) 0-12h ChIP-chip rel5.gff3
su(Hw) 0-12h ChIP-chip2 rel5.gff3
su(Hw) 0-12h ChIP-chip rel5.gff3
Table 2: Original modENCODE data files used for analysis in Chapter 3
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Data used Union outcome
H3K4Me1 0-4h ChIP-chip rel5.gff3 0-4 h H3K4Me1data
H3K4Me1 0-4h ChIP-seq rel5.gff3 0-4 h H3K4Me1 data
H3K4Me1 0-4h ChIP-chip rel5.gff3 0-12 h H3K4Me1 data
H3K4Me1 0-4h ChIP-seq rel5.gff3 0-12 h H3K4Me1 data
H3K4Me1 4-8h ChIP-chip rel5.gff3 0-12 h H3K4Me1 data
H3K4Me1 4-8h ChIP-seq rel5.gff3 0-12 h H3K4Me1 data
H3K4Me1 8-12h ChIP-chip rel5.gff3 0-12 h H3K4Me1 data
H3K4Me1 8-12h ChIP-seq rel5.gff3 0-12 h H3K4Me1 data
H3K9Me3 0-4h ChIP-chip2 rel5.gff3 0-4 h H3K9Me3 data
H3K9Me3 0-4h ChIP-chip rel5.gff3 0-4 h H3K9Me3 data
H3K9Me3 0-4h ChIP-seq rel5.gff3 0-4 h H3K9Me3 data
H3K27Me3 0-4h ChIP-chip rel5.gff3 0-4 h H3K27Me3 data
H3K27Me3 0-4h ChIP-seq rel5.gff3 0-4 h H3K27Me3 data
CTCF C-term 0-12h ChIP-chip rel5.gff3 0-12 h CTCF data
CTCF N-term 0-12h ChIP-chip rel5.gff3 0-12 h CTCF data
su(Hw) 0-12h ChIP-chip2 rel5.gff3 0-12 h su(Hw) data
su(Hw) 0-12h ChIP-chip rel5.gff3 0-12 h su(Hw) data
Table 3: modENCODE data on which unions were performed, with the union outcome
shown.
Final datasets used for analysis
BEAF32 0-12h ChIP-chip rel5.gff3
CP190 0-12h ChIP-chip rel5.gff3
CTCF 0-12h ChIP union rel5.gff3
H3K27Me3 0-12h ChIP-chip rel5.gff3
H3K27Me3 0-4h ChIP union rel5.gff3
H3K36Me3 0-12h ChIP-chip rel5.gff3
H3K36Me3 2-4h ChIP-chip rel5.gff3
H3K4Me1 0-12h ChIP union rel5.gff3
H3K4Me1 0-4h ChIP union rel5.gff3
H3K4Me3 0-12h ChIP-chip rel5.gff3
H3K4Me3 2-4h ChIP-chip rel5.gff3
H3K9Me3 0-12h ChIP-chip rel5.gff3
H3K9Me3 0-4h ChIP union rel5.gff3
mod(mdg4) 0-12h ChIP-chip rel5.gff3
suHw 0-12h ChIP union rel5.gff3
Table 4: Final modENCODE data files used for comparison to Dichaete data in
Chapter 3, after unions were performed with some of them.
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Appendix 2
C Transcription factors with motifs flagged in NMICA
searches of Dichaete binding data
Table 5: The motifs were first found using NMICA, then the matches to existing
motifs from different databases were performed using Stamp. The matches were then
filtered by e-value - only the transcription factors whose motifs matched the ones found
with NMICA with an e-value < 1E−04 are shown here. The transcription factor names
are shown, along with the number of Dichaete datasets that the transcription factor
motif in question was found in, out of a maximum of 4.
TF name Symbol D datasets with motif
Suppressor of Hairless SuH 4
Biniou bin 1
Sine oculis so 3
Snail sna 3
Knirps kni 2
Zeste z 1
Adh transcription factor 1 Adf1 1
Topoisomerase 2 Top2 3
Ovo ovo 1
Dorsal dl 3
Deformed Dfd 1
Grainyhead grh 1
Eyeless ey 2
Hunchback hb 1
Rough ro 1
Mothers against dpp Mad 1
Sloppy paired 1 slp1 1
Chorion factor 2 Cf2 2
Dichaete D 1
Boundary element associated factor of 32 kD BEAF-32 3
Tailless tll 1
Ventral nervous system defective vnd 1
Bicoid bcd 2
Achintya achi 1
CG11085 CG11085 1
Deformed epidermal autoregulatory factor 1 Deaf1 1
Brinker brk 1
Broad br 1
Slow border cells slbo 1
Traintrack ttk 2
Adult enhancer factor 1 Aef1 1
Continued on next page
Table 5 – continued from previous page
TF name Symbol D datasets with motif
Drop Dr 1
Hormone receptor-like in 46 Hr46 1
Runt run 1
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Appendix 3
D simGal4 gene expression data
Table 6: Expression data for genes differentially expressed in the simGal4 expression
studies. The cutoffs used were M value >= 0.5 or < −− 0.5 and p-value < 0.05
simGal4 simGal4 simGal4
HMG− EnRep DWT
Transcript Gene M p M p M p
CG30029-RA CR30029 0.72 0.048 0.37 0.131 0.64 0.054
CG12045-RA Cpr100A -0.60 0.008 -0.21 0.518 0.01 0.991
CG6478-RA TwdlB -2.17 0.000 -0.58 0.481 -0.64 0.479
CG10211-RA CG10211 -0.50 0.011 -0.08 0.712 0.02 0.924
CG5661-RA Sema-5c 0.78 0.031 -0.28 0.062 0.47 0.123
CG1919-RA Cpr62Bc -1.30 0.002 -0.37 0.554 -0.44 0.432
CG13063-RA CG13063 -1.15 0.002 -0.38 0.339 -0.24 0.665
CG2976-RA CG2976 -0.57 0.113 -0.50 0.112 -0.64 0.033
CG7111-RA Rack1 -0.22 0.499 -0.54 0.018 -0.29 0.121
CG10112-RA Cpr51A -1.86 0.001 -0.34 0.748 -0.64 0.309
CG13794-RA CG13794 -1.15 0.022 -0.76 0.016 -0.72 0.025
CG17697-RB fz 0.24 0.257 -0.27 0.494 0.61 0.026
CG14643-RA TwdlG -0.95 0.005 0.03 0.957 0.04 0.894
CG10475-RA Jon65Ai 0.67 0.016 0.29 0.700 0.22 0.754
CG17127-RA CG17127 -1.17 0.005 -0.14 0.826 -0.10 0.802
CG7930-RB TpnC73F -0.86 0.049 -0.57 0.468 0.19 0.779
CG4688-RA CG4688 -0.65 0.030 -0.47 0.000 -0.30 0.025
CG32405-RA Cpr65Av -0.53 0.047 -0.11 0.408 0.07 0.837
CG6259-RA CG6259 -0.24 0.054 -0.55 0.000 -0.06 0.060
CG15345-RA CG15345 -1.31 0.004 -0.75 0.011 -0.59 0.018
CG11430-RA olf186-F -0.21 0.269 -0.56 0.030 -0.41 0.019
CG6447-RA TwdlL -2.60 0.000 -1.19 0.288 -0.97 0.467
CG4060-RA TwdlW -1.03 0.001 -0.17 0.795 -0.43 0.330
CG17082-RA CG17082 0.59 0.017 0.27 0.202 0.14 0.413
CG2177-RB CG2177 -0.89 0.003 -0.15 0.520 -0.48 0.085
CG4670-RA CG4670 -0.48 0.008 -0.51 0.006 -0.52 0.020
CG15658-RA CG15658 -0.54 0.036 -0.44 0.058 -0.52 0.007
CG4464-RB RpS19a 0.53 0.044 -0.02 0.896 0.27 0.389
CG15117-RA CG15117 -0.57 0.025 -0.08 0.657 -0.13 0.306
CG10541-RA Tektin-C 0.28 0.182 0.11 0.454 0.64 0.012
CG1304-RA CG1304 0.81 0.026 0.17 0.585 0.45 0.096
CG32659-RA Ten-a -0.57 0.049 -0.10 0.795 0.12 0.695
CG10901-RB osk 0.73 0.035 0.03 0.799 0.28 0.301
CG7532-RA l(2)34Fc -0.59 0.045 -0.25 0.646 0.04 0.958
CG32305-RA CG32305 -0.44 0.024 -0.50 0.029 -0.20 0.446
CG4147-RA Hsc70-3 0.17 0.123 0.10 0.573 0.64 0.031
Continued on next page
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simGal4 simGal4 simGal4
HMG− EnRep DWT
Transcript Gene M p M p M p
CG4835-RA CG4835 0.29 0.089 0.53 0.013 0.52 0.013
CG1840-RA CG1840 0.56 0.008 0.24 0.167 0.46 0.001
CG4354-RA slbo -0.61 0.011 -0.08 0.852 -0.54 0.024
CG5514-RA CG5514 -0.45 0.056 -0.70 0.018 -0.67 0.033
CG9337-RA CR9337 -0.54 0.004 -0.38 0.028 -0.50 0.015
CG10657-RA CG10657 -0.59 0.010 -0.03 0.943 -0.22 0.513
CG1169-RA Osi18 -0.64 0.001 -0.19 0.714 -0.04 0.856
CR32205-RA CR32205 -0.62 0.007 -0.56 0.003 -0.38 0.056
CG13463-RA CG13463 -1.55 0.001 -0.90 0.023 -1.10 0.000
CG5326-RA CG5326 -0.88 0.005 -0.10 0.884 -0.32 0.481
CG32692-RA CG32694 -0.67 0.013 0.04 0.936 -0.09 0.765
CG4466-RA Hsp27 0.84 0.001 -0.08 0.663 0.30 0.263
CG11242-RA CG11242 0.63 0.001 0.25 0.099 0.14 0.531
CG14095-RA CG14095 -0.70 0.002 0.31 0.579 -0.23 0.328
CG30413-RA CG30413 -1.43 0.006 -0.56 0.355 -1.07 0.001
CG8507-RA CG8507 0.51 0.013 0.34 0.069 0.02 0.933
CG10119-RA LamC -0.63 0.026 -0.25 0.676 -0.18 0.618
CG16886-RA CG16886 -0.93 0.000 -0.06 0.901 -0.62 0.034
CG1330-RA Ccp84Ae -0.67 0.018 0.07 0.856 0.37 0.575
CG2849-RA Rala 1.45 0.008 0.58 0.020 1.14 0.006
CG8965-RA CG8965 0.29 0.115 0.26 0.440 0.62 0.040
CG15251-RA CG43386 -0.88 0.025 0.14 0.803 -0.11 0.839
CG14446-RA CG14446 0.51 0.001 0.27 0.110 0.45 0.115
CG9614-RA pip -0.56 0.029 -0.09 0.444 -0.06 0.331
CG9564-RA Try29F -0.57 0.002 -0.13 0.301 -0.44 0.000
CG14147-RA CG14147 -1.19 0.000 0.15 0.856 -0.42 0.384
CG15212-RA CG15212 -1.67 0.002 -0.43 0.548 -0.73 0.306
CG7203-RA CG7203 -0.73 0.007 -0.38 0.162 -0.16 0.535
CG11061-RA GM130 -0.51 0.029 -0.02 0.833 -0.22 0.097
CG6868-RA tld -0.00 0.953 0.00 0.958 0.51 0.002
CG11205-RB phr -0.79 0.000 -0.78 0.005 -0.83 0.000
CG10287-RA Gasp -0.75 0.010 -0.03 0.962 0.06 0.896
CG1155-RA Osi14 -0.65 0.013 0.11 0.803 -0.04 0.885
CG13067-RA CG13067 -0.98 0.022 -0.52 0.354 -0.08 0.938
CG31364-RA l(3)neo38 0.72 0.000 0.48 0.072 0.57 0.029
CG13049-RA CG13049 -1.17 0.001 -0.05 0.951 -0.36 0.486
CG31532-RA CG42574 0.58 0.023 0.31 0.150 0.39 0.028
CG18543-RA mtrm 0.80 0.042 -0.08 0.538 -0.38 0.335
CG10901-RA osk 0.83 0.049 0.02 0.860 0.08 0.610
CG17462-RA Trf4-2 0.61 0.001 0.30 0.137 0.22 0.608
CG10591-RA CG10591 -0.86 0.027 -0.43 0.293 -0.45 0.397
CG14897-RB CG42232 1.16 0.001 0.85 0.036 0.71 0.009
CG7577-RA ppk20 -0.01 0.955 2.18 0.003 0.10 0.212
CR32477-RA CR42862 -0.53 0.009 -0.37 0.014 -0.55 0.041
CG13059-RA CG13059 -1.93 0.010 -1.03 0.129 -0.95 0.279
CG13738-RA CG13738 -0.56 0.004 -0.12 0.412 -0.41 0.000
CG12876-RA ALiX -0.09 0.201 -0.39 0.027 -0.53 0.004
CG14993-RA Faa 0.75 0.014 0.60 0.025 0.63 0.065
CG10953-RA CG10953 -1.37 0.021 -0.65 0.351 -0.18 0.857
CG32237-RA CG32237 -1.05 0.001 -0.27 0.335 -0.10 0.903
CG7660-RA Pxt 0.81 0.013 0.06 0.517 -0.01 0.981
CG3509-RA CG3509 0.87 0.001 0.23 0.552 0.12 0.714
CG8844-RB Pdsw 0.60 0.016 0.16 0.018 0.36 0.056
Continued on next page
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simGal4 simGal4 simGal4
HMG− EnRep DWT
Transcript Gene M p M p M p
CR31808-RA CG31808 -1.14 0.005 -0.37 0.413 -0.68 0.129
CG18817-RB Tsp42Ea -0.77 0.019 -0.34 0.205 -0.46 0.108
CG4998-RA CG4998 -0.66 0.006 0.15 0.690 -0.13 0.700
CG6081-RA Cyp28d2 -1.13 0.009 -0.41 0.013 -0.56 0.086
CG15239-RA CG15239 -0.67 0.024 -0.10 0.748 -0.19 0.346
CG11584-RB CG11584 -0.88 0.003 0.02 0.973 -0.22 0.476
CG14143-RA CG14143 -0.68 0.038 0.32 0.333 -0.29 0.069
CG17018-RD CG17018 0.69 0.018 0.19 0.349 0.00 0.987
CG2342-RA Ccp84Ag -1.18 0.002 -0.12 0.847 -0.10 0.890
CG17052-RA obst-A -0.85 0.006 -0.16 0.847 -0.11 0.856
CG13991-RA CG13991 -0.85 0.001 -0.88 0.006 -0.82 0.001
CG8776-RA nemy -0.64 0.012 -0.15 0.579 -0.05 0.687
CG13425-RD bl -1.02 0.002 -1.04 0.009 -0.92 0.001
CG3759-RA CG3759 -0.57 0.014 -0.12 0.187 0.02 0.919
CG6146-RA Top1 0.56 0.004 0.32 0.157 0.30 0.243
CG9155-RC Myo61F 1.68 0.000 1.61 0.001 0.22 0.553
CG12743-RA otu 0.77 0.015 -0.00 0.987 0.03 0.917
CG17227-RB lig3 0.24 0.202 0.61 0.001 0.51 0.005
CG13425-RC bl -1.22 0.000 -1.24 0.015 -1.18 0.001
CG3520-RA CG3520 -0.52 0.010 -0.25 0.072 -0.13 0.698
CG14897-RA CG42232 0.78 0.033 0.72 0.013 0.67 0.016
CG3396-RA Ocho 0.60 0.006 0.11 0.477 0.14 0.362
CG1151-RA Osi6 -1.65 0.031 -0.53 0.410 -0.02 0.965
CG12418-RA Glut4EF 0.57 0.005 0.59 0.125 0.49 0.159
CG13784-RB CG13784 0.64 0.004 0.62 0.008 0.40 0.100
CG30141-RA Obp57a -0.72 0.026 -0.38 0.020 0.16 0.180
CG13069-RA CG13069 -1.71 0.002 -0.40 0.544 -0.33 0.769
CG14243-RA TwdlD -1.82 0.001 -0.54 0.522 -1.04 0.195
CG8960-RA CG8960 -0.11 0.089 -0.79 0.004 -0.76 0.015
CG3502-RA CG3502 0.16 0.287 -0.46 0.002 -0.62 0.001
CG2962-RA CG2962 -2.82 0.001 -1.27 0.296 -1.54 0.065
CG14453-RA CG14453 -0.89 0.007 -0.77 0.013 -0.81 0.028
CG8050-RA Cys 0.63 0.025 -0.18 0.306 0.82 0.013
CG13047-RA CG13047 -1.08 0.004 0.04 0.948 -0.02 0.979
CR41110-RA fog 0.88 0.006 0.39 0.030 0.44 0.411
CR32862-RA snRNA:U1:82Eb 1.40 0.011 0.75 0.039 0.78 0.337
CG18783-RA Kr-h1 -0.56 0.007 -0.32 0.150 -0.22 0.346
CG7980-RA RabX5 0.28 0.001 0.54 0.018 0.28 0.347
CG8640-RA Cpr65Ea -2.12 0.001 -0.67 0.540 -0.76 0.266
CG6874-RA HipHop -0.31 0.061 -0.58 0.010 -0.16 0.479
CG31813-RA CG31813 -0.66 0.045 -0.17 0.591 -0.11 0.659
CG17534-RA GstE9 -0.04 0.844 0.30 0.006 0.60 0.014
CG17090-RB hipk 0.23 0.219 0.38 0.107 0.55 0.012
CG12063-RA mey -0.66 0.001 -0.09 0.562 -0.41 0.004
CG14265-RB CG14265 -0.42 0.305 -0.69 0.214 -0.83 0.016
CG2341-RA Ccp84Ad -0.71 0.028 0.06 0.865 0.14 0.842
CG1742-RB Mgstl 0.51 0.004 0.47 0.002 0.42 0.002
CG15740-RA CG15740 -0.82 0.002 0.02 0.976 -0.25 0.464
CG31012-RB cindr -0.58 0.011 -0.16 0.296 -0.37 0.098
CG9614-RI pip -0.51 0.011 -0.09 0.219 -0.17 0.066
CG15022-RA CG15022 -0.92 0.002 -0.11 0.817 -0.71 0.020
CG10414-RA Atac2 -0.45 0.006 -0.53 0.001 -0.51 0.014
CG12297-RA BG4 0.25 0.064 0.88 0.004 0.54 0.004
Continued on next page
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simGal4 simGal4 simGal4
HMG− EnRep DWT
Transcript Gene M p M p M p
CG32453-RA CG32453 -0.79 0.012 -0.42 0.184 -0.63 0.057
CG12283-RA kek1 -0.64 0.013 -0.33 0.048 -0.34 0.006
CG12885-RA CG12885 -0.76 0.001 -0.39 0.023 -0.40 0.106
CG14685-RD Cap-H2 0.62 0.007 0.50 0.018 0.50 0.004
CG15321-RA nej 0.60 0.005 0.38 0.054 0.31 0.236
CG33320-RA CheB38a -0.97 0.012 -0.38 0.001 -0.46 0.027
CG3598-RA CG3598 0.68 0.049 0.29 0.278 0.99 0.269
CG9628-RA CG9628 -0.82 0.001 -0.40 0.216 -0.37 0.211
CG6460-RA TwdlK -1.38 0.002 -0.22 0.785 0.02 0.984
CG13041-RA CG13041 -0.40 0.038 -0.52 0.043 -0.15 0.403
CG7429-RA CG7429 0.64 0.003 0.07 0.463 0.12 0.316
CG12449-RB Gfat1 -0.53 0.044 -0.29 0.572 0.09 0.822
CG5468-RA TwdlM -1.36 0.011 -0.37 0.586 -0.24 0.700
CG13066-RA CG13066 -1.23 0.008 -0.47 0.267 -0.08 0.933
CG31220-RA CG31220 0.58 0.000 0.44 0.017 0.21 0.037
CG32694-RD CG32694 -0.69 0.004 0.11 0.834 -0.02 0.972
CG2961-RA Ipod -0.60 0.010 -0.07 0.880 -0.40 0.135
CG31362-RA Jon99Ciii 1.52 0.000 0.75 0.356 0.81 0.288
CG6643-RA Esyt2 -0.52 0.025 0.11 0.554 0.04 0.778
CG15013-RB dyl -0.66 0.027 -0.14 0.696 -0.06 0.803
CG1944-RA Cyp4p2 -1.45 0.004 -1.02 0.002 -1.17 0.001
CG14756-RA CG14756 -0.90 0.040 -0.42 0.362 -0.57 0.196
CG1259-RB Cpr64Ad -1.67 0.000 -0.23 0.808 0.07 0.938
CG13123-RA CG13123 -0.19 0.046 -0.61 0.002 -0.09 0.068
CG30422-RA egg 0.55 0.000 0.23 0.191 0.16 0.307
CG30458-RA CG30458 -0.79 0.002 -0.19 0.602 0.04 0.937
CG4547-RA Atx-1 -0.07 0.726 -0.54 0.049 -0.22 0.328
CG32266-RA CG32266 -1.57 0.004 -0.82 0.114 -0.22 0.783
CG13394-RA CG42819 -0.68 0.045 -0.13 0.533 0.03 0.938
CG15236-RB CG15236 -0.90 0.015 -0.63 0.008 -0.47 0.004
CG9057-RA Lsd-2 0.51 0.016 0.03 0.883 0.11 0.537
CG1555-RA cn 0.21 0.292 0.31 0.233 0.58 0.022
CG13068-RA CG13068 -1.05 0.003 -0.46 0.300 0.11 0.894
CG14096-RA CG14096 -0.79 0.009 0.28 0.499 0.01 0.983
CG12177-RA CG12177 -0.42 0.043 -0.58 0.000 -0.57 0.008
CG1157-RA Osi15 -1.48 0.010 -0.41 0.637 -0.30 0.600
CG4396-RA fne -0.53 0.045 -0.17 0.549 -0.18 0.268
CG14573-RA CG14573 -0.69 0.003 -0.32 0.187 0.02 0.973
CG33117-RA Victoria 0.65 0.000 0.29 0.010 0.40 0.010
CG13362-RA CG13362 -0.50 0.033 -0.23 0.242 -0.16 0.309
CG4115-RA CG4115 -1.15 0.007 -0.44 0.581 -0.29 0.480
CG13060-RA CG13060 -0.73 0.003 -0.22 0.286 -0.21 0.434
CG8628-RA CG8628 0.82 0.010 0.20 0.505 0.80 0.262
CG31641-RB stai 0.80 0.027 0.23 0.134 0.05 0.498
CG4038-RA CG4038 0.50 0.005 0.19 0.232 0.46 0.015
CG9411-RA CG9411 -0.64 0.011 -0.27 0.173 -0.18 0.177
CG11529-RA CG11529 0.07 0.454 0.12 0.106 0.65 0.042
CG14639-RA TwdlF -1.10 0.027 -0.29 0.603 -0.39 0.038
CG32570-RA TwdlY -1.16 0.020 -0.21 0.715 -0.20 0.664
CG14302-RA CG14302 0.60 0.039 -0.21 0.796 -0.04 0.925
CG5494-RA Cpr92F -0.53 0.004 -0.05 0.824 -0.25 0.241
CG13674-RA CG13674 -1.09 0.039 -0.30 0.532 -0.02 0.979
CG32701-RA l(1)G0320 0.13 0.641 0.20 0.052 0.50 0.014
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simGal4 simGal4 simGal4
HMG− EnRep DWT
Transcript Gene M p M p M p
CG6610-RA CG6610 -0.28 0.176 -0.57 0.010 -0.29 0.168
CG32694-RA CG32694 -0.81 0.029 0.06 0.912 -0.25 0.614
CG18124-RA mTTF -0.49 0.041 -0.19 0.030 -0.65 0.015
CG10812-RA dro5 -0.77 0.128 -0.87 0.019 -0.72 0.181
CG13454-RA CG13454 -0.68 0.045 -1.02 0.001 -0.04 0.829
CG13631-RA CG13631 -0.70 0.028 -0.35 0.436 -0.40 0.058
CG8598-RA eco -0.31 0.142 -0.55 0.023 -0.07 0.705
CG12076-RA YT521-B -0.26 0.200 -0.36 0.235 -0.50 0.004
CG12487-RA BobA 0.03 0.849 -0.73 0.016 -0.46 0.120
CG5476-RA TwdlN -1.29 0.009 -1.01 0.154 -0.55 0.530
CG31164-RA Ir94a -0.62 0.028 -0.65 0.008 -0.35 0.017
CG10214-RA CG10214 0.04 0.812 -0.56 0.013 -0.03 0.860
CG8235-RA CG8235 -0.37 0.242 -0.60 0.003 -0.03 0.882
CG3777-RC CG3777 -0.68 0.038 -0.06 0.885 0.06 0.874
CG14736-RA CG14736 0.81 0.011 0.02 0.804 0.03 0.722
CG1740-RA Ntf-2 -0.39 0.061 -0.69 0.044 -0.57 0.046
CG15213-RA CG15213 -0.90 0.017 -0.45 0.431 -0.11 0.858
CG11797-RA Obp56a 0.68 0.028 0.39 0.232 1.02 0.210
CG7361-RA RFeSP -0.34 0.205 1.53 0.001 -0.28 0.119
CG4584-RB dUTPase 0.09 0.687 -0.52 0.044 -0.18 0.613
CG15535-RA CG15535 -0.24 0.099 -0.28 0.004 -0.50 0.021
CG12822-RA CG12822 -0.39 0.017 -0.39 0.003 -0.55 0.046
CG15592-RA Osi9 -0.98 0.023 -0.38 0.524 -0.21 0.514
CG3819-RA CG3819 0.60 0.008 0.21 0.700 0.50 0.346
CG2615-RB ik2 -0.29 0.231 -0.50 0.046 -0.44 0.086
CG5025-RA Sps2 -0.30 0.098 -0.42 0.079 -0.50 0.033
CG15737-RA wisp 0.61 0.048 0.06 0.765 -0.18 0.457
CG7380-RA baf -0.25 0.309 -0.58 0.042 -0.35 0.257
CG14688-RA CG14688 -0.33 0.183 -0.52 0.020 -0.44 0.098
E prosGal4 gene expression data
Table 7: Expression data for genes differentially expressed in the prosGal4 expression
studies. The cutoffs used were M value >= 0.5 or < −− 0.5 and p-value < 0.05
prosGal4 prosGal4 prosGal4
HMG− EnRep DWT
Transcript Gene M p M p M p
CG3429-RA swa -1.08 0.103 0.81 0.043 0.03 0.970
CG1088-RA Vha26 -0.80 0.047 0.74 0.097 -0.42 0.390
CG5864-RA AP-1sigma -0.85 0.017 0.57 0.202 -0.11 0.862
CG4148-RA wek -0.53 0.023 0.36 0.238 -0.15 0.783
CG2943-RA CG2943 -0.60 0.008 0.34 0.241 -0.08 0.794
CG4759-RA RpL27 -0.59 0.006 0.11 0.701 -0.41 0.151
CG6420-RA CG6420 -0.70 0.012 0.41 0.247 -0.36 0.641
CG4165-RA CG4165 -0.83 0.036 0.48 0.343 -0.05 0.932
CG3362-RA CG3362 -0.56 0.046 0.21 0.337 -0.38 0.489
CG5946-RB CG5946 -0.69 0.042 0.55 0.117 -0.15 0.829
CG5661-RA Sema-5c 0.58 0.007 -0.12 0.122 0.20 0.475
CG33281-RA CG33281 -0.29 0.117 -0.50 0.013 -0.34 0.232
CG32606-RA mamo 0.27 0.331 0.65 0.009 0.35 0.430
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prosGal4 prosGal4 prosGal4
HMG− EnRep DWT
Transcript Gene M p M p M p
CG32654-RC Sec16 -0.52 0.007 0.55 0.092 -0.21 0.657
CR33328-RA CR33328 0.69 0.006 0.06 0.722 0.13 0.775
CG30289-RA CG30289 -0.13 0.497 -0.50 0.000 -0.51 0.160
CG5263-RA smg -1.62 0.042 0.76 0.103 -0.52 0.670
CG12626-RA CG42339 0.15 0.210 0.03 0.780 0.64 0.006
CG5362-RA Mdh1 -1.18 0.123 0.78 0.039 -0.24 0.844
CG9926-RA CG9926 0.28 0.081 0.10 0.463 0.52 0.036
CG30096-RA CG30096 -0.53 0.007 0.46 0.155 0.12 0.813
CG5053-RA RASSF8 -0.81 0.040 0.49 0.236 -0.15 0.744
CR31273-RA bxd 0.75 0.003 0.62 0.016 -0.01 0.952
CG14883-RA CG14883 -0.69 0.041 0.70 0.026 0.04 0.960
CG17369-RB Vha55 -0.45 0.229 0.75 0.030 0.27 0.709
CG18361-RA dsh -0.57 0.029 0.39 0.262 -0.06 0.934
CG7641-RA Nca -0.59 0.012 0.46 0.262 -0.10 0.832
CG4817-RA Ssrp 0.59 0.046 -0.25 0.221 0.17 0.649
CG6951-RA CG6951 -0.39 0.072 0.50 0.033 0.04 0.939
CG17883-RB CG17883 -0.75 0.029 0.61 0.106 0.01 0.988
CG11589-RA VhaM9.7-c -0.64 0.028 0.60 0.046 -0.16 0.758
CG6549-RC fws -0.57 0.012 0.32 0.368 0.07 0.884
CG7548-RA CG7548 -0.32 0.029 -0.54 0.015 -0.42 0.051
CG6171-RA CG6171 -0.88 0.022 0.65 0.078 -0.23 0.750
CG8944-RA CG8944 -0.68 0.014 0.55 0.147 0.12 0.872
CG13928-RA CG13928 0.20 0.563 0.74 0.015 0.29 0.277
CG5515-RA CG5515 -0.68 0.035 0.47 0.165 -0.11 0.880
CG14100-RA CG14100 -0.62 0.024 0.70 0.038 0.25 0.718
CG8605-RA CG8605 -0.07 0.757 -0.59 0.014 -0.61 0.359
CG9279-RA CG9279 -0.37 0.075 -0.72 0.035 -0.92 0.175
CG1815-RA CG1815 -0.71 0.018 0.49 0.080 -0.05 0.931
CG4433-RA CG4433 -0.22 0.186 0.59 0.018 0.28 0.543
CG4999-RC Tsp66E -1.20 0.027 0.81 0.024 -0.34 0.695
CG12052-RE lola -0.59 0.010 0.56 0.288 0.09 0.880
CG8931-RA CG8931 -0.76 0.009 0.51 0.184 -0.19 0.742
CG4538-RB CG4538 -0.68 0.022 0.59 0.100 0.21 0.786
CG7299-RA CG7299 -0.75 0.040 -0.96 0.048 -0.76 0.192
CG13794-RA CG13794 -1.16 0.041 -1.32 0.004 -1.09 0.159
CG1927-RA CG1927 -1.11 0.040 0.62 0.128 -0.29 0.761
CG12106-RA CG12106 -0.17 0.684 0.56 0.021 0.34 0.707
CG12787-RA hoe1 -1.26 0.051 0.78 0.036 -0.16 0.885
CG32782-RC tlk -0.57 0.046 0.51 0.194 -0.28 0.657
CG10240-RA Cyp6a22 -0.77 0.007 0.49 0.181 0.36 0.649
CG2790-RA CG2790 -0.57 0.019 0.26 0.439 -0.20 0.707
CG10475-RA Jon65Ai -1.62 0.003 -1.42 0.081 -1.82 0.007
CG14850-RA CG14850 -0.51 0.033 -0.41 0.355 -0.67 0.027
CG10529-RA Lcp65Ae -1.90 0.158 -1.28 0.398 -3.00 0.024
CG2204-RA G-oalpha47A -0.42 0.324 0.64 0.009 -0.02 0.978
CG6321-RA CG6321 -0.96 0.032 0.37 0.119 -0.27 0.727
CG3309-RA CG3309 -0.58 0.018 0.53 0.101 0.00 0.996
CG10939-RA Sip1 -0.54 0.014 0.40 0.138 -0.23 0.533
CG7184-RA Mkrn1 -0.94 0.003 0.47 0.186 -0.40 0.473
CG7192-RA CG7192 -0.57 0.043 0.39 0.094 -0.25 0.624
CG32198-RB CG32198 -1.33 0.006 -1.42 0.027 -1.63 0.019
CG8223-RA CG8223 -0.60 0.001 0.32 0.326 -0.27 0.505
CG14011-RA CG14011 0.21 0.072 0.53 0.014 0.20 0.010
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prosGal4 prosGal4 prosGal4
HMG− EnRep DWT
Transcript Gene M p M p M p
CG5880-RA CG5880 -0.75 0.006 0.47 0.112 0.01 0.991
CG8357-RA Drep-1 -0.14 0.284 0.53 0.026 0.46 0.365
CG4688-RA CG4688 -0.42 0.032 -0.77 0.073 -0.51 0.007
CG9238-RB CG9238 -0.50 0.037 0.68 0.114 0.03 0.950
CG4390-RA CG4390 -0.56 0.026 0.21 0.389 -0.28 0.618
CG4217-RA TFAM -0.58 0.023 0.60 0.265 -0.27 0.609
CG13142-RA CG13142 -0.57 0.010 0.50 0.228 0.01 0.976
CG11981-RA Prosbeta3 -0.91 0.021 0.58 0.063 -0.32 0.583
CG7138-RA r2d2 -0.64 0.008 0.39 0.324 0.03 0.951
CG14103-RA CG14103 -0.91 0.009 0.77 0.068 0.11 0.869
CG13037-RA mRpS34 0.16 0.538 -0.68 0.031 -0.40 0.382
CG2924-RA CG2924 -0.90 0.126 0.83 0.036 -0.19 0.827
CG3407-RA CG3407 -0.57 0.032 0.92 0.151 -0.09 0.887
CG17490-RC CG17490 -0.61 0.047 0.48 0.213 -0.02 0.970
CG15345-RA CG15345 -1.04 0.048 0.25 0.798 -0.85 0.319
CG2060-RA Cyp4e2 -0.47 0.082 0.66 0.002 0.14 0.802
CG11430-RA olf186-F -0.28 0.099 -0.81 0.026 -0.83 0.117
CG4060-RA TwdlW -0.56 0.045 -0.67 0.149 -0.32 0.595
CG31517-RA CG31517 -0.94 0.025 0.32 0.302 -0.30 0.682
CG8997-RA CG8997 -0.62 0.010 -1.18 0.006 -0.87 0.037
CG16869-RA Ance-2 -0.17 0.212 -0.78 0.013 -0.21 0.734
CG7700-RA Gos28 -0.46 0.289 0.51 0.034 0.09 0.911
CG10387-RA tos 0.11 0.536 -0.50 0.036 -0.21 0.574
CG13323-RA CG13323 -0.67 0.022 -0.97 0.025 -0.95 0.045
CG2177-RB CG2177 -1.77 0.023 -0.04 0.833 -1.97 0.150
CG4670-RA CG4670 -0.70 0.013 0.08 0.541 -0.18 0.620
CG2702-RA Pbp95 -0.61 0.034 0.51 0.093 -0.02 0.974
CG6897-RA bora -0.53 0.039 0.28 0.220 0.08 0.850
CG18734-RG Fur2 -1.39 0.018 0.63 0.148 -0.37 0.730
CG12244-RA lic -0.88 0.123 0.71 0.046 -0.00 0.997
CG8841-RC CG8841 -0.97 0.021 0.80 0.051 0.13 0.861
CG4898-RE Tm1 -0.73 0.046 0.36 0.237 -0.05 0.945
CG4620-RB unk -0.74 0.048 0.46 0.270 -0.06 0.921
CG33122-RA cutlet 0.06 0.281 -0.61 0.009 -0.44 0.064
CG5804-RA CG5804 -0.58 0.022 -0.65 0.066 -0.54 0.154
CG17665-RA CG17665 -0.53 0.108 0.51 0.014 0.21 0.762
CG31849-RA CG31849 -0.55 0.049 0.49 0.006 -0.07 0.895
CG1225-RA RhoGEF3 0.77 0.007 -0.35 0.374 -0.13 0.816
CG2714-RB crm -0.77 0.153 0.58 0.009 -0.07 0.944
CG8988-RA S2P -1.04 0.038 0.63 0.108 -0.16 0.887
CG8311-RA CG8311 -0.37 0.201 0.50 0.035 0.33 0.604
CG1692-RA mal -0.82 0.009 0.43 0.167 -0.09 0.898
CG11577-RA CG11577 -0.65 0.047 0.52 0.044 -0.03 0.967
CG3889-RA CSN1b -0.57 0.058 0.55 0.031 -0.09 0.887
CG1044-RA dos 0.13 0.302 -0.51 0.015 -0.10 0.613
CG10541-RA Tektin-C 1.66 0.000 -0.04 0.847 0.88 0.251
CG8798-RA CG8798 -0.57 0.025 0.44 0.080 0.24 0.694
CG9786-RA hb 0.33 0.163 0.13 0.545 0.56 0.036
CG2041-RA lgs -0.57 0.028 0.42 0.155 0.07 0.860
CG3348-RA CG3348 -0.43 0.064 -0.87 0.012 -0.36 0.401
CG8634-RA Cpr65Ec 0.12 0.678 0.68 0.025 1.30 0.499
CG32189-RA CG32189 -0.38 0.007 -0.50 0.020 -0.17 0.355
CG3679-RA CG3679 -1.09 0.030 0.74 0.076 -0.02 0.982
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prosGal4 prosGal4 prosGal4
HMG− EnRep DWT
Transcript Gene M p M p M p
CG9773-RA CG9773 -0.36 0.251 0.52 0.026 0.28 0.696
CG6668-RA atl -0.59 0.031 0.46 0.113 0.00 0.994
CG9681-RA PGRP-SB1 0.76 0.001 -0.10 0.383 -0.13 0.638
CG9834-RA endoB -0.52 0.002 0.61 0.161 0.12 0.836
CG17342-RA Lk6 -0.50 0.005 0.09 0.808 -0.42 0.246
CG32659-RA Ten-a -0.10 0.435 -0.53 0.013 -0.76 0.208
CG5690-RA CG5690 0.53 0.013 0.00 0.983 -0.29 0.685
CG17508-RA CG17508 -1.13 0.037 0.60 0.151 -0.11 0.908
CG32305-RA CG32305 -0.60 0.028 -0.65 0.057 -0.46 0.137
CG3319-RA Cdk7 -0.51 0.005 0.28 0.352 -0.09 0.810
CG4287-RA CG4287 -0.73 0.000 0.39 0.185 0.14 0.774
CG7044-RA CG7044 -0.61 0.010 0.39 0.169 0.08 0.871
CG6376-RA E2f 0.51 0.016 0.15 0.482 -0.01 0.922
CG5704-RA CG5704 -0.94 0.049 0.59 0.041 -0.11 0.874
CG18495-RB Prosalpha1 -0.61 0.029 0.20 0.548 -0.46 0.227
CG5295-RA bmm -0.70 0.017 0.24 0.457 -0.37 0.365
CG7465-RA CG7465 -0.68 0.269 -0.25 0.650 -1.07 0.004
CG11523-RA CG11523 -0.24 0.459 0.60 0.020 0.48 0.558
CG5277-RA Ip259 -0.43 0.107 -0.05 0.826 -0.56 0.009
CG32030-RA Fhos -1.12 0.027 0.67 0.105 -0.19 0.800
CG7324-RA CG7324 -0.74 0.012 0.45 0.130 -0.32 0.561
CG14025-RA Bsg25D -0.96 0.013 0.61 0.147 0.07 0.915
CG4911-RA CG4911 -1.10 0.030 0.71 0.135 -0.05 0.949
CG8177-RK CG8177 -1.02 0.030 0.69 0.040 -0.20 0.820
CG3947-RA pex16 -0.54 0.038 0.26 0.341 -0.41 0.404
CG4867-RA bc10 -0.57 0.075 0.55 0.028 -0.15 0.800
CG6498-RA CG6498 -0.60 0.034 0.36 0.331 0.30 0.653
CG8420-RA CG8420 -0.77 0.019 0.55 0.139 -0.13 0.859
CG18812-RA CG18812 -1.19 0.025 0.73 0.073 -0.15 0.872
CG7869-RA SuUR -0.77 0.019 0.27 0.391 -0.17 0.758
CG32791-RA CG32791 0.51 0.034 0.15 0.110 0.61 0.244
CG14360-RA Or88a 0.26 0.130 -0.03 0.740 0.51 0.045
CG9474-RA Snap24 -0.75 0.011 0.43 0.215 -0.23 0.667
CG3262-RA CG3262 -0.59 0.024 0.21 0.398 -0.45 0.329
CG5725-RB fbl -0.52 0.007 0.36 0.229 -0.09 0.826
CG4069-RA CG4069 -0.55 0.023 0.36 0.154 0.13 0.805
CG9326-RB vari -0.44 0.052 0.88 0.012 0.55 0.338
CG5052-RA pim -0.76 0.030 0.48 0.286 -0.09 0.913
CG1275-RB CG1275 -0.57 0.024 0.34 0.203 0.00 0.996
CG8569-RA CG8569 -0.80 0.049 0.46 0.036 -0.05 0.949
CG30000-RA CG30000 -0.89 0.012 0.52 0.194 -0.26 0.733
CG13588-RA CG42360 -0.57 0.003 0.29 0.179 -0.15 0.795
CG1169-RA Osi18 -0.58 0.058 -1.17 0.000 0.12 0.864
CG15085-RA edl 0.50 0.021 -0.54 0.179 -0.35 0.559
CG2682-RA d4 -0.52 0.043 0.39 0.275 0.10 0.834
CG7220-RB CG7220 -0.86 0.100 0.61 0.002 -0.28 0.736
CG7498-RA CG42445 -0.71 0.130 0.58 0.041 0.08 0.929
CG13641-RA CG13641 0.44 0.063 0.54 0.044 0.07 0.854
CG7597-RB Cdk12 -0.57 0.045 0.41 0.126 0.12 0.867
CG33336-RA p53 -0.64 0.007 0.19 0.234 -0.21 0.646
CG16879-RA CG16879 0.36 0.184 0.49 0.022 0.55 0.010
CG3029-RA or -0.30 0.264 0.51 0.035 0.25 0.704
CG8057-RA alc -0.57 0.147 0.64 0.041 0.30 0.709
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CG11242-RA CG11242 -1.05 0.044 0.83 0.024 0.01 0.989
CG8196-RA Ance-4 -0.29 0.120 -0.51 0.036 0.38 0.525
CG6547-RA mRpL37 0.57 0.045 -0.29 0.273 -0.02 0.922
CG8507-RA CG8507 -1.44 0.023 0.83 0.027 -0.21 0.827
CG5217-RA CG5217 0.08 0.324 0.21 0.214 0.50 0.047
CG14478-RA CG14478 -0.59 0.015 0.27 0.330 -0.04 0.954
CG6995-RA Saf-B -0.56 0.008 0.19 0.598 -0.07 0.874
CG14290-RB CG14290 -0.50 0.005 0.30 0.033 0.01 0.982
CG5061-RA capt -0.53 0.018 0.48 0.126 0.01 0.993
CG1389-RA tor -0.99 0.029 0.81 0.133 0.12 0.902
CG12785-RA Mat89Ba -0.58 0.026 0.29 0.321 -0.07 0.874
CG8593-RA qm -0.82 0.032 0.69 0.020 0.34 0.763
CG17082-RB CG17082 -0.80 0.007 0.46 0.244 -0.12 0.773
CG10237-RA CG10237 -1.07 0.021 0.69 0.022 -0.20 0.796
CG10272-RB gpp 0.75 0.012 0.05 0.719 0.25 0.607
CG14052-RA CG14052 0.23 0.465 0.69 0.006 0.46 0.048
CG4676-RA CG4676 -0.06 0.752 -0.52 0.027 -0.39 0.562
CG1221-RA miple 0.83 0.031 0.28 0.145 0.51 0.236
CG12290-RA CG12290 0.32 0.151 0.65 0.010 0.51 0.040
CG3688-RA l(2)35Bd -0.61 0.009 0.38 0.256 0.02 0.970
CG9070-RA Cpr47Eg -0.61 0.166 -0.35 0.611 -0.85 0.009
CG8460-RA CG8460 -0.88 0.018 0.60 0.150 -0.24 0.692
CG18348-RA Cpr67Fb -1.27 0.006 -0.92 0.040 -0.94 0.078
CG8274-RA Mtor -0.53 0.037 0.21 0.514 -0.09 0.807
CG11880-RB CG11880 -0.67 0.033 0.46 0.090 -0.09 0.904
CG11518-RA pygo -0.58 0.022 0.52 0.172 0.04 0.957
CG16785-RA fz3 0.53 0.008 -0.10 0.569 0.22 0.570
CG15251-RA CG43386 -0.51 0.156 -0.31 0.644 -0.72 0.046
CG11490-RA CG11490 -0.79 0.015 0.56 0.077 0.09 0.910
CG32346-RA E(bx) 0.65 0.002 0.02 0.925 0.28 0.496
CG6298-RA Jon74E -1.04 0.004 -1.33 0.000 -1.25 0.002
CG3403-RA Mob4 -0.06 0.507 -0.69 0.025 -0.64 0.318
CG17490-RB CG17490 -0.67 0.009 0.42 0.222 0.08 0.841
CG15882-RA CG15882 0.63 0.016 0.31 0.011 0.51 0.102
CG2054-RA Cht2 0.63 0.010 0.63 0.013 0.34 0.193
CG9540-RA Ag5r2 -2.16 0.002 -2.57 0.001 -2.10 0.062
CG31523-RA CG31523 -0.66 0.017 0.32 0.236 -0.35 0.510
CG1034-RA bcd -1.40 0.048 0.67 0.117 -0.23 0.851
CG1966-RA Acf1 -0.60 0.001 -0.06 0.826 -0.35 0.077
CG11596-RB CG11596 -0.52 0.007 0.36 0.270 -0.03 0.955
CG9796-RA CG9796 -0.94 0.033 0.52 0.035 -0.28 0.655
CG40293-RA Stlk -0.88 0.010 0.63 0.235 0.01 0.985
CG31673-RA CG31673 -0.69 0.035 0.45 0.059 -0.06 0.939
CG9617-RA Sgt1 -0.58 0.041 0.36 0.207 0.15 0.857
CG14215-RA CG14215 -0.72 0.009 0.13 0.682 -0.42 0.417
CG9233-RA fu2 -0.59 0.048 0.47 0.129 -0.02 0.969
CG11982-RA CG11982 -0.84 0.030 0.38 0.099 -0.39 0.578
CG4059-RA ftz-f1 -1.08 0.039 0.65 0.053 -0.18 0.854
CG14147-RA CG14147 -1.47 0.049 -1.86 0.022 -1.76 0.073
CG15361-RA Nplp4 -1.39 0.010 -1.68 0.003 -1.61 0.018
CG6190-RA Ube3a -0.52 0.027 0.30 0.220 0.07 0.888
CG8529-RA Dyb 0.23 0.219 -0.53 0.028 -0.07 0.799
CG8256-RA Gpo-1 -1.16 0.003 -1.78 0.000 -1.55 0.014
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CG13316-RB Mnt -0.53 0.038 0.37 0.195 -0.02 0.967
CG6859-RA CG6859 -0.63 0.013 0.33 0.238 0.04 0.937
CG7737-RA CG7737 -0.92 0.028 0.49 0.069 -0.20 0.800
CG32491-RM mod(mdg4) -0.71 0.020 0.37 0.102 -0.13 0.830
CG11061-RA GM130 -0.54 0.007 0.56 0.089 0.12 0.827
CG31729-RA CG31729 -0.70 0.018 0.29 0.379 -0.16 0.798
CG14358-RA CCHa1 0.27 0.037 0.27 0.081 0.50 0.011
CG4583-RA Ire1 -0.52 0.040 0.18 0.515 0.07 0.918
CG17134-RA CG17134 -0.22 0.062 -0.58 0.030 -0.30 0.192
CG11205-RB phr -0.32 0.055 -1.15 0.022 -0.91 0.161
CG4898-RC Tm1 -0.55 0.018 0.27 0.397 -0.12 0.867
CG4620-RA unk 0.50 0.020 0.05 0.842 -0.13 0.740
CG8430-RA Got1 -0.77 0.040 0.48 0.157 -0.01 0.990
CG4977-RA kek2 0.51 0.021 0.37 0.009 0.32 0.045
CG7878-RA CG7878 -0.22 0.008 -0.69 0.022 -0.68 0.057
CG4300-RA CG4300 -1.12 0.035 0.59 0.079 -0.21 0.837
CG12891-RB whd -0.79 0.021 0.56 0.073 0.13 0.886
CG7118-RA Jon66Ci -0.72 0.047 -1.28 0.006 -1.32 0.103
CG17168-RA CG17168 -0.66 0.027 0.32 0.192 -0.24 0.712
CG10390-RA mia -0.02 0.763 -0.59 0.030 -0.64 0.253
CG33181-RA CG33181 -1.22 0.041 0.69 0.034 -0.12 0.910
CG3445-RA phol 0.14 0.237 -0.73 0.037 -0.20 0.497
CG13067-RA CG13067 0.07 0.914 0.62 0.600 -0.88 0.006
CG8632-RB CG8632 -1.00 0.039 0.64 0.172 -0.15 0.884
CG1578-RA CG1578 -1.06 0.041 0.48 0.077 -0.21 0.852
CG6467-RA Jon65Aiv -2.24 0.014 -2.35 0.041 -1.88 0.213
CG31364-RA l(3)neo38 0.55 0.017 -0.28 0.369 -0.23 0.747
CG9062-RB CG9062 -0.93 0.031 0.59 0.050 -0.02 0.983
CG13049-RA CG13049 -0.88 0.083 -1.28 0.011 -0.65 0.486
CG31332-RA Unc-115b 0.63 0.009 0.32 0.192 0.09 0.871
CG33275-RA CG33275 -0.50 0.082 0.54 0.026 0.10 0.859
CG2048-RB dco -0.59 0.002 0.37 0.271 -0.05 0.928
CG11804-RA ced-6 -0.90 0.027 0.63 0.184 0.00 0.996
CG17462-RA Trf4-2 -1.25 0.026 0.64 0.163 -0.11 0.896
CG17260-RA CG17260 -0.78 0.003 0.38 0.247 0.13 0.806
CG7899-RA Acph-1 -1.10 0.023 0.78 0.098 -0.01 0.995
CG3532-RA CG3532 -0.77 0.017 0.53 0.122 -0.13 0.823
CG6425-RA CG6425 -0.66 0.006 0.49 0.277 -0.25 0.602
CG17985-RA CG17985 -0.66 0.018 0.50 0.093 0.00 0.999
CG31175-RA Dys -0.82 0.012 0.44 0.222 0.16 0.814
CG17818-RA rdgBbeta -0.70 0.010 0.50 0.142 -0.26 0.615
CG1832-RA CG1832 -0.64 0.015 0.57 0.129 -0.23 0.568
CG31992-RD gw -0.50 0.019 0.43 0.215 0.13 0.794
CG6391-RA Aps -0.67 0.040 0.46 0.091 -0.51 0.176
CG7595-RA ck -0.77 0.033 0.52 0.147 0.09 0.872
CG7577-RA ppk20 0.23 0.066 3.62 0.001 0.26 0.392
CG31322-RA Aats-met -0.59 0.001 0.18 0.451 -0.09 0.792
CG5659-RC ari-1 -0.51 0.001 0.51 0.243 0.18 0.719
CG5385-RA CG5385 -0.57 0.019 0.45 0.265 -0.23 0.563
CG8948-RC Graf -0.50 0.045 0.45 0.257 0.15 0.726
CG7960-RA Bro 0.78 0.024 0.20 0.418 0.74 0.115
CG10686-RA tral -0.74 0.006 0.55 0.208 -0.07 0.905
CG11993-RA Mst85C -0.70 0.018 0.39 0.151 -0.20 0.696
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CG30383-RA CG30383 0.01 0.945 -0.56 0.007 -0.14 0.663
CG30287-RA CG30287 -0.18 0.591 -0.50 0.017 -0.44 0.441
CG13778-RA Mnn1 -0.65 0.031 0.47 0.129 -0.02 0.971
CG8177-RG CG8177 -1.11 0.036 0.74 0.074 -0.31 0.759
CG13059-RA CG13059 -0.21 0.784 0.66 0.606 -0.96 0.027
CG7133-RA CG7133 -0.53 0.014 0.39 0.194 0.21 0.656
CG32564-RA CG32564 -0.22 0.510 -0.02 0.962 -0.51 0.042
CG3273-RA sced -0.85 0.014 0.50 0.158 -0.04 0.962
CG10083-RA CG10083 -0.77 0.046 0.58 0.099 0.05 0.950
CG5725-RA fbl -0.55 0.006 0.34 0.250 -0.07 0.874
CG18030-RA Jon99Fi -1.91 0.002 -2.31 0.003 -1.75 0.046
CG30437-RA CG42345 -0.75 0.011 0.76 0.060 0.33 0.667
CG11254-RC mael -0.76 0.047 0.58 0.161 -0.07 0.948
CG30022-RA CG30022 -0.61 0.035 0.48 0.017 -0.12 0.780
CG10847-RA enc -0.70 0.091 0.56 0.002 -0.30 0.687
CG14993-RA Faa 1.49 0.006 1.36 0.015 1.27 0.111
CG31794-RD Pax -0.91 0.026 0.49 0.085 -0.11 0.876
CG7554-RA comm2 0.32 0.035 -0.52 0.044 -0.33 0.537
CG3167-RA MAN1 -0.89 0.027 0.44 0.084 -0.33 0.690
CR32162-RA snRNA:U12:73B 0.36 0.318 0.77 0.022 0.62 0.186
CG6403-RA CG6403 -0.36 0.063 -0.55 0.011 -0.58 0.027
CG31092-RA LpR2 -0.71 0.070 0.73 0.048 0.16 0.877
CG5721-RA CG5721 0.00 0.990 -0.53 0.038 -0.55 0.280
CG7494-RA mRpL1 -0.53 0.023 0.32 0.094 -0.12 0.826
CG15015-RA Cip4 -0.56 0.019 0.34 0.255 -0.09 0.894
CG5560-RA dob -0.89 0.022 0.48 0.178 -0.23 0.813
CG2221-RA l(1)G0289 -0.66 0.035 0.41 0.183 -0.10 0.873
CG6580-RA Jon65Aii -0.72 0.033 -1.05 0.001 -1.15 0.010
CG14830-RA CG14830 0.19 0.508 -0.67 0.018 -0.33 0.647
CG6157-RA dah -0.88 0.023 0.32 0.454 0.07 0.941
CG6457-RA yip7 -0.88 0.104 -1.33 0.057 -1.57 0.036
CG3509-RA CG3509 -0.59 0.335 0.90 0.001 0.34 0.773
CG7614-RA Mat1 0.09 0.626 -0.54 0.041 -0.50 0.130
CG1242-RA Hsp83 -0.22 0.489 -0.78 0.124 -0.62 0.020
CG1896-RA CG1896 -0.79 0.032 0.43 0.344 -0.10 0.894
CG4965-RA twe -1.51 0.024 0.76 0.175 -0.36 0.697
CG5026-RB CG5026 -1.24 0.039 0.68 0.059 -0.21 0.833
CG9258-RA nrv1 -0.66 0.050 0.68 0.004 0.14 0.826
CG16713-RA CG16713 -0.34 0.085 -0.79 0.014 -0.64 0.046
CG12141-RB Aats-lys -0.85 0.022 0.40 0.298 -0.32 0.724
CG7427-RA CG7427 -0.59 0.006 0.35 0.396 0.04 0.936
CG32027-RA CR32027 -0.50 0.045 0.28 0.281 -0.04 0.936
CG8097-RA CG8097 0.51 0.021 -0.28 0.372 -0.13 0.799
CG12737-RA Crag -1.17 0.017 0.53 0.168 -0.13 0.879
CG1058-RA rpk -0.54 0.008 0.33 0.211 -0.08 0.881
CG31991-RB mdy -0.22 0.028 0.56 0.016 0.24 0.330
CG8108-RA CG8108 -0.71 0.045 0.30 0.451 -0.21 0.712
CG6932-RA CSN6 -0.78 0.026 0.42 0.182 -0.47 0.460
CG18177-RA CG18177 -0.93 0.020 0.61 0.182 -0.44 0.460
CG8986-RA TwdlBeta -0.59 0.068 -0.81 0.026 -0.75 0.176
CG5789-RA CG5789 -1.26 0.029 0.48 0.178 -0.35 0.719
CR33471-RA Ir48a -0.02 0.908 -0.55 0.007 -0.26 0.475
CG5629-RA Ppcs -0.63 0.026 0.54 0.095 0.32 0.592
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CR31808-RA CG31808 -0.31 0.682 -0.80 0.013 -0.99 0.281
CG8144-RC ps 0.50 0.011 0.17 0.628 -0.08 0.919
CG9320-RA ns4 -0.68 0.028 0.60 0.121 -0.27 0.568
CG8287-RA Rab8 -0.80 0.038 0.58 0.187 -0.25 0.708
CG7953-RA CG7953 -0.80 0.007 -1.12 0.012 -0.92 0.075
CG6889-RA tara 0.79 0.035 -0.24 0.554 -0.13 0.891
CG2863-RA Nle 0.11 0.076 -0.55 0.019 -0.47 0.415
CG7146-RA CG7146 -0.61 0.010 0.51 0.169 -0.06 0.913
CG10859-RA CG10859 -0.39 0.065 -0.71 0.016 -0.77 0.106
CG4877-RA CG4877 -0.50 0.002 0.38 0.240 -0.26 0.497
CG8379-RB CG8379 -0.67 0.031 0.50 0.086 0.06 0.920
CG10360-RA ref(2)P,ref(2)P -0.97 0.015 0.45 0.143 -0.27 0.702
CG31776-RA CG31776 -0.06 0.622 -0.56 0.000 -0.30 0.116
CG2103-RB pgant6 0.52 0.028 -0.27 0.388 -0.07 0.882
CG14616-RC l(1)G0196 -0.81 0.139 0.63 0.017 0.14 0.881
CG6081-RA Cyp28d2 -0.80 0.030 -0.85 0.015 -0.48 0.383
CG32775-RA GlcAT-I -0.66 0.021 0.49 0.194 0.03 0.971
CG32077-RA nol -0.75 0.016 -1.26 0.003 -0.99 0.020
CG33196-RB dp 0.60 0.002 0.29 0.171 0.07 0.908
CG15741-RA CG15741 -0.64 0.076 -0.89 0.016 -1.09 0.143
CG1179-RA LysB -0.45 0.089 -0.87 0.035 -0.56 0.311
CG2150-RA CG2150 -0.26 0.334 -0.36 0.187 -0.67 0.019
CG13460-RA CG13460 -0.59 0.017 -0.80 0.023 -0.42 0.368
CG9575-RA Rab35 -0.83 0.018 0.46 0.151 -0.10 0.899
CG33226-RA CG33226 0.09 0.810 -0.53 0.012 -0.32 0.553
CG15829-RA CG15829 -0.17 0.329 -0.60 0.046 -0.40 0.323
CG9795-RA CG9795 -0.72 0.030 0.41 0.241 -0.14 0.835
CG17498-RA mad2 -0.60 0.009 0.40 0.237 -0.33 0.489
CG14143-RA CG14143 -0.90 0.046 -1.17 0.006 -1.40 0.023
CG2604-RA CG2604 -0.52 0.002 0.29 0.447 -0.15 0.774
CG7996-RA snk -0.17 0.583 0.50 0.044 0.22 0.729
CG16979-RA CG16979 0.00 0.964 -0.59 0.049 -0.49 0.327
CG31223-RA CG31223 -0.18 0.241 -0.21 0.301 -0.52 0.037
CG10492-RA CG10492 -0.89 0.018 0.40 0.301 -0.15 0.868
CG4404-RA CG4404 -0.76 0.041 0.43 0.233 -0.49 0.560
CG10241-RA Cyp6a17 0.49 0.076 0.83 0.014 0.76 0.014
CG2233-RA CG2233 -0.68 0.085 -1.12 0.000 -1.16 0.065
CG17018-RD CG17018 -1.23 0.019 0.75 0.085 -0.19 0.850
CG18180-RA CG18180 -2.20 0.007 -2.85 0.000 -2.48 0.042
CG3766-RA scat 0.16 0.283 -0.52 0.044 -0.29 0.439
CG12310-RA CG12310 -1.86 0.002 -2.33 0.002 -2.13 0.023
CG7823-RA RhoGDI -0.57 0.015 0.52 0.115 -0.26 0.572
CG9446-RA coro -0.67 0.040 0.44 0.163 0.03 0.970
CG10425-RA CG10425 -0.73 0.047 0.53 0.105 -0.12 0.876
CG2316-RB CG2316 -0.65 0.025 0.71 0.116 0.18 0.756
CG15172-RA CG15172 0.36 0.090 0.07 0.849 0.52 0.012
CG13897-RA CG13897 -0.76 0.044 0.15 0.413 -0.34 0.603
CG13391-RA Aats-ala 0.12 0.250 -0.52 0.044 -0.36 0.440
CG12877-RA CG12877 -0.77 0.047 0.38 0.126 -0.16 0.834
CG5029-RA SamDC -0.79 0.019 0.53 0.132 -0.24 0.722
CG16926-RA CG16926 -0.19 0.226 -0.64 0.040 -0.34 0.231
CG15887-RA CG15887 -0.16 0.390 -0.62 0.004 -0.27 0.497
CG5214-RA CG5214 -0.38 0.075 0.54 0.021 0.13 0.836
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CG8790-RB Dic1 -0.63 0.046 0.31 0.045 -0.38 0.445
CG9734-RA glob1 -0.95 0.023 0.54 0.209 -0.18 0.816
CG15817-RB CG15817 -0.55 0.030 0.61 0.259 0.12 0.788
CG14285-RA CG14285 1.29 0.001 -0.09 0.658 -0.09 0.638
CG11790-RA CG11790 -0.49 0.154 0.51 0.020 0.02 0.981
CG3107-RB CG3107 -0.82 0.046 0.61 0.103 0.11 0.905
CG8631-RA msl-3 -0.62 0.044 0.19 0.375 0.30 0.648
CG13425-RD bl -0.98 0.010 -1.05 0.008 -1.42 0.015
CG9388-RA AP-47 -0.72 0.272 0.75 0.035 0.07 0.952
CG1544-RA CG1544 0.09 0.391 -0.50 0.014 -0.39 0.310
CG4656-RA Rassf -0.76 0.035 0.49 0.209 0.11 0.887
CG31363-RE Jupiter -0.36 0.044 0.11 0.607 -0.53 0.034
CG6146-RA Top1 -0.83 0.046 0.51 0.235 0.06 0.944
CG1417-RC slgA -0.27 0.134 0.51 0.013 -0.11 0.779
CG15439-RA CG15439 -0.53 0.024 0.14 0.362 -0.10 0.789
CG9155-RC Myo61F 2.26 0.001 2.72 0.000 0.07 0.851
CG12743-RA otu -0.16 0.777 0.58 0.015 0.47 0.624
CG17299-RA SNF4Agamma -0.92 0.014 0.49 0.285 -0.04 0.948
CG17579-RA sca 0.60 0.013 -0.26 0.266 -0.55 0.486
CG11140-RB Aldh-III -0.79 0.010 0.53 0.231 -0.43 0.406
CG30388-RA Magi -0.68 0.033 0.14 0.482 -0.45 0.131
CG5222-RA CG5222 -0.58 0.007 0.26 0.254 -0.48 0.207
CG1838-RA myoglianin -0.83 0.004 0.61 0.245 -0.19 0.722
CG7332-RA CG7332 -0.58 0.002 0.64 0.203 0.20 0.723
CG1468-RA CG1468 -0.81 0.007 -1.02 0.004 -0.69 0.065
CG10918-RA CG10918 -0.78 0.012 -1.12 0.003 -0.90 0.006
CG31633-RA CG31633 -0.56 0.037 0.46 0.127 0.35 0.474
CG6483-RA Jon65Aiii -1.45 0.003 -1.39 0.059 -1.41 0.041
CG32301-RA CG32301 -0.75 0.054 -0.91 0.006 -0.64 0.066
CG4586-RA CG4586 -1.07 0.038 0.52 0.181 -0.11 0.885
CG6975-RA gig -0.50 0.047 0.44 0.276 -0.06 0.900
CG7041-RA HP1b -0.53 0.015 0.36 0.387 -0.27 0.587
CG31173-RA Gr93c 0.62 0.032 0.25 0.071 0.42 0.132
CG17927-RK Mhc -0.44 0.492 -0.11 0.854 -0.97 0.036
CG13425-RC bl -1.13 0.025 -1.41 0.008 -1.46 0.063
CG3520-RA CG3520 -0.75 0.001 -0.15 0.366 -0.51 0.052
CG14897-RA CG42232 0.61 0.018 0.18 0.502 0.08 0.710
CG7001-RA Pk17E -0.60 0.025 0.46 0.173 0.02 0.968
CG14804-RA Vps26 -0.84 0.030 0.56 0.220 -0.22 0.716
CG5893-RA D 1.94 0.006 1.10 0.002 1.12 0.274
CG31714-RA CG31714 0.45 0.038 0.45 0.015 0.59 0.003
CG14352-RA CG14352 -0.91 0.027 0.67 0.143 -0.42 0.605
CG31893-RA Peritrophin-15b -0.38 0.048 -0.61 0.006 -0.29 0.046
CG1483-RB Map205 -0.50 0.026 0.34 0.201 -0.22 0.592
CG12418-RA Glut4EF 0.98 0.015 -0.07 0.854 0.07 0.920
CG7456-RA CG7456 -0.61 0.006 0.46 0.164 -0.03 0.951
CG9195-RA Scamp -0.39 0.199 0.63 0.048 0.04 0.957
CG1910-RA CG1910 0.51 0.001 -0.15 0.404 -0.08 0.865
CG8811-RB muskelin -1.16 0.030 0.61 0.170 -0.23 0.798
CG7824-RA CG7824 -0.56 0.035 0.45 0.230 -0.02 0.979
CG1651-RB Ank -0.54 0.031 0.43 0.320 -0.14 0.723
CG1659-RA unc-119 -0.54 0.030 0.52 0.173 -0.14 0.808
CG8174-RA SRPK 0.68 0.039 -0.06 0.774 0.05 0.924
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CG13731-RA CG13731 -0.36 0.594 0.33 0.801 -1.44 0.021
CG7037-RA Cbl -0.89 0.026 0.56 0.132 -0.44 0.542
CG8073-RA Pmm45A -0.69 0.045 0.25 0.524 -0.46 0.255
CG5320-RA Gdh -0.92 0.019 0.41 0.244 -0.14 0.871
CG6650-RA CG6650 -0.59 0.001 0.38 0.235 -0.06 0.934
CG13784-RB CG13784 0.92 0.003 -0.18 0.602 -0.15 0.794
CG7212-RA cdm -0.69 0.042 0.34 0.349 -0.01 0.987
CG1903-RA sno 0.58 0.046 0.07 0.735 0.28 0.408
CG6605-RA BicD -0.90 0.002 0.47 0.104 -0.16 0.751
CG14438-RA CG14438 -0.79 0.026 0.35 0.196 -0.29 0.592
CG4257-RC Stat92E -0.54 0.007 0.45 0.185 0.21 0.712
CG30020-RA CG30020 -0.52 0.026 0.43 0.283 0.03 0.919
CG3502-RA CG3502 0.43 0.115 -1.27 0.032 -0.96 0.174
CG3508-RB CG3508 -1.08 0.014 0.54 0.214 -0.11 0.910
CG1091-RB CG1091 -0.70 0.044 0.40 0.071 -0.14 0.859
CG6509-RB CG6509 -0.54 0.046 0.38 0.150 0.12 0.840
CG4920-RA ea -1.01 0.033 0.57 0.016 -0.23 0.804
CG10808-RA synaptogyrin -0.08 0.628 -0.43 0.006 -0.50 0.045
CG1172-RA CG1172 -0.60 0.026 0.49 0.179 -0.02 0.975
CG6955-RA Lcp65Ad -0.34 0.062 -0.60 0.011 -0.60 0.017
CG3726-RA CG3726 -0.54 0.037 0.59 0.152 0.21 0.812
CG31086-RA CG31086 -0.59 0.101 -0.57 0.017 -0.59 0.134
CG7156-RA CG7156 -0.95 0.003 0.44 0.299 -0.19 0.810
CG31373-RA CG31373 -0.10 0.543 -0.80 0.000 -0.41 0.100
CG30467-RA CG30467 -0.85 0.002 0.47 0.198 -0.03 0.957
CG10283-RA CG10283 0.13 0.505 -0.55 0.008 -0.51 0.357
CG1994-RA l(1)G0020 0.15 0.571 -0.50 0.046 -0.54 0.407
CR30024-RA tRNA:SeC 0.26 0.489 0.83 0.016 0.65 0.149
CG14829-RA CG14829 -0.15 0.510 -0.71 0.007 -0.38 0.414
CG31794-RA Pax -0.86 0.004 0.52 0.108 0.06 0.925
CG4802-RA CG4802 -0.55 0.008 0.30 0.241 -0.21 0.657
CG8924-RA CG8924 -0.93 0.047 0.61 0.082 -0.31 0.753
CG1829-RA Cyp6v1 -0.64 0.019 0.64 0.108 0.23 0.784
CG9213-RA CG9213 -0.51 0.012 0.36 0.174 -0.01 0.984
CG8449-RA CG8449 -0.68 0.017 0.39 0.063 0.02 0.961
CG14072-RA CG14072 0.39 0.265 0.67 0.007 0.65 0.046
CG10725-RB CG10725 -0.25 0.268 -0.57 0.028 -0.42 0.125
CG5490-RA Tl -0.79 0.038 0.49 0.209 -0.06 0.921
CG4428-RA Atg4 -0.62 0.049 0.17 0.348 -0.38 0.410
CG12746-RD CG12746 -0.50 0.039 0.37 0.147 -0.03 0.955
CR31400-RB Hsromega 0.72 0.012 -0.35 0.289 -0.04 0.928
CG12047-RB mud -0.88 0.024 0.54 0.158 -0.10 0.908
CG8839-RC CG8839 -0.46 0.056 0.53 0.006 0.12 0.725
CG8107-RA CalpB -0.75 0.018 0.67 0.085 -0.09 0.889
CG7254-RA GlyP -0.89 0.069 0.61 0.038 0.15 0.878
CG11217-RA CanB2 -0.35 0.264 0.79 0.036 0.31 0.653
CG12129-RA CG12129 -0.89 0.021 0.53 0.159 -0.10 0.912
CG12559-RD rl -1.23 0.012 0.60 0.133 -0.35 0.618
CG6634-RA mid -0.24 0.337 -0.78 0.025 -0.20 0.569
CG8983-RA ERp60 -0.83 0.006 0.59 0.090 -0.04 0.958
CG6258-RA RfC38 -0.53 0.004 0.25 0.345 -0.00 0.996
CR31696-RA pncr003:2L -0.69 0.041 -0.42 0.438 -0.90 0.062
CG10626-RA Lkr 0.53 0.014 0.10 0.353 0.62 0.020
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CG8589-RA tej -0.78 0.013 0.57 0.188 -0.24 0.782
CG9218-RA sm 0.81 0.004 0.02 0.944 0.08 0.860
CG7085-RA l(2)s5379 -0.75 0.014 0.50 0.233 -0.35 0.481
CG9078-RA ifc -0.70 0.002 0.50 0.290 -0.22 0.664
CG9272-RA CG9272 -0.66 0.011 0.70 0.183 -0.03 0.943
CG15104-RA Topors -0.67 0.010 0.66 0.166 -0.04 0.935
CG10978-RA jagn -0.56 0.016 0.49 0.236 -0.30 0.470
CG7902-RA bap 0.59 0.137 -0.56 0.018 -0.25 0.426
CG14005-RA CG14005 -0.71 0.004 0.57 0.297 -0.12 0.787
CG31813-RA CG31813 -0.55 0.028 -0.11 0.708 -0.13 0.778
CG5876-RA heix -0.56 0.029 0.46 0.159 -0.06 0.868
CG8768-RA CG8768 -0.56 0.021 0.42 0.293 -0.17 0.733
CG17090-RB hipk 0.10 0.477 0.51 0.030 0.46 0.117
CG3248-RA Cog3 0.95 0.013 0.18 0.415 0.32 0.446
CG7851-RA Scgalpha -0.33 0.134 -0.68 0.018 -0.68 0.191
CG7840-RA CG7840 -1.04 0.008 0.65 0.131 -0.40 0.578
CG1031-RA alpha-Est1 -0.94 0.031 0.56 0.049 -0.07 0.928
CG1836-RB Rad23 -0.60 0.035 0.48 0.195 -0.23 0.690
CG12179-RA CG12179 -0.33 0.263 0.51 0.015 0.08 0.878
CG8282-RA Snx6 -0.80 0.038 0.72 0.177 -0.19 0.794
CG7129-RA l(3)05822 -0.54 0.033 0.40 0.194 -0.10 0.849
CG10255-RA Lap1 -0.69 0.016 0.50 0.241 -0.22 0.688
CG5037-RA CG5037 -0.58 0.025 0.48 0.105 -0.30 0.546
CG9755-RC pum -0.96 0.027 0.82 0.129 -0.26 0.773
CG11911-RA CG11911 -0.94 0.036 -1.10 0.034 -1.23 0.027
CG32302-RA CG32302 -0.51 0.053 -0.69 0.098 -0.92 0.020
CG14265-RB CG14265 -0.86 0.098 -1.35 0.004 -1.30 0.002
CG6292-RA CycT 0.55 0.017 -0.24 0.327 -0.24 0.651
CG8609-RA MED4 -0.57 0.035 0.32 0.175 -0.17 0.783
CG1618-RA comt -0.58 0.005 0.30 0.029 -0.26 0.457
CG5991-RA CG5991 -0.92 0.004 0.30 0.223 -0.45 0.529
CG40300-RA AGO3 -0.84 0.012 0.63 0.277 0.28 0.679
CG9144-RA Fbw5 -0.56 0.032 0.33 0.211 -0.06 0.908
CG16704-RA CG16704 -0.54 0.207 -0.96 0.005 -1.00 0.033
CG15825-RB fon -0.84 0.191 -0.67 0.306 -1.29 0.033
CG3082-RC l(2)k09913 -0.70 0.001 0.18 0.419 -0.31 0.600
CG12182-RA CG12182 -0.47 0.065 -0.51 0.004 -0.47 0.072
CG2864-RA Parg -0.99 0.018 0.55 0.147 -0.15 0.866
CG17494-RA CG17494 -0.94 0.007 0.54 0.188 -0.22 0.727
CG17331-RA CG17331 -0.88 0.010 0.42 0.268 -0.38 0.558
CG31510-RA CG31510 -0.69 0.007 0.38 0.265 0.10 0.848
CG9538-RA Ag5r -0.73 0.042 -0.89 0.018 -0.76 0.038
CG10372-RA Faf -0.57 0.049 0.40 0.199 -0.00 0.998
CG10295-RA Pak -0.58 0.010 0.45 0.181 0.08 0.892
CG4592-RA CG4592 0.34 0.102 0.56 0.004 0.32 0.008
CG6767-RA CG6767 -0.83 0.019 0.69 0.050 -0.08 0.917
CG2186-RA CG2186 -0.69 0.019 0.31 0.315 -0.31 0.616
CG8233-RB Rcd1 -0.61 0.011 0.44 0.087 -0.03 0.958
CG7730-RC CG7730 -1.16 0.007 0.75 0.092 -0.19 0.824
CG2229-RA Jon99Fii -0.71 0.095 -1.01 0.003 -0.69 0.450
CG8869-RA Jon25Bii -1.55 0.002 -2.18 0.000 -2.05 0.026
CG7785-RA CG7785 -0.44 0.044 0.74 0.044 0.17 0.694
CG6342-RA Irp-1B -0.79 0.043 0.61 0.101 -0.25 0.758
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CG18179-RA CG18179 -0.50 0.008 -0.72 0.017 -0.59 0.102
CG18681-RA epsilonTry -1.65 0.003 -2.12 0.001 -1.94 0.023
CG1619-RB Hmr -0.66 0.048 0.33 0.028 -0.03 0.960
CG10328-RA nonA-l -0.54 0.026 0.46 0.230 -0.15 0.740
CG11148-RB CG11148 -0.60 0.029 0.44 0.126 0.15 0.817
CG9127-RA ade2 -0.51 0.031 0.11 0.374 -0.28 0.535
CG12297-RA BG4 -0.03 0.745 0.67 0.002 0.66 0.123
CG10343-RA CG10343 -0.51 0.018 0.32 0.170 0.03 0.957
CG12885-RA CG12885 -0.74 0.019 -0.95 0.006 -0.89 0.070
CG8301-RA CG8301 -0.90 0.004 0.51 0.139 -0.07 0.916
CG11567-RA Cpr -0.93 0.048 0.50 0.064 -0.31 0.735
CG12140-RA CG12140 -0.59 0.032 0.27 0.074 -0.31 0.638
CG8726-RA CG8726 -0.81 0.018 0.57 0.091 0.07 0.928
CG31108-RA CG31108 -0.91 0.036 0.54 0.082 -0.10 0.901
CG4118-RA nxf2 -0.68 0.028 0.40 0.151 -0.14 0.816
CG11504-RB CG11504 -0.53 0.032 0.29 0.233 -0.06 0.921
CG8630-RA CG8630 -0.42 0.279 -0.22 0.730 -0.84 0.013
CG1636-RA CG1636 -0.60 0.044 0.41 0.043 -0.11 0.798
CG33320-RA CheB38a -1.29 0.038 -1.46 0.007 -1.79 0.145
CG11455-RB CG11455 0.13 0.437 -0.24 0.226 -0.88 0.025
CG12234-RA Ranbp21 -0.61 0.012 0.38 0.033 -0.07 0.909
CG9768-RA hkb 0.35 0.021 -0.84 0.027 -0.29 0.615
CG12428-RC CG12428 -1.12 0.015 0.52 0.034 -0.23 0.670
CG1981-RA Thd1 -0.69 0.020 0.66 0.086 0.00 0.998
CG3136-RA Atf6 -0.58 0.006 0.61 0.153 0.02 0.955
CG1643-RA Atg5 -0.83 0.010 0.66 0.156 -0.33 0.603
CG41099-RB CG41099 -0.72 0.010 0.46 0.153 -0.08 0.890
CG2938-RB CG2938 -1.20 0.014 0.53 0.180 -0.31 0.742
CG6460-RA TwdlK -0.95 0.080 -0.71 0.501 -1.26 0.048
CG11614-RA nkd -0.04 0.850 -0.81 0.013 -0.89 0.283
CG14222-RA CG14222 -0.52 0.035 0.36 0.246 -0.16 0.718
CG6099-RA m4 0.20 0.284 -0.51 0.046 -0.54 0.425
CG10422-RA bam -0.57 0.023 0.46 0.177 0.05 0.928
CG9153-RA CG9153 -0.72 0.049 0.48 0.158 0.03 0.977
CG11771-RA CG11771 -0.91 0.019 0.66 0.081 -0.14 0.815
CG7433-RA CG7433 -0.92 0.045 0.80 0.081 -0.04 0.962
CG5608-RA CG5608 -0.83 0.011 0.57 0.208 0.31 0.565
CG14487-RA Ir54a -0.01 0.991 0.52 0.003 0.55 0.167
CG14967-RA CG14967 -0.65 0.023 0.40 0.180 -0.11 0.822
CG17223-RA alpha4GT1 -0.65 0.018 0.60 0.131 -0.17 0.756
CG4572-RB CG4572 -0.56 0.011 0.34 0.158 -0.34 0.344
CG5300-RA Klp31E -0.50 0.003 0.35 0.283 -0.06 0.845
CG11305-RA Sirt7 -0.63 0.031 0.50 0.263 -0.32 0.463
CG5726-RA CG5726 -0.82 0.021 0.86 0.050 0.01 0.990
CG4749-RA CG4749 -0.12 0.672 0.62 0.001 0.38 0.094
CG3208-RB RhoGAP5A -0.96 0.013 0.57 0.143 -0.09 0.881
CG14629-RA CG14629 -0.54 0.042 0.28 0.406 -0.75 0.330
CG3268-RA phtf -0.61 0.019 0.42 0.215 -0.23 0.618
CG6303-RA Bruce 0.63 0.002 0.25 0.363 0.48 0.191
CG14997-RB CG14997 -0.76 0.008 0.43 0.228 -0.26 0.652
CG17633-RA CG17633 -0.91 0.029 -1.09 0.022 -0.99 0.013
CG6188-RA CG6188 -0.29 0.319 -0.56 0.002 -0.59 0.261
CG14803-RA CG14803 -0.56 0.008 0.47 0.200 0.16 0.775
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CG32656-RA Muc11A -0.58 0.037 -0.80 0.009 -0.39 0.003
CG12414-RA nAcRalpha-80B -1.00 0.005 0.68 0.196 -0.04 0.959
CG8024-RA ltd -1.27 0.038 0.73 0.035 -0.36 0.717
CG7927-RA CG7927 -0.60 0.039 0.27 0.393 -0.29 0.468
CG40006-RC CG40006 -0.67 0.019 0.59 0.151 0.12 0.841
CG12467-RA CG42248 -0.94 0.015 0.60 0.219 0.03 0.964
CG7448-RB CG7448 -0.08 0.196 -0.53 0.043 -0.08 0.652
CG4665-RA Dhpr -0.01 0.969 -0.67 0.045 -0.61 0.154
CG10574-RA I-2 -0.57 0.020 0.39 0.320 -0.04 0.950
CG5395-RA nmd -0.91 0.017 0.51 0.063 -0.28 0.688
CG5084-RA CG5084 -0.39 0.130 -0.38 0.239 -0.58 0.005
CG7429-RA CG7429 0.95 0.004 -0.31 0.042 -0.07 0.858
CG30283-RA CG30283 -0.43 0.094 -0.91 0.005 -0.72 0.166
CG18211-RA betaTry -1.71 0.003 -2.11 0.005 -1.92 0.023
CG12116-RA CG12116 -1.16 0.051 -1.19 0.063 -1.42 0.032
CG9456-RA Spn1 -0.11 0.161 -0.54 0.012 -0.44 0.028
CG32697-RA l(1)G0232 -0.95 0.024 0.50 0.204 -0.25 0.775
CG13822-RA CG13822 0.88 0.056 1.00 0.022 0.19 0.308
CG5439-RA CG5439 -0.53 0.043 0.35 0.190 -0.15 0.774
CG12690-RA CHES-1-like 0.63 0.011 0.05 0.858 0.03 0.848
CG6544-RC fau -0.05 0.878 -0.19 0.382 -0.55 0.026
CG11306-RA CG11306 -0.11 0.596 -0.56 0.038 -0.86 0.264
CG3954-RB csw -1.10 0.025 0.69 0.143 -0.36 0.661
CG4495-RA CG4495 -0.71 0.017 0.47 0.116 -0.44 0.376
CG6575-RA glec 0.60 0.042 0.11 0.672 -0.01 0.984
CG30149-RB rig -0.80 0.000 0.45 0.247 -0.02 0.973
CG31220-RA CG31220 0.61 0.075 0.53 0.003 0.55 0.116
CG12104-RA CG12104 -0.70 0.100 0.56 0.039 0.05 0.945
CG14879-RA CG14879 -0.32 0.001 -0.55 0.004 -0.11 0.642
CG10424-RA CG10424 -0.68 0.040 0.44 0.137 0.16 0.830
CG30005-RA CG30005 -0.50 0.004 0.53 0.076 0.25 0.721
CG6551-RA fu -0.63 0.030 0.39 0.146 -0.19 0.756
CG32267-RA CG32267 -0.58 0.043 0.67 0.130 -0.23 0.703
CG17888-RC Pdp1 0.57 0.021 0.43 0.072 0.19 0.003
CG6493-RA Dcr-2 -0.50 0.011 0.43 0.119 -0.10 0.825
CG10851-RG B52 0.15 0.336 -0.58 0.018 -0.68 0.399
CG17800-RE Dscam 0.32 0.107 -0.55 0.030 -0.37 0.498
CG31362-RA Jon99Ciii -1.04 0.017 -1.30 0.002 -1.34 0.133
CG1944-RA Cyp4p2 -1.42 0.009 -1.86 0.005 -1.60 0.044
CG5460-RB H -0.59 0.242 0.57 0.048 0.02 0.986
CG17998-RA Gprk2 -0.54 0.006 0.35 0.237 -0.04 0.946
CG6538-RA TfIIFbeta -0.85 0.020 0.44 0.147 -0.23 0.757
CG1444-RA CG1444 -0.64 0.007 0.45 0.238 0.14 0.859
CG5447-RA CG5447 -0.53 0.006 0.43 0.294 -0.22 0.654
CG7008-RA Tudor-SN -0.50 0.032 0.27 0.140 -0.29 0.492
CG10017-RA CG34340 -0.33 0.271 -0.57 0.004 -0.60 0.265
CG7537-RB inx5 -0.12 0.265 -0.59 0.022 -0.45 0.200
CG8448-RC mrj -0.78 0.020 0.53 0.078 -0.04 0.964
CG10722-RA nesd 0.12 0.654 -0.58 0.049 -0.43 0.548
CG5489-RA Atg7 -0.71 0.027 0.42 0.140 -0.24 0.747
CG8599-RA Su(var)3-7 -0.77 0.030 0.41 0.068 -0.09 0.912
CG7481-RA RhoGAP18B -0.97 0.038 0.53 0.065 -0.37 0.692
CG30325-RA CG30325 0.22 0.299 0.20 0.314 0.54 0.026
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CG5978-RA GAPsec -0.60 0.008 0.34 0.327 0.15 0.798
CG1667-RA CG1667 -0.96 0.011 0.63 0.132 0.12 0.838
CG11279-RA CG11279 0.08 0.752 -0.69 0.015 -0.48 0.339
CG9480-RB Glycogenin -0.71 0.008 0.36 0.223 -0.14 0.768
CG5568-RA CG5568 -1.43 0.025 0.71 0.141 -0.21 0.848
CG6839-RA CG6839 -0.59 0.057 -0.78 0.019 -0.81 0.078
CG5461-RA bun 0.51 0.029 -0.15 0.597 -0.03 0.933
CG4362-RA CG4362 -0.56 0.002 -0.90 0.005 -0.64 0.250
CG6584-RB SelR -0.72 0.190 0.52 0.026 0.02 0.987
CG5588-RA Mtl -0.79 0.013 0.55 0.021 -0.14 0.797
CG13123-RA CG13123 0.01 0.940 -0.86 0.028 -0.26 0.334
CG9434-RA Fst -0.90 0.037 -1.15 0.036 -1.01 0.104
CG4332-RA CG4332 -0.83 0.001 0.42 0.235 -0.06 0.937
CG5203-RA CHIP -1.17 0.005 0.62 0.230 -0.06 0.938
CG1921-RC sty 0.73 0.008 -0.05 0.885 0.03 0.966
CG5604-RA CG5604 -0.77 0.018 0.43 0.135 0.01 0.984
CG32954-RG Adh -0.39 0.094 -0.55 0.025 -0.27 0.364
CG8588-RB pst -0.58 0.032 0.40 0.080 0.05 0.928
CG9670-RA fal -1.27 0.016 0.60 0.114 -0.30 0.720
CG17686-RA DIP1 -0.16 0.462 -0.54 0.036 -0.58 0.197
CG16762-RA CG16762 -0.34 0.114 -0.60 0.023 -0.35 0.371
CG9077-RA Cpr47Ec -0.75 0.008 -1.12 0.009 -0.99 0.010
CG9242-RA bur -0.66 0.018 0.72 0.102 -0.16 0.768
CG17667-RA CG42709 -0.95 0.014 0.39 0.189 -0.38 0.578
CG8253-RA tun -0.86 0.043 0.63 0.083 -0.23 0.772
CG32266-RA CG32266 -0.31 0.381 0.62 0.547 -0.57 0.029
CG32499-RA Cda4 -0.70 0.012 0.16 0.750 -0.42 0.403
CG8629-RA CG8629 -0.60 0.021 -0.53 0.124 -0.48 0.126
CG15236-RB CG15236 -1.48 0.017 -1.55 0.000 -1.19 0.013
CG6871-RA Cat -0.53 0.004 0.17 0.257 -0.10 0.785
CG1803-RB regucalcin -0.62 0.107 -0.58 0.009 -0.31 0.475
CG4673-RA CG4673 0.02 0.879 -0.53 0.037 -0.48 0.325
CG1227-RA CG1227 -0.58 0.046 0.49 0.146 -0.10 0.864
CG4912-RB eEF1delta -0.64 0.033 0.46 0.154 -0.43 0.445
CG6214-RO MRP -0.52 0.013 0.22 0.158 -0.08 0.818
CG2257-RA Ubc-E2H -0.76 0.136 0.93 0.037 0.05 0.960
CG3796-RA ac 0.07 0.719 -0.74 0.033 -0.66 0.301
CG9646-RA CG9646 -0.82 0.015 0.47 0.139 -0.13 0.822
CG5788-RA UbcD10 -0.75 0.009 0.36 0.297 -0.38 0.536
CG2100-RA CG2100 -0.57 0.019 0.29 0.480 -0.33 0.429
CG7291-RA Npc2a -0.89 0.109 0.74 0.005 -0.27 0.748
CG32684-RB alpha-Man-I -0.86 0.016 0.51 0.270 -0.03 0.967
CG32300-RB oxt -0.60 0.027 0.60 0.104 0.05 0.950
CG17486-RA CG17486 -0.53 0.034 0.49 0.092 -0.19 0.696
CG2051-RA CG2051 -0.76 0.027 0.60 0.089 -0.15 0.803
CG15415-RA Spindly 0.65 0.009 -0.08 0.817 -0.12 0.771
CG11798-RB chn 0.51 0.012 -0.32 0.357 -0.19 0.643
CG3045-RA CG3045 -0.80 0.035 0.74 0.018 0.04 0.962
CG6323-RB Tsp97E -0.57 0.039 0.38 0.110 -0.14 0.800
CG1962-RA CG1962 -1.34 0.015 0.59 0.168 -0.37 0.677
CG3925-RA CG3925 -0.66 0.022 0.42 0.151 -0.22 0.699
CG12177-RA CG12177 -0.69 0.014 -1.02 0.006 -1.12 0.016
CG1157-RA Osi15 -1.27 0.051 -1.49 0.018 -0.97 0.259
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CG11471-RA Aats-ile -0.58 0.003 0.33 0.383 -0.15 0.787
CG12052-RX lola -0.84 0.026 0.60 0.134 0.10 0.907
CG31272-RA CG31272 0.25 0.559 0.65 0.039 0.21 0.583
CG13319-RA CG13319 -0.53 0.078 0.52 0.031 -0.01 0.987
CG3871-RA Six4 0.54 0.032 -0.49 0.110 -0.14 0.769
CG32491-RG mod(mdg4) -0.12 0.428 0.04 0.680 -0.53 0.025
CG8390-RA vlc -0.75 0.034 0.48 0.111 -0.10 0.883
CG32241-RA CG32241 -0.55 0.028 -0.56 0.054 -0.70 0.102
CG5899-RA Etl1 -0.57 0.002 -0.59 0.045 -1.00 0.068
CG3707-RA wapl -0.80 0.032 0.49 0.152 -0.04 0.962
CG33117-RA Victoria 0.44 0.011 0.40 0.025 0.57 0.009
CG9096-RC CycD -0.78 0.032 0.59 0.051 -0.03 0.964
CG17270-RA CG17270 -0.96 0.009 0.40 0.181 -0.25 0.773
CG17060-RA Rab10 -0.66 0.021 0.32 0.413 -0.33 0.621
CG18525-RA Spn5 -0.83 0.035 0.48 0.046 -0.18 0.846
CG5026-RA CG5026 -1.15 0.039 0.61 0.126 -0.19 0.854
CG11897-RB CG11897 -0.89 0.013 0.68 0.150 -0.03 0.966
CG15371-RA Gr8a -0.53 0.014 -0.68 0.005 -0.56 0.011
CG8725-RA CSN4 -0.57 0.012 0.19 0.162 -0.22 0.667
CG2087-RA PEK -1.06 0.028 0.50 0.068 -0.17 0.853
CG3359-RD mfas 0.26 0.182 -0.78 0.016 -0.77 0.237
CG6113-RA Lip4 0.53 0.004 0.01 0.972 0.39 0.349
CG1594-RA hop -0.54 0.022 0.27 0.095 -0.16 0.798
CG8628-RA CG8628 -0.59 0.001 -0.92 0.014 -0.46 0.415
CG31641-RB stai -0.40 0.377 0.64 0.008 0.12 0.883
CG3376-RB CG3376 -0.85 0.019 0.31 0.097 -0.14 0.866
CG12399-RA Mad -0.96 0.023 0.57 0.090 -0.03 0.969
CG4032-RA Abl -0.63 0.032 0.48 0.276 0.01 0.992
CG4040-RA CG42388 0.11 0.376 0.52 0.012 0.56 0.187
CG2083-RA CG2083 0.70 0.005 -0.25 0.069 0.01 0.990
CG10504-RA Ilk -0.63 0.011 0.51 0.098 0.20 0.724
CG2258-RA CG2258 -1.00 0.045 0.71 0.012 0.19 0.853
CG15168-RA CG15168 -0.64 0.045 0.34 0.212 -0.06 0.914
CG11984-RB CG11984 -1.98 0.042 0.66 0.224 -0.44 0.649
CG3632-RC CG3632 -0.52 0.034 0.52 0.145 0.01 0.987
CG1165-RA LysS -1.09 0.007 -1.35 0.009 -1.18 0.100
CG7038-RA mRpL30 -0.23 0.177 -0.02 0.900 -0.58 0.003
CG3448-RB CG3448 -0.50 0.029 0.50 0.082 -0.07 0.904
CG14302-RA CG14302 -0.52 0.047 -0.65 0.038 -0.53 0.162
CG1848-RC LIMK1 -0.51 0.046 0.48 0.154 -0.28 0.578
CG11350-RB CG11350 -0.68 0.061 -0.73 0.006 -0.50 0.109
CG10743-RB Liprin-beta -0.64 0.026 0.48 0.227 -0.13 0.781
CG6515-RA Takr86C 0.29 0.321 0.55 0.072 0.62 0.005
CG31876-RA Cpr30F -0.47 0.012 -0.65 0.045 -0.48 0.131
CG4780-RA membrin 0.09 0.706 -0.57 0.042 -0.09 0.320
CG3619-RA Dl 0.54 0.003 -0.35 0.377 -0.12 0.857
CG8014-RA Rme-8 -0.73 0.021 0.37 0.253 -0.16 0.804
CG1862-RA Ephrin -0.35 0.082 0.65 0.041 0.25 0.596
CG3264-RA CG3264 -0.59 0.017 -0.68 0.054 -0.36 0.213
CG5072-RA Cdk4 -0.54 0.010 0.34 0.424 -0.12 0.774
CG8808-RA Pdk -1.22 0.048 0.69 0.137 -0.07 0.950
CG12567-RA CG12567 -1.11 0.020 0.68 0.189 -0.12 0.886
CG12052-RS lola 0.65 0.003 -0.00 0.984 -0.07 0.889
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CG32555-RC RhoGAPp190 0.51 0.017 -0.37 0.177 -0.23 0.635
CG9468-RA CG9468 -0.40 0.048 -0.65 0.001 -0.20 0.299
CG3008-RA CG3008 -0.52 0.041 0.42 0.213 -0.00 0.997
CG7197-RA CG7197 -0.85 0.029 0.46 0.104 -0.17 0.834
CG13947-RA CG13947 -0.50 0.017 -0.49 0.070 -0.58 0.023
CG16757-RA Spn -0.92 0.049 0.58 0.111 -0.05 0.955
CG14230-RA CG14230 -0.40 0.257 0.54 0.027 0.15 0.844
CG18024-RA SoxN 0.65 0.002 -0.16 0.696 -0.30 0.695
CG10601-RB mirr 0.64 0.006 -0.40 0.148 -0.19 0.734
CG14764-RA CG14764 -1.34 0.039 0.62 0.100 -0.62 0.583
CG14509-RA CG14509 -0.92 0.002 -0.76 0.023 -0.62 0.107
CG18124-RA mTTF -0.92 0.025 0.14 0.226 -0.57 0.396
CG10812-RA dro5 -0.80 0.045 -0.51 0.265 -1.14 0.087
CG10971-RA Hip1 -0.65 0.027 0.36 0.007 -0.32 0.527
CG3002-RB Gga -1.21 0.102 0.88 0.026 -0.08 0.946
CG17528-RD CG17528 -0.51 0.033 0.35 0.219 -0.17 0.714
CG3303-RA CG3303 -0.88 0.005 0.41 0.179 -0.31 0.645
CG31080-RA TwdlH -0.88 0.005 -1.14 0.003 -1.15 0.079
CG13454-RA CG13454 -0.11 0.739 -1.00 0.012 -0.42 0.480
CG8091-RA Nc -1.10 0.068 0.58 0.047 -0.24 0.818
CG7487-RA RecQ4 0.68 0.018 -0.13 0.577 0.08 0.822
CG5760-RA rtet -0.89 0.007 0.49 0.127 -0.19 0.801
CG2698-RA CG2698 -0.53 0.045 0.27 0.319 -0.14 0.777
CG3593-RA r-l -0.57 0.043 0.31 0.013 -0.29 0.641
CR33318-RA CR33318 -0.61 0.014 -0.22 0.377 -0.36 0.011
CG2944-RB gus -1.07 0.012 0.52 0.164 -0.31 0.710
CG10630-RA blanks 0.18 0.148 -0.73 0.032 -0.47 0.344
CG7378-RA CG7378 0.35 0.357 0.82 0.003 0.65 0.160
CG13461-RA CG13461 -0.57 0.003 -0.84 0.028 -0.77 0.076
CG31961-RA CG31961 -0.68 0.044 0.51 0.075 -0.09 0.915
CG12676-RA ed 0.52 0.043 0.03 0.884 0.31 0.387
CG8598-RA eco 0.30 0.180 -0.73 0.039 -0.10 0.750
CG12537-RA rdx 0.53 0.010 -0.30 0.099 -0.03 0.935
CG40129-RA Gprk1 -0.64 0.005 0.53 0.079 0.19 0.777
CG8090-RA CG8090 -0.58 0.002 0.29 0.159 0.01 0.986
CG12713-RA CG12713 -0.75 0.008 0.33 0.211 -0.03 0.973
CG6665-RA CG6665 -0.62 0.044 0.28 0.190 -0.27 0.618
CG32756-RA CG32756 0.08 0.762 0.56 0.012 0.91 0.325
CG1877-RC lin19 -0.73 0.033 0.38 0.251 -0.07 0.929
CG9493-RA Pez -0.76 0.022 0.40 0.189 0.02 0.981
CG11999-RA CG11999 -0.50 0.011 0.18 0.500 -0.13 0.793
CG8871-RA Jon25Biii -1.97 0.003 -2.41 0.002 -1.92 0.079
CG6147-RA Tsc1 -0.78 0.008 0.48 0.251 0.07 0.926
CG9311-RA mop -0.93 0.031 0.52 0.134 -0.29 0.663
CG33130-RC Patronin -0.70 0.049 0.35 0.345 -0.50 0.049
CG32548-RB CG32548 -0.77 0.024 -0.76 0.023 -0.41 0.141
CG15101-RA Jheh1 -0.66 0.037 0.40 0.243 -0.19 0.593
CG8312-RA CG8312 0.03 0.918 0.75 0.010 -0.45 0.637
CG17149-RA Su(var)3-3 -0.74 0.043 0.49 0.161 -0.19 0.698
CG4993-RB PRL-1 -0.67 0.023 0.80 0.178 -0.19 0.748
CG2204-RC G-oalpha47A -1.05 0.030 0.66 0.091 0.03 0.933
CG6310-RA CG6310 -0.53 0.168 0.61 0.044 -0.09 0.728
CG32473-RA CG32473 -1.38 0.198 0.61 0.030 -0.04 0.960
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prosGal4 prosGal4 prosGal4
HMG− EnRep DWT
Transcript Gene M p M p M p
CG11034-RA CG11034 -0.73 0.038 0.56 0.172 -0.10 0.894
CG12214-RB CG12214 -0.28 0.035 0.62 0.010 0.36 0.395
CG8470-RA mRpS30 -0.64 0.019 0.44 0.310 -0.12 0.821
CG3672-RA Cpr67B -0.33 0.114 -0.43 0.291 -0.57 0.008
CG8104-RA nudE -0.60 0.029 0.57 0.221 -0.18 0.749
CG11811-RA CG11811 -0.74 0.023 0.44 0.336 -0.19 0.762
CG10413-RA CG10413 -0.95 0.022 0.63 0.121 0.00 0.997
CG7370-RA CG7370 0.40 0.117 0.66 0.018 0.59 0.105
CG9705-RA CG9705 -0.83 0.010 0.54 0.340 -0.35 0.532
CG6072-RA sra -0.96 0.025 0.53 0.111 -0.37 0.635
CG11377-RA CG11377 0.09 0.353 -0.57 0.013 -0.64 0.299
CG11760-RA CG8116 -0.32 0.234 0.71 0.027 0.08 0.841
CG7361-RA RFeSP -0.26 0.321 2.61 0.001 0.00 0.999
CG11370-RA CG11370 -0.59 0.013 -0.82 0.004 -0.61 0.299
CG17492-RA mib2 -0.50 0.016 0.27 0.495 0.10 0.848
CG7400-RB Fatp 0.54 0.009 0.32 0.217 0.49 0.259
CG15524-RA sas-6 -0.09 0.115 -0.51 0.034 -0.69 0.200
CG12052-RP lola -0.40 0.279 0.56 0.027 0.03 0.912
CG9126-RB Stim -0.91 0.049 0.59 0.176 -0.31 0.692
CG17715-RE CG17715 -0.56 0.018 0.19 0.376 -0.44 0.312
CG32365-RA CG32365 -1.32 0.040 0.59 0.124 -0.36 0.730
CG11055-RC CG11055 -1.10 0.047 0.63 0.097 -0.18 0.874
CG4698-RA Wnt4 0.81 0.044 0.18 0.109 0.09 0.633
CG9113-RC AP-1gamma -0.51 0.017 0.43 0.139 -0.04 0.941
CG10962-RA CG10962 -0.84 0.034 0.79 0.066 -0.06 0.947
CG5796-RA Ppox -0.79 0.026 0.46 0.193 -0.18 0.798
CG8402-RA PpD3 -0.66 0.101 0.64 0.025 -0.11 0.886
CG15592-RA Osi9 -0.82 0.121 -0.91 0.009 -0.39 0.381
CG17163-RA CG17163 -0.56 0.045 0.26 0.363 0.12 0.837
CG8978-RA Sop2 -0.15 0.430 -0.39 0.050 -0.58 0.020
CG3819-RA CG3819 -0.44 0.037 -0.64 0.045 -0.58 0.100
CG5850-RA CG5850 -0.70 0.029 0.62 0.081 -0.07 0.901
CG33070-RA Sxl 0.69 0.032 -0.14 0.649 0.37 0.292
CG12142-RA Tsp42Eg 0.34 0.402 0.59 0.033 0.11 0.695
CG31789-RA CG31789 -1.29 0.005 -1.34 0.050 -0.77 0.338
CG15296-RA CG15296 0.24 0.404 0.60 0.010 0.30 0.185
CG15737-RA wisp -1.14 0.111 0.79 0.017 0.23 0.855
CG31007-RA CG31007 0.16 0.157 0.06 0.167 0.50 0.027
CG10383-RA CG10383 -0.65 0.038 0.35 0.243 -0.03 0.943
CG6105-RA l(2)06225 -0.52 0.038 0.14 0.620 0.32 0.581
CG15812-RA pfk -0.53 0.044 0.18 0.461 0.09 0.875
CG11660-RA CG11660 -0.87 0.007 0.41 0.248 -0.22 0.703
CG6335-RA Aats-his -0.73 0.037 0.28 0.179 0.03 0.959
CG1746-RA CG1746 -0.58 0.035 0.53 0.525 -0.31 0.299
CG9572-RA CG9572 -0.11 0.495 0.10 0.109 0.51 0.009
CG6051-RA CG6051 -0.55 0.017 0.40 0.241 0.06 0.902
CG6542-RA EDTP -1.23 0.009 0.67 0.158 -0.37 0.592
CG32140-RA nuf -0.34 0.496 0.52 0.040 0.17 0.024
CG3329-RA Prosbeta2 -0.53 0.095 0.52 0.002 -0.10 0.827
CG6005-RA CG6005 -0.64 0.047 0.28 0.203 0.03 0.954
CG31320-RA CG31320 -0.46 0.041 0.58 0.036 0.24 0.593
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Table 8: Expression data for genes differentially expressed in the Dichaete mutant
expression study. Invariant normalization was used, and the data was subsequently
analysed using limma. The cutoffs used were M value >= 1 or < − − 1 and p-value
< 0.01
Dichaete Dichaete
mutant mutant
Transcript Gene M p Transcript Gene M p
CG4250-RA CG4250 -1.01 0.001 CG30104-RA CG30104 -1.27 0.001
CG11928-RA CG34351 -1.44 0.001 CG5400-RA Eh -1.44 0.001
CG10659-RA CG10659 -1.15 0.001 CG32693-RA Gr9a -1.18 0.001
CG4714-RA CG4714 -1.15 0.001 CG2983-RA CG2983 -1.05 0.001
CG7452-RA Syx17 -1.27 0.001 CG17820-RA fit -1.11 0.001
CG31773-RA CG31773 -1.18 0.001 CG14864-RA CG14864 -1.02 0.001
CG18577-RA CG18577 -1.23 0.001 CG30029-RA CR30029 -1.60 0.001
CG14481-RA CG42561 -1.34 0.001 CG2750-RA CG2750 -1.01 0.002
CG3040-RA CG3040 -1.41 0.001 CG3931-RA Rrp4 -1.29 0.001
CG3713-RA CG3713 -1.43 0.001 CG7485-RA Oct-TyrR -1.14 0.001
CG14316-RA CG14316 -1.02 0.001 CG14591-RB CG14591 -1.13 0.001
CG14934-RA Mal-B1 -1.19 0.002 CG7571-RA Oatp74D -1.54 0.001
CG32082-RA CG32082 -1.33 0.001 CG14499-RA CR14499 -1.03 0.001
CG10834-RA CG10834 -1.25 0.001 CG14926-RA CG14926 -1.62 0.001
CG32238-RA CG32238 -1.20 0.001 CG17868-RB Or35a -1.06 0.001
CG14856-RA CG14856 -1.62 0.001 CG3644-RB bic -1.30 0.001
CG31468-RA CG31468 -1.44 0.001 CG14973-RA CG42324 -1.67 0.001
CG6969-RA CG6969 -1.11 0.001 CG4725-RA CG4725 -1.41 0.001
CG7399-RA Hn -1.40 0.001 CG14691-RB CG14691 -1.18 0.001
CG14963-RA CG14963 -1.15 0.001 CG11659-RA CG11659 -1.58 0.001
CG7533-RC chrb -1.25 0.001 CG17525-RA GstE4 -1.32 0.001
CG12045-RA Cpr100A -1.10 0.001 CG3395-RB RpS9 -1.47 0.001
CG31439-RA Muc96D -1.07 0.001 CG10936-RA CG10936 -1.06 0.001
CG31657-RA PNUTS -1.39 0.001 CG1663-RA CG1663 -1.14 0.001
CG17268-RA Pros28.1A -1.23 0.001 CG4836-RC CG4836 -1.13 0.001
CG13353-RA CG42287 -1.22 0.001 CG4658-RA CG4658 -1.18 0.001
CG5388-RA CG5388 -1.13 0.001 CG5338-RB RpS19b -1.00 0.001
CG11337-RB CG11337 -1.11 0.001 CG17921-RA HmgZ -1.95 0.001
CG18317-RA CG18317 -1.03 0.001 CG33207-RB pxb -1.90 0.001
CG1168-RA 7B2 -1.07 0.001 CG31231-RA CG31231 -1.23 0.001
CG17075-RA CG17075 -1.17 0.001 CG4753-RA CG4753 -1.03 0.001
CG2932-RA Bteb2 -1.28 0.001 CG33114-RA Gyc32E -1.19 0.001
CG11293-RA CG11293 -1.09 0.001 CG14744-RA CG14744 -1.48 0.001
CG5603-RC CYLD -1.00 0.004 CR31356-RA CR31356 -1.68 0.001
CG10911-RA CG10911 -1.31 0.001 CG32796-RA boi -1.13 0.001
CG13577-RA CG13577 -1.13 0.001 CG17991-RA CG17991 -1.30 0.001
CG3221-RA dgt3 -1.47 0.001 CG32836-RA NKAIN -2.09 0.001
CG2102-RA cas -1.82 0.001 CG6976-RD Myo28B1 -1.16 0.001
CG13813-RA CG13813 -1.01 0.001 CG13434-RA Nnf1a -1.42 0.001
CG4314-RA st -1.13 0.001 CG17778-RA CG17778 -1.17 0.001
CG14307-RA fru -1.21 0.001 CG1792-RA CG1792 -1.20 0.001
CG18331-RA Muc68Ca -1.31 0.001 CG13437-RA CG13437 -1.11 0.001
CG5706-RA CG5706 -1.22 0.001 CG4207-RA bonsai -1.37 0.001
CG10211-RA CG10211 -1.30 0.001 CG17237-RA CG17237 -1.28 0.001
CG10638-RA CG10638 -1.11 0.003 CG15000-RA nab -1.01 0.001
CG2097-RA Sym -1.17 0.001 CG18557-RA CG18557 -1.26 0.001
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Dichaete Dichaete
mutant mutant
Transcript Gene M p Transcript Gene M p
CG11401-RA Trxr-2 -1.04 0.001 CG10795-RA CG10795 -1.03 0.001
CG17970-RA Cyp4ac2 -1.25 0.001 CG3416-RA Mov34 -1.13 0.001
CG13618-RA CG13618 -1.09 0.001 CG11527-RA Tig -1.46 0.001
CG14731-RA CG14731 -1.02 0.001 CG31187-RA CG34384 -1.04 0.001
CG7579-RA CG7579 -1.32 0.001 CG3253-RA CG3253 -1.72 0.001
CG4847-RC CG4847 -1.13 0.001 CG10737-RC CG10737 -1.14 0.001
CG33300-RA Muc30E -1.35 0.001 CG10340-RA CG10340 -1.61 0.001
CG31266-RA CG31266 -1.46 0.001 CG14529-RA CG14529 -1.25 0.001
CG31363-RB Jupiter -1.44 0.001 CG32100-RA CG32100 -1.39 0.001
CG32040-RA CG32040 -1.28 0.001 CG5661-RA Sema-5c -1.26 0.001
CG31516-RA CG31516 -1.03 0.001 CG14357-RA CG14357 -1.42 0.001
CG31913-RA CG31913 -1.17 0.001 CG14843-RA CG34388 -1.19 0.001
CG7567-RA CG7567 -1.00 0.008 CG5392-RA Reck -1.19 0.001
CG9520-RB C1GalTA -1.35 0.003 CG12286-RA kar -1.32 0.001
CG8028-RA CG8028 -1.22 0.001 CG10623-RA CG10623 -1.91 0.001
CG13031-RA CG13031 -1.02 0.001 CG4440-RA CG4440 -1.78 0.001
CG8907-RA CG8907 -1.28 0.001 CG7992-RA CG7992 -1.03 0.001
CG5043-RA CG5043 -1.42 0.001 CG18646-RA CG42629 -1.26 0.001
CG13870-RA CG13870 -1.06 0.001 CG32847-RB CG32847 -1.34 0.001
CG10000-RA CG10000 -1.11 0.001 CG12486-RA CG12486 -1.27 0.001
CG7476-RA mthl7 -1.20 0.001 CG9372-RA CG9372 -1.31 0.001
CG11997-RA CG11997 -1.01 0.001 CR33328-RA CR33328 -1.66 0.001
CG14462-RA CG34384 -1.00 0.001 CG5423-RA robo3 -1.10 0.001
CG13455-RA CG13455 -1.25 0.001 CG8434-RA lbk -1.85 0.001
CG5142-RA CG5142 -1.06 0.001 CG6652-RA CG6652 -1.08 0.001
CG14031-RA Cyp4ac3 -1.33 0.001 CG10699-RA Lim3 -1.50 0.001
CG5122-RA CG5122 -1.21 0.001 CG1919-RA Cpr62Bc -1.17 0.001
CG11147-RB CG11147 -1.06 0.001 CG8816-RA Ak6 -1.04 0.001
CG8584-RA CG8584 -1.15 0.001 CG32922-RA Skeletor -1.24 0.001
CG13724-RA CG13724 -1.14 0.001 CG18110-RA CG18110 -1.44 0.001
CG7886-RA CG7886 -1.16 0.001 CG13687-RA Ptth -1.20 0.001
CG4324-RA CG4324 -1.17 0.001 CG16739-RA CG16739 -1.03 0.001
CG30289-RA CG30289 -1.23 0.001 CG5925-RA desat2 -1.17 0.001
CG13784-RA CG13784 -1.07 0.001 CG13243-RA CG13243 -1.44 0.001
CG9465-RA CG9465 -1.35 0.001 CG3948-RA zetaCOP -1.64 0.001
CG13063-RA CG13063 -1.00 0.001 CG13744-RA CG13744 -1.18 0.001
CG4882-RA CG4882 -1.16 0.001 CG5557-RA sqz -1.21 0.001
CG12768-RA CG12768 -1.07 0.001 CG32006-RA CG32006 -1.04 0.003
CG32700-RB CG32700 -1.66 0.001 CG11301-RA Mes4 -1.19 0.001
CG8083-RA CG8083 -1.08 0.003 CG7377-RA CG7377 -1.62 0.001
CG1265-RB CG1265 -1.03 0.001 CG8487-RB garz -1.59 0.001
CG6789-RA CG6789 -1.36 0.001 CG10050-RA CG10050 -1.20 0.001
CG9338-RA CG9338 -1.21 0.001 CG6656-RA CG6656 -1.00 0.001
CR30298-RA CR30298 -1.74 0.001 CG9926-RA CG9926 -1.03 0.001
CG8850-RB CG8850 -1.45 0.001 CG12511-RA CG12511 -1.22 0.001
CG30487-RA CG30487 -1.17 0.001 CG8421-RA Asph -1.56 0.001
CG14430-RA bou -1.86 0.001 CG13788-RA Gr28b -1.33 0.001
CG18265-RA CG18265 -1.50 0.002 CG18814-RA CG18814 -1.04 0.002
CG18765-RA CG18765 -1.28 0.001 CG9475-RA Rpt3R -1.00 0.001
CG31960-RA CG31960 -1.60 0.001 CG6571-RA rdgC -1.12 0.007
CG13661-RA CG34110 -1.40 0.001 CG5565-RA CG5565 -1.52 0.001
CG9432-RB l(2)01289 -1.25 0.001 CG30103-RA CG30103 -1.07 0.001
CG10130-RA Sec61beta -2.16 0.001 CG3680-RA CG3680 -1.10 0.002
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Dichaete Dichaete
mutant mutant
Transcript Gene M p Transcript Gene M p
CG6612-RB Adk3 -1.02 0.001 CG11312-RA insc -1.83 0.001
CG10658-RA Hf -1.18 0.001 CG10090-RA Tim17a1 -1.32 0.001
CG30147-RB Hil -1.25 0.001 CG9289-RA CG9289 -1.24 0.001
CG12643-RA CG12643 -1.85 0.001 CG11182-RA PHDP -1.20 0.001
CG8531-RA CG8531 -1.35 0.001 CG13953-RA Camta -1.18 0.001
CG3959-RA pelo -1.15 0.001 CG16781-RA CG16781 -1.34 0.001
CG7076-RA Cpr66Cb -1.21 0.001 CG12030-RA Gale -1.77 0.001
CG13672-RA Dscam4 -1.08 0.001 CG12535-RB CG12535 -1.11 0.001
CG14249-RB beat-VII -1.18 0.001 CG8541-RA CG8541 -1.41 0.001
CG5747-RA mfr -1.31 0.001 CG3996-RA CG42795 -1.00 0.001
CG9427-RA CG9427 -1.23 0.001 CG8964-RA CG8964 -1.01 0.001
CG6527-RA CG6527 -1.04 0.001 CG4653-RA CG4653 -1.07 0.001
CG13779-RA CG13779 -1.51 0.001 CG1322-RB zfh1 -1.18 0.001
CG5187-RA Doc2 -1.87 0.001 CG5948-RA CG5948 -1.36 0.001
CR31273-RA bxd -1.13 0.001 CG32944-RB CG32944 -1.21 0.001
CG6608-RA Tpc1 -1.02 0.004 CG6582-RA Aac11 -1.18 0.001
CG12073-RA 5-HT7 -1.04 0.001 CG13942-RA Shroom -1.36 0.001
CG8127-RB Eip75B -1.63 0.001 CG6698-RA NtR -1.33 0.001
CG12763-RA Dpt -1.32 0.001 CG12490-RA CG12490 -1.60 0.001
CG13162-RA ana3 -1.19 0.001 CG12362-RB CG12362 -1.24 0.001
CG12892-RA Caf1-105 -1.12 0.001 CG5269-RA vib -1.36 0.001
CG4269-RA CG4269 -1.32 0.001 CG13477-RA CG13477 -1.19 0.001
CG5424-RA f -1.03 0.002 CG10723-RA Kua -1.21 0.001
CG7888-RA CG7888 -1.12 0.001 CG3032-RA CG3032 -1.02 0.001
CG14112-RA SNCF -1.73 0.002 CG1856-RA ttk -1.54 0.001
CR33315-RA CR33315 -1.12 0.001 CG31869-RA CG31869 -1.19 0.001
CG4260-RA alpha-Adaptin -1.12 0.001 CG5638-RA Rh7 -1.26 0.001
CG15650-RA CG15650 -1.06 0.001 CG11608-RA CG11608 -1.06 0.001
CG30053-RA CG30053 -1.26 0.001 CG5262-RA CG5262 -1.13 0.001
CG3629-RA Dll -1.31 0.001 CG7514-RA CG7514 -1.04 0.001
CG14957-RA CG14957 -1.23 0.001 CG31160-RA CG34376 -1.21 0.001
CG18445-RA oys -1.97 0.001 CG7589-RA CG7589 -1.28 0.001
CG3671-RC Mvl -1.25 0.001 CG10851-RD B52 -1.24 0.001
CG10823-RA SIFR -1.51 0.001 CG7503-RA Con -1.40 0.001
CG14982-RB CG14982 -1.05 0.001 CG11700-RA CR11700 -1.21 0.001
CG7557-RA CG7557 -1.07 0.001 CG11000-RA CG11000 -1.19 0.001
CG31710-RA CG31710 -1.47 0.001 CG5367-RA CG5367 -1.16 0.001
CG11437-RA CG11437 -1.13 0.001 CG7958-RA tna -1.64 0.001
CG17941-RA ds -1.78 0.001 CG3168-RA CG3168 -1.09 0.001
CG10914-RA CG10914 -1.28 0.001 CG5758-RB CG5758 -1.30 0.001
CG4321-RA Cyp4d8 -1.35 0.001 CG7068-RA TepIII -1.27 0.001
CG33140-RA CG33140 -1.03 0.001 CG12946-RA Whamy -1.09 0.001
CG11619-RA CG11619 -1.35 0.001 CG5623-RA CG5623 -1.33 0.001
CG6012-RA CG6012 -1.22 0.001 CR32525-RA CR32525 -1.34 0.001
CG33234-RA CG33234 -1.04 0.001 CG6405-RA CG6405 -1.24 0.001
CG4817-RA Ssrp -1.17 0.001 CG6451-RA blue -1.45 0.001
CG32240-RA CG32240 -1.22 0.001 CG33012-RB CG33012 -1.35 0.001
CG14905-RA CG14905 -1.14 0.001 CG2976-RA CG2976 -1.07 0.001
CG2816-RA CG2816 -1.58 0.001 CG13702-RB AlCR2 -1.29 0.001
CG4334-RA CG4334 -1.11 0.001 CG32946-RA CG31530 -1.03 0.001
CG17950-RA HmgD -1.14 0.001 CG5378-RA Rpn7 -1.50 0.001
CG17957-RA Sry-alpha -1.42 0.002 CG18375-RA ASPP -1.14 0.001
CG13466-RA DCX-EMAP -1.11 0.001 CG5723-RB Ten-m -1.89 0.001
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Dichaete Dichaete
mutant mutant
Transcript Gene M p Transcript Gene M p
CG9826-RB CG9826 -1.26 0.001 CG18538-RA CG18538 -1.02 0.001
CG4221-RA CG4221 -1.38 0.001 CG33474-RA CG33474 -1.61 0.001
CG4779-RA hgo -1.14 0.001 CG5772-RA Sur -1.21 0.001
CG6706-RB GABA-B-R2 -1.09 0.001 CG14458-RA CG33769 -1.14 0.001
CG11404-RA CG11404 -1.33 0.001 CG15018-RA CG33514 -1.13 0.001
CG2857-RA Tpc2 -1.00 0.002 CG10308-RA CycJ -1.06 0.001
CG15538-RA Osi23 -1.00 0.001 CG3548-RA CG3548 -1.17 0.001
CG32031-RA Argk -1.16 0.002 CG17738-RA CG17738 -1.25 0.001
CG4509-RB Cad86C -1.50 0.001 CG14709-RA Mrp4 -1.54 0.001
CG7994-RA CG42796 -1.30 0.001 CG33269-RA CG33269 -1.71 0.001
CG4863-RC RpL3 -1.51 0.001 CG7548-RA CG7548 -1.06 0.001
CG10651-RA CG10651 -1.36 0.001 CG31561-RA Osi16 -1.21 0.001
CG1946-RA CG1946 -1.47 0.001 CG10688-RA CG10688 -1.03 0.001
CG14556-RA CG14556 -1.09 0.003 CG31805-RA CG31805 -1.27 0.001
CG32283-RA dro3 -1.05 0.002 CG5681-RA CG5681 -1.54 0.001
CG14391-RA CG14391 -1.09 0.002 CG5155-RA CG5155 -1.19 0.001
CG4807-RA ab -1.90 0.001 CG18469-RA CG18469 -1.04 0.006
CG11066-RA scaf -1.13 0.001 CG14876-RA CG43318 -1.12 0.001
CG8087-RA CG8087 -1.40 0.001 CG16890-RA CG16890 -1.29 0.001
CR7249-RA Cyp6a16Psi -1.68 0.001 CG7629-RA AttD -1.09 0.001
CG31146-RD Nlg1 -1.33 0.001 CG5408-RA trbl -1.35 0.002
CG8975-RA RnrS -1.58 0.002 CG8822-RA PpD6 -1.22 0.001
CG9547-RA CG9547 -1.10 0.001 CG12433-RA CG12433 -1.25 0.001
CG4467-RA CG4467 -1.14 0.001 CG5060-RA cic -1.12 0.001
CG6713-RA Nos -1.22 0.001 CG1867-RA Or98b -1.47 0.001
CG30270-RA CG30270 -1.31 0.001 CG3288-RA CG3288 -1.34 0.001
CG10031-RA CG10031 -1.11 0.001 CG10718-RA neb -1.19 0.001
CG1363-RA blow -1.65 0.001 CG12017-RA CG12017 -1.03 0.001
CR9700-RA Or85e -1.44 0.001 CG13490-RA CG34369 -1.19 0.002
CG4531-RA aos -1.13 0.002 CG5528-RA Toll-9 -1.10 0.001
CG10601-RA mirr -1.44 0.001 CG31988-RA CG31988 -1.03 0.001
CG9224-RA sog -1.48 0.001 CG8457-RA Cyp6t3 -1.10 0.001
CG5169-RA GckIII -1.72 0.001 CG6729-RA CG6729 -1.19 0.001
CG5493-RA CG5493 -1.32 0.001 CG8605-RA CG8605 -1.61 0.001
CG9279-RA CG9279 -1.33 0.001 CG5070-RA CG5070 -1.32 0.001
CG8100-RA CG8100 -1.23 0.001 CG9261-RA nrv2 -1.76 0.001
CG1262-RA Acp62F -1.35 0.001 CG4636-RA SCAR -1.41 0.001
CG13811-RA CG42674 -1.05 0.001 CG5546-RA MED19 -1.58 0.001
CR32665-RB roX2 -1.07 0.003 CG3973-RA pigs -1.08 0.001
CG9460-RA Spn42De -1.31 0.001 CG5344-RB wkd -1.16 0.001
CG13771-RA CG13771 -1.13 0.001 CG12841-RA Tsp42Ek -1.26 0.001
CG32031-RC Argk -1.36 0.001 CG5458-RA CG5458 -1.06 0.001
CG11321-RB CG11321 -1.10 0.001 CG8102-RA CG8102 -1.27 0.001
CG1865-RA Spn43Ab -1.00 0.003 CG12724-RA IP3K2 -1.28 0.001
CG10073-RA CG10073 -1.33 0.001 CG10120-RB Men -1.80 0.001
CG11158-RA CG11158 -1.19 0.001 CG9361-RA Task7 -1.21 0.001
CG12496-RA CG12496 -1.17 0.001 CG9995-RA htt -1.25 0.001
CG8167-RA Ilp2 -1.17 0.001 CR31511-RA α-Est4aPsi -1.46 0.001
CG8870-RA CG8870 -1.02 0.001 CG12581-RA CG12581 -2.00 0.001
CG5121-RA MED28 -1.35 0.001 CG8445-RA calypso -1.42 0.001
CG14482-RA CG14482 -1.74 0.001 CG18287-RA ppk19 -1.07 0.001
CG16825-RA CG16825 -1.36 0.001 CG32811-RA CG32811 -1.09 0.002
CG10595-RB d -1.54 0.001 CG9626-RA CG9626 -1.17 0.001
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CG9500-RA CG9500 -1.13 0.002 CG16876-RA nimC4 -1.48 0.001
CG32853-RA mthl12 -1.12 0.003 CG6589-RA spag4 -1.49 0.001
CG13692-RA CG13692 -1.30 0.001 CG6898-RA Zip3 -1.09 0.001
CG5592-RA CG5592 -1.39 0.001 CG14199-RA ksh -1.55 0.001
CG10153-RA CG10153 -1.24 0.001 CG3999-RA CG3999 -1.57 0.001
CG10112-RA Cpr51A -1.35 0.001 CG10079-RB Egfr -1.83 0.001
CG12674-RA CG12674 -1.06 0.001 CG30118-RA CG30118 -1.87 0.001
CR14753-RA Cyp6a15Psi -1.03 0.001 CG14004-RA CG34381 -1.43 0.001
CG3984-RA CG3984 -1.67 0.001 CG16801-RA Hr51 -1.21 0.002
CG7191-RA CG7191 -1.01 0.001 CG13713-RA CG13713 -1.28 0.001
CG14291-RA CG14291 -1.06 0.008 CG8557-RA CG8557 -1.60 0.001
CG5837-RA Hem -1.49 0.001 CG7299-RA CG7299 -1.33 0.001
CG8427-RA SmD3 -1.23 0.001 CG18088-RA CG18088 -1.24 0.001
CG13290-RA CG33993 -1.16 0.006 CG6349-RA DNApol-α180 -1.24 0.001
CG6630-RA CG42533 -1.13 0.002 CG6601-RA Rab6 -1.52 0.001
CG8595-RA Toll-7 -1.16 0.001 CG9770-RA p -1.44 0.001
CG7841-RA CG7841 -1.44 0.001 CG31174-RA CG31174 -1.19 0.001
CG17697-RB fz -1.05 0.001 CG9283-RA Cpr76Ba -1.01 0.001
CG17083-RA CG17083 -1.14 0.001 CG7973-RB CG33985 -1.41 0.001
CG7670-RA WRNexo -1.71 0.001 CG17623-RA CG42686 -1.00 0.001
CG6174-RA Arp87C -1.42 0.001 CG16964-RA CG16964 -1.00 0.001
CG1675-RA CG1675 -1.21 0.001 CG9135-RB CG9135 -1.80 0.001
CG32560-RA CG42684 -1.04 0.002 CG9347-RA ninaB -1.10 0.001
CG7815-RA ran-like -1.04 0.001 CG14643-RA TwdlG -1.05 0.001
CG11099-RA CG11099 -1.37 0.001 CG4972-RA CG4972 -1.46 0.001
CG10475-RA Jon65Ai -1.12 0.001 CG18598-RA CG18598 -1.19 0.001
CG13335-RA CG42808 -1.47 0.001 CG32985-RA CG32985 -1.25 0.001
CG15109-RB CG15109 -1.14 0.001 CG4336-RA rux -1.60 0.001
CG13299-RA CG13299 -1.01 0.001 CG17196-RA CG17196 -1.06 0.001
CG13310-RA CG13310 -1.20 0.001 CG11396-RA CG11396 -1.49 0.001
CG14850-RA CG14850 -1.28 0.001 CG10529-RA Lcp65Ae -1.49 0.001
CG6833-RA CG6833 -1.09 0.001 CG9894-RA CG9894 -2.15 0.002
CG15590-RA Osi5 -1.22 0.001 CG31718-RA Ir31a -1.11 0.001
CG17127-RA CG17127 -1.24 0.001 CG32282-RA dro4 -1.49 0.001
CG6890-RA Tollo -2.06 0.001 CG6800-RA CG6800 -1.15 0.001
CG3250-RA Os-C -1.23 0.001 CG2852-RA CG2852 -1.80 0.001
CG18788-RA CG18788 -1.36 0.001 CG13315-RA CG13315 -1.38 0.001
CG14541-RA CG42261 -1.21 0.001 CG13260-RA CG42389 -1.00 0.001
CG8647-RA mp -1.06 0.001 CG14015-RA CG14015 -1.32 0.001
CG4650-RA CG4650 -1.20 0.001 CG2671-RA l(2)gl -1.19 0.001
CG16987-RA daw -1.13 0.001 CG8354-RA m6 -1.19 0.001
CG6883-RA trh -1.89 0.001 CG6784-RB CG42827 -1.13 0.001
CG32483-RA CG32483 -1.18 0.001 CG7930-RB TpnC73F -1.15 0.001
CG2867-RA Prat -1.78 0.001 CG17735-RA CG42574 -1.03 0.005
CG31817-RA CG31817 -1.07 0.001 CG32198-RB CG32198 -1.38 0.001
CG4677-RA lmd -1.97 0.001 CG12292-RA spict -1.30 0.001
CG14011-RA CG14011 -1.12 0.001 CG5872-RA CG5872 -1.11 0.001
CG7759-RA CG7759 -1.31 0.001 CG17562-RA CG17562 -1.00 0.001
CG6847-RA CG6847 -1.06 0.002 CG4552-RA CG4552 -1.06 0.001
CG15904-RA Ir56d -1.19 0.001 CG6282-RB CG6282 -1.24 0.001
CG7148-RA CG7148 -1.46 0.001 CG1030-RA Scr -1.67 0.001
CG3689-RB CG3689 -1.72 0.001 CG4527-RD slik -1.02 0.001
CG2614-RA CG2614 -1.46 0.001 CG9073-RA TpnC47D -1.25 0.001
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CG8967-RA otk -1.38 0.001 CG10950-RA CG10950 -1.12 0.001
CG4956-RA CG4956 -1.07 0.001 CG11053-RA CG34345 -1.09 0.001
CG41105-RC CG34334 -1.10 0.001 CG3306-RA CG3306 -1.06 0.001
CG8251-RA Pgi -1.06 0.001 CG7856-RA CG7856 -1.08 0.001
CG12523-RA CG12523 -1.12 0.001 CG3244-RA Clect27 -1.33 0.001
CG31823-RA CG31823 -1.40 0.001 CG10369-RA Irk3 -1.68 0.001
CG11309-RB CG11309 -1.01 0.001 CG12268-RA CG12268 -1.25 0.001
CG7890-RA Hs3st-B -1.08 0.001 CG8497-RA Rhp -1.46 0.001
CG12231-RA CG12231 -1.18 0.001 CG7847-RA sr -1.18 0.001
CG31744-RA Gr36b -1.32 0.001 CG3792-RA CG3792 -1.31 0.001
CG3738-RA Cks30A -1.13 0.001 CG18155-RA CG18155 -1.36 0.001
CG10325-RA abd-A -2.01 0.001 CG16916-RA Rpt3 -1.65 0.001
CG31269-RA CG31269 -1.16 0.001 CG12919-RA egr -1.24 0.001
CG5842-RA nan -1.46 0.001 CG2762-RA ush -1.47 0.001
CG10177-RA CG10177 -1.23 0.001 CG33056-RA CG33056 -1.16 0.001
CG2559-RA Lsp1alpha -1.00 0.001 CG6338-RA Ets97D -1.30 0.001
CG6738-RA CG6738 -1.10 0.001 CG16956-RA CG16956 -1.22 0.001
CG10361-RA CG10361 -1.26 0.001 CG7656-RA CG7656 -1.47 0.001
CG13248-RA CG13248 -1.15 0.001 CG8277-RA eIF4E-5 -1.43 0.001
CG7251-RA CG7251 -1.13 0.001 CG9775-RA CG9775 -1.55 0.001
CG12865-RA CG12865 -1.12 0.001 CG12857-RA CG12857 -1.12 0.001
CG8286-RA P58IPK -1.67 0.001 CG13970-RA CG13970 -1.62 0.001
CG15203-RA CG15203 -1.19 0.001 CG6259-RA CG6259 -1.10 0.003
CG10993-RA CG10993 -1.78 0.001 CG31778-RA CG31778 -1.01 0.001
CG5933-RA Mta70 -1.61 0.001 CG15874-RA Pgam5-2 -1.14 0.001
CG4894-RC Ca-alpha1D -1.45 0.001 CG11759-RA Kap3 -1.00 0.003
CG1154-RA Osi12 -1.25 0.001 CG11882-RA CG11882 -1.25 0.001
CG3803-RA CG3803 -1.00 0.003 CG2105-RA Corin -1.00 0.002
CG14654-RA CG14654 -1.18 0.001 CG30084-RA Zasp52 -1.46 0.003
CG15280-RA CR15280 -1.16 0.001 CG11866-RA CG11866 -1.90 0.001
CG10472-RA CG10472 -1.10 0.001 CG7297-RA pgant8 -1.22 0.001
CG14536-RA Herp -1.38 0.001 CG5064-RA Srp68 -1.29 0.001
CG13140-RA dpr19 -1.01 0.001 CG9657-RA CG9657 -1.28 0.001
CG13076-RB Notum -1.71 0.001 CG33351-RA CheB42b -1.02 0.001
CG9712-RA TSG101 -1.36 0.005 CG31845-RA CR31845 -1.07 0.001
CG10366-RA CG10366 -1.11 0.002 CG3290-RA CG3290 -1.16 0.001
CG3349-RA CG3349 -1.19 0.001 CG11929-RA CG11929 -1.18 0.001
CG11387-RA ct -1.64 0.001 CG14258-RA CG14258 -1.03 0.001
CG31664-RA CG31664 -1.13 0.001 CG33203-RC CG33203 -1.03 0.001
CG32081-RA CG32081 -1.15 0.001 CG15293-RA CG15293 -1.28 0.001
CG33478-RA Or46a -1.08 0.001 CG1319-RA CG1319 -1.17 0.001
CG33197-RB mbl -1.14 0.001 CG5442-RA SC35 -1.62 0.001
CG32356-RB ImpE1 -1.04 0.001 CG14275-RA CG14275 -2.06 0.001
CG11333-RA CG11333 -1.03 0.001 CG13037-RA mRpS34 -1.60 0.001
CG4276-RD aru -1.88 0.001 CG6308-RA CG6308 -1.07 0.001
CG3346-RA pon -1.99 0.001 CG31391-RA CG31391 -1.54 0.001
CG1958-RA CG1958 -1.26 0.001 CG32096-RB rols -1.25 0.001
CG15634-RA CG15634 -1.89 0.001 CG8613-RA CG8613 -1.01 0.001
CG5538-RA CG5538 -1.19 0.001 CG7507-RA Dhc64C -1.10 0.001
CG14088-RA CG14088 -1.13 0.001 CG13196-RA CG13196 -1.14 0.001
CG7289-RA CG7289 -1.38 0.001 CG17438-RA CR17438 -1.05 0.001
CG32052-RA CG32052 -1.03 0.001 CG9813-RB CG9813 -1.33 0.001
CG9541-RA CG9541 -1.11 0.001 CG3573-RA CG3573 -1.02 0.001
Continued on next page
277
Table 8 – continued from previous page
Dichaete Dichaete
mutant mutant
Transcript Gene M p Transcript Gene M p
CG31632-RA sens-2 -1.12 0.001 CG3474-RA Cpr35B -1.48 0.001
CG3129-RA Rab-RP4 -1.41 0.001 CG15210-RA CG15210 -1.15 0.001
CG31524-RA CG31524 -1.06 0.001 CG15427-RE tutl -1.22 0.001
CG6447-RA TwdlL -1.23 0.001 CG17360-RA CG17360 -1.14 0.001
CG12172-RA Spn43Aa -1.51 0.001 CG6042-RA Cyp12a4 -1.01 0.001
CG12269-RA CG12269 -1.11 0.001 CG31406-RA CG31406 -1.04 0.001
CG7339-RA CG7339 -1.67 0.001 CG7722-RA Spn47C -1.31 0.001
CG3992-RA srp -1.51 0.001 CG11419-RA Apc10 -1.14 0.001
CG13021-RB CG13021 -1.25 0.001 CG10353-RB CG10353 -1.27 0.002
CG6333-RA CG6333 -1.00 0.001 CG1969-RB CG1969 -1.19 0.001
CG14577-RA ORMDL -1.00 0.001 CG15393-RA CG15393 -1.39 0.001
CG15002-RB mas -1.60 0.001 CG1968-RA CG1968 -1.19 0.001
CG2075-RA aly -1.15 0.001 CG6138-RA CG6138 -1.03 0.001
CG9149-RA CG9149 -1.29 0.001 CG15366-RA CG15366 -1.35 0.001
CG9614-RE pip -1.54 0.001 CG16978-RA CG16978 -1.09 0.001
CG10488-RA eyg -1.27 0.001 CG6071-RA CG6071 -1.12 0.001
CG33228-RA CG33228 -1.15 0.001 CG9376-RA CG9376 -1.00 0.001
CG8661-RA CG8661 -1.12 0.001 CG9799-RA CG9799 -1.75 0.001
CG3090-RA Sox14 -1.26 0.001 CG9614-RD pip -1.24 0.001
CG9097-RA bab1 -1.03 0.001 CG9876-RA CG9876 -1.01 0.001
CG17054-RC Cap-G -1.20 0.001 CG14216-RA CG14216 -1.17 0.001
CG3894-RA CG3894 -1.32 0.001 CG31348-RA Octbeta3R -1.08 0.001
CG9565-RA Nep3 -1.05 0.001 CG32131-RA CG34400 -1.05 0.001
CG3108-RA CG3108 -1.08 0.001 CG9254-RA CG9254 -1.32 0.001
CG33290-RA CG33290 -1.00 0.001 CG6131-RA Cpr97Ea -1.24 0.001
CG30042-RA Cpr49Ab -1.04 0.001 CG6140-RA CG6140 -1.29 0.001
CG4060-RA TwdlW -1.03 0.001 CG31021-RA CG31021 -1.35 0.001
CG15106-RA Jheh3 -1.14 0.001 CG2666-RB kkv -1.20 0.001
CG15405-RA CG34393 -1.51 0.001 CG11482-RA Mlh1 -1.41 0.001
CG9134-RA CG9134 -1.10 0.001 CG8997-RA CG8997 -1.26 0.001
CG11710-RB CG11710 -1.07 0.001 CR31930-RA Gr22d -1.26 0.001
CG33047-RA Fuca -1.20 0.001 CG9633-RA RpA-70 -1.55 0.002
CG17117-RD hth -1.84 0.001 CG11113-RA CG11113 -1.04 0.001
CG10210-RA tst -1.13 0.001 CG16869-RA Ance-2 -1.34 0.001
CG7123-RA LanB1 -2.09 0.001 CG10297-RA Acp65Aa -1.01 0.001
CG16817-RA CG16817 -1.61 0.001 CG9451-RA CG9451 -1.15 0.001
CG9614-RK pip -1.48 0.001 CG7833-RA Orc5 -1.08 0.001
CG17712-RA CG17712 -1.36 0.001 CG7963-RA CG7963 -1.33 0.001
CG10300-RA CG10300 -1.03 0.001 CG12202-RA Nat1 -1.15 0.003
CG10566-RA CG10566 -1.00 0.001 CG18673-RA CG18673 -1.00 0.001
CG13374-RA pcl -1.05 0.001 CG15124-RA CG15124 -1.25 0.001
CG4409-RA CG4409 -1.24 0.001 CG13317-RA Ilp7 -1.24 0.001
CG1299-RA CG1299 -1.03 0.001 CG12846-RA Tsp42Ed -1.33 0.001
CG2194-RC su(r) -1.19 0.001 CG3725-RH Ca-P60A -1.01 0.003
CG11012-RA Ugt37a1 -1.19 0.001 CG2177-RB CG2177 -1.40 0.001
CG17183-RA MED30 -1.52 0.001 CG8333-RA HLHmγ -1.08 0.003
CG31738-RB CG42389 -1.02 0.002 CG13000-RA CG13000 -1.06 0.001
CG5022-RA CG5022 -1.15 0.001 CG17193-RA CG17193 -1.08 0.001
CG6912-RA CG6912 -1.28 0.001 CG6821-RA Lsp1γ -1.22 0.001
CG31202-RA CG31202 -1.06 0.001 CG15555-RA CG15555 -1.21 0.001
CG8013-RA Su(z)12 -1.17 0.001 CG7791-RA CG7791 -1.25 0.001
CG13287-RA CG13287 -1.07 0.001 CG8733-RA Cyp305a1 -1.26 0.001
CG14032-RA Cyp4ac1 -1.36 0.001 CG33115-RA nimB4 -1.19 0.002
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CG8404-RA Sox15 -1.01 0.002 CG14567-RA CG14567 -1.07 0.001
CG17265-RA CG17265 -1.53 0.001 CG6231-RA CG6231 -1.01 0.001
CG7206-RA CG7206 -1.14 0.001 CG8395-RA Rrp42 -1.08 0.001
CG32256-RA Gr64c -1.26 0.001 CG4697-RA CSN1a -1.11 0.001
CG11062-RA Actbeta -1.30 0.001 CG12313-RA ttm2 -1.37 0.001
CG31730-RA CG31730 -1.43 0.001 CG8246-RA Poxn -1.34 0.001
CG16997-RA Phae2 -1.11 0.001 CG14365-RA CG34383 -1.18 0.001
CG5911-RB ETHR -1.28 0.001 CG7779-RA Cng -1.11 0.001
CG8853-RA CG8853 -1.04 0.001 CG15678-RA pirk -1.02 0.001
CG17594-RA scro -1.51 0.001 CG1665-RA CG1665 -1.06 0.001
CG8582-RB Sh3beta -1.21 0.001 CG3711-RA CG3711 -1.08 0.001
CG32531-RA mRpS14 -1.30 0.001 CG9106-RA CG9106 -1.04 0.001
CG2663-RA CG2663 -1.17 0.001 CG9013-RA Vha16-4 -1.20 0.001
CG10972-RA ppk12 -1.02 0.001 CG8355-RC sli -1.39 0.001
CG4979-RA sxe2 -1.03 0.001 CG11076-RA CG11076 -1.55 0.001
CG4143-RB mbf1 -1.37 0.001 CG8297-RA CG8297 -1.16 0.002
CG7879-RA CG7879 -1.24 0.001 CG10436-RA Pbprp1 -1.08 0.002
CG4661-RA CG4661 -1.15 0.001 CG11620-RA CG42399 -1.25 0.001
CG7912-RA CG7912 -1.00 0.003 CG1225-RA RhoGEF3 -1.57 0.001
CG15599-RA CG15599 -1.01 0.001 CG3760-RB CG3760 -1.68 0.001
CG13415-RA Cby -1.15 0.001 CG15262-RA CG15262 -1.07 0.001
CG8539-RA CG8539 -1.17 0.001 CG12950-RA CG12950 -1.22 0.001
CG5860-RA CG5860 -1.32 0.001 CG18550-RA yellow-f -1.25 0.001
CG13922-RA mRpL46 -1.27 0.001 CG32458-RA nrm -1.48 0.001
CG32506-RA CG32506 -1.02 0.001 CG14064-RA beat-VI -1.26 0.001
CG2505-RA alpha-Est2 -1.26 0.001 CG8230-RA CG8230 -1.43 0.001
CG12209-RA CG12209 -1.14 0.001 CG10663-RA CG10663 -1.03 0.001
CG7678-RA Vha100-4 -1.20 0.001 CG3242-RA sob -1.23 0.001
CG1399-RA CG1399 -1.32 0.001 CG4629-RA CG4629 -1.00 0.001
CG15224-RB CkIIbeta -1.33 0.001 CG6297-RB JIL-1 -1.44 0.001
CG11033-RA Kdm2 -1.09 0.001 CG7921-RA Mgat2 -1.33 0.001
CG1572-RA CG1572 -1.00 0.001 CG7163-RA mkg-p -1.37 0.001
CG1028-RI Antp -1.41 0.001 CG5958-RA CG5958 -1.91 0.001
CG3868-RA CG3868 -1.25 0.001 CG11951-RA CG11951 -1.02 0.001
CG11780-RA beta4GalT7 -1.09 0.001 CG31622-RC Gr39a -1.12 0.001
CG17329-RA CG17329 -1.23 0.001 CG15311-RA CG15311 -1.06 0.001
CG1044-RA dos -1.27 0.001 CG11895-RA stan -1.67 0.001
CG31507-RA TotZ -1.05 0.002 CG10498-RB cdc2c -1.15 0.001
CG6004-RB Muc68D -1.53 0.001 CG15377-RA Or22c -1.27 0.001
CG14708-RA CG14708 -1.25 0.001 CG12156-RA Rab39 -1.42 0.002
CG15890-RA CG15890 -1.14 0.001 CG5289-RA Pros26.4 -1.09 0.001
CG31652-RA CG34124 -1.07 0.001 CG10541-RA Tektin-C -1.30 0.001
CG8732-RA Acsl -1.13 0.004 CG13186-RA CG13186 -1.02 0.001
CG33461-RA CG33461 -1.35 0.001 CG9726-RA PH4αMP -1.29 0.001
CG9739-RB fz2 -1.78 0.001 CG17230-RA CG17230 -1.07 0.001
CG10391-RA Cyp310a1 -1.68 0.001 CG13113-RA CG13113 -1.27 0.001
CG15564-RA CG15564 -1.23 0.001 CG3371-RA ebd1 -1.27 0.001
CG12014-RA CG12014 -1.15 0.001 CG15819-RA CG42533 -1.06 0.001
CG14296-RB endoA -1.39 0.001 CG11796-RA CG11796 -1.12 0.001
CG31681-RA CG31681 -1.43 0.001 CG30285-RA CG30285 -1.26 0.001
CG15327-RA Ir7d -1.11 0.001 CG3446-RA CG3446 -1.22 0.001
CG3348-RA CG3348 -1.38 0.001 CG31478-RA mRpL9 -1.25 0.001
CG3320-RB Rab1 -1.28 0.001 CG8780-RA tey -1.20 0.001
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CG30446-RA Tdc2 -1.18 0.001 CG4050-RB CG4050 -1.42 0.001
CG13070-RA CG13070 -1.26 0.001 CG40198-RA CG40198 -1.19 0.001
CG2759-RA w -1.07 0.001 CG11668-RA CG11668 -1.13 0.001
CG4550-RA ninaE -1.19 0.001 CG33481-RB dpr7 -1.18 0.001
CG31418-RA CG31418 -1.00 0.001 CG1978-RA Or45a -1.01 0.001
CG15685-RA Ir92a -1.24 0.001 CG4058-RA Nep4 -1.00 0.001
CG32189-RA CG32189 -1.37 0.001 CG1343-RA Sp1 -1.28 0.001
CG4133-RA CG4133 -1.40 0.001 CG32071-RA CG32071 -1.44 0.001
CG9394-RA CG9394 -1.00 0.001 CG15792-RA zip -1.11 0.001
CG33325-RA CG33325 -1.24 0.001 CG30416-RA CG30416 -1.28 0.001
CG6053-RA CG6053 -1.21 0.001 CG3386-RA CG3386 -1.08 0.001
CG31002-RA CG31002 -1.63 0.003 CG12242-RA GstD5 -1.03 0.001
CG6059-RA CG6059 -1.05 0.002 CG31431-RA CG31431 -1.41 0.001
CG2246-RA CG2246 -1.17 0.001 CG13308-RA CG13308 -1.10 0.001
CG10379-RA mbc -1.79 0.001 CG14837-RA CG14837 -1.05 0.001
CG32062-RB A2bp1 -1.64 0.001 CG9606-RA Rrp45 -1.12 0.001
CG10512-RA CG10512 -1.82 0.001 CG6104-RA m2 -1.68 0.001
CG9449-RB CG9449 -1.03 0.001 CG13211-RA CG42336 -1.17 0.001
CG2969-RA Atet -1.23 0.005 CG9591-RA omd -1.40 0.001
CG3214-RA CG3214 -1.38 0.002 CG31104-RA CG31104 -1.03 0.003
CG6018-RA CG6018 -1.06 0.002 CG1212-RA p130CAS -1.00 0.002
CG9159-RA Kr-h2 -1.48 0.001 CG31533-RA CG31533 -1.00 0.006
CG9938-RA Ndc80 -1.25 0.001 CG13491-RA Gr58c -1.08 0.001
CG5242-RA mRpL40 -1.21 0.001 CG30092-RD jbug -1.57 0.001
CG18548-RA GstD10 -1.30 0.001 CG5399-RA CG5399 -1.43 0.002
CG10650-RA CG10650 -1.00 0.001 CG32659-RA Ten-a -1.55 0.001
CG4713-RA l(2)gd1 -1.00 0.001 CG14369-RA CG14369 -1.40 0.001
CG7761-RA pcs -1.63 0.001 CG13564-RA CG13564 -1.07 0.001
CG13845-RA CG34376 -1.53 0.001 CG11100-RA Mes2 -1.07 0.006
CG12725-RA CG12725 -1.14 0.001 CG31763-RA bru-2 -1.23 0.001
CG5611-RA CG5611 -1.33 0.001 CG14861-RA CG14861 -1.45 0.001
CG10160-RA ImpL3 -1.29 0.004 CG14632-RB CG14632 -1.07 0.001
CG5226-RA CG43066 -1.23 0.001 CG6536-RB mthl4 -1.06 0.001
CG14579-RA CG14579 -1.02 0.001 CG10749-RA CG10749 -1.08 0.001
CG32281-RA CG32281 -1.08 0.007 CG5690-RA CG5690 -1.80 0.001
CG14847-RA cv-c -1.15 0.002 CG17754-RD CG17754 -1.29 0.005
CG14972-RA CG42324 -1.33 0.001 CG4723-RA CG4723 -1.10 0.002
CG7367-RA CG7367 -1.13 0.004 CG11654-RA Ahcy13 -1.48 0.001
CG30339-RA CG30339 -1.05 0.001 CG4159-RA CG4159 -1.48 0.001
CG7532-RA l(2)34Fc -1.07 0.001 CG3380-RA Oatp58Dc -1.89 0.002
CG14542-RA vps2 -1.23 0.001 CG17267-RA CG17267 -1.54 0.001
CG13333-RA CG13333 -2.18 0.002 CG5369-RA CG34367 -1.06 0.002
CG11320-RA CG11320 -1.11 0.001 CG6763-RA CG6763 -1.22 0.002
CG3234-RC tim -1.04 0.001 CG17524-RA GstE3 -1.80 0.001
CG17054-RB Cap-G -1.59 0.001 CG2930-RD CG2930 -1.22 0.001
CG12481-RA CG12481 -1.00 0.002 CG3210-RA Drp1 -1.46 0.001
CG14723-RA HisCl1 -1.25 0.001 CR31273-RB bxd -1.24 0.001
CG4147-RA Hsc70-3 -1.76 0.001 CG10842-RA Cyp4p1 -1.09 0.001
CG17988-RA Ance-3 -1.15 0.004 CG32833-RA CG32833 -1.03 0.001
CG14889-RA CG42342 -1.02 0.001 CG2211-RA CG2211 -1.05 0.001
CG3687-RA CG3687 -1.08 0.002 CG31045-RC Mhcl -1.08 0.002
CG6965-RA mthl5 -1.20 0.001 CG13766-RA CG13766 -1.19 0.001
CG17843-RA CG17843 -1.21 0.001 CG31176-RA CG31176 -1.17 0.001
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CG17929-RA CG17929 -1.19 0.001 CG17824-RA CG17824 -1.19 0.001
CG13432-RA qsm -1.31 0.001 CG4206-RA Mcm3 -1.46 0.001
CG32356-RA ImpE1 -1.00 0.001 CG33316-RB sick -1.04 0.001
CG17839-RA CG17839 -1.32 0.001 CG11966-RA CG11966 -1.05 0.001
CG5744-RB Frq1 -1.09 0.001 CG6401-RA CG6401 -1.09 0.003
CG1722-RA CG1722 -1.11 0.001 CG30111-RA grh -1.15 0.001
CG11221-RA CG11221 -1.07 0.001 CG1499-RA nyo -1.63 0.001
CG32150-RA CG32150 -1.64 0.001 CG10122-RA RpI1 -1.79 0.001
CG15302-RA Or9a -1.02 0.001 CG1774-RA CG1774 -1.20 0.001
CG14680-RA Cyp12e1 -1.01 0.002 CG7598-RA CG7598 -1.02 0.001
CG3361-RA mrt -1.29 0.004 CG7937-RA C15 -1.16 0.002
CG30070-RA CG34443 -1.02 0.001 CG3114-RA ewg -1.83 0.001
CG7578-RA sec71 -1.54 0.001 CG6281-RB Timp -1.24 0.001
CG4846-RA beat-Ia -1.28 0.001 CG10734-RA CG10734 -1.00 0.001
CG33299-RA CG33299 -1.03 0.001 CG17795-RA mthl2 -1.09 0.001
CG18048-RA CG18048 -1.22 0.001 CG1480-RA bnk -1.47 0.002
CG14528-RA CG14528 -1.27 0.001 CG5646-RA CG5646 -1.14 0.001
CG31732-RA yuri -1.12 0.001 CG1427-RA CG1427 -1.15 0.001
CG32091-RB CG32091 -1.43 0.001 CG15009-RC ImpL2 -2.30 0.001
CG5660-RA CG5660 -1.05 0.001 CG14355-RA CG14355 -1.17 0.001
CG9903-RA CG9903 -1.04 0.001 CG4835-RA CG4835 -1.34 0.001
CG4786-RA Rcd2 -1.17 0.001 CG1840-RA CG1840 -1.02 0.001
CG14841-RA CG14841 -1.01 0.001 CR32901-RA snR38:54Ec -1.10 0.001
CG7565-RA CG7565 -1.13 0.001 CG8953-RA Actn3 -1.06 0.002
CG4386-RA CG4386 -1.08 0.004 CG9383-RA asf1 -1.52 0.001
CG5432-RA CG5432 -1.10 0.001 CG9519-RA CG9519 -1.14 0.001
CG30354-RA CG30354 -1.04 0.001 CG4439-RA S-Lap8 -1.04 0.001
CG13850-RA CG13850 -1.35 0.001 CG6690-RA CG6690 -1.21 0.001
CG30190-RA CG42678 -1.33 0.001 CG6939-RA Sbf -1.23 0.004
CG40042-RA CG40042 -1.96 0.001 CG10689-RA l(2)37Cb -1.38 0.001
CG13541-RA CG13541 -1.12 0.001 CG7462-RB Ank2 -1.03 0.001
CG5500-RA CG5500 -1.45 0.001 CG31936-RA Gr22e -1.13 0.001
CG9203-RA CG9203 -1.13 0.001 CG10698-RA GRHRII -1.34 0.001
CG5115-RB mun -1.19 0.001 CG1916-RA Wnt2 -1.92 0.001
CG5904-RA mRpS31 -1.23 0.001 CG9247-RA CG9247 -1.24 0.001
CG13721-RA CG13721 -1.08 0.001 CG16738-RA slp1 -1.38 0.001
CG30288-RA CG30288 -1.12 0.002 CG1655-RA sofe -1.51 0.001
CG18214-RB trio -1.49 0.001 CG1873-RA Ef1α100E -1.13 0.002
CG9463-RA CG9463 -1.12 0.001 CG9170-RA CG9170 -1.45 0.001
CG13737-RB CG13737 -1.06 0.001 CG12755-RB l(3)mbn -1.13 0.001
CG32005-RA pan -1.02 0.001 CG5387-RA Cdk5α -1.05 0.001
CG7368-RA CG7368 -1.28 0.001 CG18627-RA betaggt-II -1.59 0.001
CG12655-RA CG12655 -1.04 0.001 CG14068-RA dpr2 -1.01 0.001
CG13671-RA CG13671 -1.16 0.001 CG8486-RA CG8486 -1.15 0.007
CG1004-RA rho -1.82 0.002 CG12455-RB CG42817 -1.31 0.001
CG5147-RA CG5147 -1.47 0.001 CG6654-RA CG6654 -1.07 0.001
CG32568-RA CG32568 -1.40 0.001 CR30087-RA CG30087 -1.07 0.001
CG30486-RA CG30486 -1.47 0.001 CG5093-RA Doc3 -1.85 0.001
CG3917-RA Grip84 -1.22 0.001 CG32791-RA CG32791 -1.12 0.001
CG32832-RA CG32832 -1.14 0.001 CG6570-RA lbl -1.31 0.001
CG13659-RA CG13659 -1.30 0.001 CG6824-RA ovo -1.12 0.002
CG5562-RA gbb -1.96 0.001 CG9432-RA l(2)01289 -1.14 0.001
CG8564-RA CG8564 -1.04 0.001 CG30101-RA CG30101 -1.17 0.001
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CG32019-RA bt -1.52 0.001 CG11310-RA Cpr78Ca -1.05 0.001
CG10657-RA CG10657 -1.26 0.001 CG8858-RA CG8858 -1.04 0.001
CG12640-RA CG12640 -1.01 0.001 CG9987-RA CG9987 -1.20 0.001
CG16777-RA ps -1.46 0.001 CG12028-RA dib -1.28 0.001
CG13083-RB CG13083 -1.08 0.001 CG9885-RA dpp -1.33 0.001
CG3033-RA CG3033 -1.06 0.001 CG3897-RB blot -1.11 0.005
CG4871-RB ST6Gal -1.19 0.001 CG8184-RB CG8184 -1.38 0.001
CG4646-RA CG4646 -1.43 0.001 CG10011-RA CG10011 -1.43 0.001
CG18039-RA KaiRIA -1.30 0.001 CG3189-RA Dpit47 -1.45 0.001
CG5186-RA slim -1.68 0.001 CG5586-RB Tusp -1.07 0.001
CG31907-RA CG31907 -1.36 0.001 CR31271-RB iab-4 -1.08 0.001
CG10612-RA Or83a -1.12 0.001 CG6607-RA CG6607 -1.58 0.001
CG12072-RA wts -1.42 0.001 CG8127-RA Eip75B -1.67 0.001
CG12479-RA CG12479 -1.30 0.001 CG11255-RA CG11255 -1.06 0.002
CG32751-RA CG32751 -1.21 0.001 CG9509-RA CG9509 -1.25 0.001
CG4268-RD Pitslre -1.10 0.001 CG3222-RA CG3222 -1.04 0.001
CG14788-RA ns3 -1.28 0.001 CG3000-RA rap -1.37 0.001
CG4733-RA CG4733 -1.04 0.001 CG7883-RA eIF2B-α -1.25 0.001
CG7073-RC sar1 -1.49 0.001 CG13085-RA CG13085 -1.07 0.001
CG11453-RA CG11453 -1.22 0.001 CG18605-RA CG18605 -1.13 0.001
CG15628-RA CG15628 -1.30 0.001 CG30048-RA CG30048 -1.12 0.001
CG30052-RA Obp49a -1.03 0.001 CG14659-RA CG14659 -1.17 0.001
CG5261-RA CG5261 -1.16 0.001 CG14609-RA CG14609 -1.15 0.001
CG13627-RA CG13627 -1.04 0.002 CG14343-RA CG42329 -1.05 0.001
CG31839-RA nimB2 -1.08 0.001 CG3505-RA CG3505 -1.18 0.001
CG31116-RC ClC-a -1.65 0.001 CG7588-RA Eig71Ej -1.19 0.001
CG15116-RA CG15116 -1.03 0.001 CG3671-RA Mvl -1.14 0.001
CG31543-RA Hph -1.05 0.003 CG30078-RA trpm -1.07 0.001
CG4743-RA CG4743 -1.21 0.001 CG10922-RA La -1.88 0.001
CG10822-RA CG10822 -1.28 0.001 CG14981-RB mge -1.60 0.001
CG13549-RA yip3 -1.17 0.001 CG31702-RA CG31702 -1.29 0.001
CG16993-RA in -1.31 0.001 CG4995-RB CG4995 -1.25 0.001
CG10913-RA Spn6 -1.43 0.001 CG32376-RA CG32376 -1.17 0.001
CG33264-RB Or69a -1.31 0.001 CG31647-RA CG31647 -1.27 0.001
CG17352-RC CG17352 -1.90 0.001 CG31280-RA Gr94a -1.12 0.001
CG12926-RA CG12926 -1.20 0.001 CG6957-RA Oscillin -1.41 0.001
CG18507-RB CG18507 -1.38 0.001 CG10946-RA dpr14 -1.08 0.001
CG5621-RA CG5621 -1.29 0.001 CG15085-RA edl -2.03 0.002
CG30038-RA MCPH1 -1.31 0.001 CG10958-RA CG10958 -1.12 0.001
CG33221-RA CR33221 -1.16 0.001 CG10861-RA Atg12 -1.27 0.001
CG6404-RA CG6404 -1.16 0.002 CG4815-RA CG4815 -1.16 0.001
CG6450-RC lva -1.35 0.001 CG18023-RA Eip78C -1.03 0.001
CG3731-RA CG3731 -1.43 0.002 CG31093-RA CG31093 -1.19 0.001
CG1391-RB sol -1.21 0.002 CG1367-RA CecA2 -1.04 0.001
CG4330-RA CG4330 -1.36 0.002 CG14329-RA CG14329 -1.11 0.001
CG1794-RA Mmp2 -1.23 0.001 CG3652-RA CG3652 -1.46 0.001
CG5722-RA Npc1a -1.00 0.001 CG9820-RA Or59a -1.19 0.001
CG18537-RA CG18537 -1.25 0.001 CG4220-RC elB -1.14 0.001
CG33464-RA CG33464 -1.38 0.001 CG5326-RA CG5326 -1.08 0.001
CG4778-RA obst-B -1.10 0.001 CG10479-RA CG10479 -1.94 0.001
CG6705-RA tsl -1.31 0.001 CG15017-RA CG33514 -1.32 0.001
CG2846-RA CG2846 -1.16 0.001 CG11051-RA Nplp2 -1.89 0.001
CG1028-RH Antp -1.60 0.001 CG32263-RA CG32263 -1.05 0.001
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CG32023-RA CG32023 -1.14 0.001 CG17737-RA CG17737 -1.39 0.001
CG10882-RA gho -1.14 0.001 CG7669-RA CG7669 -1.14 0.001
CG3513-RA CG3513 -1.02 0.001 CG11249-RA CG11249 -1.12 0.001
CG5670-RE Atpalpha -1.38 0.001 CG32236-RA CG32236 -1.36 0.001
CG15029-RA CG15029 -1.05 0.001 CG5680-RB bsk -1.71 0.003
CG6459-RA CG6459 -1.60 0.001 CG1438-RA Cyp4c3 -1.20 0.001
CG9868-RA Prosbeta5R -1.03 0.001 CG1102-RA MP1 -1.20 0.001
CG32922-RB Skeletor -1.30 0.001 CG8085-RB RN-tre -1.13 0.001
CG16879-RA CG16879 -1.27 0.001 CG2955-RA CG2955 -1.00 0.001
CG5407-RA Sur-8 -1.02 0.003 CG8821-RB vis -1.23 0.001
CG4422-RA Gdi -1.67 0.001 CG32692-RA CG32694 -1.05 0.001
CG1239-RA CG1239 -1.17 0.001 CG12432-RA CG12432 -1.03 0.001
CG1897-RA Dr -1.50 0.001 CG1066-RB Shab -1.25 0.001
CG18302-RA CG18302 -1.09 0.001 CG5059-RA CG5059 -1.88 0.001
CG3285-RA CG3285 -1.24 0.001 CG12502-RA CG12502 -1.00 0.001
CG10717-RB ImpL1 -1.10 0.001 CG9397-RA jing -1.18 0.001
CG10166-RA CG10166 -1.58 0.001 CG4527-RA slik -1.36 0.002
CG8454-RA Vps16A -1.23 0.001 CG5168-RA CG5168 -1.03 0.001
CG6728-RA ninaG -1.18 0.002 CG14095-RA CG14095 -1.01 0.001
CG1072-RB Awh -1.40 0.001 CG1942-RA CG1942 -1.55 0.001
CG12682-RA CG12682 -1.02 0.001 CG8603-RA Shroom -1.45 0.001
CG32953-RA CG14929 -1.01 0.001 CG18156-RA Mis12 -1.67 0.001
CG5028-RA CG5028 -1.16 0.001 CG9259-RA CG9259 -1.03 0.001
CG7512-RA CG7512 -1.19 0.001 CG12624-RA Ir10a -1.06 0.001
CG4627-RA CG4627 -1.05 0.001 CG18250-RC Dg -1.03 0.001
CG13810-RA CG13810 -1.34 0.001 CR32865-RA CR32865 -1.96 0.001
CG16716-RB CG16716 -1.12 0.001 CG8196-RA Ance-4 -1.24 0.002
CG12151-RA Pdp -1.18 0.001 CG13801-RA CG13801 -1.20 0.001
CG5341-RA sec6 -1.38 0.001 CG7549-RA mtg -1.12 0.001
CG6547-RA mRpL37 -1.66 0.001 CG32029-RA Cpr66D -1.09 0.001
CG32717-RC sdt -1.87 0.001 CG13868-RA CG13868 -1.95 0.001
CG13700-RA CG13700 -1.07 0.001 CG6850-RA Ugt -1.47 0.001
CG12493-RA CG12493 -1.24 0.001 CG18231-RA CG18231 -1.37 0.001
CG3258-RA ase -1.50 0.002 CG9994-RA Rab9 -1.18 0.001
CG4477-RB CG4477 -1.25 0.001 CG8166-RA unc-5 -1.86 0.002
CG8443-RA clu -1.00 0.001 CG5107-RA CG5107 -1.21 0.001
CG1273-RB CG1273 -1.01 0.001 CG16886-RA CG16886 -1.23 0.001
CG16820-RA CG16820 -1.24 0.001 CG14411-RA CG14411 -1.14 0.003
CG9499-RA ppk7 -1.04 0.001 CG6618-RB Patsas -1.25 0.001
CG6893-RA CG6893 -1.17 0.001 CG5591-RA CG5591 -1.35 0.001
CG8114-RA pbl -1.79 0.001 CG10109-RA L -1.79 0.001
CG30163-RA Cpr60D -1.17 0.001 CG9308-RA CG9308 -1.28 0.001
CG8885-RA Scox -1.01 0.004 CG10077-RB CG10077 -1.65 0.001
CG12673-RA olf413 -1.29 0.001 CG11219-RA PIP82 -1.13 0.001
CR12953-RA Ir51a -1.19 0.001 CG40053-RA CG40053 -1.07 0.004
CG4500-RA CG4500 -2.05 0.001 CG5073-RA CG5073 -1.56 0.001
CG13279-RA Cyt-b5-r -1.15 0.001 CG3295-RA CG3295 -1.06 0.003
CG6754-RB nbs -1.16 0.001 CG12384-RA CG12384 -1.42 0.003
CG9528-RA retm -1.44 0.001 CG9760-RB CG9760 -1.26 0.001
CG1108-RA alpha-Est6 -1.45 0.001 CG7973-RA obst-H -1.46 0.001
CG33136-RA CG33136 -1.22 0.001 CG16779-RA CG16779 -1.04 0.001
CG7100-RE CadN -1.43 0.001 CG16963-RA Cry -1.13 0.001
CG9125-RA CG9125 -1.30 0.001 CG9323-RA CG9323 -1.12 0.002
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CG10327-RB TBPH -1.86 0.003 CG7814-RA CG34133 -1.00 0.003
CG8231-RA Tcp-1zeta -1.41 0.002 CG4568-RA fzo -1.25 0.001
CG16947-RA CG16947 -1.13 0.001 CG1333-RA Ero1L -1.09 0.001
CG13332-RA CG13332 -1.05 0.001 CG4329-RA CG4329 -1.15 0.001
CG6751-RA CG6751 -1.65 0.001 CG3124-RA CG3124 -1.18 0.001
CG10078-RB Prat2 -1.57 0.002 CG13586-RA itp -1.41 0.001
CG2157-RA CG2157 -1.46 0.001 CG7961-RB alphaCop -1.56 0.001
CG3851-RA odd -1.95 0.001 CG5000-RA msps -1.41 0.001
CG6889-RB tara -1.80 0.004 CG32508-RB shakB -1.23 0.001
CG18768-RD Ank2 -1.02 0.009 CG13314-RA CG13314 -1.05 0.001
CG8791-RA CG8791 -1.09 0.001 CG7768-RA CG7768 -1.37 0.002
CG14013-RA CG14013 -1.15 0.001 CG33099-RA CG33099 -1.82 0.002
CG6878-RA CG6878 -1.22 0.002 CG10933-RA CG10933 -1.58 0.004
CG1809-RA CG1809 -1.15 0.003 CG2865-RA CG2865 -1.37 0.002
CG17732-RA CG17732 -1.09 0.001 CG4927-RA CG4927 -1.11 0.001
CG7189-RA Gr66a -1.31 0.001 CG4676-RA CG4676 -1.33 0.002
CG11043-RA CG11043 -1.18 0.001 CG1221-RA miple -1.54 0.001
CG12290-RA CG12290 -1.30 0.001 CG14237-RA CG14237 -1.20 0.006
CG8222-RD Pvr -1.53 0.001 CG5871-RA Oga -1.10 0.002
CG7758-RA ppl -1.27 0.002 CG6845-RA CG6845 -1.35 0.001
CG10307-RA CG10307 -1.07 0.003 CG7802-RB neo -1.15 0.003
CG15626-RA CG15626 -1.24 0.003 CG4604-RA GLaz -1.11 0.002
CG8965-RA CG8965 -1.65 0.001 CG9035-RA Tapdelta -2.24 0.001
CG11052-RA CG11052 -1.18 0.001 CG17046-RA klar -1.96 0.001
CG12327-RA Best3 -1.02 0.001 CG8380-RA DAT -1.38 0.001
CG4641-RA CG4641 -1.23 0.001 CG8913-RA Irc -1.65 0.001
CG13390-RA CG13390 -1.15 0.001 CG16998-RA CG16998 -1.14 0.001
CG17147-RA CG17147 -1.14 0.001 CG8458-RA wntD -1.25 0.002
CG10176-RA CG10176 -1.29 0.001 CG13654-RA CG13654 -1.27 0.003
CG12908-RB Ndg -1.34 0.001 CG6337-RA CG6337 -1.03 0.001
CG16954-RB Hsp60D -1.18 0.001 CG13139-RA lft -1.82 0.001
CG11942-RA skpE -1.06 0.001 CG10230-RA Rpn9 -1.23 0.002
CG7250-RA Toll-6 -2.14 0.001 CG32404-RA Cpr65Aw -1.26 0.001
CG5010-RA CG5010 -1.33 0.001 CG5793-RA CG5793 -1.48 0.001
CG10992-RA CG10992 -1.55 0.001 CG7134-RA cdc14 -1.17 0.001
CG10261-RA aPKC -1.49 0.001 CG31777-RA CG31777 -1.28 0.001
CG33129-RA CG33129 -1.22 0.001 CG11909-RA tobi -1.35 0.001
CG15006-RA Cpr64Aa -1.19 0.001 CG7017-RA CG7017 -1.17 0.001
CG2104-RA CG2104 -1.10 0.001 CG14638-RA TwdlU -1.12 0.001
CG11865-RA CG11865 -1.30 0.001 CG7376-RA CG7376 -1.15 0.002
CG15661-RA CG15661 -1.04 0.001 CG5063-RA Trax -1.05 0.004
CG13124-RB CG13124 -1.43 0.001 CG1998-RA CG1998 -1.07 0.001
CG9656-RA grn -1.59 0.001 CG31097-RA CG31097 -1.05 0.001
CG33349-RA ppk25 -1.17 0.001 CG9631-RA CG9631 -1.19 0.001
CG16785-RA fz3 -1.09 0.006 CG6083-RA CG6083 -1.04 0.001
CG11922-RA fd96Cb -1.09 0.001 CG3982-RA CG3982 -1.00 0.005
CG14254-RA TwdlC -1.06 0.001 CG11767-RA Or24a -1.14 0.001
CG31662-RA Gr22a -1.12 0.001 CG30179-RA Mlp60A -1.08 0.001
CG1528-RA gammaCop -1.34 0.006 CG13198-RA CG13198 -1.02 0.001
CG33197-RA mbl -1.20 0.001 CG15066-RA IM23 -1.03 0.001
CG5810-RA CG5810 -1.21 0.001 CG32346-RA E(bx) -1.55 0.001
CG11330-RA cort -1.01 0.001 CG30385-RA CG30385 -1.02 0.002
CG15461-RA CG15461 -1.21 0.001 CG7330-RA CG7330 -1.11 0.001
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CG2448-RA FucT6 -1.40 0.002 CG3403-RA Mob4 -1.78 0.001
CG32094-RA CG42255 -1.09 0.001 CG7464-RA CS-2 -1.38 0.001
CG14087-RA CG14087 -1.51 0.001 CG17390-RA Oaz -1.10 0.001
CG3556-RA CG3556 -1.01 0.001 CG3460-RA Nmd3 -1.51 0.003
CG5583-RA Ets98B -1.06 0.001 CG3352-RA ft -1.86 0.003
CG31014-RA PH4αSG1 -1.14 0.001 CG3829-RA CG3829 -1.65 0.001
CG6041-RA CG6041 -1.21 0.001 CG9746-RA ird1 -1.21 0.002
CG9701-RA CG9701 -1.22 0.001 CG32139-RA Sox21b -1.07 0.001
CG6027-RA cdi -1.22 0.001 CG31405-RA Gr85a -1.22 0.001
CG7365-RA CG7365 -1.15 0.001 CG11418-RA CG11418 -1.03 0.001
CG6329-RB CG6329 -1.28 0.001 CG11656-RA CG11656 -1.03 0.001
CG4035-RE eIF-4E -1.23 0.001 CG1968-RB CG1968 -1.27 0.001
CG1448-RA inx3 -2.34 0.001 CG15387-RA CG15387 -1.86 0.001
CG32042-RE PGRP-LA -1.22 0.001 CG6356-RA CG6356 -1.46 0.001
CG9148-RA scf -1.73 0.002 CG15438-RA CG15438 -1.18 0.002
CG9614-RA pip -1.32 0.001 CG10481-RA CG10481 -1.08 0.001
CG6069-RA CG34129 -1.22 0.001 CG9494-RA Tsp29Fa -1.17 0.001
CG33227-RB CG34370 -1.16 0.001 CG11821-RA Cyp12a5 -1.19 0.001
CG15427-RD tutl -1.33 0.001 CG8660-RC Fibp -1.04 0.001
CG13190-RA cuff -1.42 0.001 CG9614-RC pip -1.21 0.001
CG6421-RA CG6421 -1.26 0.001 CG8673-RA CG8673 -1.00 0.001
CG33098-RB CG33098 -1.16 0.001 CG33339-RA CG33339 -1.10 0.001
CG9564-RA Try29F -1.21 0.001 CG3212-RA Sr-CIV -1.27 0.001
CG31089-RA CG31089 -1.38 0.001 CG33287-RA CG33287 -1.27 0.001
CG6034-RA CG6034 -1.16 0.001 CG13025-RA CG13025 -1.45 0.001
CG14147-RA CG14147 -1.06 0.001 CG14815-RA CG14815 -1.04 0.001
CG31020-RA spdo -1.15 0.001 CG10405-RA CG10405 -1.05 0.001
CG15025-RA CG15025 -1.14 0.001 CG15403-RA CG15403 -1.32 0.001
CG17334-RA lin-28 -1.38 0.001 CG15902-RA Ugt86Dj -1.16 0.001
CG15361-RA Nplp4 -1.13 0.001 CG9911-RA CG9911 -1.40 0.001
CR31273-RD bxd -1.03 0.001 CG8141-RA CG8141 -1.15 0.001
CG33045-RG Kaz1-ORFB -1.26 0.001 CG17721-RA CG17721 -1.59 0.001
CG9614-RJ pip -1.14 0.001 CG17117-RA hth -2.18 0.001
CG31161-RA CG31161 -1.29 0.001 CG7122-RA RhoGAP16F -1.22 0.003
CG16815-RA CG16815 -1.06 0.001 CG31225-RA Ir94f -1.04 0.001
CG9422-RA CG9422 -1.01 0.001 CG10382-RA wrapper -1.13 0.001
CG31766-RB Ance-3 -1.37 0.001 CG4596-RA CG4596 -1.14 0.001
CG12201-RA CG12201 -1.36 0.001 CG2835-RB G-sα60A -1.87 0.001
CG17063-RA inx6 -1.10 0.001 CG10561-RA CG10561 -1.01 0.001
CG18672-RA CG18672 -1.17 0.001 CG15122-RA Ir56c -1.07 0.001
CG14077-RA CG14077 -1.02 0.001 CG17212-RA rho-6 -1.06 0.001
CG13322-RB CG13322 -1.45 0.003 CG2191-RA Smvt -1.35 0.002
CG15735-RA CG15735 -1.02 0.004 CG17180-RA CG17180 -1.07 0.001
CG15605-RA CG15605 -1.27 0.001 CG3879-RA Mdr49 -1.18 0.001
CG5021-RA CG5021 -1.60 0.001 CG17191-RA CG17191 -1.19 0.001
CG3239-RA CG3239 -1.21 0.001 CG6203-RA Fmr1 -1.45 0.001
CG13421-RA Obp57c -1.18 0.001 CG2239-RC jdp -1.39 0.001
CG15553-RA CG15553 -1.13 0.001 CG13008-RA CG13008 -1.29 0.001
CG14618-RA CG14618 -1.02 0.002 CG13285-RA CG13285 -1.30 0.001
CG17224-RA CG17224 -1.19 0.002 CG33113-RG Rtnl1 -1.07 0.001
CG6806-RA Lsp2 -1.15 0.001 CG10960-RA CG10960 -1.00 0.001
CG32425-RB CG32425 -1.20 0.001 CG7264-RA CG7264 -1.05 0.001
CG12837-RA Tsp42Er -1.05 0.001 CG4947-RA Tgt -1.01 0.001
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CG12241-RA CG12241 -1.42 0.001 CG12311-RA tw -1.41 0.001
CG8245-RA CG8245 -1.01 0.001 CG2522-RA Gtp-bp -1.30 0.001
CG32410-RA CG33523 -1.14 0.001 CG5909-RA CG5909 -1.21 0.001
CG6868-RA tld -1.41 0.003 CG1650-RA unpg -1.20 0.001
CG6304-RA CG6304 -1.30 0.001 CG8577-RA PGRP-SC1b -1.28 0.001
CG17134-RA CG17134 -1.20 0.001 CG10335-RA Pbgs -1.40 0.001
CG11205-RB phr -1.32 0.001 CG4582-RA CG4582 -1.29 0.001
CG9449-RA CG9449 -1.60 0.001 CG4620-RA unk -1.40 0.001
CG9160-RA mtacp1 -1.07 0.009 CG10108-RA phyl -1.69 0.003
CG33121-RA Spn28Db -1.07 0.001 CG10970-RA CG10970 -1.30 0.001
CG8353-RA CG8353 -1.50 0.001 CG4977-RA kek2 -1.26 0.001
CG5803-RA Fas3 -1.89 0.001 CG15115-RA CG15115 -1.10 0.001
CG17662-RA CG17662 -1.03 0.001 CG33093-RA CG33093 -1.08 0.001
CG31848-RA CG31848 -1.27 0.001 CG11498-RA CG11498 -1.22 0.001
CG7911-RA CG7911 -1.78 0.002 CG31761-RA bru-2 -1.37 0.001
CG3815-RA CG3815 -1.10 0.001 CG3758-RA esg -1.02 0.001
CG14811-RA CG14811 -1.06 0.001 CG2713-RA ttm50 -1.38 0.001
CG1828-RA dre4 -1.22 0.009 CG7748-RA OstStt3 -1.95 0.001
CG15259-RA nht -1.16 0.001 CG31287-RA CG31287 -1.05 0.002
CG12948-RA CG12948 -1.60 0.001 CG18545-RA CG18545 -1.15 0.001
CG13920-RA CG13920 -1.53 0.003 CG12934-RA CG12934 -1.16 0.001
CG16971-RB CR42862 -1.55 0.003 CG13400-RA D12 -1.33 0.001
CG7676-RA cona -1.26 0.001 CG7276-RA CG7276 -1.38 0.001
CG32428-RA CG32428 -1.07 0.001 CG9981-RA CG9981 -1.15 0.001
CG5030-RA CG34139 -1.23 0.001 CG15224-RA CkIIbeta -1.38 0.001
CG10287-RA Gasp -1.11 0.001 CG5949-RA DNApol-δ -1.04 0.001
CG11949-RA cora -1.70 0.001 CG11778-RA CG11778 -1.24 0.001
CG11575-RA Ir100a -1.20 0.001 CG7227-RA CG7227 -1.05 0.001
CG11886-RA Slbp -1.35 0.001 CG31622-RB Gr39a -1.00 0.001
CG30156-RA CG30156 -1.03 0.001 CG17304-RA CG17304 -1.02 0.001
CG9076-RA Cpr47Ed -1.06 0.001 CG15778-RA CG42449 -1.06 0.001
CG31501-RA nxf4 -1.09 0.001 CG7321-RA Rim -1.13 0.001
CG15725-RA CG15725 -1.16 0.001 CG14704-RA PGRP-LB -1.03 0.001
CG2144-RA CG2144 -1.24 0.004 CG9273-RA RPA2 -1.06 0.004
CG31651-RA pgant5 -1.69 0.001 CG10540-RA cpa -1.43 0.001
CG1317-RB CG1317 -1.05 0.002 CG13160-RA CG13160 -1.04 0.001
CG1155-RA Osi14 -1.06 0.001 CG2110-RA Cyp4ad1 -1.30 0.001
CG3345-RA CG3345 -1.07 0.001 CG9704-RA Nrt -1.46 0.001
CG32092-RB CG42255 -1.15 0.001 CG10390-RA mia -1.37 0.001
CG14120-RA CG14120 -1.39 0.001 CG13110-RA CG13110 -1.12 0.001
CG9784-RA CG9784 -1.04 0.001 CG6117-RA Pka-C3 -1.33 0.001
CG33265-RA Muc68E -1.11 0.002 CG4120-RA Cyp12c1 -1.44 0.001
CG10560-RA CG10560 -1.10 0.001 CG7454-RA Or85a -1.04 0.001
CG15818-RA CG15818 -1.02 0.001 CG9952-RA ppa -1.67 0.001
CG32105-RB CG32105 -1.22 0.001 CG33489-RA CG33489 -1.02 0.001
CG13221-RA Vhl -1.19 0.001 CG5656-RA CG5656 -1.60 0.001
CG15478-RA CG15478 -1.01 0.001 CG6136-RA CG6136 -1.26 0.001
CG1429-RF Mef2 -1.03 0.001 CG4017-RA CG4017 -1.07 0.001
CG30431-RA CG30431 -1.44 0.001 CG13067-RA CG13067 -1.04 0.001
CG1600-RC CG1600 -1.30 0.001 CG15483-RA CG15483 -1.10 0.001
CG3423-RA SA -1.74 0.001 CG33481-RA dpr7 -1.30 0.001
CG31414-RA CG31414 -1.41 0.001 CG17195-RA CG17195 -1.17 0.001
CG7760-RA cato -1.30 0.001 CG14116-RA CG34428 -1.41 0.001
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CG17461-RA Kif3C -1.00 0.001 CG7306-RA obst-F -1.34 0.001
CG4128-RE nAcRα-30D -1.30 0.001 CG2082-RA CG2082 -1.03 0.001
CG33323-RA Fer1 -1.05 0.001 CG31645-RA CG34381 -1.05 0.001
CG31319-RA cv-c -1.50 0.001 CG40249-RA CG40249 -1.41 0.001
CG11459-RA CG11459 -1.16 0.001 CG3385-RA nvy -1.16 0.001
CG31538-RA CG31538 -1.23 0.001 CG6056-RA AP-2sigma -1.61 0.001
CG9722-RA CG9722 -1.11 0.001 CG32159-RB dsx-c73A -1.02 0.001
CG1984-RA djl -1.26 0.001 CG14720-RA CG14720 -1.10 0.001
CG2093-RA Vps13 -1.72 0.001 CG9603-RA CG9603 -1.93 0.001
CG11630-RA CG11630 -1.25 0.001 CG31370-RA CG31370 -1.32 0.001
CG6103-RD CrebB-17A -1.12 0.001 CG11395-RA CG11395 -1.10 0.001
CG9884-RA oaf -1.04 0.002 CG31009-RA Cad99C -1.17 0.003
CG8644-RA Osi22 -1.03 0.001 CG2275-RB Jra -1.27 0.001
CG9630-RA CG9630 -1.36 0.001 CG6467-RA Jon65Aiv -1.06 0.001
CG33456-RA mute -1.09 0.001 CG31364-RA l(3)neo38 -1.85 0.001
CG31332-RA Unc-115b -1.98 0.001 CG15440-RA CG15440 -1.05 0.001
CG12770-RA Vps28 -1.10 0.002 CG3088-RA CG3088 -1.17 0.001
CG17320-RA ScpX -1.30 0.001 CG13487-RA Fili -1.39 0.001
CG5237-RA unc79 -1.18 0.001 CG30067-RB Obp50a -1.06 0.001
CG5398-RA CG5398 -1.02 0.001 CG2989-RA Cht6 -1.08 0.002
CG32639-RA CG32639 -1.23 0.002 CG4710-RA Pino -1.13 0.002
CG14366-RA CG34383 -1.33 0.001 CG7756-RA Hsc70-2 -1.38 0.001
CG13842-RA CG13842 -1.19 0.001 CG5610-RA nAcRα-96Aa -1.00 0.001
CG1856-RD ttk -1.92 0.001 CG3132-RA Ect3 -1.73 0.001
CG1447-RB Ptx1 -1.25 0.005 CG5225-RA CG5225 -1.29 0.001
CG12052-RU lola -1.03 0.003 CG3702-RA CG3702 -1.57 0.003
CG32280-RA CG32280 -1.62 0.002 CG3368-RA CG3368 -1.28 0.003
CG17754-RA CG17754 -1.10 0.004 CG4722-RA bib -2.03 0.003
CG7335-RA CG7335 -1.18 0.004 CG4158-RA wor -1.72 0.002
CG6484-RA CG6484 -1.09 0.002 CG18314-RA DopEcR -1.01 0.001
CG31177-RA CG42335 -1.09 0.004 CG2906-RA CG2906 -1.45 0.001
CG33061-RA CG33061 -1.01 0.005 CG6931-RA CG6931 -1.10 0.001
CG14693-RA CG14693 -1.34 0.001 CG5597-RA CG5597 -1.07 0.007
CG2937-RA mRpS2 -1.57 0.002 CG18507-RA CG18507 -1.13 0.008
CG3456-RA Mct1 -1.20 0.008 CG3669-RA CG3669 -1.06 0.002
CG7013-RA Manf -1.57 0.001 CG1339-RA Gr43b -1.24 0.001
CG11208-RA CG11208 -1.14 0.004 CG17840-RA CG17840 -1.20 0.001
CG5348-RA CG5348 -1.20 0.001 CG9752-RA CG9752 -1.23 0.001
CG3715-RA Shc -1.52 0.002 CG6919-RA oa2 -1.09 0.001
CG18493-RA CG18493 -1.10 0.001 CG7463-RA yellow-k -1.10 0.001
CG5740-RA CG42390 -1.14 0.001 CG17190-RA CG17190 -1.19 0.001
CG1442-RA eIF4E-6 -1.29 0.001 CG10591-RA CG10591 -1.27 0.006
CG14999-RA RfC4 -1.20 0.002 CG10121-RB SP1173 -1.21 0.003
CG1851-RA Ady43A -1.13 0.009 CG17645-RA Pglym87 -1.19 0.001
CG1076-RA Vha14-2 -1.02 0.006 CG3399-RA capu -1.26 0.007
CG32664-RA Gr10a -1.24 0.001 CG18581-RA CG18581 -1.01 0.006
CG4845-RA psidin -1.10 0.005 CG17786-RA CG17786 -1.45 0.003
CG31251-RA CG31251 -1.05 0.002 CG3172-RA twf -1.17 0.004
CG15009-RB ImpL2 -1.84 0.002 CG4827-RA veil -1.06 0.001
CG31900-RA CG43394 -1.32 0.001 CG9381-RA mura -1.32 0.001
CG32666-RB Drak -1.36 0.001 CG8026-RB CG8026 -1.12 0.001
CG10621-RA CG10621 -1.74 0.003 CG12404-RA CG12404 -1.17 0.001
CG4438-RA CG4438 -1.03 0.001 CG8896-RA 18w -1.80 0.003
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CG31867-RA CG31867 -1.11 0.001 CG30447-RA CG30447 -1.00 0.001
CG11196-RA Dic3 -1.07 0.001 CG32845-RA CG32845 -1.54 0.001
CG40041-RB Gpb5 -1.11 0.001 CR33319-RA CR33319 -1.19 0.001
CG14455-RA CG14455 -1.22 0.001 CG3808-RA CG3808 -1.18 0.002
CG5498-RB CG5498 -1.43 0.001 CG5137-RA Cyp312a1 -1.12 0.001
CG6646-RA DJ-1alpha -1.17 0.001 CG4793-RB CG4793 -1.34 0.001
CG10695-RA Pat1 -1.45 0.001 CG5111-RA CG5111 -1.10 0.001
CG30383-RA CG30383 -1.12 0.001 CG5474-RA SsRbeta -1.72 0.001
CG11145-RA CG11145 -1.05 0.001 CG8581-RA fra -1.07 0.001
CG13720-RA CG13720 -1.26 0.001 CG12592-RA CG12592 -1.30 0.003
CG16736-RA CG16736 -1.17 0.001 CG30287-RA CG30287 -1.37 0.001
CR32477-RA CR42862 -2.01 0.003 CG11262-RA CG11262 -1.17 0.001
CG18731-RA CG18731 -1.54 0.001 CG5509-RA CG5509 -1.21 0.001
CG13059-RA CG13059 -1.33 0.001 CG9121-RA CG9121 -1.19 0.001
CG5249-RA Blimp-1 -1.65 0.001 CG13738-RA CG13738 -1.25 0.001
CG12754-RA Or42b -1.09 0.001 CG8075-RA Vang -1.24 0.001
CG13827-RA CG13827 -1.47 0.001 CG12620-RA CG12620 -1.02 0.001
CG18619-RD CG18619 -1.17 0.001 CG10047-RA Syt4 -1.66 0.001
CG31858-RA t-cup -1.09 0.001 CG6653-RA Ugt86De -1.13 0.001
CG16726-RA CG33696 -1.46 0.001 CG12370-RA Dh44-R2 -1.06 0.001
CG8134-RA CG8134 -1.00 0.001 CR30068-RA CR30068 -1.29 0.001
CG8843-RA sec5 -1.11 0.004 CG8417-RA CG8417 -1.26 0.001
CG5078-RA CG5078 -1.07 0.001 CG12023-RA GV1 -1.14 0.001
CG3916-RA CG3916 -1.02 0.001 CG16786-RA CG16786 -1.06 0.001
CG1056-RA 5-HT2 -1.17 0.001 CG9266-RB CG42238 -1.53 0.001
CG16834-RA lectin-33A -1.28 0.001 CG6514-RA TpnC25D -1.00 0.001
CG6569-RA CG6569 -1.06 0.001 CG13658-RA CG13658 -1.22 0.001
CG6803-RC Mf -1.11 0.001 CG3625-RB CG3625 -1.77 0.001
CG6599-RA CG42534 -1.07 0.001 CG1130-RA scrt -1.81 0.001
CG8856-RA Sr-CII -1.22 0.004 CG1263-RB RpL8 -1.03 0.001
CG7204-RA Neu2 -1.14 0.001 CG3956-RA sna -1.85 0.001
CG13653-RA CG13653 -1.15 0.001 CG12920-RA CG12920 -1.02 0.001
CG9792-RA yellow-e -1.26 0.001 CG5737-RA dmrt93B -1.15 0.001
CG30338-RA CG30338 -1.13 0.001 CG3896-RA Nox -1.06 0.002
CG4842-RA CG4842 -1.00 0.001 CG6441-RA CG6441 -1.29 0.001
CG8007-RA CG42796 -1.25 0.001 CG5050-RA CG5050 -1.00 0.001
CG12799-RA Ubc84D -1.20 0.001 CG5892-RA CG5892 -1.11 0.001
CG13833-RA CG13833 -1.00 0.001 CG31906-RA Ndae1 -1.32 0.001
CR31271-RA iab-4 -1.27 0.001 CG30151-RA CG30151 -1.15 0.001
CG12758-RB sano -1.63 0.001 CG12478-RA bru-3 -1.10 0.001
CG13154-RA CG13154 -1.02 0.001 CG32750-RA CG32750 -1.22 0.001
CG9508-RA CG42370 -1.08 0.001 CG13527-RA CG13527 -1.09 0.001
CG5267-RA CG5267 -1.15 0.001 CG32228-RA CG32228 -1.00 0.001
CG13475-RA HGTX -1.05 0.001 CG5421-RA CG5421 -1.32 0.001
CG30008-RA CG30008 -1.19 0.001 CG4211-RA nonA -1.25 0.001
CG32712-RA CG32712 -1.06 0.001 CG14049-RA Ilp6 -1.31 0.001
CG18412-RA ph-p -1.44 0.002 CG15617-RA CG15617 -1.13 0.001
CG14502-RB CG14502 -1.11 0.001 CG3625-RA CG3625 -1.72 0.007
CG14608-RA CG14608 -2.15 0.001 CG10772-RA Fur1 -1.17 0.002
CG13624-RA CG13624 -1.29 0.001 CG7586-RA Mcr -1.46 0.002
CG14940-RA Pde1c -1.01 0.001 CG3517-RA CG3517 -1.20 0.001
CG14993-RA Faa -0.81 0.002 CG4742-RA mRpL22 -1.18 0.001
CG7496-RA PGRP-SD -1.21 0.001 CG14981-RA mge -1.47 0.001
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CG4185-RA NC2beta -1.18 0.001 CG7554-RA comm2 -1.62 0.001
CG14562-RA CG14562 -1.08 0.001 CG4853-RB CG4853 -1.27 0.001
CG4963-RA mfrn -1.08 0.001 CG10809-RA CG10809 -1.37 0.003
CG7079-RA CG7079 -1.12 0.001 CG6993-RA ss -1.25 0.001
CG4319-RA rpr -1.84 0.002 CG31624-RA CG31624 -1.01 0.002
CG33159-RA CG33159 -1.07 0.001 CG30035-RA Tret1-1 -1.65 0.001
CG5973-RA CG5973 -1.36 0.001 CG17564-RB CG17564 -1.36 0.001
CG4170-RD vig -1.45 0.002 CG6403-RA CG6403 -1.02 0.001
CG2939-RA slp2 -1.01 0.001 CG11121-RA so -1.34 0.001
CG13916-RA SA-2 -1.09 0.001 CG17776-RA CG17776 -1.46 0.001
CG14328-RA CG34281 -1.27 0.001 CG1345-RA Gfat2 -1.25 0.001
CG5721-RA CG5721 -1.35 0.001 CG17871-RB Or71a -1.29 0.001
CG8095-RB scb -1.29 0.001 CG6692-RA Cp1 -1.38 0.001
CG32396-RA CG32396 -1.18 0.001 CG10284-RA CG42564 -1.17 0.001
CG15408-RA CG15408 -1.11 0.001 CG11470-RA CG11470 -1.05 0.001
CG14913-RA CG14913 -1.23 0.001 CG3430-RA CG3430 -1.10 0.001
CG30084-RB Zasp52 -1.55 0.003 CG13640-RA CG13640 -1.21 0.001
CG33206-RA Gmap -1.64 0.001 CG5315-RA CG5315 -1.41 0.001
CG33007-RA CG33007 -1.03 0.001 CG6545-RA lbe -1.01 0.001
CG10639-RA CG10639 -1.03 0.001 CG17821-RA CG17821 -1.01 0.002
CG14830-RA CG14830 -1.37 0.001 CG5670-RD Atpalpha -1.89 0.001
CG14497-RA CG34386 -1.19 0.001 CG32444-RA CG32444 -1.03 0.001
CG32161-RA CG32161 -1.20 0.001 CG5114-RA CG5114 -1.28 0.001
CG4803-RA Takl2 -1.12 0.001 CG18466-RB Nmdmc -1.20 0.001
CG11029-RA CG11029 -1.26 0.001 CG7614-RA Mat1 -1.01 0.001
CG4421-RA GstD8 -1.03 0.001 CG32690-RA CR32690 -1.09 0.001
CG8936-RA Arpc3B -1.18 0.001 CG9539-RA Sec61alpha -1.76 0.001
CG30372-RA CG30372 -1.36 0.001 CG12443-RA ths -1.10 0.001
CG18096-RA TepI -1.25 0.001 CG8053-RB eIF-1A -1.03 0.001
CG13050-RA CG13050 -1.31 0.001 CG4463-RA Hsp23 -1.22 0.001
CG8927-RA CG8927 -1.14 0.001 CG5058-RD grh -1.80 0.001
CG32680-RB spri -1.08 0.001 CG30268-RA CG30268 -1.26 0.002
CG31882-RA CG31882 -1.27 0.001 CG32859-RA eIF4E-7 -1.15 0.001
CG10021-RD bowl -1.82 0.001 CG4006-RA Akt1 -1.35 0.001
CG12501-RA Or56a -1.03 0.001 CG1070-RC Alh -1.56 0.001
CG13632-RA CG42331 -1.16 0.001 CG9392-RA CG9392 -1.08 0.001
CG12011-RA CG12011 -1.77 0.002 CG14384-RA CG14384 -1.08 0.001
CG4784-RA Cpr72Ec -1.07 0.001 CG4525-RA CG4525 -1.04 0.001
CG5526-RA Dhc36C -1.20 0.001 CG5507-RA T48 -1.23 0.001
CG9215-RA CG9215 -1.13 0.001 CG8051-RA CG8051 -1.07 0.001
CG12623-RA Ir10a -1.17 0.001 CG4589-RC Letm1 -1.24 0.001
CG16752-RA SPR -1.05 0.001 CG30329-RA Vha100-3 -1.34 0.001
CG12605-RB CG12605 -1.03 0.001 CG16700-RA CG16700 -1.12 0.001
CG1380-RB sut4 -1.25 0.001 CR32863-RA MeU5-C46 -1.37 0.001
CG11281-RA snky -1.18 0.001 CG16713-RA CG16713 -1.10 0.001
CG8192-RA CG8192 -1.34 0.001 CG1309-RA CG1309 -1.10 0.001
CG9396-RA CG9396 -1.08 0.001 CG13792-RA CG13792 -1.05 0.001
CG5576-RA imd -1.40 0.001 CG5441-RA tx -1.28 0.001
CG8097-RA CG8097 -1.61 0.001 CG13867-RA MED8 -1.02 0.001
CG18657-RA NetA -1.75 0.001 CG1271-RB CG1271 -1.08 0.001
CG8505-RA Cpr49Ae -1.01 0.001 CG31873-RA CG31873 -1.19 0.001
CG6098-RA Lrr47 -1.22 0.001 CR31400-RC Hsromega -2.29 0.001
CG5118-RA CG5118 -1.39 0.001 CG16885-RB CG16885 -1.08 0.001
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CG1681-RA CG1681 -1.57 0.001 CG3280-RA CG3280 -1.09 0.001
CG9504-RA Eo -1.14 0.001 CG9497-RA CG9497 -1.03 0.001
CG32850-RA CG32850 -2.15 0.002 CG5590-RA CG5590 -1.34 0.001
CG10145-RA mspo -1.07 0.001 CG32037-RA CG32037 -1.24 0.001
CG5154-RA Idgf5 -1.27 0.001 CG5481-RA lea -2.05 0.001
CG8546-RA CG8546 -1.06 0.001 CG3980-RB Cep97 -1.02 0.004
CG13129-RA CG34109 -1.23 0.001 CG8205-RE fus -1.50 0.001
CG4720-RB Pk92B -1.05 0.001 CG13263-RA Cyt-c-d -1.01 0.004
CR31808-RA CG31808 -1.34 0.001 CG12101-RA Hsp60 -1.17 0.004
CG8144-RC ps -1.69 0.001 CG30460-RC CG30460 -1.13 0.005
CG11086-RA Gadd45 -1.26 0.001 CG7972-RA mus301 -1.09 0.001
CG10185-RA CG10185 -1.11 0.002 CG7088-RA bnb -2.49 0.002
CG13295-RA CG13295 -1.29 0.001 CG4554-RA CG4554 -1.22 0.005
CG12817-RA CG12817 -1.02 0.001 CG17152-RA Ir68b -1.07 0.002
CG15581-RA Or83c -1.00 0.002 CG7708-RA CG7708 -1.00 0.009
CG6889-RA tara -1.69 0.002 CG13396-RA fy -1.00 0.002
CG2201-RB CG2201 -1.16 0.002 CG18766-RA CG18766 -1.57 0.001
CG8596-RA CG8596 -1.50 0.009 CG14022-RA CG14022 -1.67 0.001
CG4648-RA CG42399 -1.09 0.003 CG32476-RA mthl14 -1.05 0.002
CG17239-RA CG17239 -1.03 0.007 CG7230-RA rib -2.25 0.004
CG2863-RA Nle -1.25 0.005 CG1772-RA dap -2.35 0.001
CG8172-RA CG8172 -1.09 0.002 CG5869-RA CG5869 -1.79 0.003
CG17544-RB CG17544 -1.01 0.004 CG10859-RA CG10859 -1.05 0.005
CG9220-RB CG9220 -1.25 0.001 CG8846-RA Thor -1.63 0.001
CG31121-RA CG31121 -1.01 0.001 CG8325-RA l(2)k14710 -1.05 0.001
CG5781-RA CG5781 -1.01 0.002 CG4109-RA Syx8 -1.22 0.009
CG12402-RA CG12402 -1.17 0.001 CG31821-RA CG31821 -1.03 0.002
CG12264-RA CG12264 -1.29 0.003 CG31742-RA CG31742 -1.49 0.001
CG16992-RA mthl6 -1.15 0.003 CG12917-RA CG12917 -1.00 0.001
CG9879-RA CG9879 -1.00 0.001 CG6331-RA Orct -1.34 0.001
CG32443-RA Pc -1.11 0.001 CG13125-RA CG13125 -1.11 0.001
CG2374-RA lbm -1.23 0.001 CG11849-RA dan -1.03 0.001
CG12068-RA sro -1.11 0.001 CG32403-RA Or65c -1.14 0.001
CG9737-RA CG9737 -1.17 0.001 CG7131-RA CG7131 -1.06 0.001
CG16894-RA CG16894 -1.28 0.001 CG14983-RA CG14983 -1.04 0.001
CG11537-RA CG11537 -1.03 0.003 CG6930-RA l(3)neo38 -2.05 0.001
CG2103-RB pgant6 -1.61 0.001 CG15596-RA Osi11 -1.37 0.001
CG12102-RA CG34104 -1.16 0.001 CG2114-RA FR -1.06 0.001
CG1987-RA Rbp1-like -1.26 0.001 CG13074-RA CG13074 -1.04 0.001
CG33348-RA CheB42a -1.13 0.001 CG9624-RA CG9624 -1.00 0.001
CG16755-RA Or85f -1.29 0.001 CG3178-RA Rrp1 -1.47 0.001
CG33171-RE mp -1.16 0.001 CG6081-RA Cyp28d2 -1.39 0.001
CG2005-RC Ptp99A -1.55 0.001 CG33494-RA CG33494 -1.44 0.001
CG11921-RA fd96Ca -1.17 0.001 CG7428-RA halo -1.71 0.001
CG14118-RA CG14118 -1.31 0.001 CG32077-RA nol -1.01 0.001
CG15287-RA ms(2)34Fe -1.07 0.001 CG3412-RA slmb -1.34 0.001
CG33476-RA CG33476 -1.15 0.001 CG33196-RB dp -1.59 0.005
CG1133-RA opa -1.48 0.001 CG32335-RA CG32335 -1.25 0.001
CG15771-RA CG15771 -1.04 0.001 CG14269-RA CG14269 -1.40 0.001
CG1132-RA fd64A -1.11 0.001 CG2918-RA CG2918 -1.31 0.005
CG11639-RA TfIIA-S-2 -1.10 0.001 CG4216-RA term -1.06 0.001
CG9084-RB CG9084 -1.07 0.001 CG3401-RA betaTub60D -2.54 0.001
CG14086-RA CG14086 -1.08 0.001 CG8714-RA sut1 -1.38 0.001
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CG2053-RA CG2053 -1.16 0.001 CG3544-RA CG3544 -1.05 0.001
CG33296-RA CG33296 -1.00 0.001 CG5545-RA Oli -1.23 0.005
CG15655-RA CG34396 -1.35 0.001 CG15427-RA tutl -1.04 0.001
CG1179-RA LysB -1.57 0.001 CG3822-RA CG3822 -1.00 0.001
CG7364-RA TM9SF4 -1.71 0.001 CG7635-RA Mec2 -1.13 0.001
CG2069-RA Oseg4 -1.18 0.001 CG6348-RB ro -1.00 0.002
CG15437-RA morgue -1.28 0.001 CG9602-RA CG9602 -1.11 0.001
CG1671-RA CG1671 -1.38 0.001 CG31352-RA Unc-115a -1.36 0.001
CG15423-RA CG15423 -1.35 0.001 CG15829-RA CG15829 -1.10 0.001
CG8624-RA melt -1.09 0.001 CG12189-RA Rev1 -1.03 0.002
CG2196-RA salt -1.21 0.001 CG14214-RA Sec61γ -1.30 0.003
CG4928-RA CG4928 -1.22 0.001 CG33092-RA P5CDh2 -1.05 0.001
CG1546-RB PH4αSG2 -1.04 0.001 CG33338-RA p38c -1.15 0.001
CG9036-RA Cpr56F -1.35 0.001 CG32120-RA sens -1.61 0.002
CG6127-RA Ser -1.49 0.001 CG30037-RA CG30037 -1.14 0.001
CG14735-RA ssp5 -1.20 0.001 CG31019-RA CG31019 -1.05 0.001
CG10396-RA CG10396 -1.20 0.001 CG15094-RB CG15094 -1.16 0.002
CG4103-RA l(2)35Bc -1.18 0.001 CG15400-RA CG15400 -1.18 0.001
CG9908-RA disco -1.47 0.003 CG11699-RA CG11699 -1.32 0.001
CG8080-RA CG8080 -1.43 0.001 CG1771-RB mew -1.71 0.001
CG7695-RA CG7695 -1.37 0.001 CG7120-RA CG7120 -1.29 0.001
CG10289-RA CG10289 -1.31 0.001 CG16979-RA CG16979 -1.18 0.002
CG16813-RA CG16813 -1.34 0.001 CG17707-RA CG17707 -1.01 0.002
CG8254-RA exex -1.30 0.001 CG4986-RA Mst57Dc -1.00 0.008
CG12194-RA CG12194 -1.03 0.001 CG17054-RD Cap-G -1.47 0.001
CG13348-RA Aats-phe -1.08 0.001 CG33013-RB CG33013 -1.09 0.001
CG15120-RA CG15120 -1.05 0.001 CG13321-RA CG13321 -1.03 0.001
CG8332-RB RpS15 -1.22 0.001 CG2189-RA Dfd -1.42 0.001
CG3723-RA Dhc93AB -1.01 0.001 CG11718-RA CG42286 -1.20 0.001
CG8320-RA CG8320 -1.09 0.002 CG31735-RA CG31735 -1.12 0.001
CG5018-RA CG5018 -1.21 0.001 CG2233-RA CG2233 -1.35 0.001
CG13494-RA CG13494 -1.13 0.001 CG17221-RA CG17221 -1.18 0.001
CG15211-RA CG15211 -1.13 0.001 CG15270-RA CG15270 -1.11 0.002
CG7945-RC CR43159 -1.27 0.001 CG17262-RA cnir -1.06 0.002
CG8396-RA Ssb-c31a -1.77 0.001 CG8386-RA CG8386 -1.25 0.001
CG32245-RB CG42540 -1.07 0.001 CG3766-RA scat -1.06 0.001
CG12310-RA CG12310 -1.18 0.001 CG5885-RA CG5885 -1.61 0.001
CG8837-RA CG8837 -1.01 0.001 CG10334-RA spi -1.91 0.004
CG4701-RA CG4701 -1.00 0.001 CG4898-RB Tm1 -1.29 0.001
CG9138-RA uif -1.70 0.002 CG9010-RA CG9010 -1.09 0.001
CG4937-RA RhoGAP15B -1.06 0.001 CG4976-RA Mes-4 -1.36 0.001
CG17660-RA CG17660 -1.37 0.001 CG8289-RA CG8289 -1.49 0.002
CG7910-RA CG7910 -1.22 0.001 CG8909-RB CG8909 -1.22 0.001
CG15595-RA Osi13 -1.24 0.001 CG8981-RA MCPH1 -1.13 0.007
CG10344-RB CG10344 -1.04 0.001 CG7745-RA CG7745 -1.12 0.001
CG1693-RA tty -1.21 0.001 CG2621-RC sgg -1.51 0.001
CG32454-RA CG32454 -1.14 0.001 CG13391-RA Aats-ala -1.29 0.001
CG8214-RA CG8214 -1.05 0.001 CG12178-RA Nhe1 -1.10 0.001
CG10248-RA Cyp6a8 -1.49 0.001 CG13277-RA LSm7 -1.00 0.009
CG12287-RA pdm2 -1.41 0.009 CG8303-RA CG8303 -1.26 0.001
CG10262-RA CG10262 -1.10 0.001 CG15929-RA lin-52 -1.07 0.002
CG4901-RA CG4901 -1.17 0.001 CG14892-RA CG14892 -1.00 0.001
CG31622-RA Gr39a -1.12 0.001 CG3014-RA CG3014 -1.05 0.001
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CG17324-RA CG17324 -1.15 0.001 CG17302-RA Prosbeta4R2 -1.19 0.001
CG11888-RA Rpn2 -1.38 0.001 CG7395-RA sNPF-R -1.38 0.001
CG5999-RA CG5999 -1.02 0.001 CG7320-RA CG7320 -1.18 0.001
CG2140-RB Cyt-b5 -1.20 0.001 CG10539-RA S6k -1.62 0.001
CG8728-RA CG8728 -1.09 0.001 CG13178-RA CG13178 -1.09 0.001
CG9674-RB CG9674 -1.23 0.002 CG32087-RA CG32087 -1.02 0.001
CG10388-RA Ubx -1.33 0.001 CG13109-RA tai -1.06 0.001
CG33178-RA CG33178 -1.20 0.001 CG6262-RB CG6262 -1.19 0.001
CG14285-RA CG14285 -1.03 0.001 CG32104-RB CG32104 -1.04 0.009
CG30272-RA CG30272 -1.25 0.003 CG8776-RA nemy -1.26 0.001
CG1429-RD Mef2 -1.53 0.001 CG33480-RA hig -1.00 0.001
CG31413-RA CG31413 -1.28 0.001 CG1976-RA RhoGAP100F -1.01 0.001
CG32110-RA CG32110 -1.46 0.001 CG7304-RA CG7304 -1.12 0.001
CG17477-RA CG17477 -1.23 0.001 CG4125-RA rst -1.64 0.001
CG31317-RA stumps -1.98 0.001 CG15308-RA CG15308 -1.02 0.001
CG3097-RA CG3097 -1.19 0.001 CG6055-RA CG6055 -1.23 0.001
CG9596-RA CG9596 -1.10 0.001 CG15480-RA CG15480 -1.77 0.002
CG15871-RA mRpL38 -1.06 0.002 CG9588-RA CG9588 -1.19 0.007
CG1418-RA CG1418 -1.18 0.003 CG9015-RA en -1.10 0.004
CG4196-RB CG42542 -1.16 0.007 CG17579-RA sca -1.97 0.002
CG31757-RA Pde1c -1.13 0.001 CG31323-RA CG31323 -1.13 0.001
CG30021-RA metro -1.25 0.001 CG13604-RA CG13604 -1.01 0.003
CG1082-RA alpha-Est4 -1.00 0.008 CG14332-RA CG14332 -1.54 0.001
CG1079-RA Fie -1.01 0.001 CG1597-RA CG1597 -1.32 0.004
CG17012-RA CG17012 -1.07 0.001 CG33052-RA CG33052 -1.50 0.001
CG7619-RA Pros54 -1.54 0.003 CG31043-RA gukh -1.40 0.004
CG17669-RA CG17669 -1.28 0.001 CG14304-RA CG14304 -1.16 0.003
CG17927-RK Mhc -1.08 0.001 CG17838-RA CG17838 -1.01 0.004
CG10576-RA CG10576 -1.52 0.001 CG3194-RA CG3194 -1.00 0.005
CG6388-RA CG6388 -1.34 0.001 CG3353-RA CG3353 -1.51 0.001
CG3396-RA Ocho -1.46 0.006 CG13611-RA CG13611 -1.02 0.002
CG3260-RA Zfrp8 -1.24 0.002 CG7702-RB CG7702 -1.47 0.002
CG6520-RA CG6520 -1.59 0.001 CG10234-RA Hs2st -1.21 0.001
CG31313-RA CG31313 -1.21 0.001 CG5893-RA D -1.92 0.004
CG31714-RA CG31714 -1.24 0.001 CG14219-RA CG14219 -1.00 0.001
CG5658-RA Klp98A -1.06 0.002 CG31493-RA CG31493 -1.24 0.001
CG4783-RA CG4783 -1.37 0.001 CG7556-RA CG7556 -1.60 0.001
CG5384-RA CG5384 -1.35 0.001 CG4383-RA CG33960 -1.00 0.001
CG30277-RA Oatp58Da -1.07 0.001 CG9517-RB CG9517 -1.10 0.001
CG12418-RA Glut4EF -1.72 0.001 CG10619-RB tup -1.33 0.001
CG13018-RA CG13018 -1.53 0.001 CG12403-RA Vha68-1 -1.18 0.001
CG4437-RA PGRP-LF -1.13 0.001 CG7957-RA MED17 -1.27 0.001
CG10642-RA Klp64D -1.08 0.001 CG18269-RA CG18269 -1.24 0.002
CG13859-RA CG34377 -1.15 0.001 CG30189-RA Gr59a -1.01 0.001
CG11194-RA Hey -1.05 0.002 CG32843-RA Dh31-R1 -1.06 0.001
CG7311-RA CG7311 -1.28 0.001 CG9366-RA RhoL -1.33 0.002
CG14307-RC fru -1.07 0.001 CR33294-RA CR33294 -1.22 0.001
CG13386-RA CG13386 -1.33 0.001 CG10134-RA beat-Va -1.08 0.001
CG14451-RA CG14451 -1.14 0.001 CG3775-RA CG3775 -1.02 0.001
CG10575-RA Ppat-Dpck -1.11 0.002 CG5411-RA Pde8 -1.09 0.001
CG8424-RA Jhedup -1.04 0.001 CG6638-RA CG6638 -1.09 0.001
CG14020-RA CG14020 -1.36 0.001 CG1910-RA CG1910 -1.51 0.003
CG8695-RA Mal-A3 -1.08 0.001 CG5870-RA beta-Spec -1.13 0.007
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CG13715-RA axo -1.42 0.001 CG16735-RA CR16735 -1.02 0.001
CG30284-RA CG30284 -1.03 0.001 CG1257-RA alpha-Est3 -1.08 0.001
CR32385-RA CR32385 -1.20 0.001 CG8174-RA SRPK -1.43 0.001
CG9458-RA CG9458 -1.03 0.001 CG13058-RA CG13058 -1.01 0.001
CG9102-RA bab2 -1.87 0.002 CG7125-RA PKD -1.12 0.001
CG6488-RA CG6488 -1.21 0.001 CG13737-RA CG13737 -1.09 0.001
CG3017-RA Alas -1.24 0.001 CG5550-RA CG5550 -1.19 0.001
CG11291-RA CG11291 -1.02 0.001 CG32798-RA Vml -1.67 0.001
CG12653-RA btd -1.47 0.001 CG13664-RA Cad96Cb -1.24 0.001
CG31857-RA bun -1.45 0.001 CG5102-RA da -1.05 0.006
CG5703-RA CG5703 -1.26 0.001 CG1818-RA Updo -1.18 0.001
CG4448-RA wda -1.19 0.001 CR30009-RA CR30009 -1.58 0.001
CG8416-RB Rho1 -1.34 0.001 CG13784-RB CG13784 -1.05 0.001
CG18258-RA CG18258 -1.00 0.001 CG18810-RA CG18810 -1.27 0.001
CG3278-RA Tif-IA -1.37 0.001 CG16833-RA CG16833 -1.39 0.001
CG6567-RA CG6567 -1.45 0.001 CG11983-RA CG11983 -1.17 0.001
CG6798-RA nAcRβ-96A -1.14 0.001 CG32627-RA NnaD -1.00 0.001
CG14141-RA CG14141 -1.14 0.001 CG8506-RA Rbsn-5 -1.15 0.001
CG3009-RA CG3009 -1.13 0.001 CG3624-RA CG3624 -1.72 0.002
CG6568-RA CG6568 -1.33 0.001 CG11308-RA sa -1.27 0.001
CG5125-RA ninaC -1.03 0.001 CG30141-RA Obp57a -1.07 0.001
CG9284-RB CG9284 -1.29 0.001 CG12636-RA CG42685 -1.06 0.001
CG8468-RB CG8468 -1.84 0.001 CG9983-RB Hrb98DE -1.59 0.002
CG30491-RA CG30491 -1.38 0.001 CG12026-RB Tmhs -1.29 0.001
CG13651-RA danr -1.12 0.001 CG18131-RD CG18131 -1.04 0.001
CG14243-RA TwdlD -1.05 0.001 CG8536-RA β4GalNAcTA -1.11 0.001
CG5732-RA Gld2 -1.35 0.001 CG3988-RA γSnap -1.41 0.001
CG8960-RA CG8960 -1.92 0.001 CG6417-RA Oatp33Eb -1.21 0.001
CG7955-RC ABCB7 -1.27 0.001 CG5048-RA CG5048 -1.03 0.001
CG5863-RA CG5863 -1.42 0.001 CG8120-RA HP1e -1.36 0.001
CG12470-RA CG12470 -1.01 0.001 CG8566-RD unc-104 -1.20 0.001
CG17975-RA sut2 -1.37 0.001 CG32227-RA gogo -1.46 0.001
CG18585-RA CG18585 -1.43 0.001 CG13472-RA CG13472 -1.29 0.001
CG5418-RA CG5418 -1.26 0.001 CG10706-RA SK -1.03 0.001
CG14401-RA CG14401 -1.03 0.001 CG7852-RC CG7852 -1.15 0.001
CG30188-RA CG34371 -1.58 0.001 CG7072-RA CG34462 -1.21 0.001
CG18340-RA Ucp4B -1.07 0.001 CG5630-RA CG5630 -1.01 0.001
CG30044-RA s-cup -1.11 0.001 CG14606-RA CG14606 -1.17 0.001
CG32310-RA zormin -1.08 0.001 CG3502-RA CG3502 -1.26 0.001
CG31038-RA CG31038 -1.46 0.001 CG18420-RA CG18420 -1.01 0.002
CG14820-RA CG14820 -1.30 0.001 CG14938-RA crol -1.72 0.001
CG3246-RA CG3246 -1.20 0.002 CG17894-RC cnc -1.24 0.001
CG18304-RA CG18304 -1.19 0.001 CG3666-RA Tsf3 -1.40 0.001
CG3153-RA Npc2b -1.04 0.001 CG11695-RA CG11695 -1.04 0.001
CG13540-RA CG13540 -1.06 0.001 CG17599-RA CG17599 -1.01 0.001
CG16914-RA Lcp9 -1.01 0.001 CG32320-RA CG32320 -1.08 0.001
CG6494-RA h -1.36 0.001 CG7950-RB CG7950 -1.43 0.001
CG17932-RB Ugt36Bc -1.16 0.001 CG31676-RA CG31676 -1.08 0.001
CG10909-RA CG10909 -1.29 0.001 CG11211-RA CG11211 -1.42 0.001
CG32372-RA ltl -1.53 0.001 CG33256-RA Lmpt -1.09 0.001
CG4318-RA CG4318 -1.13 0.001 CG30091-RA CG30091 -1.16 0.001
CG7059-RC CG7059 -1.22 0.001 CG33129-RC CG33129 -1.28 0.001
CG12899-RA CG42732 -1.08 0.001 CG32156-RC Mbs -1.30 0.001
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CG1150-RA Osi3 -1.00 0.001 CG14947-RA CG14947 -1.07 0.001
CG5618-RA CG5618 -1.51 0.001 CR32777-RA roX1 -2.25 0.003
CG17560-RA CG17560 -1.31 0.001 CG13597-RA CG13597 -1.18 0.001
CG32235-RA CG32235 -1.07 0.001 CG14902-RA decay -1.32 0.001
CG13614-RA CG13614 -1.24 0.001 CG18012-RA CG18012 -1.18 0.001
CG17758-RA CG42265 -1.04 0.001 CG31240-RA repo -1.16 0.001
CG14324-RA CG14324 -1.16 0.001 CG5375-RA CG5375 -1.16 0.001
CG18368-RA CG18368 -1.18 0.001 CG13459-RA cp309 -1.06 0.001
CG18528-RA CG18528 -1.38 0.001 CG32388-RA CG32388 -1.18 0.001
CG5322-RA CG5322 -1.14 0.001 CG17870-RB 14-3-3zeta -1.34 0.001
CG8093-RA CG8093 -1.20 0.001 CG4772-RA Ugt86Dh -1.20 0.001
CG12162-RB CG12162 -1.02 0.001 CG6666-RA SdhC -1.20 0.001
CG17453-RA Cyp317a1 -1.03 0.001 CG11354-RA Lim1 -1.05 0.006
CG15014-RA CG15014 -1.32 0.001 CG10283-RA CG10283 -1.60 0.001
CG1994-RA l(1)G0020 -1.61 0.001 CG32261-RA Gr64a -1.18 0.001
CG15404-RA CG15404 -1.02 0.001 CG3541-RC pio -1.13 0.001
CG1771-RA mew -1.57 0.001 CG14911-RA CG42747 -1.01 0.001
CG4402-RA lox2 -1.15 0.001 CG14695-RA CG14695 -1.44 0.001
CG10864-RA CG10864 -1.16 0.001 CG5553-RA DNApol-α60 -1.29 0.001
CG1799-RA ras -1.19 0.001 CG3473-RA CG3473 -1.05 0.001
CG13636-RA CG13636 -1.22 0.001 CG33150-RA Gr59f -1.07 0.002
CG11581-RA CG11581 -1.11 0.001 CG5313-RA RfC3 -1.45 0.001
CG6571-RD rdgC -1.14 0.001 CG33333-RA CG33333 -1.15 0.001
CG7542-RA CG7542 -1.20 0.001 CG17819-RA CG17819 -1.38 0.001
CG31446-RA CG31446 -1.10 0.001 CG18808-RA CG18808 -1.10 0.001
CG10674-RA CG10674 -1.63 0.001 CG14829-RA CG14829 -1.03 0.001
CG14548-RA HLHmbeta -1.78 0.001 CG5669-RA Spps -1.41 0.001
CG31663-RA CG31663 -1.41 0.001 CG6456-RA Mip -1.03 0.001
CG9861-RA CG9861 -1.15 0.001 CG5103-RA CG5103 -1.30 0.001
CG18455-RA Optix -1.28 0.001 CG11020-RA nompC -1.27 0.001
CG1486-RB CG1486 -1.08 0.001 CG7610-RA ATPsynγ -1.00 0.003
CG5405-RA KrT95D -1.12 0.001 CG4420-RA rngo -1.37 0.001
CG32688-RA Hk -1.03 0.001 CG6972-RA CG6972 -1.20 0.001
CG12439-RA CG12439 -1.28 0.001 CG13047-RA CG13047 -1.55 0.001
CG4459-RA CG4459 -1.16 0.001 CG13872-RA CG13872 -1.20 0.001
CG6704-RA CG6704 -1.32 0.001 CG18669-RA CG42811 -1.24 0.001
CG13919-RA CG13919 -1.34 0.001 CG7538-RA Mcm2 -1.04 0.003
CG12009-RA CG12009 -1.12 0.001 CG14377-RA CG14377 -1.17 0.001
CG13474-RA CG13474 -1.25 0.001 CG10164-RA CG10164 -1.13 0.001
CG14493-RA dpr13 -1.35 0.001 CG31973-RB Cda5 -1.05 0.001
CG6718-RC iPLA2-VIA -1.26 0.001 CG10725-RB CG10725 -1.08 0.001
CG9206-RA Gl -1.02 0.001 CG8956-RD Ahcy89E -1.43 0.001
CG5932-RA CG5932 -1.11 0.001 CG8827-RA Ance -2.07 0.002
CG9265-RA CG9265 -1.08 0.001 CG9257-RA CG9257 -1.28 0.001
CG32594-RB be -1.47 0.001 CG4580-RA CG4580 -1.05 0.001
CG5983-RA ACXC -1.00 0.001 CG12602-RA Vha100-5 -1.22 0.001
CG18249-RA CG18249 -1.26 0.001 CR32862-RA U1:82Eb -1.57 0.001
CG11280-RA trn -2.21 0.001 CG16712-RA CG16712 -1.31 0.001
CG8191-RA CG8191 -1.19 0.001 CG12139-RB Megalin -1.92 0.001
CG9483-RA CG9483 -1.19 0.001 CG3964-RA CG3964 -1.08 0.002
CG4955-RA CG4955 -1.10 0.001 CG12832-RA Tsp42Eq -1.12 0.001
CG5434-RA Srp72 -1.64 0.001 CG11317-RA CG11317 -1.10 0.001
CG8094-RA Hex-C -1.29 0.001 CG10068-RA CG10068 -1.24 0.001
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CG11154-RA ATPsyn-β -1.81 0.001 CG5404-RA CG5404 -1.43 0.001
CG5992-RA Adgf-A -1.47 0.001 CG6667-RC dl -1.04 0.001
CG18228-RA CR18228 -1.08 0.001 CG5204-RA CG5204 -1.06 0.001
CR31400-RB Hsromega -1.79 0.001 CG8864-RA Cyp28a5 -1.12 0.001
CG5461-RC bun -1.15 0.001 CG5116-RA CG5116 -1.23 0.001
CG3935-RA al -1.36 0.001 CG12730-RA CG12730 -1.06 0.001
CG16885-RA CG16885 -1.03 0.001 CG32806-RB CG32806 -1.10 0.001
CG10589-RA CG10589 -1.14 0.001 CG16863-RA CG16863 -1.16 0.001
CG12002-RE Pxn -1.24 0.001 CG13211-RB CG42336 -1.12 0.001
CG30121-RA CG30121 -1.04 0.001 CG30159-RA CG30159 -1.14 0.001
CG30110-RA CG30110 -1.00 0.001 CG8492-RA CG8492 -1.00 0.001
CG3978-RA pnr -1.76 0.001 CG16793-RA CG16793 -1.04 0.001
CG7142-RA CG7142 -1.04 0.001 CG13693-RA CG13693 -1.04 0.001
CG4535-RA FKBP59 -1.09 0.001 CG7279-RA Lip1 -1.24 0.001
CG6724-RA CG6724 -1.10 0.001 CG8202-RA CG8202 -1.21 0.001
CG9342-RA Mtp -1.13 0.001 CG6719-RA CG6719 -1.30 0.001
CG3298-RB JhI-1 -1.11 0.001 CG17611-RA eIF6 -1.37 0.002
CG6168-RB CG6168 -1.08 0.001 CG16960-RA Or33a -1.13 0.001
CG7936-RA mex1 -1.23 0.001 CG8228-RA Vps45 -1.04 0.001
CG16931-RA Eig71Ea -1.17 0.001 CG1046-RA zen -1.10 0.001
CG13293-RA CG13293 -1.27 0.001 CG12692-RB CG12692 -1.01 0.002
CG13307-RA CG34426 -1.08 0.001 CG3694-RA Gγ30A -1.11 0.001
CG9847-RA Fkbp13 -1.17 0.001 CG8258-RA CG8258 -1.27 0.001
CG7902-RA bap -1.56 0.005 CG2209-RA CG2209 -1.05 0.001
CG6177-RA ldlCp -1.39 0.002 CG6792-RA CG6792 -1.01 0.002
CG13394-RB CG42820 -1.05 0.001 CG3117-RA CG3117 -1.06 0.001
CG7764-RA mrn -1.29 0.002 CG31783-RA ninaD -1.36 0.001
CG8587-RA Cyp301a1 -1.20 0.001 CG17199-RA CG17199 -1.28 0.001
CG8340-RA 128up -1.41 0.002 CG6874-RA HipHop -1.38 0.001
CG17234-RA CG17234 -1.12 0.001 CG12284-RA th -1.75 0.002
CG2412-RA Rad51C -1.03 0.001 CG5867-RA CG5867 -1.35 0.001
CG15636-RA HP6 -1.44 0.001 CG17534-RA GstE9 -1.52 0.001
CG6836-RA CG6836 -1.00 0.001 CG7144-RA LKR -1.39 0.001
CG10303-RA Osi4 -1.03 0.001 CG7798-RA CG7798 -1.17 0.001
CG15138-RA beat-IIIc -1.27 0.001 CG9063-RA CG9063 -1.09 0.002
CG4914-RA CG4914 -1.21 0.001 CG33103-RA Ppn -1.73 0.004
CG31120-RA CG31120 -1.08 0.003 CG8323-RA CG8323 -1.16 0.001
CG4952-RE dac -1.26 0.001 CG32160-RA CG32160 -1.35 0.001
CG1104-RA CG1104 -1.40 0.001 CG33062-RA CG33062 -1.26 0.001
CG7851-RA Scgalpha -1.15 0.001 CG8376-RA ap -1.34 0.001
CG10345-RA CG10345 -1.42 0.001 CG12263-RA CG12263 -1.02 0.001
CG7884-RA CG7884 -1.43 0.003 CG8425-RA Jhe -1.26 0.001
CG3781-RA CG3781 -1.38 0.001 CG3734-RA CG3734 -1.10 0.001
CG13895-RA CG13895 -1.31 0.001 CG18130-RA CG18130 -1.06 0.001
CG15148-RA btv -1.24 0.001 CG4154-RC Gyc88E -1.00 0.001
CG17145-RA CG17145 -1.03 0.001 CG2720-RA Hop -1.48 0.001
CG6330-RA CG6330 -1.07 0.001 CG16952-RC CG16952 -1.51 0.002
CG10318-RA NC2alpha -1.14 0.002 CG10226-RA CG10226 -1.11 0.001
CG13226-RA CG13226 -1.23 0.001 CG12063-RA mey -1.28 0.001
CG7239-RA CG7239 -1.23 0.001 CG32402-RA Or65b -1.36 0.001
CG9663-RA CG9663 -1.23 0.002 CG5005-RA HLH54F -1.17 0.001
CG4608-RB bnl -1.09 0.001 CG5790-RA CG5790 -1.35 0.001
CG14745-RA PGRP-SC2 -1.23 0.002 CG7893-RB vav -1.38 0.001
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CG17031-RA ref2 -1.09 0.001 CG5927-RA Her -1.00 0.001
CG4889-RA wg -1.69 0.001 CG33127-RA CG33127 -1.11 0.001
CG11907-RA Ent1 -1.37 0.008 CG2101-RA mRpS35 -1.51 0.001
CG15743-RA CG15743 -1.04 0.004 CG17279-RA CG17279 -1.24 0.001
CG9044-RA CG9044 -1.23 0.001 CG31548-RA CG31548 -1.09 0.002
CG3048-RA Traf4 -1.93 0.003 CG6736-RA Ilp4 -1.82 0.002
CG14496-RA CG34386 -1.28 0.001 CG2112-RA CG42233 -1.12 0.001
CG15845-RB Adf1 -1.56 0.005 CG8704-RA dpn -1.70 0.002
CG10362-RA CG10362 -1.08 0.001 CG14098-RA Rcd7 -1.11 0.001
CG13081-RA CG13081 -1.11 0.001 CG1999-RA CG1999 -1.12 0.001
CG32694-RB CG32694 -1.22 0.001 CG33493-RA CG33493 -1.26 0.001
CG11911-RA CG11911 -1.20 0.001 CG11489-RB srpk79D -1.02 0.001
CG3972-RA Cyp4g1 -1.03 0.001 CG1137-RA CG1137 -1.23 0.001
CG15749-RA dmrt11E -1.25 0.001 CG14252-RA CG14252 -1.12 0.001
CG11763-RA RanBPM -1.54 0.001 CG9919-RA CG9919 -1.27 0.001
CG14085-RA CG14085 -1.12 0.001 CG33200-RA CG33200 -1.73 0.001
CG15286-RA CG15286 -1.06 0.001 CG33194-RA CheA29a -1.02 0.002
CG15036-RA CG15036 -1.02 0.001 CG8745-RA CG8745 -1.46 0.006
CG5779-RA proPO-A1 -1.39 0.001 CG32302-RA CG32302 -1.01 0.002
CG13029-RB CG13029 -1.34 0.004 CG31059-RA Gr98b -1.25 0.001
CG6292-RA CycT -1.14 0.004 CG33467-RA CG33467 -1.04 0.001
CG31385-RA Neu3 -1.29 0.001 CG32088-RA CG32088 -1.00 0.001
CG5506-RA CG5506 -1.30 0.001 CG7369-RA CG7369 -1.11 0.001
CG14084-RB Bet1 -1.64 0.001 CG8713-RA CG8713 -1.12 0.001
CG1742-RB Mgstl -1.55 0.001 CG3536-RA CG42260 -1.01 0.001
CG15196-RA CG15196 -1.03 0.001 CG31522-RA CG31522 -1.59 0.001
CG31012-RB cindr -1.16 0.001 CG3818-RA Cpr30B -1.29 0.001
CG12159-RA CG12159 -1.12 0.001 CG6038-RA crim -1.91 0.001
CG9742-RA SmG -1.62 0.001 CG32137-RA CG32137 -1.26 0.001
CG6024-RA CG6024 -1.23 0.001 CG7363-RA w-cup -1.23 0.001
CG7336-RA Eig71Eg -1.12 0.001 CG6327-RA CG6327 -1.14 0.005
CG14468-RA Tsp42A -1.34 0.001 CG13458-RA CG13458 -1.07 0.001
CG14975-RA Rdh -1.11 0.001 CG11593-RA CG11593 -1.29 0.001
CG6130-RA h-cup -1.35 0.001 CG31697-RA CG31697 -1.07 0.001
CG16704-RA CG16704 -1.16 0.001 CG33225-RA CG33225 -1.35 0.001
CG8652-RA Ugt37c1 -1.03 0.001 CG3948-RB zetaCOP -1.31 0.001
CG15825-RB fon -1.08 0.001 CG9001-RA ste24b -1.24 0.001
CG3166-RB aop -1.09 0.001 CG6416-RB Zasp66 -1.00 0.001
CG9614-RI pip -1.33 0.001 CG9870-RA CG9870 -1.26 0.001
CG15127-RA CG15127 -1.13 0.001 CG11768-RA CG11768 -1.16 0.001
CG11582-RA srw -1.11 0.002 CG11915-RA Lmpt -1.01 0.001
CG33083-RA Gr97a -1.23 0.001 CG31343-RA CG31343 -1.07 0.001
CG15468-RA SIP3 -1.19 0.001 CG9033-RB Tsp47F -1.05 0.001
CG32117-RA CG32117 -1.20 0.001 CG31087-RA CG31087 -1.12 0.001
CG33285-RA CG33285 -1.20 0.001 CG6123-RA CG6123 -1.14 0.001
CG30033-RB CG30033 -1.24 0.001 CG13022-RA CG13022 -1.42 0.001
CG14718-RA CG14718 -1.02 0.001 CG4054-RA Fili -1.18 0.001
CG7404-RA ERR -1.37 0.001 CG33232-RC CG33232 -1.66 0.001
CG14180-RA CG14180 -1.09 0.001 CG15022-RA CG15022 -1.18 0.001
CG1539-RB tmod -1.62 0.001 CG2017-RB CG2017 -1.06 0.004
CG11473-RA CG42492 -1.07 0.001 CG15897-RA wuho -1.16 0.001
CG12289-RA CG12289 -1.08 0.001 CG17717-RA CG17717 -1.01 0.001
CG9538-RA Ag5r -1.07 0.001 CG11101-RA pwn -1.11 0.001
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CG31157-RA CG31157 -1.20 0.001 CG16854-RA CG16854 -1.07 0.001
CG7105-RA Proct -1.12 0.001 CG10286-RA CG10286 -1.76 0.001
CG31221-RA CG31221 -1.10 0.001 CG32543-RA CG42450 -1.16 0.001
CG7830-RA CG7830 -1.44 0.001 CG10486-RA CG10486 -1.21 0.001
CG8511-RA Cpr49Ag -1.14 0.001 CG7956-RA CG7956 -1.58 0.001
CG4592-RA CG4592 -1.22 0.001 CG2827-RA Tal -1.05 0.001
CG17044-RA yellow-e2 -1.65 0.001 CG12912-RA CG12912 -1.13 0.001
CG12842-RA CR12842 -1.29 0.001 CG8331-RA CG8331 -1.59 0.001
CG11007-RA CG11007 -1.37 0.001 CG10585-RA CG10585 -1.10 0.001
CG6854-RA CTPsyn -1.12 0.001 CG2174-RA Myo10A -1.69 0.001
CG15732-RA Ir11a -1.17 0.001 CG15602-RA CG15602 -1.20 0.004
CG31733-RA ms(2)35Ci -1.30 0.001 CG3252-RA NAAT1 -1.04 0.001
CG13418-RA RpI12 -1.16 0.001 CG3119-RA CG3119 -1.28 0.001
CG1893-RA scramb2 -1.46 0.001 CG13492-RB CG13492 -1.10 0.001
CG8006-RA CG8006 -1.25 0.001 CG8667-RA dimm -1.14 0.001
CG13283-RA CG13283 -1.25 0.001 CG15269-RA CG15269 -1.14 0.001
CG8400-RB casp -1.44 0.001 CG10956-RA Spn53F -1.13 0.001
CG17753-RA CCS -1.03 0.001 CG12825-RA CG12825 -1.04 0.001
CG6225-RA CG6225 -1.32 0.001 CG18681-RA epsilonTry -1.05 0.001
CG14949-RA CG14949 -1.13 0.001 CG32244-RB NT1 -1.04 0.001
CG3764-RA CG3764 -1.41 0.001 CG12236-RA CG12236 -1.21 0.001
CG12307-RA CG12307 -1.21 0.001 CG31721-RA Trim9 -1.74 0.001
CG8238-RA Buffy -1.04 0.001 CG13906-RA nerfin-1 -1.83 0.001
CG6301-RA CG34460 -1.07 0.001 CG13978-RA CG13978 -1.01 0.001
CG17124-RA CG17124 -1.28 0.001 CG11201-RA TTLL3B -1.12 0.001
CG4575-RA CR4575 -1.64 0.001 CG15155-RA CG15155 -1.01 0.001
CG2657-RA Ir21a -1.00 0.001 CG8345-RA Cyp6w1 -1.01 0.002
CG4132-RA pkaap -1.32 0.001 CG12345-RB Cha -1.21 0.001
CG10414-RA Atac2 -1.59 0.001 CG7908-RA Tace -1.31 0.001
CG8881-RA skpB -1.06 0.001 CG15594-RA CG15594 -1.13 0.002
CG17167-RA CG17167 -1.17 0.001 CG13927-RA GC -1.02 0.001
CG8980-RA NiPp1 -1.28 0.001 CG7742-RA CG7742 -1.19 0.001
CG16936-RA CG16936 -1.57 0.001 CG4261-RA Hel89B -1.75 0.001
CG17213-RA Gr33a -1.35 0.001 CG3823-RA CG3823 -1.00 0.001
CG31286-RB CG31286 -1.00 0.001 CG13377-RA CG13377 -1.08 0.002
CG10581-RA CG10581 -1.38 0.001 CG10247-RA Cyp6a21 -1.14 0.001
CG14655-RA CG14655 -1.00 0.001 CG4624-RA VhaAC39-2 -1.10 0.001
CG10279-RB Rm62 -1.99 0.001 CG31792-RA CG31792 -1.07 0.001
CG15919-RA CG15919 -1.01 0.001 CG3858-RA gcm2 -1.23 0.001
CG33141-RA sns -1.76 0.001 CG15125-RA CG15125 -1.18 0.001
CG11742-RA Or85d -1.21 0.001 CG11876-RD CG11876 -1.20 0.001
CG30145-RA Obp57e -1.21 0.001 CG17323-RA CG17323 -1.44 0.001
CG17301-RA Prosβ4R1 -1.05 0.001 CG11887-RA Elp2 -1.73 0.001
CG10491-RA vn -1.04 0.001 CG5998-RA Adgf-B -1.21 0.001
CG7102-RA CG7102 -1.00 0.001 CG15883-RA Obp18a -1.24 0.001
CG3164-RC CG3164 -1.49 0.001 CG13155-RA CG13155 -1.17 0.001
CG2098-RA ferrochelatase -1.14 0.001 CG9673-RA CG9673 -1.07 0.001
CG13095-RA Bace -1.03 0.002 CG33457-RA CheB53a -1.34 0.001
CG9780-RA CG9780 -1.02 0.001 CG3360-RA Cyp313a1 -1.04 0.001
CG12004-RA CG12004 -1.45 0.001 CG7450-RB CrebA -1.69 0.001
CG6223-RA betaCop -1.50 0.001 CG31467-RA CG31467 -1.13 0.001
CG33207-RA pxb -1.26 0.001 CG5653-RA CG5653 -1.29 0.001
CG15425-RA CG15425 -1.08 0.001 CG6116-RA CG6116 -1.48 0.001
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CG11348-RB nAcRβ-64B -1.04 0.002 CG1598-RA CG1598 -1.61 0.001
CG15479-RA CG15479 -1.00 0.002 CG31411-RA CG34409 -1.33 0.001
CG7744-RA CG7744 -1.01 0.001 CG4124-RA PNUTS -1.60 0.001
CG9841-RA EfSec -1.00 0.003 CG33320-RA CheB38a -1.00 0.003
CG3096-RA Brd -2.13 0.001 CG15878-RA CG15878 -1.03 0.001
CG9768-RA hkb -1.43 0.001 CG6057-RA SMC1 -1.63 0.001
CG1470-RA Gycβ100B -1.00 0.001 CG15623-RA c-cup -1.24 0.001
CG2086-RA drpr -1.18 0.001 CG15475-RA CG15475 -1.03 0.002
CG31948-RB CG31948 -1.05 0.003 CG6096-RA HLHm5 -1.13 0.001
CG15449-RA CG15449 -1.00 0.002 CG8676-RC Hr39 -1.16 0.001
CG8639-RA Cirl -1.27 0.008 CG9025-RA Fem-1 -1.11 0.002
CG9628-RA CG9628 -1.76 0.001 CG14233-RA meso18E -1.54 0.001
CG11614-RA nkd -1.73 0.001 CG3340-RA Kr -1.53 0.001
CG6099-RA m4 -1.91 0.001 CG2812-RA CG2812 -1.28 0.001
CG2046-RA CG2046 -1.11 0.001 CG17258-RA CG17258 -1.10 0.001
CG32201-RA CG32201 -1.07 0.001 CG18540-RA CG18540 -1.29 0.001
CG13441-RA Gr57a -1.10 0.001 CG5394-RA Aats-glupro -1.83 0.001
CG10620-RA Tsf2 -1.40 0.004 CG4195-RA l(3)73Ah -1.31 0.009
CG4706-RA CG4706 -1.02 0.001 CG1435-RA CBP -1.95 0.002
CG2901-RA CG2901 -1.24 0.001 CG7047-RA Vdup1 -1.33 0.006
CG13836-RA CG13836 -1.06 0.001 CG14413-RA mRpS25 -1.56 0.001
CR32874-RA Me18S-G1620 -1.13 0.001 CG12689-RA CG12689 -1.04 0.001
CG31748-RA Gr36c -1.29 0.001 CG14855-RA CG14855 -1.21 0.002
CG15326-RA Ir7b -1.04 0.001 CG31321-RB CG31321 -1.06 0.001
CG1152-RA Gld -1.00 0.001 CG3036-RA CG3036 -1.05 0.002
CG6531-RA wgn -1.43 0.002 CG10746-RA fok -1.42 0.001
CG12010-RA CG12010 -1.50 0.001 CG13603-RA CG13603 -1.10 0.001
CG3477-RA Pxd -1.31 0.001 CG3020-RA Sytbeta -1.25 0.001
CG7560-RA CG7560 -1.21 0.001 CG14321-RA CG14321 -1.93 0.002
CG14919-RA Ast-C -1.25 0.001 CG33329-RB Sp212 -1.01 0.002
CG32250-RA CG32250 -1.01 0.001 CG14767-RB CG14767 -1.74 0.002
CG3635-RA CG3635 -1.18 0.001 CG10737-RA CG10737 -1.04 0.002
CG4717-RA kni -1.71 0.002 CG10799-RA CG10799 -1.40 0.001
CG7329-RA CG7329 -1.00 0.001 CG14687-RA CG14687 -1.48 0.001
CG1495-RA CaMKI -1.37 0.001 CG4153-RA eIF-2beta -1.00 0.007
CG31469-RA CG31469 -1.06 0.001 CG7527-RA CadN2 -1.25 0.001
CG1744-RA chp -1.20 0.001 CG33462-RA CG33462 -1.22 0.001
CG10915-RA CG10915 -1.36 0.001 CG14535-RA CG14535 -1.12 0.001
CG15889-RA Ravus -1.38 0.001 CG4821-RC Tequila -1.18 0.001
CG13229-RA CG13229 -1.12 0.001 CG6464-RA salm -1.84 0.001
CG5333-RA trus -1.08 0.001 CG17907-RA Ace -1.14 0.001
CG6723-RA CG6723 -1.48 0.002 CG32343-RA Atac3 -1.34 0.001
CG11666-RA CG11666 -1.04 0.003 CG31105-RA CG31105 -1.07 0.001
CG17010-RA CG17010 -1.23 0.001 CG12321-RA CG12321 -1.28 0.001
CG3528-RA CG3528 -1.13 0.001 CG11246-RA Rpb8 -1.13 0.007
CG14629-RA CG14629 -1.74 0.002 CG30015-RB CG30015 -1.61 0.001
CG2931-RA CG2931 -1.57 0.001 CG13567-RA CG13567 -1.26 0.001
CG4789-RA CG4789 -1.30 0.001 CG17976-RA sut3 -1.07 0.001
CG32210-RA l(3)76BDr -1.28 0.001 CG14886-RA Gyc-89Db -1.47 0.001
CG3658-RA CDC45L -1.00 0.001 CG13726-RA Or74a -1.24 0.001
CG13385-RA CG13385 -1.16 0.001 CG1782-RA Uba1 -1.28 0.002
CG3578-RA bi -1.36 0.002 CG5346-RA CG5346 -1.30 0.001
CG13424-RA lms -1.00 0.001 CG31299-RA cu -1.04 0.001
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CG9735-RA Aats-trp -1.36 0.001 CG3663-RA CG3663 -1.15 0.001
CG5282-RA CG5282 -1.18 0.001 CG17836-RA Xrp1 -1.19 0.001
CG4755-RA RhoGAP92B -1.13 0.001 CG17121-RA CG17121 -1.27 0.001
CG10571-RA ara -1.53 0.001 CG10798-RA dm -1.41 0.001
CG18437-RA CG18437 -1.01 0.004 CG3570-RA CG3570 -1.01 0.001
CG3515-RA CG3515 -1.26 0.001 CG11356-RA CG11356 -1.25 0.001
CG17633-RA CG17633 -1.17 0.001 CG14675-RA glob3 -1.06 0.001
CG1074-RA CG1074 -1.00 0.004 CG7924-RA CG7924 -1.15 0.001
CG3389-RA Cad88C -1.00 0.001 CG13610-RA Orct2 -1.32 0.008
CG14719-RA I-t -1.01 0.001 CG31119-RA HdacX -1.14 0.001
CG6188-RA CG6188 -1.03 0.001 CG7698-RA Cpsf73 -1.15 0.004
CG7000-RA Snmp1 -1.21 0.001 CG6518-RA inaC -1.06 0.001
CG17784-RA CG17784 -1.05 0.001 CG10587-RA CG10587 -1.35 0.001
CG5888-RA CG5888 -1.15 0.001 CG32048-RA CG42673 -1.06 0.001
CG15007-RA Cpr64Ab -1.01 0.002 CG14351-RA haf -1.31 0.001
CG9880-RA Or23a -1.39 0.001 CG3187-RB Sirt4 -1.25 0.002
CG4781-RA CG4781 -1.15 0.001 CG14838-RA CG14838 -1.16 0.001
CG15666-RA CG15666 -1.04 0.001 CG2917-RA Orc4 -1.26 0.002
CG31062-RA side -1.09 0.001 CG5382-RA CG5382 -1.55 0.001
CG8800-RA CG8800 -1.13 0.001 CG4382-RA CG4382 -1.25 0.001
CG8910-RA CG8910 -1.17 0.001 CG5429-RA Atg6 -1.43 0.001
CG6901-RA CG6901 -1.40 0.001 CG30275-RB CG30275 -1.03 0.001
CG30345-RA CG30345 -1.02 0.001 CG1804-RA kek6 -1.10 0.001
CG12309-RA CG12309 -1.22 0.001 CG12273-RA angel -1.29 0.001
CG10618-RA CHKov1 -1.17 0.001 CG8892-RC CG8892 -1.17 0.002
CG13841-RA CG13841 -1.42 0.001 CG18268-RA CG18268 -1.03 0.001
CG6687-RA Spn88Eb -1.04 0.001 CG18631-RA CG43370 -1.09 0.001
CG13858-RA CG34377 -1.00 0.001 CG30187-RA CG30187 -1.10 0.002
CG6933-RC CG6933 -1.12 0.001 CG7305-RA Rim -1.11 0.001
CG7448-RB CG7448 -1.05 0.002 CR33258-RA CG33258 -1.24 0.001
CG4665-RA Dhpr -1.36 0.001 CG10132-RA CG10132 -1.18 0.004
CG4483-RA CG4483 -1.22 0.001 CG5495-RA Txl -1.14 0.001
CG13427-RA CG13427 -2.53 0.001 CG8422-RA Dh44-R1 -1.17 0.001
CG4721-RA CG4721 -1.23 0.001 CG14014-RA CG14014 -1.37 0.001
CG10693-RA slo -1.15 0.001 CG30378-RA CG30378 -1.16 0.001
CG12766-RA CG12766 -1.06 0.001 CG8637-RA trc -1.39 0.001
CG5859-RA CG5859 -1.10 0.001 CG12516-RA CG12516 -1.26 0.001
CG13707-RA CG13707 -1.02 0.003 CG8031-RA CG8031 -1.26 0.003
CG5274-RA CG5274 -1.09 0.002 CG4886-RA cyp33 -1.59 0.001
CG13675-RA CG13675 -1.14 0.001 CG7429-RA CG7429 -1.17 0.001
CG30283-RA CG30283 -1.07 0.001 CG5910-RA CG5910 -1.35 0.001
CG18211-RA betaTry -1.45 0.001 CG1374-RA tsh -1.59 0.001
CG13232-RA BBS4 -1.08 0.001 CG12116-RA CG12116 -1.20 0.001
CR31931-RA Gr22b -1.29 0.001 CG9456-RA Spn1 -1.13 0.001
CG3942-RA CG3942 -1.16 0.001 CG13728-RA CG13728 -1.24 0.001
CG4843-RC Tm2 -1.18 0.001 CG30177-RA CG30177 -1.00 0.001
CG3199-RA CG3199 -1.07 0.001 CG5379-RA CG5379 -1.06 0.001
CG12590-RA CG12590 -1.29 0.001 CG18609-RA CG18609 -1.24 0.001
CG14062-RA CG14062 -1.01 0.001 CG10092-RA CG10092 -1.24 0.001
CG5285-RA CG5285 -1.00 0.001 CG1112-RA alpha-Est7 -1.21 0.001
CG9333-RA Oseg5 -1.33 0.001 CG5687-RA CG5687 -1.04 0.001
CG18188-RA Damm -1.06 0.001 CG12700-RA skpD -1.10 0.001
CG5140-RA nopo -1.25 0.001 CG9962-RA CG9962 -1.13 0.001
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CG12369-RA Lac -1.09 0.002 CG5076-RA elk -1.13 0.001
CG18747-RA CG18747 -1.11 0.001 CG12690-RA CHES-1-like -1.25 0.001
CG1683-RA Ant2 -1.06 0.001 CG14333-RA lute -1.34 0.001
CG9470-RA MtnA -1.12 0.001 CG16827-RA alphaPS4 -1.07 0.001
CG6508-RA CG6508 -1.12 0.001 CG4337-RA mtSSB -1.50 0.001
CG32823-RB Sdic3 -1.49 0.001 CG6793-RA CG6793 -1.14 0.001
CG5558-RB CG42359 -1.36 0.001 CG14137-RA CG14137 -1.13 0.001
CG9429-RA Crc -2.22 0.002 CG13164-RC SIP2 -1.12 0.001
CG30099-RA CG30099 -1.19 0.001 CG3592-RA CG3592 -1.05 0.001
CG11306-RA CG11306 -1.26 0.002 CG10081-RA CG10081 -1.21 0.001
CG8852-RA CG8852 -1.12 0.001 CG10052-RA Rx -1.06 0.001
CG7199-RD Hr78 -1.12 0.001 CG11175-RA Rcd6 -1.24 0.001
CG16765-RB ps -2.08 0.001 CG13648-RA tnc -1.18 0.001
CG9730-RA mRpL21 -1.04 0.001 CG5731-RA CG5731 -1.10 0.002
CG3987-RA CG3987 -1.50 0.001 CG7225-RA wbl -1.82 0.001
CG9416-RA CG9416 -1.37 0.001 CG8958-RA CG8958 -1.13 0.001
CG5697-RA CG5697 -1.04 0.001 CG14107-RA CG14107 -1.06 0.001
CR32886-RA Uhg1 -1.43 0.001 CG10006-RA CG10006 -1.01 0.001
CG9325-RC hts -1.14 0.004 CG5171-RA CG5171 -2.15 0.001
CG5524-RA CG5524 -1.19 0.001 CG9294-RB CG9294 -1.35 0.001
CG32937-RA FoxP -1.12 0.002 CG6575-RA glec -1.27 0.001
CG13931-RA CG13931 -1.38 0.001 CG8118-RA mam -1.26 0.001
CG1246-RB CG1246 -1.34 0.001 CG30432-RA CG30432 -1.14 0.001
CG9503-RA CG9503 -1.21 0.001 CG17905-RA ChLD3 -1.15 0.001
CG13518-RA Obp58b -1.17 0.001 CG5265-RA CG5265 -1.02 0.001
CG14766-RA CG34431 -1.05 0.001 CG14400-RA CG14400 -1.09 0.001
CG7665-RB Fsh -1.18 0.001 CG13969-RA bwa -1.44 0.001
CG14437-RA COQ7 -1.13 0.001 CG11143-RA Inos -1.77 0.001
CG11326-RA Tsp -1.11 0.001 CG18599-RA CG18599 -1.21 0.001
CG15551-RA Ctr1C -1.27 0.001 CG11597-RA CG11597 -1.29 0.001
CG30043-RA CG30043 -1.29 0.001 CG14605-RB CG14605 -1.38 0.001
CG1075-RA CR1075 -1.30 0.001 CG3769-RA CG3769 -1.23 0.001
CG13622-RA CG13622 -1.17 0.001 CG32308-RA CG42355 -1.04 0.001
CG10845-RA CG10845 -1.09 0.001 CG14546-RA CG14546 -1.16 0.001
CG14937-RA CG14937 -1.49 0.001 CG17888-RC Pdp1 -1.26 0.001
CG3665-RB Fas2 -1.97 0.001 CG31537-RA cno -1.27 0.001
CG30074-RA Obp50d -1.39 0.001 CG14989-RB CG14989 -1.00 0.002
CG6981-RB CG6981 -1.51 0.001 CG10823-RB SIFR -1.32 0.001
CG10917-RA fj -1.77 0.001 CG10814-RA CG10814 -1.02 0.001
CG7484-RB CG7484 -1.67 0.001 CG14979-RA Gr63a -1.06 0.001
CG30421-RA CG30421 -1.24 0.001 CG7551-RB CG7551 -1.10 0.001
CG1455-RA CanA1 -1.00 0.001 CG17343-RA CG17343 -1.13 0.001
CG4908-RA CG4908 -1.40 0.001 CG11407-RA CG11407 -1.28 0.001
CG31668-RA CG31668 -1.05 0.001 CG10908-RA Der-1 -1.70 0.001
CG7031-RA CG7031 -1.14 0.001 CG17916-RA Or92a -1.15 0.001
CG5751-RA TrpA1 -1.18 0.001 CG31482-RA CG31482 -1.16 0.001
CG17266-RA CG17266 -1.01 0.001 CG7058-RA CG7058 -1.18 0.001
CG33125-RA CG33125 -1.10 0.001 CG32149-RC RhoGAP71E -1.05 0.001
CG6954-RA CG6954 -1.64 0.001 CG1849-RA run -1.13 0.001
CG5614-RA CG5614 -1.18 0.001 CG30030-RA Gr47b -1.12 0.001
CG5955-RA CG5955 -1.14 0.001 CG4163-RA Cyp303a1 -1.24 0.001
CG10851-RG B52 -1.74 0.001 CG4812-RA Ser8 -1.26 0.001
CG32970-RA wb -1.03 0.001 CG14901-RA Gr89a -1.19 0.001
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CG11109-RA CG11109 -1.52 0.001 CG17800-RE Dscam -1.15 0.001
CG14323-RA CG14323 -1.12 0.001 CG5373-RA Pi3K59F -1.34 0.001
CG31362-RA Jon99Ciii -1.30 0.001 CG9806-RA CG9806 -1.02 0.001
CG3989-RA ade5 -1.35 0.001 CG32386-RA corn -1.63 0.001
CG5321-RA CG5321 -1.14 0.001 CG5765-RA Muc55B -1.20 0.001
CG6643-RA Esyt2 -1.02 0.001 CG17381-RA Ir94g -1.21 0.001
CG10233-RA rtp -1.18 0.001 CG1944-RA Cyp4p2 -1.02 0.001
CG32259-RB CG32259 -1.09 0.001 CG15399-RA CG15399 -1.15 0.001
CG3541-RB pio -1.26 0.002 CG14694-RA CG14694 -1.01 0.001
CG3427-RA Epac -1.22 0.001 CG30081-RA Ir51b -1.50 0.001
CG33148-RB Mctp -1.23 0.001 CG2182-RA CG2182 -1.00 0.003
CG10752-RA CG10752 -1.00 0.001 CG7794-RA CG7794 -1.05 0.001
CG33324-RA gpp -1.06 0.003 CG7540-RA M6 -1.42 0.001
CG18660-RC Nckx30C -1.18 0.001 CG14825-RA BBS1 -1.09 0.001
CG31659-RA CG31659 -1.35 0.001 CG31786-RA CG42750 -1.17 0.001
CG32145-RA ome -1.26 0.001 CG14380-RA CG14380 -1.25 0.001
CG9969-RA Or63a -1.08 0.001 CG9855-RA CG9855 -1.31 0.002
CG31950-RA CG31950 -1.46 0.001 CG18449-RA CG18449 -1.09 0.002
CG32855-RA CG32855 -1.27 0.001 CG8818-RA CG8818 -1.58 0.001
CG9406-RA CG9406 -1.07 0.001 CG8932-RA CG42235 -1.00 0.001
CG9536-RA CG9536 -1.08 0.001 CG12438-RA CG12438 -1.17 0.001
CG12436-RA CG43373 -1.20 0.001 CG32634-RA Rbp1-like -1.22 0.001
CG13046-RA CG13046 -1.08 0.001 CG12424-RB CG12424 -1.52 0.001
CG18296-RA axo -1.17 0.001 CG18662-RA CG18662 -1.28 0.001
CG30468-RA Ir52c -1.00 0.001 CG32856-RA CG32856 -1.29 0.001
CG10017-RA CG34340 -1.21 0.001 CG12499-RA CG12499 -1.16 0.001
CG1362-RB cdc2rk -1.11 0.001 CG12008-RC kst -1.42 0.001
CG4767-RA Tektin-A -1.42 0.001 CG4521-RA mthl1 -1.05 0.001
CG5518-RA sda -1.08 0.001 CG10598-RA CG10598 -1.26 0.001
CG13504-RA CG34205 -1.43 0.001 CG31962-RA Sr-CIII -1.16 0.001
CG10722-RA nesd -1.42 0.001 CG3039-RA ogre -2.17 0.001
CG11162-RA CG11162 -1.32 0.001 CG5929-RA Ir40a -1.10 0.003
CG32950-RB CG14245 -1.07 0.001 CG9264-RB tadr -1.20 0.001
CG4427-RA cbt -1.85 0.001 CG12617-RA CG12617 -1.23 0.001
CG4576-RA CG4576 -1.26 0.001 CG1674-RB CG1674 -1.09 0.001
CG11279-RA CG11279 -1.39 0.001 CG8190-RA eIF2B-γ -1.20 0.001
CG30203-RA CG30203 -1.44 0.001 CG32024-RA CG32024 -1.38 0.001
CG13856-RA CG13856 -1.31 0.001 CG32813-RA CG32813 -1.40 0.001
CG1864-RB Hr38 -1.20 0.001 CG12715-RA CG12715 -1.09 0.001
CG14104-RA CG14104 -1.16 0.001 CG13695-RB gk -1.26 0.001
CG8502-RC Cpr49Ac -1.00 0.001 CG6839-RA CG6839 -1.30 0.001
CG10067-RA Act57B -2.32 0.001 CG31871-RA CG31871 -1.12 0.001
CG6675-RA CG6675 -1.29 0.001 CG18223-RB CG18223 -1.14 0.001
CG16740-RA Rh2 -1.22 0.001 CG32584-RB CG42299 -1.27 0.001
CG5197-RA CG34457 -1.10 0.001 CG9990-RB CG9990 -1.06 0.001
CG5461-RA bun -1.15 0.001 CG30495-RA CG30495 -1.01 0.001
CG5099-RA msi -1.05 0.001 CG1827-RB CG1827 -1.18 0.001
CG3934-RA Npc2c -1.11 0.001 CG14398-RA CG33510 -1.18 0.001
CG32643-RA CG32643 -1.07 0.001 CG8795-RA CG8795 -1.05 0.001
CG3011-RA CG3011 -1.05 0.001 CG10143-RA Adgf-E -1.17 0.001
CG8874-RA Fps85D -1.50 0.001 CG12663-RA Ir7a -1.15 0.001
CG30106-RA CCHa1r -1.12 0.001 CG11212-RA Ptr -1.62 0.001
CG8544-RB sd -1.97 0.001 CG3977-RA Ctr1A -1.02 0.002
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CG3050-RA Cyp6d5 -1.93 0.001 CG8550-RA CG8550 -1.01 0.001
CG8982-RA Acp26Aa -1.06 0.001 CG3921-RA CG3921 -1.11 0.001
CG8197-RA CG8197 -1.06 0.003 CG5065-RA CG5065 -1.06 0.002
CG1806-RA CG1806 -1.32 0.001 CG1921-RC sty -1.90 0.002
CG32954-RG Adh -1.17 0.001 CG10625-RC CG10625 -1.15 0.001
CG6746-RA CG6746 -1.61 0.001 CG32988-RA CG32988 -1.35 0.001
CG17078-RA CG17078 -1.48 0.001 CG31139-RA CG31139 -1.17 0.002
CG10181-RA Mdr65 -1.04 0.001 CG16710-RA CG16710 -1.39 0.001
CG10309-RA pad -1.12 0.001 CG7807-RA AP-2 -1.24 0.001
CG31749-RA Fas3 -1.58 0.001 CG4959-RB CG34168 -1.27 0.001
CG12161-RA Prosβ2R2 -1.20 0.001 CG13337-RA CG13337 -1.60 0.001
CG13325-RA CG13325 -1.17 0.001 CG6744-RA CG6744 -1.16 0.003
CG12680-RA CG12680 -1.29 0.001 CG17186-RA CG17186 -1.00 0.001
CG13306-RA CG13306 -1.42 0.001 CG3691-RA Pof -1.12 0.001
CG13563-RA CG13563 -1.02 0.001 CG10484-RA Rpn3 -1.40 0.001
CG6829-RA Ark -1.13 0.001 CG17085-RA CG43129 -1.06 0.001
CG6885-RA CG6885 -1.30 0.001 CG6790-RA CG6790 -1.33 0.001
CG32499-RA Cda4 -1.38 0.001 CG7978-RA Ac76E -1.05 0.001
CG12975-RA CG12975 -1.69 0.001 CG15506-RA CG15506 -1.16 0.001
CG8590-RA Klp3A -1.57 0.002 CG7763-RA CG7763 -2.13 0.001
CG14526-RA CG14526 -1.46 0.001 CG13251-RA CG13251 -1.18 0.001
CG31782-RB CG31782 -1.17 0.001 CG15180-RA glob2 -1.25 0.001
CG14001-RA bchs -1.28 0.001 CG4645-RA CG4645 -1.37 0.003
CG2665-RA PebII -1.15 0.001 CG8337-RA malpha -2.33 0.001
CG17233-RC CG17233 -1.51 0.001 CG7228-RA pes -1.24 0.001
CG8363-RC Papss -1.34 0.001 CG2861-RA CG2861 -1.02 0.001
CG17725-RA Pepck -2.14 0.001 CG7177-RA Wnk -1.00 0.004
CG4673-RA CG4673 -1.12 0.001 CG11037-RA CG11037 -1.04 0.001
CG14122-RA Smyd4 -1.24 0.001 CG2411-RA ptc -2.08 0.001
CG16874-RA Vm32E -1.11 0.001 CG1394-RA CG1394 -1.05 0.001
CG32392-RA CG32392 -1.37 0.001 CG5874-RA Nelf-A -1.62 0.001
CG15632-RA Taf12L -1.12 0.001 CG1387-RA CG1387 -1.07 0.001
CG15877-RA CG15877 -1.07 0.001 CG6269-RA unc-4 -1.07 0.001
CG10302-RA bsf -1.61 0.001 CG32486-RD CG32486 -1.81 0.005
CG1071-RA E2f2 -1.80 0.001 CG7796-RA dpr12 -1.03 0.001
CG4679-RA CG4679 -1.40 0.002 CG32487-RA CG32487 -1.18 0.001
CG8756-RC verm -1.15 0.001 CG1773-RA CG1773 -1.34 0.001
CG8110-RB syd -1.18 0.001 CG2574-RA CG2574 -1.30 0.001
CG15618-RA CG15618 -1.28 0.003 CG8365-RA E(spl) -1.83 0.004
CG33101-RA Nsf2 -1.13 0.001 CG10943-RA CG10943 -1.21 0.001
CG8322-RB ATPCL -1.14 0.001 CG33060-RA CG33060 -1.15 0.001
CG1703-RA CG1703 -1.45 0.002 CG8374-RA dmt -1.26 0.004
CG10339-RA CG10339 -1.00 0.001 CG4631-RA CG4631 -1.16 0.001
CG7882-RA CG7882 -1.05 0.001 CG8364-RA Drep-3 -1.09 0.001
CG1555-RA cn -1.72 0.001 CG18335-RA CG18335 -1.42 0.001
CG3173-RA CG3173 -1.34 0.002 CG13893-RA CG13893 -1.08 0.001
CG14770-RA CG14770 -1.19 0.001 CG10317-RA CG10317 -1.19 0.001
CG15227-RA CG15227 -1.08 0.001 CG3796-RA ac -1.57 0.001
CG12911-RA CG12911 -1.23 0.001 CG5835-RA CG5835 -1.27 0.001
CG10170-RA CG10170 -1.59 0.003 CG9836-RA CG9836 -1.65 0.001
CG32434-RA siz -1.76 0.001 CG6733-RA CG6733 -1.35 0.001
CG4090-RA Mur89F -1.13 0.001 CG14040-RA CG14040 -1.02 0.001
CG10253-RA CG10253 -1.24 0.001 CG13225-RA Or47a -1.01 0.001
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CG12056-RA CG12056 -1.04 0.001 CG32401-RA Or65a -1.25 0.001
CG4608-RA bnl -1.21 0.001 CG14740-RA CG14740 -1.12 0.001
CG15695-RA CG15695 -1.14 0.001 CG7127-RA exo70 -1.28 0.001
CG5924-RA CG5924 -1.01 0.001 CG15864-RA CG15864 -1.03 0.001
CG4881-RA salr -1.20 0.001 CG14946-RA CG14946 -1.56 0.001
CG31557-RA Obp83ef -1.25 0.001 CG1728-RA Tim8 -1.07 0.001
CG17278-RA CG17278 -1.77 0.001 CG9042-RC Gpdh -1.08 0.001
CG7371-RA CG7371 -1.01 0.001 CG10463-RA CG10463 -1.26 0.001
CG15646-RA CG15646 -1.00 0.001 CG14479-RA CG43164 -1.39 0.001
CG12096-RA CG12096 -1.27 0.001 CG5017-RA CG5017 -1.08 0.001
CG13117-RA CG13117 -1.12 0.001 CG9653-RA brk -1.10 0.002
CG31091-RA CG31091 -1.28 0.001 CG9706-RA CG9706 -1.15 0.001
CG16719-RA CG16719 -1.28 0.001 CG10359-RA CG10359 -1.08 0.001
CG14096-RA CG14096 -1.16 0.001 CG13079-RA CG13079 -1.31 0.001
CG6073-RA CG6073 -1.11 0.001 CG4110-RA ppk16 -1.15 0.001
CG33492-RA Ir41a -1.15 0.001 CG11905-RF CG11905 -1.33 0.001
CG7422-RA Snmp2 -1.12 0.001 CG3969-RB PR2 -1.47 0.001
CG15747-RA CG15747 -1.07 0.001 CG14251-RA ms(3)K81 -1.13 0.001
CG9918-RC Pk1r -1.39 0.001 CG33473-RB luna -1.74 0.001
CG31437-RA CG31437 -1.24 0.001 CG13194-RA pyr -1.46 0.002
CG33193-RA sav -1.30 0.001 CG5342-RA CG5342 -1.29 0.001
CG5718-RA CG5718 -1.26 0.001 CG11327-RA CG11327 -1.20 0.001
CG30380-RA CG30380 -1.30 0.001 CG13028-RA CG13028 -1.04 0.001
CG2331-RA TER94 -1.06 0.001 CG2904-RB ec -1.03 0.001
CG31050-RA CG31050 -1.04 0.001 CG11637-RA CG11637 -1.19 0.002
CG33466-RA Fs -1.29 0.001 CG31380-RA CG31380 -1.37 0.001
CG32085-RA CG32085 -1.21 0.001 CG15615-RA CG15615 -1.22 0.001
CG14080-RA Mkp3 -1.30 0.001 CG8712-RB CG8712 -1.34 0.001
CG7283-RB RpL10Ab -1.07 0.001 CG33293-RA CG33293 -1.47 0.001
CG31623-RA dtr -1.19 0.001 CG15415-RA Spindly -1.42 0.001
CG11798-RB chn -1.57 0.001 CG3814-RA CG3814 -1.49 0.001
CG17348-RA drl -2.01 0.001 CG6036-RA CG6036 -1.12 0.001
CG32135-RA Nxf3 -1.08 0.001 CG2140-RA Cyt-b5 -1.48 0.001
CG7584-RA Obp99c -1.08 0.001 CG5987-RA CG5987 -1.08 0.002
CG4029-RA jumu -1.93 0.001 CG14964-RA CG14964 -1.17 0.001
CG2064-RA CG2064 -1.47 0.001 CG11592-RA CG11592 -1.26 0.001
CG6126-RA CG6126 -1.48 0.001 CG9140-RA CG9140 -1.26 0.008
CG9598-RA bbg -1.44 0.001 CG31693-RA CG31693 -1.35 0.001
CG10477-RA CG10477 -1.08 0.001 CG9472-RA CG9472 -1.22 0.001
CG8651-RA trx -1.60 0.001 CG9852-RA 140up -1.16 0.001
CG13188-RB CG13188 -1.18 0.001 CG9610-RA Poxm -1.20 0.001
CG31666-RD chinmo -1.14 0.001 CG6410-RA Snx16 -1.33 0.001
CG9614-RG pip -1.14 0.001 CG1698-RA CG1698 -1.17 0.001
CG4829-RB CG4829 -1.41 0.001 CG11761-RA trsn -1.65 0.002
CG8665-RA CG8665 -1.43 0.001 CG1157-RA Osi15 -1.24 0.001
CG11913-RA CG11913 -1.29 0.001 CG32115-RA CG32115 -1.11 0.001
CG31085-RA CG33970 -1.15 0.001 CG32136-RB Tsp68C -1.10 0.001
CG33283-RA CR33283 -1.34 0.001 CG5976-RA isoQC -1.14 0.001
CG13016-RA CG13016 -1.18 0.001 CG14717-RA CG14717 -1.08 0.001
CG4053-RA CG4053 -1.13 0.001 CG7402-RA CG7402 -1.38 0.001
CG14153-RA CG14153 -1.43 0.001 CG3322-RA LanB2 -2.39 0.001
CG31017-RA PH4αNE3 -1.11 0.001 CG10393-RA amos -1.15 0.001
CG2540-RA CG2540 -1.07 0.001 CG4099-RA Sr-CI -1.56 0.001
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CG2016-RB CG2016 -1.15 0.001 CG15526-RA CG15526 -1.35 0.001
CG17330-RA jhamt -1.13 0.001 CG31509-RA TotA -1.10 0.001
CG31189-RA CG31189 -1.11 0.001 CG17716-RA fas -1.12 0.001
CG17108-RA CG17108 -1.00 0.001 CG11100-RB Mes2 -1.36 0.001
CG7990-RB CG7990 -1.32 0.001 CG7112-RA CG7112 -1.07 0.001
CG17637-RA CG17637 -1.08 0.001 CG7104-RA spz3 -1.20 0.001
CG10278-RA GATAe -1.58 0.001 CG16791-RA CG16791 -1.79 0.001
CG31219-RA CG31219 -1.07 0.001 CG32542-RA CG34401 -1.80 0.001
CG9480-RA Glycogenin -1.02 0.001 CG10371-RB Plip -1.17 0.001
CG8476-RA CG8476 -1.10 0.001 CG14684-RA CG14684 -1.25 0.001
CG10293-RA how -2.08 0.002 CG31764-RB vir-1 -1.23 0.001
CG4590-RA inx2 -1.18 0.003 CG2826-RA lectin-21Ca -1.35 0.001
CG18649-RA CG18649 -1.00 0.001 CG13366-RA CG13366 -1.13 0.002
CG1915-RC sls -1.16 0.001 CG33006-RD CG43164 -1.75 0.001
CG4396-RA fne -1.19 0.001 CG14070-RA CG14070 -1.16 0.001
CG13312-RA CG13312 -1.27 0.001 CG4593-RA CG4593 -1.18 0.001
CG12906-RA Gr47a -1.02 0.001 CG2184-RA Mlc2 -1.36 0.001
CG13701-RA skl -1.49 0.001 CG14890-RA CG42342 -1.15 0.001
CG10582-RA Sin -1.40 0.001 CG10236-RA LanA -2.27 0.001
CR33326-RA mir-34 -1.24 0.001 CG15731-RA CG15731 -1.01 0.001
CG17176-RA ACXA -1.13 0.001 CG8306-RA CG8306 -1.83 0.001
CG3871-RA Six4 -1.39 0.001 CG13417-RA Gr93a -1.13 0.001
CG2872-RB AlstR -1.12 0.001 CG13488-RA CG13488 -1.07 0.001
CG8654-RA CG8654 -1.28 0.001 CG7781-RA CG7781 -1.32 0.001
CG31804-RA CG31804 -1.30 0.001 CG33110-RA CG33110 -1.05 0.001
CG2684-RA lds -1.34 0.001 CG17005-RA CG17005 -1.35 0.001
CG8398-RA CG8398 -1.13 0.001 CG6802-RA Cyp313a4 -1.00 0.001
CG32415-RA CG42272 -1.36 0.001 CG18174-RA Rpn11 -1.66 0.001
CG7257-RA Rpt4R -1.06 0.001 CG2909-RA CG2909 -1.08 0.001
CG17752-RA CG17752 -1.06 0.001 CG12824-RA CG12824 -1.01 0.001
CG3182-RB sei -1.09 0.001 CG7214-RA CG7214 -1.04 0.001
CG11059-RA cals -1.94 0.001 CG8236-RA CG8236 -1.02 0.001
CG16986-RA CG16986 -1.01 0.001 CG14317-RA CG14317 -1.60 0.002
CG32407-RA CG32407 -1.04 0.001 CG5899-RA Etl1 -1.48 0.001
CG5883-RA CG5883 -1.25 0.001 CG13904-RA CG34057 -1.09 0.001
CG31233-RA CG31233 -1.04 0.001 CG6300-RA CG6300 -1.35 0.001
CG8560-RA CG8560 -1.14 0.001 CG17122-RA CG17122 -1.17 0.001
CG10327-RC TBPH -1.92 0.004 CG11200-RA CG11200 -1.26 0.001
CG9398-RA king-tubby -1.59 0.001 CG15154-RA Socs36E -1.90 0.001
CG9115-RA mtm -1.91 0.001 CG4933-RA CG4933 -1.27 0.001
CG8344-RA RpIII128 -1.14 0.001 CG4974-RA dally -1.60 0.001
CG11064-RA Rfabg -2.06 0.001 CG17657-RA frtz -1.01 0.004
CG4123-RA Mipp1 -1.73 0.002 CG6234-RA CG6234 -2.18 0.001
CG12784-RA CG12784 -1.23 0.001 CG3245-RA PpN58A -1.18 0.001
CG12296-RA klu -1.45 0.001 CG7906-RA CG7906 -1.01 0.002
CG12250-RA ymp -1.44 0.001 CG15593-RA Osi10 -1.21 0.001
CG1844-RA SelG -1.38 0.001 CG2708-RA unc-45 -1.44 0.001
CG15169-RA CG15169 -1.15 0.001 CG13405-RA CG13405 -1.17 0.001
CG4225-RA Hmt-1 -1.31 0.001 CG15256-RA CG15256 -1.11 0.001
CG17024-RA CG17024 -1.40 0.001 CG17204-RA mun -1.16 0.001
CG8510-RA Cpr49Af -1.07 0.001 CG31284-RC wtrw -1.11 0.001
CG5853-RA CG5853 -1.46 0.001 CG2794-RA CG2794 -1.02 0.001
CG10197-RA kn -1.01 0.003 CG32451-RB SPoCk -1.48 0.001
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CG6354-RB Rb97D -1.23 0.001 CG16969-RA dgt2 -1.54 0.001
CG13362-RA CG13362 -1.38 0.001 CG12143-RA Tsp42Ej -1.30 0.001
CG10246-RA Cyp6a9 -1.05 0.001 CG13271-RA Ugt36Bb -1.04 0.001
CG12254-RA MED25 -1.10 0.001 CG7266-RC Eip71CD -1.65 0.001
CG2331-RB TER94 -1.43 0.001 CG8300-RA CG8300 -1.42 0.001
CG13990-RA Muc26B -1.00 0.001 CG10251-RA CG10251 -1.08 0.001
CG14787-RA CG14787 -1.01 0.001 CG31791-RA CG43339 -1.25 0.001
CG1691-RA Imp -1.55 0.001 CG4899-RA Pdh -1.01 0.001
CG15095-RA l(2)08717 -1.51 0.002 CG2125-RA ci -2.10 0.001
CG14866-RA CG14866 -1.11 0.001 CG17321-RA CG17321 -1.38 0.001
CG6414-RA CG6414 -1.04 0.001 CG17300-RA CG17300 -1.40 0.001
CG9071-RB NaCP60E -1.01 0.001 CG31601-RA CG31601 -1.42 0.001
CG1575-RA CG1575 -1.20 0.001 CG1048-RA zen2 -1.19 0.001
CG15371-RA Gr8a -1.00 0.001 CG7062-RA Rab-RP3 -1.25 0.001
CG1213-RB CG1213 -1.28 0.001 CG15881-RA CG15881 -1.10 0.001
CG1316-RA CG1316 -1.68 0.001 CG8785-RA CG8785 -1.02 0.001
CG11552-RA Rpn12R -1.17 0.001 CG13094-RC Dh31 -1.24 0.001
CG9731-RA pyd -1.24 0.001 CG32079-RA CG32079 -1.54 0.001
CG1411-RB CRMP -1.70 0.001 CG15412-RA CG15412 -1.11 0.001
CG9778-RA Syt14 -1.06 0.001 CG4115-RA CG4115 -1.34 0.001
CG3359-RD mfas -1.80 0.001 CG7449-RB hbs -1.81 0.001
CG11502-RB svp -1.21 0.001 CG4007-RA Nrk -1.07 0.001
CG6217-RA knk -1.17 0.001 CG9945-RA CG9945 -1.33 0.001
CG31677-RA CG31677 -1.39 0.001 CG32102-RA CG32102 -1.29 0.002
CG3437-RA CG3437 -1.11 0.001 CG31464-RA CG31464 -1.24 0.001
CG13217-RA CG13217 -1.50 0.001 CG15422-RA CG15422 -1.29 0.001
CG8772-RB CG42708 -1.06 0.001 CG6113-RA Lip4 -1.74 0.001
CG15828-RB CG15828 -1.72 0.001 CG14298-RA CG14298 -1.01 0.001
CG3041-RA Orc2 -1.44 0.001 CG40188-RC CG40188 -1.12 0.001
CG2692-RA gsb-n -1.43 0.001 CG2977-RA inx7 -1.25 0.001
CG4446-RA CG34456 -1.33 0.001 CG9098-RA CG9098 -1.16 0.001
CG33479-RA clos -1.08 0.001 CG3140-RA Adk2 -1.20 0.001
CG1973-RA yata -1.59 0.001 CG5733-RA Nup75 -1.63 0.001
CG14111-RA CG14111 -1.26 0.001 CG1634-RB Nrg -1.35 0.004
CG15369-RA CG15369 -1.08 0.001 CG32182-RA CG32182 -1.68 0.001
CG17470-RA CG17470 -1.08 0.001 CG32064-RA S-Lap4 -1.46 0.001
CG9577-RA CG9577 -1.13 0.001 CG11451-RA Spc105R -1.10 0.001
CG5820-RC Gp150 -2.15 0.001 CG31028-RB CG31028 -1.18 0.001
CG6476-RB Su(var)3-9 -1.55 0.001 CG6052-RA CG6052 -1.17 0.001
CG9766-RB CG9766 -1.25 0.001 CG6043-RD CG6043 -1.00 0.001
CG31421-RA Takl1 -1.07 0.001 CG6050-RA EfTuM -1.18 0.001
CG1980-RB dj -1.16 0.001 CG14696-RA CG14696 -1.11 0.001
CG32054-RA CG32054 -1.39 0.001 CG2083-RA CG2083 -2.02 0.001
CG9593-RA CG9593 -1.15 0.001 CG11624-RB Ubi-p63E -1.61 0.001
CG6197-RA CG6197 -1.29 0.001 CG15382-RA CG15382 -1.49 0.001
CG9650-RA CG9650 -1.72 0.001 CG31369-RA CG31369 -1.18 0.001
CG1641-RA sisA -1.86 0.001 CG9550-RA CG9550 -1.22 0.001
CG15546-RA CG15546 -1.16 0.001 CG33253-RA CG33253 -1.23 0.001
CG11851-RA CG11851 -1.06 0.001 CG1138-RA CG1138 -1.00 0.001
CG8676-RB Hr39 -1.26 0.001 CG8638-RA Cpr65Eb -1.32 0.001
CG12252-RA Fcp1 -1.09 0.001 CG13202-RA CG13202 -1.02 0.001
CG9024-RB Acp26Ab -1.00 0.004 CG9623-RB if -1.13 0.001
CG9119-RA CG9119 -1.04 0.001 CG31684-RA CG34447 -1.31 0.001
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CG6454-RA CG6454 -1.20 0.001 CG9887-RA VGlut -1.35 0.001
CG5097-RA MtnC -1.51 0.001 CG11841-RA CG11841 -1.42 0.001
CG11607-RA H2.0 -1.20 0.001 CG11961-RA CG11961 -1.36 0.001
CG1421-RA CG1421 -1.07 0.001 CG9054-RA Ddx1 -1.11 0.001
CG32141-RA CG32141 -1.01 0.002 CG31100-RA CG31100 -1.17 0.001
CG32382-RA sphinx2 -1.41 0.001 CG6143-RA Pep -1.21 0.001
CG6006-RA CG6006 -1.40 0.001 CG14893-RA CG14893 -1.01 0.001
CG14173-RA Ilp1 -1.08 0.001 CG10421-RA Cad96Cb -1.10 0.001
CG15152-RA CG15152 -1.35 0.001 CG2808-RA CG34340 -1.03 0.001
CG17364-RA CG17364 -1.06 0.001 CG12120-RA t -1.04 0.001
CG15922-RA CG15922 -1.17 0.001 CG11726-RA CG11726 -1.26 0.001
CG3054-RA l(2)k05819 -1.22 0.001 CG13478-RA shd -1.07 0.001
CG3219-RA Klp59C -1.02 0.001 CG13438-RA CG13438 -1.25 0.002
CG4194-RA CG4194 -1.73 0.001 CG4704-RA CG4704 -1.25 0.001
CG7046-RA CG7046 -1.52 0.001 CG11136-RA Lrt -1.42 0.001
CG15316-RA Megalin -1.52 0.001 CG31318-RB Rpb4 -1.03 0.001
CG10002-RA fkh -2.04 0.001 CG11529-RA CG11529 -1.09 0.001
CG30364-RA hubl -1.12 0.001 CG3790-RA CG3790 -1.29 0.001
CG3526-RA CG3526 -1.19 0.001 CG14570-RA CG14570 -1.31 0.001
CG3699-RA CG3699 -1.20 0.004 CG13602-RA CG13602 -1.09 0.001
CG14585-RA Ir75a -1.15 0.001 CG3469-RA betaggt-I -1.09 0.001
CG32057-RC dpr10 -1.02 0.001 CG14312-RA CG14312 -1.04 0.001
CG14916-RA Gr32a -1.02 0.001 CG32177-RA CG32177 -1.63 0.001
CG31454-RA CG31454 -1.01 0.001 CG10794-RA DptB -1.01 0.001
CG7295-RA CG7295 -1.29 0.001 CG14686-RA Desi -1.13 0.001
CG14959-RC ckd -1.30 0.001 CG33344-RA CcapR -1.20 0.001
CG10912-RA CG10912 -1.15 0.001 CG14531-RA CheB98a -1.21 0.001
CG6479-RA CG6479 -1.05 0.003 CG7889-RA CG7889 -1.24 0.001
CG17906-RA CG17906 -1.18 0.001 CG31606-RB CG31606 -1.32 0.001
CG1077-RA CG1077 -1.13 0.001 CG6971-RA CG6971 -1.06 0.001
CG11069-RA CG11069 -1.46 0.001 CG17280-RA levy -1.01 0.004
CG5724-RA CG5724 -1.27 0.001 CG1165-RA LysS -1.55 0.001
CG4271-RA CG4271 -1.01 0.002 CG31204-RA CG31204 -1.14 0.001
CG33017-RB CG33017 -1.05 0.001 CG18472-RA CG18472 -1.11 0.001
CG7615-RA fig -1.06 0.001 CG14598-RA CG14598 -1.13 0.001
CG5776-RA CG5776 -1.23 0.001 CG10888-RA Rh3 -1.20 0.001
CG2930-RB CG2930 -1.46 0.001 CG13566-RA CG13566 -1.07 0.002
CG6416-RJ Zasp66 -1.04 0.001 CG17974-RA CG17974 -1.31 0.001
CG32209-RB serp -1.44 0.002 CG1967-RA p24-1 -1.80 0.001
CG13716-RA CG13716 -1.13 0.001 CG17828-RB mod(r) -1.17 0.001
CG31148-RA CG31148 -1.31 0.001 CG3567-RA Cyp6u1 -1.20 0.001
CG18321-RA miple2 -1.81 0.001 CG13422-RA CG13422 -1.18 0.001
CG5693-RA CG5693 -1.15 0.001 CG32351-RA S-Lap2 -1.09 0.001
CG5281-RA CG5281 -1.29 0.003 CG17835-RB inv -1.59 0.001
CG7459-RA Poxm -1.63 0.001 CG5734-RA CG5734 -1.33 0.002
CG6284-RA Sirt6 -1.69 0.001 CG2979-RA Yp2 -1.22 0.001
CG10772-RB Fur1 -1.34 0.001 CG15179-RA sunz -1.02 0.001
CG6385-RA CG6385 -1.07 0.001 CG11350-RB CG11350 -1.05 0.001
CG17549-RA CG17549 -1.49 0.001 CG14673-RA CG14673 -1.21 0.001
CG7570-RA hale -1.14 0.001 CG5185-RA Tom -2.56 0.002
CG7916-RA CG7916 -1.32 0.001 CG30060-RA CG30060 -1.11 0.001
CG3388-RA gsb -1.69 0.006 CG18568-RA CG18568 -1.15 0.001
CG31118-RA RabX4 -1.37 0.002 CG11154-RB ATPsyn-β -1.86 0.002
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CG10730-RA CG10730 -1.06 0.001 CG7691-RA CG7691 -1.21 0.001
CG6515-RA Takr86C -1.05 0.003 CG10186-RC CG10186 -1.06 0.002
CG31226-RA CG31226 -1.24 0.001 CG1787-RA Hexo2 -1.22 0.001
CG10586-RA CG10586 -1.17 0.001 CG14518-RA CG14518 -1.27 0.001
CG5639-RA CG5639 -1.08 0.004 CG33209-RA comm3 -1.10 0.001
CG14127-RA CG14127 -1.43 0.001 CG3184-RA CG3184 -1.18 0.001
CG15003-RA Teh4 -1.35 0.001 CG6429-RA CG6429 -1.19 0.001
CG31473-RA CG31473 -1.22 0.001 CG9873-RA RpL37b -1.18 0.001
CG31876-RA Cpr30F -1.13 0.001 CG4780-RA membrin -1.21 0.001
CG8003-RA CG8003 -1.71 0.001 CG15657-RA CG15657 -1.23 0.001
CG7539-RA Edg91 -1.04 0.001 CG3104-RA CG3104 -1.07 0.001
CG3619-RA Dl -1.99 0.001 CG5381-RA CG5381 -1.03 0.001
CG32655-RA CG32655 -1.32 0.001 CG5427-RA Oatp33Ea -1.21 0.001
CG30271-RC CG30271 -1.04 0.001 CG9512-RA CG9512 -1.18 0.001
CG12410-RA cv -1.45 0.001 CG13010-RA CG13010 -1.02 0.001
CG4434-RA CG4434 -1.21 0.001 CG7907-RA CG7907 -1.05 0.001
CG18815-RA CG18815 -1.79 0.001 CG18266-RA CG18266 -1.18 0.001
CG6917-RA Est-6 -1.43 0.001 CG13521-RB robo -1.82 0.001
CG7442-RA CG7442 -1.08 0.001 CG14294-RA CG14294 -1.20 0.001
CG10573-RA ko -1.59 0.001 CG31929-RA Gr22c -1.07 0.001
CG8421-RE Asph -1.31 0.001 CG5133-RA Doc1 -1.74 0.001
CG4685-RA Ssadh -1.40 0.001 CG1908-RA CG1908 -1.20 0.001
CG9175-RA CG9175 -1.00 0.003 CG12765-RA fsd -1.26 0.001
CG1264-RA lab -1.31 0.001 CG8616-RA BHD -1.26 0.002
CG5841-RA mib1 -1.15 0.001 CG18103-RB fos28F -1.20 0.001
CG9232-RA Galt -1.37 0.001 CG4394-RB Traf-like -1.14 0.001
CG5907-RC Frq2 -1.15 0.001 CG13749-RA CG13749 -1.22 0.001
CG13231-RA CG13231 -1.25 0.001 CG18682-RA CG18682 -1.25 0.001
CG12052-RS lola -1.96 0.001 CR31927-RA snRNA:U3:22A -1.02 0.001
CG9454-RA Spn42Db -1.07 0.001 CG3940-RA CG3940 -1.38 0.001
CG9059-RA CG9059 -1.14 0.001 CG4830-RA CG4830 -1.07 0.001
CG7094-RA CG7094 -1.11 0.001 CG13725-RA CG13725 -1.04 0.001
CG7026-RA VhaPPA1-2 -1.04 0.001 CG7348-RA obst-J -1.21 0.001
CG12589-RA CG12589 -1.03 0.001 CG18607-RA CG18607 -1.14 0.001
CG13662-RA CG34110 -1.04 0.001 CG10042-RB MBD-R2 -1.70 0.001
CG5215-RA Zn72D -1.41 0.001 CG9331-RC CG9331 -1.65 0.001
CG5069-RA croc -1.14 0.001 CG5682-RA Edem2 -1.01 0.001
CG32555-RC RhoGAPp190 -1.49 0.001 CR15821-RA CR15821 -1.22 0.001
CG8834-RA CG8834 -1.24 0.001 CG30480-RA CG30480 -1.14 0.001
CG5085-RA Sirt2 -1.10 0.001 CG5075-RA Vha68-3 -1.17 0.001
CG7786-RA CG7786 -1.00 0.002 CG1268-RA VhaM9.7-a -1.35 0.002
CG16782-RA CG16782 -1.21 0.001 CG10562-RA CG10562 -1.26 0.001
CG9468-RA CG9468 -1.03 0.001 CG16826-RA CG16826 -1.05 0.001
CG31949-RA CG31949 -1.24 0.001 CG11977-RA CG11977 -1.31 0.001
CG9428-RA ZIP1 -1.27 0.001 CG8493-RA Den1 -1.22 0.001
CG8084-RA ana -1.25 0.001 CG3579-RA CG42361 -1.29 0.001
CG11303-RA TM4SF -1.13 0.001 CG5123-RA W -1.42 0.001
CG1007-RA emc -1.87 0.001 CG30128-RB Obp56c -1.26 0.001
CG9280-RC Glt -1.10 0.001 CG10051-RA CG10051 -1.40 0.001
CG5467-RA scrib -1.44 0.001 CG3949-RA hoip -2.15 0.001
CG30488-RA CG30488 -1.12 0.001 CG18125-RA CG18125 -1.11 0.001
CG12526-RA Or67a -1.32 0.001 CG9635-RF RhoGEF2 -1.35 0.001
CG4491-RA noc -2.00 0.001 CG7223-RB htl -1.43 0.001
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CG9415-RA Xbp1 -1.79 0.001 CG8957-RA CG42235 -1.23 0.001
CG4821-RA Tequila -1.39 0.001 CG4605-RA Acp32CD -1.08 0.001
CG12972-RA ebd2 -1.24 0.001 CG10005-RA CG10005 -1.59 0.001
CG5170-RE Dp1 -1.55 0.001 CG5044-RB CG5044 -1.60 0.001
CG18024-RA SoxN -1.74 0.002 CG30389-RA CG30389 -1.41 0.001
CG5177-RA CG5177 -1.16 0.001 CG12769-RA CG12769 -1.10 0.001
CG31902-RA Spn28Da -1.01 0.001 CG3292-RA CG3292 -1.13 0.001
CG10601-RB mirr -1.35 0.001 CG6669-RA klg -1.31 0.001
CG12462-RA tlk -1.08 0.001 CG11247-RB CG11247 -1.44 0.001
CG12869-RA CG12869 -1.27 0.001 CG32744-RA Ubi-p5E -1.64 0.001
CG31195-RA CG31195 -1.25 0.002 CG17856-RA CG17856 -1.23 0.001
CG5264-RA btn -1.43 0.001 CG4262-RA elav -2.07 0.002
CG30371-RA CG30371 -1.02 0.001 CG12052-RA lola -1.48 0.001
CG30002-RA CG30002 -1.16 0.001 CG32755-RA CG32755 -1.22 0.001
CG32694-RA CG32694 -1.00 0.003 CG4726-RA CG4726 -1.81 0.001
CG14396-RD Ret -1.06 0.001 CG7549-RB mtg -1.15 0.001
CG13956-RA kat80 -1.32 0.001 CG11139-RA p47 -1.66 0.001
CG12976-RA CG42337 -1.24 0.001 CG1129-RB CG1129 -1.76 0.001
CG14877-RA CG14877 -1.06 0.001 CG18596-RA CG18596 -1.33 0.001
CG15547-RA CG15547 -1.11 0.001 CG10352-RA CG10352 -1.09 0.001
CG1449-RA zfh2 -1.76 0.001 CG2956-RA twi -1.47 0.001
CG14651-RA CG14651 -1.25 0.001 CG5246-RA CG5246 -1.08 0.001
CG3611-RA CG3611 -1.15 0.001 CG3756-RA CG3756 -1.58 0.001
CG32307-RA zormin -1.17 0.001 CG14948-RA dpr18 -1.02 0.001
CG18418-RA CG18418 -1.32 0.001 CG14509-RA CG14509 -1.35 0.001
CG10844-RA Rya-r44F -1.51 0.001 CG14813-RA deltaCOP -1.43 0.001
CG14534-RA TwdlE -1.22 0.001 CG14936-RA Tsp33B -1.06 0.001
CG32265-RA Eip63F-2 -1.00 0.002 CG17885-RA Or1a -1.05 0.001
CG3665-RA Fas2 -2.20 0.001 CG3152-RA Trap1 -1.17 0.001
CG6980-RA CG6980 -1.14 0.001 CG10800-RA Rca1 -1.65 0.001
CG31746-RA CG42750 -1.15 0.001 CG14559-RA CG33970 -1.43 0.001
CG6503-RA CG6503 -1.05 0.002 CG4848-RA CG4848 -1.22 0.001
CG13445-RA CG13445 -1.08 0.001 CG17930-RA CG17930 -1.58 0.001
CG31661-RA CG31661 -1.36 0.001 CG18336-RA CG18336 -1.09 0.001
CG17914-RA yellow-b -1.30 0.001 CG31481-RA pb -1.20 0.001
CG30062-RA CG30062 -1.06 0.001 CG7057-RB AP-50 -1.71 0.001
CG33152-RA hbn -1.21 0.001 CG6953-RA fat-spondin -1.34 0.001
CG3558-RA CG3558 -1.13 0.001 CG18497-RA spen -1.44 0.001
CG14909-RA VhaM9.7-d -1.23 0.001 CG5613-RA CG5613 -1.09 0.001
CG15073-RA CG15073 -1.22 0.001 CG5952-RA Fer2 -1.11 0.001
CG2958-RA lectin-24Db -1.29 0.001 CG32232-RA CG32232 -1.12 0.001
CG14900-RA Cad89D -1.16 0.001 CG3491-RA CG3491 -1.06 0.001
CG2297-RA Obp44a -1.04 0.001 CG13582-RA Ir60d -1.08 0.001
CG4190-RA Hsp67Bc -1.46 0.001 CG4322-RA moody -1.32 0.001
CG17799-RA lectin-29Ca -1.11 0.001 CG17962-RA Z600 -1.71 0.004
CG14322-RA CG14322 -1.04 0.001 CG17943-RA comm -2.29 0.001
CG17917-RA CG17917 -1.05 0.001 CG18363-RA Dic4 -1.18 0.001
CG13454-RA CG13454 -1.71 0.001 CG5715-RA CG5715 -1.04 0.001
CG3134-RA ord -1.11 0.001 CG6944-RA Lam -1.75 0.001
CG18518-RA CG18518 -1.18 0.001 CG32384-RA form3 -1.11 0.001
CG33350-RA CheB42c -1.03 0.001 CG1786-RA Cyp318a1 -1.03 0.001
CG4770-RA CG4770 -1.25 0.001 CG10337-RA CG10337 -1.04 0.001
CG6614-RA CG6614 -1.28 0.001 CG14447-RA Grip -1.08 0.001
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CG11318-RA CG11318 -1.39 0.001 CG10850-RA ida -1.12 0.001
CG1939-RA Dpck -1.10 0.001 CG32257-RA Gr64b -1.27 0.001
CG15396-RA Gr23a -1.40 0.001 CG18109-RA CG18109 -1.25 0.001
CG4345-RA grim -1.18 0.001 CG14692-RA CG14692 -1.08 0.001
CG10853-RA CG10853 -1.63 0.001 CG7631-RA CG7631 -1.27 0.001
CG3424-RA path -1.17 0.001 CG5409-RA Arp53D -1.05 0.001
CG7968-RA CG7968 -1.12 0.001 CG17994-RA CG17994 -1.19 0.001
CG3610-RA CG3610 -1.66 0.001 CG33109-RA CG33109 -1.17 0.001
CG9985-RA sktl -1.21 0.001 CG4858-RA CG4858 -1.58 0.001
CG33322-RA CG33322 -1.21 0.001 CG6541-RA Mst33A -1.14 0.001
CG31368-RA CG31368 -1.71 0.001 CG10662-RA sick -1.47 0.001
CG14544-RA CG14544 -1.19 0.001 CG31774-RA fred -1.38 0.001
CG14436-RA C3G -1.38 0.001 CG32132-RA CG32132 -1.05 0.001
CG15019-RA CG15019 -1.83 0.001 CG6453-RA CG6453 -1.31 0.001
CG14379-RA CheA87a -1.14 0.001 CG5080-RA CG5080 -1.68 0.002
CG31941-RA Obp22a -1.08 0.001 CG18446-RA CG18446 -1.34 0.001
CG1099-RA Dap160 -1.02 0.001 CG3440-RA Pcp -1.19 0.001
CG32838-RA CG42345 -1.04 0.001 CG16717-RA CG16717 -1.02 0.001
CG8966-RA CG42235 -1.20 0.001 CG4414-RA Ugt58Fa -1.06 0.001
CG32686-RB CG32686 -1.03 0.001 CG4372-RA CG4372 -1.33 0.001
CG9535-RA mmy -1.08 0.001 CG12437-RA raw -1.27 0.001
CG18090-RA Dsk -1.26 0.001 CG12375-RA CG12375 -1.06 0.001
CG10630-RA blanks -1.29 0.001 CG8918-RA CG8918 -1.03 0.001
CG8110-RA syd -1.15 0.001 CG1890-RA CG1890 -1.19 0.001
CG13912-RA CG13912 -1.46 0.001 CG32676-RA CG32676 -1.36 0.001
CG7005-RA Esp -1.89 0.001 CG10016-RA drm -1.83 0.001
CG4005-RA yki -1.28 0.001 CG7535-RA GluClα -1.04 0.001
CG12007-RA CG12007 -1.26 0.001 CG14367-RA CG14367 -1.33 0.001
CR40465-RA CR40465 -1.12 0.001 CG13461-RA CG13461 -1.53 0.001
CG4761-RA knrl -1.99 0.001 CG14490-RA CG14490 -1.24 0.001
CG4008-RA und -1.26 0.001 CG5517-RA Ide -1.55 0.001
CG10596-RA Msr-110 -1.16 0.001 CG13500-RA CG13500 -1.03 0.002
CG9211-RA ihog -1.44 0.001 CG5161-RA CG5161 -1.03 0.001
CG6699-RA beta’Cop -1.53 0.001 CG4893-RA CG4893 -1.07 0.001
CG1406-RA U2A -1.39 0.002 CG30396-RA Gr58a -1.26 0.001
CG1934-RA ImpE2 -1.74 0.001 CG9204-RC Ate1 -1.15 0.001
CG12789-RA santa-maria -1.20 0.001 CG5488-RA B-H2 -1.09 0.001
CG8934-RA CG42235 -1.36 0.001 CG5928-RA CG5928 -1.22 0.001
CG8598-RA eco -1.15 0.001 CG32945-RA CG32945 -1.14 0.001
CG5012-RA mRpL12 -1.23 0.001 CG4426-RA ast -1.02 0.001
CG32592-RA hiw -1.27 0.001 CG16749-RA CG16749 -1.61 0.001
CG30323-RA CG30323 -1.02 0.001 CG18241-RA Toll-4 -1.07 0.001
CG1331-RA Ccp84Af -1.38 0.001 CR32646-RB fne -1.45 0.001
CG3960-RD CG34417 -1.27 0.001 CG13088-RA CG13088 -1.14 0.001
CG9345-RA Adgf-C -1.07 0.001 CG30195-RA CG30195 -1.16 0.001
CG7077-RA CG7077 -1.02 0.001 CG12819-RB sle -1.30 0.001
CG11313-RA CG11313 -1.13 0.001 CG7409-RA CG7409 -1.01 0.001
CG18647-RA bin -1.36 0.001 CG13694-RA CG13694 -1.06 0.002
CG8502-RA Cpr49Ac -1.20 0.001 CG10113-RA wa-cup -1.15 0.001
CG11149-RA CG11149 -1.08 0.001 CG31870-RC CG31870 -1.00 0.001
CG12487-RA BobA -2.18 0.004 CG5961-RA CG5961 -1.47 0.001
CG18217-RA CR18217 -1.08 0.001 CG5196-RA CG5196 -1.58 0.001
CG9989-RA CG9989 -1.00 0.001 CG12387-RA zetaTry -1.19 0.001
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CR31273-RC bxd -1.33 0.001 CG5460-RC H -1.16 0.001
CG30494-RA CG43340 -1.10 0.001 CG8072-RA CG8072 -1.37 0.001
CG9461-RA FBX011 -1.61 0.001 CG14395-RA CG14395 -1.29 0.001
CG6863-RA tok -1.74 0.001 CG9444-RA CG9444 -1.39 0.001
CG10140-RA CG10140 -1.16 0.001 CG10671-RB CG10671 -1.09 0.001
CG10101-RA Ir84a -1.07 0.001 CG8871-RA Jon25Biii -1.09 0.002
CG7245-RA eys -1.18 0.001 CG11209-RA ppk6 -1.07 0.002
CG8542-RA Hsc70-5 -1.75 0.001 CG8489-RA soti -1.27 0.001
CG9996-RA CG9996 -1.37 0.001 CG13989-RA CG13989 -1.26 0.002
CG3975-RA CG3975 -1.17 0.001 CG16789-RA CG16789 -1.05 0.001
CG12052-RF lola -1.36 0.001 CG1424-RA mst -1.17 0.001
CG12557-RA dpr13 -1.16 0.001 CG40045-RA CG40045 -1.38 0.001
CG30356-RA CG30356 -1.13 0.001 CG5006-RA Or33c -1.10 0.001
CG5762-RA CG5762 -1.08 0.001 CG13035-RB CG13035 -1.12 0.001
CG14160-RA CG14160 -1.31 0.001 CG13788-RB Gr28b -1.19 0.001
CG4329-RB CG4329 -1.18 0.001 CG9339-RB sky -1.43 0.001
CG5062-RA CG5062 -1.09 0.001 CG13247-RA CG13247 -1.24 0.001
CG5201-RA Dad -1.91 0.001 CG12847-RA Tsp42Ec -1.28 0.001
CG13873-RB Obp56g -1.18 0.001 CG1921-RB sty -2.02 0.001
CG5648-RA Prosα6T -1.20 0.002 CG5602-RA DNA-ligI -1.30 0.001
CG6622-RA Pkc53E -1.24 0.004 CG6592-RA CG6592 -1.41 0.001
CG12091-RA CG12091 -1.88 0.001 CG13954-RA CG13954 -1.04 0.001
CG8137-RA Spn2 -1.05 0.001 CG30456-RA CG30456 -1.12 0.002
CG12374-RA CG12374 -1.28 0.002 CG8586-RA CG8586 -1.15 0.002
CG9522-RA CG9522 -1.19 0.001 CG17077-RB pnt -1.46 0.005
CG7966-RA CG7966 -1.18 0.003 CG16957-RA CG16957 -1.08 0.001
CG9020-RA Aats-arg -1.34 0.001 CG10035-RA CG10035 -2.21 0.001
CG8224-RB babo -1.13 0.001 CG31747-RA Gr36a -1.31 0.001
CG12154-RA oc -1.21 0.001 CG18802-RA α-Man-II -1.16 0.002
CG32972-RA CG43332 -1.38 0.001 CG6739-RA CG6739 -1.09 0.001
CG2160-RA Socs44A -1.63 0.001 CG14826-RA CG14826 -1.37 0.001
CG10483-RA CG10483 -1.14 0.001 CG6827-RB Nrx-IV -1.71 0.001
CG2145-RA CG2145 -1.30 0.002 CG15576-RB CG15576 -1.03 0.003
CG3843-RA RpL10Aa -1.23 0.001 CG17084-RA mthl9 -1.26 0.001
CG2198-RA Ama -2.32 0.008 CG2839-RA CG2839 -1.07 0.004
CG13206-RA Or47b -1.00 0.001 CG7975-RA Grx-1 -1.29 0.001
CG12974-RA CG12974 -1.41 0.001 CG7762-RA Rpn1 -1.63 0.001
CG13250-RA CG13250 -1.05 0.001 CG8561-RA conv -1.17 0.003
CG8335-RA CG8335 -1.29 0.001 CG14495-RA CG14495 -1.09 0.001
CG6870-RA CG6870 -1.08 0.001 CG1279-RA Rtnl2 -1.11 0.001
CG3739-RA CG3739 -1.03 0.002 CG31695-RA scw -1.15 0.001
CG8209-RA CG8209 -1.46 0.001 CG16870-RA Acyp -1.00 0.001
CG13930-RA CG13930 -1.05 0.004 CG32391-RA CG32391 -1.11 0.001
CG5873-RA CG5873 -1.16 0.001 CG31210-RA CG4836 -1.12 0.001
CG13937-RA CG13937 -1.33 0.001 CG17086-RA CG43129 -1.09 0.001
CG10301-RA CG10301 -1.16 0.001 CG10947-RB CG10947 -1.18 0.001
CG8668-RA CG8668 -1.00 0.007 CG15128-RA CG15128 -1.08 0.001
CG17736-RA schuy -1.21 0.001 CG2560-RA Cpr11A -1.22 0.001
CG15616-RA Acp53C14b -1.08 0.001 CG8925-RA CG8925 -1.10 0.001
CG31116-RA ClC-a -1.44 0.001 CG8321-RA CG8321 -1.55 0.001
CG5773-RA CG5773 -1.32 0.001 CG15086-RB CG15086 -1.13 0.001
CG17625-RA CG17625 -1.01 0.003 CG7848-RA CG7848 -1.00 0.002
CG12316-RA CG12316 -1.16 0.001 CG12245-RA gcm -1.91 0.001
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CG11210-RA CG11210 -1.04 0.001 CG17136-RD Rbp1 -1.07 0.001
CG3777-RC CG3777 -1.31 0.001 CG14759-RA CG14759 -1.11 0.001
CG8888-RA CG8888 -1.06 0.001 CG18111-RA Obp99a -1.26 0.002
CG15144-RA CG15144 -1.05 0.002 CG17131-RA tyn -1.51 0.001
CG8442-RA Glu-RI -1.07 0.001 CG4169-RA CG4169 -1.30 0.001
CG3793-RA CG3793 -1.12 0.001 CG12910-RA CG12910 -1.25 0.001
CG5830-RA CG5830 -1.45 0.001 CG33048-RA Mocs1 -1.07 0.001
CG6730-RA Cyp4d21 -1.00 0.001 CG32432-RA CG32432 -1.53 0.001
CG12858-RA CG12858 -1.31 0.001 CG5002-RA CG5002 -1.32 0.009
CG6246-RA nub -2.03 0.001 CG10250-RA nau -1.50 0.001
CG5923-RA DNApol-α73 -1.21 0.001 CG11905-RE CG11905 -1.08 0.002
CG6844-RA nAcRα-96Ab -1.06 0.001 CG3773-RA CG3773 -1.00 0.001
CG15733-RA Ten-a -1.24 0.001 CG11711-RA Mob2 -1.03 0.001
CG11801-RA Elo68beta -1.15 0.001 CG31556-RA CG31556 -1.24 0.001
CG15275-RA CG42313 -1.10 0.001 CG31545-RA MTA1-like -1.66 0.001
CG7370-RA CG7370 -1.03 0.003 CG5959-RA MCO3 -1.20 0.001
CG7290-RA CG7290 -1.23 0.001 CG4061-RA CG4061 -1.16 0.001
CG13526-RA CG13526 -1.08 0.001 CG13127-RA CG13127 -1.41 0.001
CG11512-RA GstD4 -1.13 0.001 CG31090-RA CG42235 -1.30 0.001
CG9614-RH pip -1.04 0.001 CG16708-RA Cerk -1.18 0.001
CG31753-RA ham -1.25 0.001 CG10357-RA CG10357 -1.00 0.001
CG14089-RA CG14089 -1.10 0.001 CG33169-RA CG33169 -1.08 0.001
CG1988-RB CG1988 -1.35 0.001 CG33490-RA CG33490 -1.24 0.001
CG11377-RA CG11377 -1.45 0.001 CG6153-RA CG6153 -1.29 0.001
CG15745-RA CG15745 -1.44 0.001 CG14242-RA TwdlS -1.10 0.001
CG14075-RA CG14075 -1.24 0.001 CG31653-RA CG34126 -1.05 0.001
CG33197-RC mbl -1.12 0.001 CG32072-RA Elo68alpha -1.38 0.001
CG30159-RB CG30159 -1.26 0.001 CG3408-RA CG3408 -1.06 0.001
CG33472-RA qvr -1.06 0.001 CG31436-RA CG31436 -1.16 0.001
CG33192-RA MtnD -1.31 0.001 CG1501-RA unc -1.25 0.001
CG5677-RA Spase22-23 -1.16 0.002 CG14259-RA CG14259 -1.37 0.001
CG11326-RE Tsp -1.58 0.001 CG31057-RA tau -1.00 0.001
CG15909-RA CG15909 -1.06 0.001 CG2898-RA CG2898 -1.05 0.001
CG9080-RA Listericin -1.25 0.001 CG15614-RA CG15614 -1.59 0.001
CG5479-RA mRpL43 -1.51 0.001 CG7343-RA btsz -1.65 0.001
CG13032-RA CG13032 -1.08 0.001 CG9801-RA CG9801 -1.13 0.001
CG15736-RA Chrac-16 -1.19 0.004 CG14372-RA CG14372 -1.45 0.001
CG33292-RA CG33292 -1.09 0.001 CG31622-RD Gr39a -1.05 0.001
CG31291-RB CG31291 -1.20 0.001 CG30349-RA CG30349 -1.31 0.001
CG4019-RC CG4019 -1.32 0.001 CG3065-RA CG3065 -1.40 0.001
CG31519-RA Or82a -1.16 0.001 CG15627-RA Ir25a -1.12 0.001
CG15406-RA CG15406 -1.17 0.001 CG6435-RA CG6435 -1.04 0.001
CG32134-RA btl -1.58 0.002 CG6019-RA mus308 -1.74 0.001
CG30450-RA Obp56f -1.15 0.001 CG12212-RA peb -1.94 0.001
CG7333-RA CG7333 -1.14 0.001 CG2121-RA CG2121 -1.09 0.001
CG11642-RA TRAM -1.04 0.003 CG15288-RB wb -1.47 0.001
CG13442-RA CG13442 -1.18 0.001 CG14958-RA CG14958 -1.03 0.001
CG2062-RA Cyp4e1 -1.52 0.001 CG9139-RA Rabex-5 -1.31 0.001
CG31691-RA TotF -1.19 0.001 CG1630-RB IP3K2 -1.24 0.001
CG6061-RA mip120 -1.06 0.001 CG33223-RA CG33223 -1.09 0.001
CG8648-RA Fen1 -1.18 0.001 CG3922-RB RpS17 -1.26 0.001
CG15822-RC CG15822 -1.18 0.001 CG4104-RA Tps1 -2.12 0.001
CG12173-RA CG12173 -1.02 0.001 CG13188-RA CG13188 -1.00 0.001
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CG30191-RA Gr59b -1.29 0.001 CG9609-RA CG9609 -1.55 0.001
CG9614-RF pip -1.17 0.001 CG16899-RA FoxP -1.08 0.001
CG13011-RA sing -1.23 0.001 CG31300-RA CG31300 -1.24 0.001
CG7400-RB Fatp -1.45 0.001 CG14151-RA CG14151 -1.15 0.001
CG15008-RA Cpr64Ac -1.22 0.001 CG2507-RB sas -1.41 0.001
CG15396-RB Gr23a -1.06 0.001 CG11466-RA Cyp9f2 -1.02 0.001
CG1732-RA CG1732 -1.22 0.001 CG15350-RA Cp7Fb -1.02 0.001
CG12272-RA CG12272 -1.41 0.001 CG9900-RB mit(1)15 -1.56 0.001
CG9455-RA Spn42Dc -1.06 0.001 CG17107-RA CG17107 -1.12 0.001
CG7988-RA CG7988 -1.38 0.001 CG16850-RA CG42784 -1.13 0.001
CG6185-RA Ir68a -1.21 0.001 CG9286-RA CG9286 -1.55 0.001
CG1028-RL Antp -1.16 0.001 CG17011-RA lectin-30A -1.29 0.001
CG15118-RA CG15118 -1.42 0.001 CG14066-RB larp -1.22 0.001
CG12348-RB Sh -1.00 0.001 CG3126-RA C3G -1.21 0.001
CG12905-RA Obp46a -1.06 0.001 CG10146-RA AttA -1.55 0.001
CG12839-RA Tsp42En -1.14 0.001 CG13318-RA CG13318 -1.10 0.001
CG8328-RA HLHmδ -2.34 0.001 CG11648-RA Abd-B -1.96 0.001
CG10996-RA CG10996 -1.27 0.001 CG17174-RA ACXB -1.21 0.001
CG1559-RA Upf1 -1.23 0.001 CG6813-RA CG6813 -1.06 0.001
CG2219-RA CG2219 -1.05 0.001 CG1887-RA CG1887 -1.10 0.001
CG13423-RA CG13423 -1.29 0.001 CG13001-RA CG13001 -1.04 0.001
CG7780-RA DNaseII -2.11 0.001 CG14572-RA CG14572 -1.14 0.001
CG31803-RA CG31803 -1.23 0.001 CG17217-RA CG17217 -1.12 0.001
CG15208-RA CG15208 -1.12 0.001 CG14027-RA TotM -1.29 0.001
CG33108-RA CG33108 -1.00 0.001 CG6891-RA CG6891 -2.05 0.001
CG12822-RA CG12822 -1.15 0.001 CG18676-RA Teh3 -1.21 0.001
CG12232-RA Gα73B -1.38 0.001 CG12304-RA CG12304 -1.07 0.001
CG3171-RA Tre1 -1.17 0.002 CG8234-RA Tret1-2 -1.42 0.001
CG16959-RA CG16959 -1.48 0.001 CG32406-RA CG32406 -1.00 0.001
CG5882-RA CG5882 -1.07 0.001 CG7771-RA sim -1.12 0.001
CG8823-RA Lip3 -1.08 0.001 CG17577-RA Cyp9h1 -1.14 0.001
CG6860-RB Lrch -1.23 0.001 CG1605-RA az2 -1.12 0.001
CG13976-RA Gr98a -1.15 0.001 CG8526-RA CG8526 -1.05 0.001
CG7164-RA CG7164 -1.30 0.001 CG10327-RA TBPH -1.55 0.001
CG11186-RA toy -1.39 0.001 CG4559-RA Idgf3 -1.30 0.001
CG4896-RB CG4896 -1.54 0.001 CG8408-RA CG8408 -1.40 0.001
CG33116-RA CG33116 -1.68 0.001 CG8342-RA m1 -1.65 0.001
CG15109-RC CG15109 -1.13 0.001 CG32199-RA CG32199 -1.15 0.001
CG11063-RB jub -1.47 0.001 CG17650-RA CG17650 -1.34 0.001
CG17269-RA Fancd2 -1.16 0.001 CG8271-RA Sln -1.21 0.001
CG6233-RA Ufd1-like -1.45 0.001 CG12344-RA CG12344 -1.31 0.001
CG32459-RA CG32459 -1.26 0.001 CG2302-RA nAcRα-7E -1.35 0.001
CG12249-RA mira -2.06 0.002 CG15592-RA Osi9 -1.11 0.001
CG7857-RA CG7857 -1.01 0.002 CG13923-RA CG42676 -1.11 0.001
CG18234-RB CG18234 -1.04 0.001 CG16932-RA Eps-15 -1.08 0.001
CG15255-RA CG15255 -1.48 0.001 CG4279-RA LSm1 -1.64 0.001
CG3819-RA CG3819 -1.26 0.001 CG12942-RA CG12942 -1.15 0.001
CG10195-RA CG10195 -1.11 0.001 CG33070-RA Sxl -2.26 0.001
CG13857-RA CG13857 -1.02 0.001 CG32450-RA CG32450 -1.40 0.001
CG16965-RA CG16965 -1.21 0.001 CG32491-RO mod(mdg4) -1.00 0.001
CG13349-RA CG13349 -1.27 0.001 CG12205-RA Bsg25A -1.17 0.001
CG8205-RA fus -1.24 0.001 CG10514-RA CG10514 -1.37 0.001
CG7671-RA Nup43 -1.37 0.001 CG10244-RA Cad96Ca -1.28 0.001
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CG13270-RA Ugt36Ba -1.14 0.001 CG8288-RA mRpL3 -1.28 0.001
CG7266-RA Eip71CD -1.66 0.001 CG1287-RA CG1287 -1.55 0.001
CG12866-RA CG12866 -1.52 0.001 CG15216-RA CG42748 -1.13 0.001
CG11019-RA CG11019 -1.22 0.001 CG10275-RA kon -1.65 0.001
CG17049-RA CG17049 -1.35 0.001 CG15905-RA CG15905 -1.14 0.001
CG33139-RA Ranbp11 -1.15 0.001 CG7166-RA CG7166 -1.13 0.001
CG3841-RA CG3841 -1.10 0.001 CG14854-RA CG14854 -1.03 0.001
CG11735-RA Or85b -1.13 0.001 CG11875-RA CG11875 -1.04 0.001
CG6379-RA CG6379 -1.43 0.001 CG17298-RA CG17298 -1.12 0.001
CG10440-RA CG10440 -1.01 0.001 CG11883-RB CG11883 -1.19 0.001
CG7387-RA CG7387 -1.14 0.001 CG10489-RA Pole2 -1.01 0.001
CG5993-RA os -1.40 0.001 CG7313-RA CheA75a -1.11 0.001
CG12131-RA Adam -1.64 0.001 CG13894-RA CG13894 -1.07 0.001
CG9256-RA Nhe2 -1.33 0.001 CG5182-RA Pk34A -1.22 0.001
CG31648-RA CG31648 -1.06 0.001 CG8722-RC Nup44A -1.01 0.001
CG13148-RA CG13148 -1.26 0.001 CG9668-RA Rh4 -1.02 0.001
CG13091-RA CG13091 -1.13 0.001 CG14119-RA CG14119 -1.16 0.001
CG13102-RA CG13102 -1.28 0.001 CG4114-RA ex -1.48 0.001
CG3356-RA CG3356 -1.27 0.001 CG12001-RA CG12001 -1.16 0.001
CG14232-RA CG14232 -1.32 0.001 CG31675-RA CG31675 -1.10 0.001
CG3434-RA CG3434 -1.10 0.001 CG31463-RA CG31463 -1.25 0.001
CG14297-RA CG14297 -1.28 0.001 CG11347-RA DOR -1.33 0.001
CG3106-RA CG3106 -1.20 0.001 CG31064-RA CG31064 -1.05 0.003
CG33478-RB Or46a -1.36 0.001 CG31407-RA CG31407 -1.34 0.001
CG40485-RB CG40485 -1.02 0.002 CG1750-RA CG1750 -1.22 0.001
CG14110-RA CG14110 -1.48 0.001 CG1743-RB Gs2 -1.73 0.001
CG7298-RA CG7298 -1.24 0.001 CG9837-RA CG9837 -1.23 0.001
CG9377-RA CG9377 -1.50 0.001 CG31640-RA CG34380 -1.42 0.001
CG3581-RA CG3581 -1.20 0.001 CG15816-RA CG42684 -1.37 0.001
CG31022-RA PH4αEFB -1.83 0.001 CG11833-RA Ssl2 -1.17 0.001
CG3894-RB CG3894 -2.20 0.001 CG6043-RC CG6043 -1.04 0.001
CG12398-RA CG12398 -1.15 0.001 CG31419-RA CG31419 -1.11 0.001
CG7350-RA Eig71Ed -1.21 0.001 CG13213-RA fbl6 -1.59 0.001
CG10370-RA Tbp-1 -1.33 0.001 CG1979-RA CG1979 -1.08 0.001
CG15591-RA Osi8 -1.23 0.001 CG1502-RA tsg -1.01 0.002
CG32053-RA CG32053 -1.29 0.001 CG2082-RD CG2082 -1.07 0.001
CG11622-RA Rlip -1.08 0.001 CG9162-RA CG9162 -1.16 0.001
CG31367-RA CG42724 -1.40 0.001 CG6091-RA CG6091 -1.07 0.001
CG1553-RC CG1553 -1.21 0.001 CG11387-RB ct -1.06 0.001
CG8676-RA Hr39 -1.77 0.001 CG15860-RA pain -1.13 0.005
CG31004-RA CG31004 -1.00 0.003 CG12250-RB ymp -1.13 0.001
CG15167-RA CG15167 -1.09 0.001 CG5079-RA CG5079 -1.12 0.001
CG11958-RB Cnx99A -1.90 0.001 CG33307-RA CG33307 -1.02 0.001
CG15488-RA nub -1.07 0.001 CG9582-RA CG9582 -1.29 0.001
CG6094-RA CG6094 -1.09 0.001 CG6142-RA CG6142 -1.10 0.002
CG13039-RA CG13039 -1.13 0.001 CG14853-RA CG14853 -1.25 0.001
CG17520-RB CkIIα -1.15 0.002 CG14990-RA CG14990 -1.49 0.001
CG12609-RB CG12609 -1.14 0.001
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G All binding datasets used for analysis
Table 9: All binding datasets used for analysis in Chapter 6
No. of peaks Dataset
7827 BEAF32 0-12h ChIP-chip rel5.gff3
2232 CBP 0-4h ChIP-chip2 rel5.gff3
926 CBP 0-4h ChIP-chip rel5.gff3
3296 CBP 0-4h ChIP-seq rel5.gff3
7736 CBP 4-8h ChIP-chip rel5.gff3
2348 CBP 4-8h ChIP-seq rel5.gff3
329 CBP 8-12h ChIP-chip rel5.gff3
2407 CBP 8-12h ChIP-seq rel5.gff3
10456 CP190 0-12h ChIP-chip rel5.gff3
4432 CTCF C-term 0-12h ChIP-chip rel5.gff3
3833 CTCF N-term 0-12h ChIP-chip rel5.gff3
4947 CtBP 0-12h ChIP-chip rel5.gff3
75 Dll 0-12h ChIP-chip rel5.gff3
1927 E(z) 8-16h ChIP-chip rel5.gff3
3011 GATAe 0-8h ChIP-chip rel5.gff3
8279 H3K18Ac 2-4h ChIP-chip rel5.gff3
5089 H3K27Ac 0-4h ChIP-chip2 rel5.gff3
5431 H3K27Ac 0-4h ChIP-chip rel5.gff3
3658 H3K27Ac 0-4h ChIP-seq rel5.gff3
6944 H3K27Ac 4-8h ChIP-chip rel5.gff3
1119 H3K27Ac 4-8h ChIP-seq rel5.gff3
8101 H3K27Ac 8-12h ChIP-chip rel5.gff3
4430 H3K27Ac 8-12h ChIP-seq rel5.gff3
1519 H3K27Me3 0-12h ChIP-chip rel5.gff3
4429 H3K27Me3 0-4h ChIP-chip rel5.gff3
438 H3K27Me3 0-4h ChIP-seq rel5.gff3
944 H3K27Me3 4-8h ChIP-chip rel5.gff3
245 H3K27Me3 4-8h ChIP-seq rel5.gff3
5830 H3K27Me3 8-12h ChIP-chip rel5.gff3
230 H3K27Me3 8-12h ChIP-seq rel5.gff3
6814 H3K36Me3 0-12h ChIP-chip rel5.gff3
5952 H3K36Me3 2-4h ChIP-chip rel5.gff3
5238 H3K4Me1 0-4h ChIP-chip rel5.gff3
6162 H3K4Me1 0-4h ChIP-seq rel5.gff3
6149 H3K4Me1 4-8h ChIP-chip rel5.gff3
62 H3K4Me1 4-8h ChIP-seq rel5.gff3
9792 H3K4Me1 8-12h ChIP-chip rel5.gff3
5326 H3K4Me1 8-12h ChIP-seq rel5.gff3
4236 H3K4Me3 0-12h ChIP-chip rel5.gff3
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12968 H3K4Me3 0-4h ChIP-chip2 rel5.gff3
6095 H3K4Me3 0-4h ChIP-chip rel5.gff3
3840 H3K4Me3 0-4h ChIP-seq rel5.gff3
3495 H3K4Me3 2-4h ChIP-chip rel5.gff3
3504 H3K4Me3 4-8h ChIP-chip rel5.gff3
1967 H3K4Me3 4-8h ChIP-seq rel5.gff3
6867 H3K4Me3 8-12h ChIP-chip rel5.gff3
4508 H3K4Me3 8-12h ChIP-seq rel5.gff3
5133 H3K9Ac 0-4h ChIP-chip rel5.gff3
5513 H3K9Ac 0-4h ChIP-seq rel5.gff3
5844 H3K9Ac 4-8h ChIP-chip rel5.gff3
755 H3K9Ac 4-8h ChIP-seq rel5.gff3
6432 H3K9Ac 8-12h ChIP-chip rel5.gff3
4869 H3K9Ac 8-12h ChIP-seq rel5.gff3
3625 H3K9Me2 2-4h ChIP-chip rel5.gff3
3511 H3K9Me3 0-12h ChIP-chip rel5.gff3
454 H3K9Me3 0-4h ChIP-chip2 rel5.gff3
2994 H3K9Me3 0-4h ChIP-chip rel5.gff3
409 H3K9Me3 0-4h ChIP-seq rel5.gff3
805 H3K9Me3 4-8h ChIP-chip rel5.gff3
427 H3K9Me3 4-8h ChIP-seq rel5.gff3
5646 H3K9Me3 8-12h ChIP-chip rel5.gff3
438 H3K9Me3 8-12h ChIP-seq rel5.gff3
2091 HDAC11 0-12h ChIP-chip2 rel5.gff3
7215 HDAC11 0-12h ChIP-chip rel5.gff3
1513 HDAC11 0-12h ChIP-seq2 rel5.gff3
989 HDAC11 0-12h ChIP-seq rel5.gff3
9377 HDAC1 0-12h ChIP-chip2 rel5.gff3
9940 HDAC1 0-12h ChIP-chip rel5.gff3
4123 HDAC1 0-12h ChIP-seq2 rel5.gff3
3011 HDAC1 0-12h ChIP-seq rel5.gff3
12119 HDAC3 0-12h ChIP-chip2 rel5.gff3
12111 HDAC3 0-12h ChIP-chip rel5.gff3
2565 HDAC3 0-12h ChIP-seq2 rel5.gff3
2620 HDAC3 0-12h ChIP-seq rel5.gff3
7309 HDAC4a 0-12h ChIP-chip2 rel5.gff3
8965 HDAC4a 0-12h ChIP-chip rel5.gff3
4033 HDAC4a 0-12h ChIP-seq2 rel5.gff3
2732 HDAC4a 0-12h ChIP-seq rel5.gff3
5385 HDAC6 0-12h ChIP-chip2 rel5.gff3
5709 HDAC6 0-12h ChIP-chip rel5.gff3
3485 HDAC6 0-12h ChIP-seq2 rel5.gff3
2989 HDAC6 0-12h ChIP-seq rel5.gff3
1688 HP1a 2-4h ChIP-chip rel5.gff3
869 Kr 0-8h ChIP-chip rel5.gff3
4485 PolII 0-12h ChIP-chip rel5.gff3
5235 PolII 4-8h ChIP-seq rel5.gff3
1333 PolII 8-12h ChIP-seq rel5.gff3
3220 PolII unphosp 0-4h ChIP-chip rel5.gff3
5040 PolII unphosp 4-8h ChIP-chip2 rel5.gff3
5040 PolII unphosp 4-8h ChIP-chip rel5.gff3
105 Stat92E 0-12h ChIP-chip rel5.gff3
6438 Trl 0-12h ChIP-chip rel5.gff3
1300 Ubx 0-12h ChIP-chip rel5.gff3
729 Ubx 3-8h ChIP-chip2 rel5.gff3
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161 Ubx 3-8h ChIP-chip rel5.gff3
1227 bab1 0-12h ChIP-chip rel5.gff3
2697 cad 0-4h ChIP-chip rel5.gff3
1700 cad 0-4h T7GFP ChIP-chip rel5.gff3
2207 cad 0-4h T7GFP ChIP-seq rel5.gff3
5626 cad 4-8h T7GFP ChIP-seq rel5.gff3
7054 chinmo 0-12h ChIP-chip rel5.gff3
699 cnc 0-12h ChIP-chip rel5.gff3
2687 disco 0-8h ChIP-chip rel5.gff3
26 en 0-12h ChIP-chip rel5.gff3
286 en 7-24h ChIP-chip rel5.gff3
1738 eve 1-6h GFP ChIP-chip rel5.gff3
28 ftz-f1 0-12h ChIP-chip rel5.gff3
1338 gro 0-12h ChIP-chip1 rel5.gff3
626 gro 0-12h ChIP-chip2 rel5.gff3
765 gsbn 7-24h ChIP-chip rel5.gff3
2745 h 0-8h ChIP-chip rel5.gff3
2995 hkb 0-8h ChIP-chip rel5.gff3
3222 inv 0-12h ChIP-chip rel5.gff3
2690 jumu 0-8h ChIP-chip rel5.gff3
792 kn 0-12h ChIP-chip rel5.gff3
3975 mod(mdg4) 0-12h ChIP-chip rel5.gff3
2174 mod(mdg4) 8-16h ChIP-chip rel5.gff3
333 run 0-12h ChIP-chip rel5.gff3
2884 sbb 0-4h ChIP-chip rel5.gff3
11773 sens 4-8h ChIP-chip2 rel5.gff3
2640 sens 4-8h ChIP-chip rel5.gff3
16070 sens 4-8h GFP ChIP-chip rel5.gff3
4779 su(Hw) 0-12h ChIP-chip2 rel5.gff3
3947 su(Hw) 0-12h ChIP-chip rel5.gff3
384 ttk 0-12h ChIP-chip rel5.gff3
895 zfh1 0-12h ChIP-chip rel5.gff3
H TF datasets used for initial analysis
Table 10: Transcription factor datasets used for comparison with Dichaete in Chapter
6
No. of intervals Dataset
1227 bab1 0-12h ChIP-chip rel5.gff3
802 bcd 2-3h ChIP Berk fdr1 union rel5.gff3
9708 cad 0-8h ChIP timeunion rel5.gff3
7054 chinmo 0-12h ChIP-chip rel5.gff3
699 cnc 0-12h ChIP-chip rel5.gff3
5534 da 2-3h ChIP-chip Berk fdr1 intervals sym rel5.gff
6227 Dichaete core uberset.gff3
2687 disco 0-8h ChIP-chip rel5.gff3
9358 dl 2-3h ChIP-chip Berk fdr1 intervals sym rel5.gff
75 Dll 0-12h ChIP-chip rel5.gff3
26 en 0-12h ChIP-chip rel5.gff3
1738 eve 1-6h GFP ChIP-chip rel5.gff3
403 ftz 2-3h ChIP-chip Berk fdr1 intervals sym rel5.gff
28 ftz-f1 0-12h ChIP-chip rel5.gff3
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3011 GATAe 0-8h ChIP-chip rel5.gff3
1412 gro 0-12h ChIP union rel5.gff3
765 gsbn 7-24h ChIP-chip rel5.gff3
1070 gt 2-3h ChIP-chip Berk fdr1 intervals sym rel5.gff
5145 h 0-8h ChIP timeunion rel5.gff3
2180 hb 2-3h ChIP Berk fdr1 union rel5.gff3
3840 hkb 0-8h ChIP timeunion rel5.gff3
3222 inv 0-12h ChIP-chip rel5.gff3
2690 jumu 0-8h ChIP-chip rel5.gff3
792 kn 0-12h ChIP-chip rel5.gff3
197 kni 2-3h ChIP Berk fdr1 union rel5.gff3
4553 Kr 0-8h ChIP timeunion rel5.gff3
204 mad 2-3h ChIP-chip Berk fdr1 intervals sym rel5.gff
5458 med 2-3h ChIP-chip Berk fdr1 intervals sym rel5.gff
2098 prd 2-3h ChIP Berk fdr1 union rel5.gff3
1478 prospero 4-7h FDR25 DamID Brandlab rel5.gff3
1244 run 0-12h ChIP timeunion rel5.gff3
2884 sbb 0-4h ChIP-chip rel5.gff3
19307 sens 4-8h ChIP union rel5.gff3
368 shn 2-3h ChIP Berk fdr1 union rel5.gff3
1171 slp1 2-3h ChIP-chip Berk fdr1 intervals sym rel5.gff
2814 sna 2-3h ChIP Berk fdr1 union rel5.gff3
105 Stat92E 0-12h ChIP-chip rel5.gff3
429 tll 2-3h ChIP-chip Berk fdr1 intervals sym rel5.gff
384 ttk 0-12h ChIP-chip rel5.gff3
7674 twi 2-3h ChIP Berk fdr1 union rel5.gff3
1512 Ubx 0-12h ChIP timeunion rel5.gff3
895 zfh1 0-12h ChIP-chip rel5.gff3
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I Midline targets
Table 11: All potential midline targets. The genes shown were differentially expressed
in at least one of the simGal4 studies, as well as being associated with Dichaete in vivo
binding
Gene identifier Gene name
CG10214 CG10214
CG10287 Gasp
CG10812 dro5
CG11430 olf186-F
CG12045 Cpr100A
CG12177 CG12177
CG12297 BG4
CG12487 BobA
CG13425 bl
CG13454 CG13454
CG13784 CG13784
CG14147 CG14147
CG14685 Cap-H2
CG14688 CG14688
CG15117 CG15117
CG15319 nej
CG15345 CG15345
CG15658 CG15658
CG17082 CG17082
CG17090 hipk
CG1740 Ntf-2
CG17697 fz
CG18783 Kr-h1
CG18817 Tsp42Ea
CG2177 CG2177
CG2849 Rala
CG31012 cindr
CG31220 CG31220
CG31808 CG31808
CG3396 Ocho
CG34360 Glut4EF
CG3759 CG3759
CG3777 CG3777
CG4147 Hsc70-3
CG42232 CG42232
CG42574 CG42574
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CG4396 fne
CG4464 RpS19a
CG4547 Atx-1
CG4584 dUTPase
CG4688 CG4688
CG5025 Sps2
CG5514 CG5514
CG5661 Sema-5c
CG6146 Top1
CG6610 CG6610
CG6643 Esyt2
CG6868 tld
CG6874 HipHop
CG6930 l(3)neo38
CG7111 Rack1
CG7380 baf
CG7577 ppk20
CG8050 Cys
CG8235 CG8235
CG8965 CG8965
CG9559 fog
CG9614 pip
CG9628 CG9628
CR32862 snRNA:U1:82Eb
CR42862 CR42862
Table 12: Potential midline targets at stage 9. The genes shown were differentially
expressed in at least one of the simGal4 studies, as well as being associated with
Dichaete binding at stage 9, as estimated from DNase I accessibility data.
Gene identifier Gene name
CG10214 CG10214
CG10657 CG10657
CG10812 dro5
CG11430 olf186-F
CG12045 Cpr100A
CG12177 CG12177
CG12297 BG4
CG12487 BobA
CG13425 bl
CG13454 CG13454
CG13784 CG13784
CG14685 Cap-H2
CG14688 CG14688
CG15319 nej
CG15345 CG15345
CG15658 CG15658
CG17090 hipk
CG1740 Ntf-2
CG17697 fz
CG18783 Kr-h1
CG18817 Tsp42Ea
CG2177 CG2177
CG2849 Rala
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CG31012 cindr
CG31220 CG31220
CG3396 Ocho
CG34360 Glut4EF
CG3759 CG3759
CG3777 CG3777
CG4147 Hsc70-3
CG42232 CG42232
CG42574 CG42574
CG4396 fne
CG4547 Atx-1
CG4584 dUTPase
CG4688 CG4688
CG5025 Sps2
CG5514 CG5514
CG5661 Sema-5c
CG6146 Top1
CG6610 CG6610
CG6643 Esyt2
CG6868 tld
CG6874 HipHop
CG6930 l(3)neo38
CG7111 Rack1
CG7380 baf
CG7577 ppk20
CG8050 Cys
CG8235 CG8235
CG8965 CG8965
CG9559 fog
CG9614 pip
CG9628 CG9628
CR32862 snRNA:U1:82Eb
CR42862 CR42862
J Neuroblast targets
Table 13: Potential neuroblast targets at stage 9. The genes shown were differentially
expressed in at least one of the prosGal4 studies, as well as being associated with
Dichaete binding at stage 9, as estimated from DNase I accessibility data.
Gene identifier Gene name
CG10083 CG10083
CG10283 CG10283
CG10295 Pak
CG10328 nonA-l
CG1034 bcd
CG10343 CG10343
CG10360 ref(2)P
CG10372 Faf
CG1044 dos
CG10492 CG10492
CG1058 rpk
CG10601 mirr
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CG10686 tral
CG10812 dro5
CG10847 enc
CG10851 B52
CG10859 CG10859
CG1088 Vha26
CG1091 CG1091
CG10939 Sip1
CG10962 CG10962
CG11034 CG11034
CG11140 Aldh-III
CG11148 CG11148
CG11254 mael
CG11279 CG11279
CG1129 CG1129
CG11306 CG11306
CG11430 olf186-F
CG11455 CG11455
CG11504 CG11504
CG11518 pygo
CG11523 CG11523
CG11567 Cpr
CG11614 nkd
CG1172 CG1172
CG11790 CG11790
CG11798 chn
CG11804 ced-6
CG11880 CG11880
CG11897 CG11897
CG11981 Prosbeta3
CG11982 CG11982
CG11993 Mst85C
CG11999 CG11999
CG12047 mud
CG12052 lola
CG12104 CG12104
CG12140 CG12140
CG12177 CG12177
CG12182 CG12182
CG1221 miple
CG12244 lic
CG12297 BG4
CG12399 Mad
CG12414 nAcRalpha-80B
CG12676 ed
CG12690 CHES-1-like
CG12737 Crag
CG12785 Mat89Ba
CG12891 whd
CG13316 Mnt
CG13323 CG13323
CG13391 Aats-ala
CG13425 bl
CG13454 CG13454
CG13778 Mnn1
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CG13784 CG13784
CG13822 CG13822
CG13897 CG13897
CG14005 CG14005
CG14025 Bsg25D
CG1417 slgA
CG14222 CG14222
CG14230 CG14230
CG14438 CG14438
CG1444 CG1444
CG14478 CG14478
CG14616 l(1)G0196
CG14879 CG14879
CG14997 CG14997
CG15015 Cip4
CG15085 edl
CG15104 Topors
CG15345 CG15345
CG15524 sas-6
CG1594 hop
CG1636 CG1636
CG1643 Atg5
CG1651 Ank
CG1659 unc-119
CG1667 CG1667
CG16757 Spn
CG16785 fz3
CG1692 mal
CG17060 Rab10
CG17090 hipk
CG17149 Su(var)3-3
CG17223 alpha4GT1
CG17299 SNF4Agamma
CG17342 Lk6
CG17369 Vha55
CG1746 CG1746
CG17579 sca
CG17686 DIP1
CG17800 Dscam
CG17818 rdgBbeta
CG17883 CG17883
CG17998 Gprk2
CG18024 SoxN
CG1829 Cyp6v1
CG18350 Sxl
CG1836 Rad23
CG1838 myoglianin
CG1848 LIMK1
CG1862 Ephrin
CG1877 lin19
CG1910 CG1910
CG1921 sty
CG1966 Acf1
CG1981 Thd1
CG2041 lgs
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CG2048 dco
CG2087 PEK
CG2177 CG2177
CG2186 CG2186
CG2221 l(1)G0289
CG2257 Ubc-E2H
CG2316 CG2316
CG2682 d4
CG2924 CG2924
CG2938 CG2938
CG2944 gus
CG3001 Hex-A
CG3002 Gga
CG3008 CG3008
CG30283 CG30283
CG30388 Magi
CG3082 l(2)k09913
CG3107 CG3107
CG31220 CG31220
CG31223 CG31223
CG3136 Atf6
CG31363 Jupiter
CG31523 CG31523
CG31729 CG31729
CG31794 Pax
CG31991 mdy
CG31992 gw
CG32300 oxt
CG32346 E(bx)
CG32365 CG32365
CG3248 Cog3
CG32491 mod(mdg4)
CG32499 Cda4
CG32555 RhoGAPp190
CG3262 CG3262
CG32654 Sec16
CG3268 phtf
CG32697 l(1)G0232
CG32756 CG32756
CG33196 dp
CG33226 CG33226
CG3329 Prosbeta2
CG3359 mfas
CG33979 capt
CG33991 nuf
CG3403 Mob4
CG3407 CG3407
CG34157 Dys
CG34360 Glut4EF
CG34412 tlk
CG3445 phol
CG3532 CG3532
CG3619 Dl
CG3632 CG3632
CG3688 l(2)35Bd
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CG3707 wapl
CG3796 ac
CG3871 Six4
CG3925 CG3925
CG3947 pex16
CG3954 csw
CG40293 Stlk
CG4032 Abl
CG4059 ftz-f1
CG4165 CG4165
CG4217 TFAM
CG42232 CG42232
CG42248 CG42248
CG42274 RhoGAP18B
CG42275 alpha-Man-I
CG42281 bun
CG42345 CG42345
CG42378 RhoGEF3
CG42388 CG42388
CG4257 Stat92E
CG42632 mRpL37
CG42803 gpp
CG4300 CG4300
CG4404 CG4404
CG4538 CG4538
CG4572 CG4572
CG4583 Ire1
CG4656 Rassf
CG4673 CG4673
CG4688 CG4688
CG4698 Wnt4
CG4802 CG4802
CG4898 Tm1
CG4912 eEF1delta
CG4993 PRL-1
CG5029 SamDC
CG5052 pim
CG5053 RASSF8
CG5072 Cdk4
CG5263 smg
CG5277 Ip259
CG5295 bmm
CG5362 Mdh1
CG5439 CG5439
CG5490 Tl
CG5588 Mtl
CG5594 kcc
CG5659 ari-1
CG5661 Sema-5c
CG5725 fbl
CG5726 CG5726
CG5788 UbcD10
CG5876 heix
CG5893 D
CG5946 CG5946
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CG6051 CG6051
CG6099 m4
CG6105 l(2)06225
CG6146 Top1
CG6157 dah
CG6190 Ube3a
CG6214 MRP
CG6292 CycT
CG6335 Aats-his
CG6376 E2f
CG6391 Aps
CG6498 CG6498
CG6509 CG6509
CG6542 EDTP
CG6551 fu
CG6575 glec
CG6584 SelR
CG6634 mid
CG6650 CG6650
CG6668 atl
CG6859 CG6859
CG6889 tara
CG6930 l(3)neo38
CG6932 CSN6
CG6995 Saf-B
CG7001 Pk17E
CG7003 Msh6
CG7005 Esp
CG7041 HP1b
CG7044 CG7044
CG7085 l(2)s5379
CG7129 l(3)05822
CG7133 CG7133
CG7138 r2d2
CG7156 CG7156
CG7184 Mkrn1
CG7192 CG7192
CG7324 CG7324
CG7378 CG7378
CG7400 Fatp
CG7494 mRpL1
CG7554 comm2
CG7577 ppk20
CG7595 ck
CG7597 Cdk12
CG7785 CG7785
CG7869 SuUR
CG7902 bap
CG8014 Rme-8
CG8057 alc
CG8090 CG8090
CG8097 CG8097
CG8104 nudE
CG8108 CG8108
CG8174 SRPK
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CG8177 CG8177
CG8223 CG8223
CG8233 Rcd1
CG8274 Mtor
CG8287 Rab8
CG8312 CG8312
CG8390 vlc
CG8402 PpD3
CG8420 CG8420
CG8448 mrj
CG8529 Dyb
CG8589 tej
CG8593 qm
CG8631 msl-3
CG8790 Dic1
CG8839 CG8839
CG8924 CG8924
CG8931 CG8931
CG8948 Graf
CG9078 ifc
CG9096 CycD
CG9113 AP-1gamma
CG9126 Stim
CG9153 CG9153
CG9218 sm
CG9238 CG9238
CG9242 bur
CG9446 coro
CG9474 Snap24
CG9493 Pez
CG9670 fal
CG9755 pum
CG9768 hkb
CG9786 hb
CR31273 bxd
CR31400 Hsromega
CR32027 CR32027
Table 14: Potential neuroblast targets at stage 9, with annotated roles in the gen-
eration of neurons. The genes shown were differentially expressed in at least one of
the prosGal4 studies, as well as being associated with Dichaete binding at stage 9, as
estimated from DNase I accessibility data. The selection was further based on which
genes are associated with the ’generation of neurons’ GO term.
Gene identifier Gene name
CG17579 sca
CG5661 Sema-5c
CG1848 LIMK1
CG12047 mud
CG11804 ced-6
CG2682 d4
CG17800 Dscam
CG4898 Tm1
CG9218 sm
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CG3359 mfas
CG11518 pygo
CG9755 pum
CG3954 csw
CG15085 edl
CG4032 Abl
CG12052 lola
CG3796 ac
CG10295 Pak
CG6376 E2f
CG1966 Acf1
CG18024 SoxN
CG9242 bur
CG1044 dos
CG32555 RhoGAPp190
CG6634 mid
CG5490 Tl
CG6190 Ube3a
CG1594 hop
CG9768 hkb
CG4698 Wnt4
CG32346 E(bx)
CG3619 Dl
CG1921 sty
CG1862 Ephrin
CG3403 Mob4
CG42281 bun
CG11614 nkd
CG9786 hb
CG12676 ed
Table 15: Potential neuroblast targets at multiple Dichaete binding at stage 9. The
genes shown were differentially expressed in at least one of the prosGal4 studies, as
well as being associated with 4 or more intervals of Dichaete binding at stage 9, as
estimated from DNase I accessibility data.
Gene identifier Gene name
CG11140 Aldh-III
CG11148 CG11148
CG11430 olf186-F
CG11614 nkd
CG11798 chn
CG12052 lola
CG12414 nAcRalpha-80B
CG12676 ed
CG12690 CHES-1-like
CG13316 Mnt
CG13897 CG13897
CG15085 edl
CG16785 fz3
CG18024 SoxN
CG1921 sty
CG2048 dco
CG31363 Jupiter
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Gene identifier Gene name
CG31523 CG31523
CG32491 mod(mdg4)
CG33196 dp
CG33991 nuf
CG34360 Glut4EF
CG34412 tlk
CG3619 Dl
CG42281 bun
CG4257 Stat92E
CG5295 bmm
CG5490 Tl
CG5661 Sema-5c
CG5893 D
CG6376 E2f
CG6575 glec
CG6634 mid
CG6889 tara
CG7001 Pk17E
CG7554 comm2
CG8312 CG8312
CG8448 mrj
CG9238 CG9238
CG9755 pum
CG9768 hkb
CG9786 hb
CR31273 bxd
Table 16: GO enrichments of multiply bound neuroblast targets
GO term p-value No. of genes
organ development [GO:0048513] 4.9152E-7 21
positive regulation of biological process [GO:0048518] 1.2E-6 15
cell fate commitment [GO:0045165] 1.7E-6 12
regulation of cell fate specification [GO:0042659] 2.7E-6 6
embryonic pattern specification [GO:0009880] 3.2E-6 11
regulation of cell fate commitment [GO:0010453] 3.6E-6 6
positive regulation of cellular process [GO:0048522] 4.7E-6 14
embryo development [GO:0009790] 4.8E-6 15
cell fate specification [GO:0001708] 6.4E-6 8
pattern specification process [GO:0007389] 9.9E-6 14
generation of neurons [GO:0048699] 2.3E-5 15
regionalization [GO:0003002] 4.7E-5 13
system development [GO:0048731] 7.2E-5 24
multicellular organismal development [GO:0007275] 1.3E-4 26
segmentation [GO:0035282] 1.4E-4 10
nervous system development [GO:0007399] 1.5E-4 20
anatomical structure morphogenesis [GO:0009653] 1.7E-4 20
regulation of cell differentiation [GO:0045595] 2.1E-4 10
regulation of developmental process [GO:0050793] 2.7E-4 12
blastoderm segmentation [GO:0007350] 4.2E-4 9
locomotion [GO:0040011] 5.8E-4 12
central nervous system development [GO:0007417] 6.2E-4 9
anatomical structure development [GO:0048856] 1.1E-3 25
developmental process [GO:0032502] 1.6E-3 26
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GO term p-value No. of genes
transcription, DNA-dependent [GO:0006351] 1.7E-3 15
RNA biosynthetic process [GO:0032774] 1.8E-3 15
regulation of biological process [GO:0050789] 2.1E-3 26
multicellular organismal process [GO:0032501] 2.1E-3 28
positive regulation of cellular biosynthetic process [GO:0031328] 2.8E-3 8
positive regulation of biosynthetic process [GO:0009891] 2.9E-3 8
regulation of cellular process [GO:0050794] 2.9E-3 25
regulation of transcription, DNA-dependent [GO:0006355] 3.7E-3 14
regulation of RNA biosynthetic process [GO:2001141] 3.7E-3 14
regulation of cellular biosynthetic process [GO:0031326] 3.9E-3 15
regulation of biosynthetic process [GO:0009889] 3.9E-3 15
organ morphogenesis [GO:0009887] 4.2E-3 12
negative regulation of cell fate specification [GO:0009996] 4.2E-3 4
negative regulation of cell fate commitment [GO:0010454] 4.2E-3 4
cell surface receptor linked signaling pathway [GO:0007166] 5.2E-3 13
cell fate determination [GO:0001709] 5.8E-3 7
positive regulation of cellular metabolic process [GO:0031325] 6.6E-3 8
positive regulation of metabolic process [GO:0009893] 8.6E-3 8
regulation of RNA metabolic process [GO:0051252] 0.01 14
positive regulation of macromolecule biosynthetic process [GO:0010557] 0.01 7
biological regulation [GO:0065007] 0.01 26
regulation of macromolecule biosynthetic process [GO:0010556] 0.01 14
regulation of cellular macromolecule biosynthetic process [GO:2000112] 0.01 14
cellular developmental process [GO:0048869] 0.01 20
negative regulation of cell differentiation [GO:0045596] 0.01 6
regulation of multicellular organismal process [GO:0051239] 0.02 10
negative regulation of biological process [GO:0048519] 0.02 13
sensory organ development [GO:0007423] 0.03 10
positive regulation of cell proliferation [GO:0008284] 0.03 4
neuroblast fate commitment [GO:0014017] 0.03 4
regulation of nucleobase-containing compound metabolic 0.03 14
process [GO:0019219]
regulation of nitrogen compound metabolic process [GO:0051171] 0.03 14
cell differentiation [GO:0030154] 0.03 19
positive regulation of macromolecule metabolic process [GO:0010604] 0.03 7
neuron differentiation [GO:0030182] 0.03 11
axis specification [GO:0009798] 0.05 7
negative regulation of cellular process [GO:0048523] 0.05 12
K Global targets
Table 17: High probability direct Dichaete targets during early embryogenesis. The
genes shown were differentially expressed in a Dichaete mutant, as well as being asso-
ciated with 4 or more Dichaete high confidence binding intervals
Gene identifier Gene name
CG10016 drm
CG10021 bowl
CG10079 Egfr
CG10109 L
CG1028 Antp
CG1030 Scr
CG10325 abd-A
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Gene identifier Gene name
CG10388 Ubx
CG10479 CG10479
CG10488 eyg
CG10601 mirr
CG10619 tup
CG10772 Fur1
CG10798 dm
CG11100 Mes2
CG11140 Aldh-III
CG11186 toy
CG11280 trn
CG1133 opa
CG11502 svp
CG11614 nkd
CG11648 Abd-B
CG12154 oc
CG12212 peb
CG12287 pdm2
CG12487 BobA
CG12673 olf413
CG13076 Notum
CG13194 pyr
CG1343 Sp1
CG1374 tsh
CG1429 Mef2
CG1449 zfh2
CG14926 CG14926
CG15138 beat-IIIc
CG15154 Socs36E
CG1634 Nrg
CG1691 Imp
CG17046 klar
CG17077 pnt
CG17117 hth
CG17348 drl
CG1771 mew
CG17941 ds
CG18024 SoxN
CG18350 Sxl
CG18657 NetA
CG1897 Dr
CG1921 sty
CG1958 CG1958
CG2125 ci
CG2621 sgg
CG2692 gsb-n
CG2969 Atet
CG2977 inx7
CG30015 CG30015
CG30084 Zasp52
CG3048 Traf4
CG31043 gukh
CG31363 Jupiter
CG31481 pb
CG32019 bt
Continued on next page
330
Table 17 – continued from previous page
Gene identifier Gene name
CG32062 A2bp1
CG3242 sob
CG32434 siz
CG3258 ase
CG32592 hiw
CG32676 CG32676
CG33196 dp
CG33232 CG33232
CG3340 Kr
CG34110 lobo
CG34360 Glut4EF
CG34368 Fili
CG34371 CG34371
CG34379 Shroom
CG34380 CG34380
CG34389 cv-c
CG34395 nub
CG3474 Cpr35B
CG3578 bi
CG3619 Dl
CG3796 ac
CG42230 bbg
CG42238 CG42238
CG42281 bun
CG42311 grh
CG42333 Sytbeta
CG42589 sick
CG42611 Megalin
CG42684 CG42684
CG42865 trh
CG43140 pyd
CG4319 rpr
CG4491 noc
CG4717 kni
CG4722 bib
CG4889 wg
CG4974 dally
CG5123 W
CG5187 Doc2
CG5201 Dad
CG5481 lea
CG5661 Sema-5c
CG5723 Ten-m
CG5803 Fas3
CG5893 D
CG6027 cdi
CG6531 wgn
CG6570 lbl
CG6889 tara
CG7100 CadN
CG7230 rib
CG7250 Toll-6
CG7450 CrebA
CG7649 Neu3
CG7807 AP-2
Continued on next page
331
Table 17 – continued from previous page
Gene identifier Gene name
CG7958 tna
CG8118 mam
CG8127 Eip75B
CG8355 sli
CG8376 ap
CG8676 Hr39
CG8896 18w
CG9102 bab2
CG9224 sog
CG9381 mura
CG9650 CG9650
CG9656 grn
CG9704 Nrt
CG9739 fz2
CG9755 pum
CR42862 CR42862
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